data_1wtb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wtb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 30.2 t . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 18.5 mttt -150.14 -35.11 0.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.591 -1.244 . . . . 0.0 112.462 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.652 ' CD ' ' HB1' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -102.55 -167.46 1.4 Allowed 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.603 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 17.3 pt -165.11 139.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.261 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.638 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.8 OUTLIER -109.32 96.75 6.5 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.382 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.638 HG13 ' HB2' ' A' ' 252' ' ' CYS . 2.0 t -79.39 122.09 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.576 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -67.32 -170.34 4.61 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.924 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -26.14 158.03 0.0 OUTLIER Glycine 0 N--CA 1.466 0.675 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -177.24 -143.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.526 ' O ' HD12 ' A' ' 189' ' ' LEU . 10.7 t -89.69 134.52 32.12 Favored Pre-proline 0 C--N 1.344 0.33 0 CA-C-O 121.13 0.49 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 190' ' ' SER . 80.8 Cg_exo -28.65 -35.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.432 2.755 . . . . 0.0 113.22 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 190' ' ' SER . 34.7 p30 -151.36 56.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.158 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 6.1 m -39.4 123.23 1.39 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.549 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 6.6 Cg_endo -48.79 99.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.661 2.24 . . . . 0.0 112.23 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.577 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.45 -19.59 0.18 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.442 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 26.0 mt-10 -64.29 -39.0 93.03 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.549 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -77.56 -46.77 21.24 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.99 -29.79 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.832 176.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.503 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 4.7 mtt180 -75.83 -28.57 58.32 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.86 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -86.12 -63.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.792 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -39.75 -39.16 0.74 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.556 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.748 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -99.64 -34.16 10.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.452 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.42 -45.59 96.09 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.28 -23.29 68.08 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.0 -33.69 76.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 122.053 0.93 . . . . 0.0 108.651 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.24 -139.72 6.29 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.01 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.5 mm-40 -91.57 94.24 9.33 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.097 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.54 142.6 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.557 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 11.3 tt0 -89.6 -52.45 5.0 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.1 p -169.82 152.92 4.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.35 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.72 167.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.491 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -167.2 130.15 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.478 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.497 ' CD2' HD13 ' A' ' 198' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.529 0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.477 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.261 0.077 . . . . 0.0 111.193 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.53 ' O ' HD13 ' A' ' 189' ' ' LEU . . . 32.21 76.1 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.602 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 8.1 p90 -135.4 -128.95 0.15 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.85 162.44 39.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.64 0.733 . . . . 0.0 111.326 178.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.728 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 2.8 m-85 -149.95 124.62 9.76 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.664 HD11 ' CE1' ' A' ' 202' ' ' PHE . 1.4 mt -122.94 153.06 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.972 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.6 m -130.03 152.87 49.01 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.016 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.5 m-85 -130.1 120.62 24.93 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -40.81 -37.53 0.79 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.8 mt-10 -90.85 -157.64 0.5 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.572 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -137.53 1.23 2.35 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.04 -60.46 0.49 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.775 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 63.9 Cg_exo -48.89 -33.83 26.77 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.578 ' HB ' HG11 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -64.73 -51.16 70.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.747 178.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -46.12 -57.41 4.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.081 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.669 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.19 -52.83 63.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.679 179.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.653 HG22 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -34.2 -64.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.133 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.49 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.0 OUTLIER -48.72 -26.73 2.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.894 0.378 . . . . 0.0 110.588 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.1 mm-40 -68.1 -40.07 82.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.56 13.94 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.345 178.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.72 -50.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.562 1.164 . . . . 0.0 111.998 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.6 m-85 -84.29 74.15 10.37 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.449 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.653 ' CE1' HG22 ' A' ' 239' ' ' ILE . 10.0 m-70 -74.81 152.24 38.99 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.388 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 74.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.371 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -66.05 103.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.23 -83.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.86 -41.23 5.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.175 0.512 . . . . 0.0 110.538 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 67.7 m -87.87 145.46 26.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.398 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.98 141.61 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.848 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.638 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.97 167.58 29.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.476 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 44.5 tt0 -73.11 95.09 2.01 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.511 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.643 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.6 mt -83.03 78.96 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.716 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.32 123.67 33.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.571 ' O ' ' CG1' ' A' ' 256' ' ' VAL . 1.9 p -37.41 99.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 123.331 1.538 . . . . 0.0 111.035 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.728 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.412 -2.35 0 CA-C-N 112.006 -2.361 . . . . 0.0 112.998 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 36.7 t . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 22.8 mttt -151.86 -34.83 0.13 Allowed 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.411 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -95.36 -175.11 3.39 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.255 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.614 HD12 ' CD1' ' A' ' 239' ' ' ILE . 8.2 pt -163.08 120.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.704 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -95.68 104.46 16.38 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.389 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.605 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.9 t -90.73 112.76 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.763 0.825 . . . . 0.0 112.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.533 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -48.44 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.632 0.613 . . . . 0.0 114.632 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.92 160.98 0.0 OUTLIER Glycine 0 C--N 1.341 0.846 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.618 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -173.33 -144.8 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 189' ' ' LEU . 70.1 m -88.88 135.59 31.76 Favored Pre-proline 0 C--N 1.342 0.261 0 CA-C-O 120.977 0.418 . . . . 0.0 110.623 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 190' ' ' SER . 56.6 Cg_exo -28.77 -37.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.325 2.684 . . . . 0.0 113.051 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 190' ' ' SER . 62.4 t0 -151.4 54.23 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.08 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.573 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 86.3 m -39.87 123.87 1.57 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.149 0.499 . . . . 0.0 110.75 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.579 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 10.1 Cg_endo -51.2 101.95 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.351 2.701 . . . . 0.0 113.728 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.791 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.2 OUTLIER -45.74 -20.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.145 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.5 mt-10 -65.2 -41.96 94.02 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.579 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 2.2 mttp -75.34 -50.03 17.26 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.791 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.48 -26.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.975 176.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.555 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.4 mtp180 -80.12 -28.65 38.93 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.302 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.9 pt-20 -86.89 -47.56 8.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.597 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.691 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.4 t80 -56.46 -40.73 75.32 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 110.342 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.768 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.9 OUTLIER -97.95 -33.9 11.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.43 -44.22 95.6 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.44 -23.2 68.31 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.768 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -66.4 -36.32 82.53 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.155 0.979 . . . . 0.0 108.88 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.9 -142.78 7.99 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.651 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 27.2 mt-10 -91.09 92.59 8.77 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.976 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.15 143.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.0 tp10 -89.64 -46.9 8.31 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.419 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 3.0 p -175.16 152.64 1.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.788 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.671 HG23 HD12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -116.02 161.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.956 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.518 ' OE1' ' NZ ' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -159.02 125.64 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.922 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 121.473 0.654 . . . . 0.0 111.054 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.539 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 111.204 0.075 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 20.9 76.46 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 O-C-N 123.906 0.754 . . . . 0.0 112.032 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.618 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -144.27 -121.73 0.08 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -178.068 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.504 ' HB3' ' CD1' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -166.37 164.3 17.46 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.153 0.978 . . . . 0.0 113.251 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.704 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 3.8 m-85 -147.83 117.0 6.86 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.764 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.742 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -114.35 147.57 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.606 0.717 . . . . 0.0 110.354 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.592 ' N ' HG21 ' A' ' 228' ' ' ILE . 1.2 m -120.21 172.36 7.84 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.43 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 95.4 m-85 -150.63 111.83 4.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -39.33 -37.13 0.41 Allowed 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 230' ' ' PHE . 21.8 mt-10 -89.09 -155.56 0.35 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.776 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.614 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.4 pt-20 -142.33 -0.93 1.22 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.953 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.13 -58.93 0.56 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.766 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 50.9 Cg_exo -48.09 -36.32 28.07 Favored 'Trans proline' 0 CA--C 1.491 -1.654 0 N-CA-C 108.845 -1.252 . . . . 0.0 108.845 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 183' ' ' LYS . 1.0 OUTLIER -63.14 -51.79 67.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.177 -1.829 . . . . 0.0 108.921 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -45.04 -59.45 2.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.126 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.667 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.28 -54.23 49.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.539 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.661 HD12 ' CE2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -33.42 -64.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.142 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.488 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -48.04 -36.18 12.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 238' ' ' LYS . 12.1 mt-10 -60.52 -38.85 85.76 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -103.28 21.65 15.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.558 177.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.53 -50.08 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 O-C-N 124.493 1.12 . . . . 0.0 112.069 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.6 m-85 -83.44 74.91 10.04 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.627 ' CE1' HG23 ' A' ' 239' ' ' ILE . 8.1 m170 -76.65 159.35 30.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 7.4 m-80 -123.01 79.13 1.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.167 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.67 107.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 37.25 -88.18 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.611 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -95.52 -44.93 7.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 247' ' ' VAL . 5.4 m -88.9 148.09 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.24 140.39 30.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.372 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.605 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.25 166.81 30.5 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.523 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 51.7 tt0 -71.42 97.44 1.63 Allowed 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.411 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.649 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.4 mt -86.55 80.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.968 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.2 OUTLIER -89.18 122.63 32.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.4 p -34.52 116.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 122.434 1.112 . . . . 0.0 110.036 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.669 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.418 -2.045 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.518 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.591 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 37.6 t . . . . . 0 CA--C 1.497 -1.074 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 23.8 mttt -151.2 -34.9 0.14 Allowed 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.073 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.652 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -92.08 -172.47 3.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.188 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 184' ' ' ILE . 5.9 pt -166.45 111.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 122.12 0.962 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.709 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -87.16 107.74 18.6 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.593 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.608 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.9 t -94.42 109.55 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.461 0.704 . . . . 0.0 112.299 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.33 -176.77 0.01 OUTLIER Glycine 0 N--CA 1.476 1.366 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -30.68 160.36 0.0 OUTLIER Glycine 0 C--N 1.344 1.025 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.618 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -174.07 -142.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.537 ' N ' HD11 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -89.04 132.1 39.0 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 110.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -31.96 -33.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.152 2.568 . . . . 0.0 113.01 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 190' ' ' SER . 16.5 t0 -150.99 53.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.623 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.545 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 52.2 m -40.21 121.68 1.63 Allowed Pre-proline 0 C--N 1.33 -0.246 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -52.01 94.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.634 2.223 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.577 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -41.91 -24.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.296 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 194' ' ' PRO . 36.2 mt-10 -61.22 -34.79 75.68 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -86.11 -35.05 20.45 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.619 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -62.08 -25.24 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.614 176.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.527 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 19.2 mtp180 -77.61 -25.73 50.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 197' ' ' LYS . 3.7 mt-10 -86.07 -60.01 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.928 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.709 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -43.3 -40.63 3.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.761 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.768 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -99.6 -30.66 12.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 -178.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -46.22 92.42 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.84 -22.8 66.8 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.785 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.66 -36.47 84.38 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.961 0.886 . . . . 0.0 108.726 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -138.26 5.21 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 231' ' ' LYS . 1.7 mt-10 -91.95 89.99 7.23 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.813 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -56.33 142.96 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.559 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.2 tp10 -90.25 -49.05 6.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.447 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 5.8 p -172.75 156.75 3.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.543 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.621 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -122.78 153.81 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.237 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -154.41 133.04 12.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.073 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.545 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 4.4 mm? . . . . . 0 C--N 1.333 -0.125 0 CA-C-O 121.229 0.537 . . . . 0.0 111.842 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.571 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.511 -0.52 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 11.79 80.52 0.01 OUTLIER Glycine 0 C--N 1.336 0.546 0 O-C-N 123.982 0.801 . . . . 0.0 112.416 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.618 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -145.87 -119.98 0.07 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.533 ' SG ' ' CD1' ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.47 169.15 14.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.247 1.022 . . . . 0.0 112.798 178.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.709 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 3.5 m-85 -152.17 111.92 3.98 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.908 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.718 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -110.79 161.58 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.3 m -138.14 168.98 18.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.165 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.5 m-85 -146.74 115.61 6.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.2 OUTLIER -39.64 -35.3 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.531 ' O ' ' O ' ' A' ' 230' ' ' PHE . 7.9 mm-40 -88.89 -156.74 0.4 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.998 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.591 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.5 pm0 -144.16 12.77 1.6 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.615 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -92.29 -63.29 0.17 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.785 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 95.2 Cg_exo -48.47 -32.26 20.13 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.553 HG11 HG22 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.97 -53.43 34.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.372 -1.74 . . . . 0.0 110.209 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.4 OUTLIER -51.6 -46.58 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.609 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.647 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -64.89 -54.29 33.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.69 0.757 . . . . 0.0 109.933 177.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.657 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -30.84 -64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.531 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -46.19 -31.96 2.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 238' ' ' LYS . 30.4 mm-40 -62.71 -45.04 94.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -94.01 19.77 8.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.14 177.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.97 -50.31 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.625 1.203 . . . . 0.0 111.928 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.1 m-85 -84.84 71.29 10.89 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.621 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 9.3 m-70 -72.99 153.03 41.09 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.75 82.34 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.3 t -75.01 97.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.749 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.06 -80.91 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.752 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.82 -43.45 4.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.44 148.32 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.625 0.726 . . . . 0.0 112.344 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -145.54 140.69 27.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.8 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.608 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.23 169.44 24.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.464 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 76.4 tt0 -75.35 91.58 2.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.58 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.642 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.3 mt -77.99 80.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.534 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.605 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.4 mtpt -91.67 120.09 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -30.55 120.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-O 122.29 1.043 . . . . 0.0 110.367 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.676 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.42 -1.966 0 CA-C-N 113.19 -1.823 . . . . 0.0 112.342 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 236' ' ' VAL . 23.1 t . . . . . 0 CA--C 1.499 -1.004 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 19.7 mttt -150.21 -36.46 0.15 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.064 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.1 OUTLIER -94.17 -171.54 2.57 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.633 HD11 ' CD1' ' A' ' 239' ' ' ILE . 10.2 pt -164.62 121.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.687 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -96.02 109.51 21.9 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.357 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.615 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -97.71 112.71 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.708 0.803 . . . . 0.0 113.103 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.41 -178.38 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -31.53 161.41 0.0 OUTLIER Glycine 0 C--N 1.342 0.861 0 N-CA-C 114.607 0.603 . . . . 0.0 114.607 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -174.67 -144.67 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.556 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.541 ' N ' HD13 ' A' ' 189' ' ' LEU . 49.2 m -89.44 133.32 34.92 Favored Pre-proline 0 C--N 1.338 0.069 0 CA-C-O 121.018 0.437 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 84.7 Cg_exo -28.18 -36.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.5 2.8 . . . . 0.0 113.116 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.0 t70 -150.85 56.45 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.551 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 21.7 m -38.8 132.57 1.09 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.067 0.461 . . . . 0.0 110.308 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.505 ' O ' HG13 ' A' ' 198' ' ' ILE . 14.7 Cg_endo -56.42 92.29 0.05 OUTLIER 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 123.025 2.483 . . . . 0.0 112.381 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.557 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.31 -24.53 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 8.7 mm-40 -62.94 -36.65 84.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.917 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 200' ' ' GLU . 22.7 mmmt -78.12 -49.23 14.3 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.4 -28.81 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.471 176.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.522 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -77.1 -28.61 54.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.737 178.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.2 mm-40 -85.61 -63.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.668 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.705 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.1 t80 -40.17 -39.33 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.732 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -100.34 -33.3 10.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.48 -178.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.89 -45.99 95.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.47 -23.12 66.43 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.77 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.6 -34.18 77.64 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.014 0.911 . . . . 0.0 108.818 178.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.35 -141.04 7.02 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.045 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 77.3 mm-40 -91.82 91.54 7.98 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.757 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.6 142.24 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.561 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.5 tp10 -88.96 -48.64 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 26.7 m -175.96 150.02 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.344 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.654 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.34 167.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.556 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -166.34 125.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.809 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.551 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 4.4 mm? . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.963 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.524 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 111.401 0.148 . . . . 0.0 111.401 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 23.87 75.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 O-C-N 123.673 0.608 . . . . 0.0 111.807 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.604 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -138.38 -120.2 0.14 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.533 ' SG ' ' CD1' ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.72 169.87 13.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.449 1.119 . . . . 0.0 113.02 178.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.687 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 5.6 m-85 -151.79 125.21 8.84 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.614 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.681 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.6 mt -122.3 156.57 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.539 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.1 m -134.33 160.31 38.33 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.947 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.2 m-85 -137.86 115.76 11.54 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.561 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -38.51 -36.59 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.301 1.048 . . . . 0.0 108.265 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.1 mt-10 -88.82 -153.88 0.27 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.647 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.1 pt-20 -144.54 4.46 1.18 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.355 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -84.84 -58.19 0.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.77 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 88.6 Cg_exo -50.4 -33.53 37.94 Favored 'Trans proline' 0 CA--C 1.492 -1.605 0 N-CA-C 108.763 -1.283 . . . . 0.0 108.763 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -64.94 -51.91 60.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.618 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.9 mttt -45.71 -57.4 4.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.031 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.674 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.94 -52.49 65.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.605 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -34.72 -63.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.237 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.539 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -50.83 -19.16 0.9 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -77.55 -37.22 51.24 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.92 13.36 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.582 178.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.582 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -15.43 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.517 1.135 . . . . 0.0 112.433 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.1 m-85 -86.0 72.46 10.45 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.366 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.653 ' CE1' HG23 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.52 141.64 46.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.262 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -105.26 75.5 1.17 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.354 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -67.05 138.36 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.139 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 15.22 -77.62 0.0 OUTLIER Glycine 0 C--N 1.342 0.895 0 O-C-N 123.932 0.77 . . . . 0.0 113.729 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.07 -40.54 3.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.312 0.577 . . . . 0.0 110.529 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.75 152.92 21.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.886 -178.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.07 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.942 179.174 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.615 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 156.47 29.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.995 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.551 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 41.6 tt0 -60.88 120.27 9.84 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.657 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.2 mt -104.52 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.746 0.784 . . . . 0.0 112.428 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.59 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.06 119.47 28.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.465 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.7 p -33.62 122.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.149 0.976 . . . . 0.0 110.055 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.663 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.426 -1.649 0 CA-C-N 113.405 -1.725 . . . . 0.0 113.049 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 20.5 t . . . . . 0 CA--C 1.499 -0.981 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 21.1 mttt -150.04 -34.58 0.17 Allowed 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.149 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.67 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -89.78 -171.4 3.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.67 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.1 pt -168.75 110.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.941 0.877 . . . . 0.0 108.92 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.666 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -83.08 101.76 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.733 -177.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -87.68 111.22 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.32 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.573 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -101.39 120.5 6.89 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 97.04 109.92 2.7 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.59 ' C ' ' CD1' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.56 -157.66 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.564 ' N ' HD11 ' A' ' 189' ' ' LEU . 3.4 m -89.03 133.65 34.94 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.197 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -32.46 -29.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.43 2.754 . . . . 0.0 113.473 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 47.8 t0 -149.38 52.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.532 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 17.6 m -43.08 126.79 3.36 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.494 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -53.1 94.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.677 2.251 . . . . 0.0 112.068 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.9 OUTLIER -45.13 -20.67 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 8.0 mt-10 -64.96 -36.55 84.75 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.12 -47.65 17.75 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.631 HG21 HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.25 -28.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.847 176.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 211' ' ' ILE . 11.3 mtp180 -76.41 -28.86 56.84 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 mt-10 -85.27 -61.94 1.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.811 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.705 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -39.56 -42.65 1.18 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.727 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 1.0 OUTLIER -97.75 -31.49 12.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.728 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.21 -46.85 93.09 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.41 -24.27 65.55 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.65 -34.21 77.74 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.11 -139.8 6.36 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.833 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.6 mt-10 -91.86 95.3 9.76 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.854 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -57.31 144.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.576 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 10.5 tt0 -90.6 -50.58 5.85 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 73.1 m -172.42 147.18 1.88 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.914 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.31 162.08 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.629 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -157.79 123.86 4.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 0.0 111.596 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.483 HD11 ' HB ' ' A' ' 193' ' ' THR . 2.0 mm? . . . . . 0 C--N 1.333 -0.125 0 CA-C-O 121.372 0.606 . . . . 0.0 111.028 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.587 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.59 80.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 O-C-N 123.906 0.754 . . . . 0.0 112.505 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.583 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.02 -121.04 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.475 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -167.5 164.58 14.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.347 1.07 . . . . 0.0 113.074 178.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.666 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 3.9 m-85 -149.18 114.91 5.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.071 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.717 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.6 mt -112.98 161.58 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.344 0.592 . . . . 0.0 110.588 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.8 m -138.7 172.36 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.537 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 89.1 m-85 -145.23 119.8 9.75 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.576 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.38 -37.3 0.99 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.8 mt-10 -89.42 -155.59 0.36 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.57 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.6 pt-20 -143.02 5.27 1.5 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.495 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 1.0 OUTLIER -86.9 -57.28 0.32 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.775 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 99.3 Cg_exo -49.74 -33.22 31.54 Favored 'Trans proline' 0 CA--C 1.493 -1.573 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.7 -51.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 112.988 -1.915 . . . . 0.0 109.065 178.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 12.4 mttt -46.3 -57.6 4.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.276 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.626 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.13 -54.74 42.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.673 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.646 ' CG2' ' CG2' ' A' ' 254' ' ' ILE . 0.4 OUTLIER -28.95 -63.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.029 -179.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 9.9 mtp -45.73 -31.32 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 111.139 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.3 mm-40 -63.33 -43.09 98.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -96.56 19.96 11.47 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.268 178.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.18 -50.55 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.696 1.247 . . . . 0.0 111.716 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.9 m-85 -85.51 71.03 10.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.271 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.9 m-70 -70.49 146.41 50.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.029 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.41 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 4.6 m-80 -107.43 79.75 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -69.12 149.48 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.71 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 6.59 -72.08 0.0 OUTLIER Glycine 0 C--N 1.343 0.953 0 O-C-N 124.014 0.821 . . . . 0.0 113.682 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -119.64 -41.88 2.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.076 0.465 . . . . 0.0 110.454 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.546 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 2.0 m -88.89 148.54 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.689 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -131.76 147.62 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.054 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.625 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -160.34 161.85 33.32 Favored 'General case' 0 C--O 1.228 -0.042 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.238 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 185' ' ' PHE . 56.7 tt0 -69.86 93.12 0.73 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.609 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.646 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.4 mt -83.92 82.73 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.591 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.592 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.7 mtpt -98.4 118.91 36.12 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.8 p -28.72 110.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-O 122.612 1.196 . . . . 0.0 110.594 -177.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.652 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.418 -2.026 0 CA-C-N 112.634 -2.076 . . . . 0.0 112.758 -176.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 29.9 t . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 22.0 mttt -152.19 -35.66 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.575 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -94.91 -177.94 4.34 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.37 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 202' ' ' PHE . 4.6 pt -161.82 111.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 122.245 1.022 . . . . 0.0 109.57 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.723 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -85.41 101.79 12.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.551 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.621 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.6 t -87.27 106.21 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.246 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.574 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -97.43 122.1 7.33 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.45 106.66 2.73 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.676 0.631 . . . . 0.0 114.676 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.617 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -168.08 -157.16 0.2 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 189' ' ' LEU . 71.0 m -88.6 134.38 34.22 Favored Pre-proline 0 C--N 1.345 0.372 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.187 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -29.29 -32.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.789 2.993 . . . . 0.0 113.919 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.72 54.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.482 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.531 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 14.3 m -40.17 123.74 1.68 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.927 0.394 . . . . 0.0 110.537 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.493 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 8.2 Cg_endo -50.32 92.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.745 2.297 . . . . 0.0 112.077 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.568 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -42.16 -23.67 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 194' ' ' PRO . 10.0 mt-10 -63.87 -33.5 75.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -85.76 -34.45 21.17 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.605 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.7 OUTLIER -62.33 -20.87 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.863 176.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.537 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.7 mtt180 -85.39 -25.03 27.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.293 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -88.99 -31.2 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.878 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.697 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -72.99 -38.7 66.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.749 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 1.0 OUTLIER -100.43 -30.99 11.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.449 -178.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.92 -46.26 92.01 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.63 64.51 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.794 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.22 -34.68 78.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.968 0.89 . . . . 0.0 108.916 178.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.26 -139.99 6.37 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.063 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.6 mt-10 -91.43 90.47 7.69 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.993 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -55.36 143.59 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.585 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 9.7 tt0 -89.71 -50.33 6.12 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 50.3 m -172.03 147.25 2.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.293 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.613 HG21 HD12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.34 159.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.466 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.3 OUTLIER -155.5 124.67 6.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.34 . . . . 0.0 111.372 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 193' ' ' THR . 1.4 mm? . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.414 0.626 . . . . 0.0 111.066 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.564 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.682 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.06 79.64 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 O-C-N 123.994 0.809 . . . . 0.0 112.857 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.617 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.78 -121.16 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.471 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -167.23 162.19 14.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.987 0.899 . . . . 0.0 112.587 177.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 2.9 m-85 -144.34 113.84 7.09 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.709 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.732 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -111.47 159.13 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-O 121.498 0.666 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.5 m -135.04 178.05 7.33 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.338 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 92.0 m-85 -152.56 117.22 5.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.585 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.93 -37.54 1.34 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -89.49 -155.84 0.37 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.606 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -141.43 1.86 1.6 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.716 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -81.62 -58.42 0.48 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.794 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 84.9 Cg_exo -48.91 -35.34 31.27 Favored 'Trans proline' 0 CA--C 1.494 -1.501 0 N-CA-C 109.035 -1.179 . . . . 0.0 109.035 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.568 HG11 HG23 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.66 -51.74 66.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.774 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -44.94 -55.35 5.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.482 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.62 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.0 -54.19 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.107 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.649 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -29.95 -62.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.06 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -49.24 -27.13 3.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.889 0.376 . . . . 0.0 111.255 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 238' ' ' LYS . 11.5 mm-40 -68.59 -34.98 76.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.09 20.57 18.75 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.458 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.587 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.77 -49.54 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.516 1.135 . . . . 0.0 112.009 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.0 m-85 -85.0 72.83 10.78 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.488 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.2 m-70 -73.04 150.34 42.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.248 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.94 80.94 1.36 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 249' ' ' LEU . 0.9 OUTLIER -75.84 103.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.658 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 47.64 -85.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.486 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -106.01 -44.94 4.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.976 0.417 . . . . 0.0 110.907 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.21 147.21 24.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.765 0.793 . . . . 0.0 112.372 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.02 145.65 46.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.058 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.621 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.9 163.24 36.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.568 -1.253 . . . . 0.0 114.204 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.487 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 64.2 tt0 -71.55 91.34 1.06 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.471 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.64 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.3 mt -80.76 80.19 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.512 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.624 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.3 OUTLIER -93.13 120.46 33.45 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -30.54 116.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.941 1.246 . . . . 0.0 109.972 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.648 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.426 -1.662 0 CA-C-N 112.971 -1.922 . . . . 0.0 113.369 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.2 t . . . . . 0 CA--C 1.497 -1.092 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.531 ' HA ' HG22 ' A' ' 236' ' ' VAL . 26.3 mttt -151.26 -36.38 0.13 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.727 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -93.57 -176.8 4.2 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 184' ' ' ILE . 4.5 pt -161.34 114.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 122.15 0.976 . . . . 0.0 109.118 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.677 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -91.12 110.54 21.81 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.098 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.628 HG12 ' HB2' ' A' ' 252' ' ' CYS . 3.0 t -100.15 108.72 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.37 -179.87 0.01 OUTLIER Glycine 0 CA--C 1.531 1.065 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.42 161.59 0.0 OUTLIER Glycine 0 C--N 1.344 0.988 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.592 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -173.93 -143.67 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.551 ' N ' HD13 ' A' ' 189' ' ' LEU . 33.1 m -89.18 132.93 36.22 Favored Pre-proline 0 C--N 1.34 0.165 0 CA-C-O 121.037 0.446 . . . . 0.0 110.88 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 72.1 Cg_exo -27.8 -36.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.588 2.859 . . . . 0.0 113.301 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.59 54.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.576 0.226 . . . . 0.0 111.084 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.535 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 8.1 m -39.68 120.7 1.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.394 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.569 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -50.35 99.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.717 2.278 . . . . 0.0 112.275 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.582 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -45.88 -21.72 0.15 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.379 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 34.5 mt-10 -60.76 -37.87 83.31 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.569 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.2 mttp -79.73 -46.86 16.27 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.622 HG22 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.98 -26.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.897 177.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.541 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 5.3 mtt180 -80.56 -27.1 37.6 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.836 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.4 mt-10 -85.36 -59.85 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.719 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -44.89 -41.56 7.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.58 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.751 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -97.29 -35.08 10.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.997 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.51 -47.04 92.3 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.01 -22.79 65.2 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.787 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.53 -37.86 87.97 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.044 0.926 . . . . 0.0 108.837 178.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.93 -142.0 7.3 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.7 mm-40 -91.66 92.64 8.54 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.874 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.35 143.54 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.533 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.6 tp10 -89.45 -51.02 5.76 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.408 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 5.0 p -170.34 155.48 5.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.1 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.644 HG23 HD13 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -120.34 159.48 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.121 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.408 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -157.77 132.75 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 1.6 mm? . . . . . 0 C--N 1.333 -0.15 0 CA-C-O 121.428 0.632 . . . . 0.0 111.001 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.579 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.581 0 CA-C-O 119.841 -0.123 . . . . 0.0 111.25 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 17.28 75.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.77 0 O-C-N 124.015 0.822 . . . . 0.0 111.362 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.592 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.54 -119.64 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.611 -0.795 . . . . 0.0 108.923 -176.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -166.4 163.58 17.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.905 0.859 . . . . 0.0 112.487 178.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.677 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 3.0 m-85 -148.54 118.09 6.99 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.963 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.67 HD11 ' CG ' ' A' ' 202' ' ' PHE . 1.5 mt -113.23 152.85 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.6 m -131.04 152.97 49.77 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.072 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 87.8 m-85 -131.95 116.77 17.57 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.44 -37.75 0.73 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.2 mm-40 -89.21 -158.24 0.49 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.788 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.613 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 16.5 pt-20 -141.09 11.6 2.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.856 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.5 OUTLIER -89.84 -62.75 0.21 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.787 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 66.9 Cg_exo -47.55 -34.08 19.32 Favored 'Trans proline' 0 CA--C 1.494 -1.498 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.563 ' HB ' HG11 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -64.92 -52.69 50.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.611 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 8.0 pttt -52.8 -49.64 65.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.422 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.66 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -61.45 -53.55 55.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.671 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -34.13 -64.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.333 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.486 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 2.3 mtp -49.23 -22.15 0.96 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.137 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 4.0 mm-40 -73.57 -36.9 65.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.619 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.16 20.88 15.88 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.312 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.583 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.96 -48.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.634 1.209 . . . . 0.0 112.416 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.3 m-85 -86.55 73.91 9.99 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.466 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 9.1 m-70 -77.0 147.34 36.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.156 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.436 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -111.48 81.35 1.43 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.987 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.41 96.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.8 -78.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.61 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.81 -43.48 3.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 0.0 110.922 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.32 148.53 24.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.512 0.672 . . . . 0.0 112.209 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.76 145.71 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.628 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -161.6 155.02 21.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.751 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.537 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 47.6 tt0 -59.75 120.47 9.59 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.663 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.3 mt -105.06 84.6 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.749 0.785 . . . . 0.0 112.214 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.573 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.68 120.45 30.08 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 114.234 -1.348 . . . . 0.0 107.893 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -35.21 120.39 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 119.457 1.026 . . . . 0.0 109.696 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.656 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.426 -1.649 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.14 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.632 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.1 t . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 25.9 mttt -151.63 -35.35 0.13 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.148 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.653 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -93.13 -171.79 2.78 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.656 HG13 ' O ' ' A' ' 184' ' ' ILE . 6.0 pt -166.46 110.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 122.197 0.998 . . . . 0.0 109.318 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.702 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -84.71 104.14 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.643 -178.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.634 HG12 ' HB2' ' A' ' 252' ' ' CYS . 3.8 t -89.82 114.46 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.716 0.806 . . . . 0.0 112.735 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -46.21 -177.21 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.936 0.735 . . . . 0.0 114.936 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -33.32 163.5 0.01 OUTLIER Glycine 0 C--N 1.341 0.832 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.573 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -177.7 -146.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.526 ' N ' HD13 ' A' ' 189' ' ' LEU . 39.7 m -89.03 133.13 35.98 Favored Pre-proline 0 C--N 1.34 0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 111.105 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.72 -33.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.498 2.799 . . . . 0.0 113.181 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.2 m-20 -151.45 55.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.53 0.205 . . . . 0.0 111.461 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.581 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 24.3 m -39.19 123.21 1.31 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.484 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.2 Cg_endo -49.51 88.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 0.0 111.682 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.57 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -39.74 -25.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 194' ' ' PRO . 49.7 mt-10 -61.32 -33.42 73.56 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -88.21 -31.28 19.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.608 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.9 OUTLIER -66.22 -21.95 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.621 176.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.547 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 13.9 mtp180 -82.44 -25.24 33.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.365 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 197' ' ' LYS . 4.3 pt-20 -88.91 -37.77 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.842 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.694 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -65.36 -37.69 87.8 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.121 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.748 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -100.69 -30.72 11.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.18 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.97 -44.93 93.81 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.61 -23.53 67.06 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.773 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.36 -35.89 82.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 122.182 0.991 . . . . 0.0 108.849 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 162.77 -138.93 5.61 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.981 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.9 mm-40 -91.46 92.09 8.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.643 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -58.07 142.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.547 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.61 -47.74 7.49 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 12.3 m -175.41 150.14 1.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.809 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.613 HG22 HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.23 158.62 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.833 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.441 ' HG2' ' C ' ' A' ' 211' ' ' ILE . 0.8 OUTLIER -156.14 129.22 8.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 111.289 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 213' ' ' LEU . 4.4 mm? . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 121.09 0.471 . . . . 0.0 111.428 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.689 0 CA-C-O 120.934 0.397 . . . . 0.0 109.949 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 20.76 79.96 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.05 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.573 ' CD2' ' HE1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -142.91 -118.76 0.1 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 213' ' ' LEU . 0.4 OUTLIER -167.69 169.24 11.95 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.209 1.004 . . . . 0.0 112.442 177.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.702 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 3.3 m-85 -150.66 110.52 4.08 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.886 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.71 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -108.17 160.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.514 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.4 m -138.94 167.63 21.61 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.251 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.659 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 82.8 m-85 -144.05 119.82 10.54 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.547 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.36 -39.4 3.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.6 mt-10 -92.45 -176.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.894 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.632 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.9 pt-20 -119.05 3.83 11.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.485 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 0.8 OUTLIER -79.86 -61.41 0.46 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.773 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 57.8 Cg_exo -47.59 -35.69 23.16 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 CA-C-N 120.422 1.186 . . . . 0.0 109.203 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.588 HG11 HG22 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -62.68 -50.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.017 178.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 11.2 mttt -46.78 -59.85 2.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.12 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.643 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -58.46 -51.97 67.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.629 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.655 HD13 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -33.62 -65.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.339 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.446 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 0.1 OUTLIER -47.94 -28.12 2.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.574 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 238' ' ' LYS . 25.6 mm-40 -66.46 -42.15 88.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -98.88 21.64 11.28 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.258 177.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.46 -49.69 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 O-C-N 124.632 1.207 . . . . 0.0 111.846 -179.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.603 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.7 m-85 -85.12 72.57 10.76 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.653 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 9.7 m-70 -73.06 152.18 41.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -114.77 80.88 1.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.892 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -74.93 97.5 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.767 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.37 -83.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.568 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.31 -43.57 4.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.964 0.412 . . . . 0.0 110.687 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 1.2 m -88.33 145.34 25.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.695 0.759 . . . . 0.0 112.357 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -140.33 140.57 35.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.855 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.634 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.85 166.42 33.42 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 53.2 tt0 -72.68 93.54 1.65 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.774 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.4 mt -81.47 82.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.604 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.567 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -93.8 120.29 33.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -31.01 118.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.373 1.082 . . . . 0.0 110.431 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.672 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.423 -1.823 0 CA-C-N 113.072 -1.876 . . . . 0.0 112.343 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.619 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 38.6 t . . . . . 0 CA--C 1.499 -0.995 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 20.7 mttt -152.56 -35.48 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.736 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.1 OUTLIER -94.24 -174.61 3.42 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 184' ' ' ILE . 6.5 pt -163.64 114.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.988 0.899 . . . . 0.0 108.878 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.701 ' HB2' ' CE1' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -89.38 110.07 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.864 -177.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 252' ' ' CYS . 2.7 t -100.35 107.66 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.15 -179.56 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -30.06 160.3 0.0 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.589 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -172.15 -145.04 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.542 ' N ' HD11 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -89.23 130.51 43.82 Favored Pre-proline 0 C--N 1.339 0.121 0 CA-C-O 120.898 0.38 . . . . 0.0 110.644 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -30.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.236 2.624 . . . . 0.0 112.979 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 190' ' ' SER . 15.1 t70 -150.43 52.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.266 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.531 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 55.1 m -42.9 124.51 3.15 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.271 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.465 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.9 Cg_endo -52.17 92.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.761 2.307 . . . . 0.0 112.286 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.562 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -39.75 -27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 199' ' ' ARG . 2.6 mp0 -61.49 -37.23 82.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 200' ' ' GLU . 20.4 mmmt -73.99 -50.03 21.73 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.628 HG22 HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -51.72 -27.43 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 113.142 -1.844 . . . . 0.0 107.556 175.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.559 ' HD3' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -75.72 -30.92 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.813 178.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -85.59 -64.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.805 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.721 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -39.35 -39.06 0.61 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.407 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.758 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -99.92 -34.26 10.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.831 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.5 -46.08 94.53 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.63 -22.42 67.96 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.79 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.62 -37.57 86.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.962 0.887 . . . . 0.0 108.834 178.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.07 -142.85 7.86 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.997 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mm-40 -91.48 89.79 7.37 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.809 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.427 ' O ' ' HE2' ' A' ' 231' ' ' LYS . 1.8 t -53.19 141.88 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.546 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.4 -48.04 7.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 17.9 m -175.8 150.91 1.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.169 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.659 HG21 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -115.62 158.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.701 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.56 124.76 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.76 0.314 . . . . 0.0 111.018 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.48 HD23 ' CD1' ' A' ' 198' ' ' ILE . 1.7 mm? . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.443 0.64 . . . . 0.0 111.438 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.52 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.52 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 25.28 74.68 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.589 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.4 OUTLIER -138.49 -123.26 0.13 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.484 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -159.51 162.8 35.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.08 0.943 . . . . 0.0 112.692 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.701 ' CE1' ' HB2' ' A' ' 185' ' ' PHE . 2.9 m-85 -149.66 109.95 4.18 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 113.602 -1.636 . . . . 0.0 108.28 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.667 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.6 mt -106.87 157.88 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.723 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 6.6 m -138.38 154.18 48.92 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.527 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 68.9 m-85 -132.37 120.55 22.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.546 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -42.13 -38.26 1.65 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 230' ' ' PHE . 31.3 mt-10 -89.32 -164.0 1.08 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.657 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 25.8 pt-20 -134.67 16.93 3.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.6 -63.06 0.17 Allowed Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.015 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.79 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 76.4 Cg_exo -48.03 -34.9 24.28 Favored 'Trans proline' 0 CA--C 1.494 -1.487 0 N-CA-C 108.94 -1.215 . . . . 0.0 108.94 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.573 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -65.82 -54.06 31.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.221 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 37.3 pttt -51.37 -41.83 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.022 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.65 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.22 -55.17 8.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.574 0.702 . . . . 0.0 110.048 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.662 HD13 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -29.8 -60.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.846 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.531 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -51.89 -18.21 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 111.801 -178.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.4 mm-40 -79.5 -33.47 42.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -104.71 20.87 17.89 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.946 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.59 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.05 -47.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.394 1.059 . . . . 0.0 112.148 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.609 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.6 m-85 -85.73 71.2 10.72 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.359 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 11.3 m-70 -73.12 144.71 46.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.147 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -107.6 78.37 1.2 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -68.77 152.74 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.349 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 2.87 -70.87 0.0 OUTLIER Glycine 0 C--N 1.343 0.949 0 O-C-N 123.97 0.794 . . . . 0.0 113.854 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -120.91 -40.01 2.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.519 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.9 OUTLIER -88.94 152.41 21.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.81 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.0 134.55 28.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.575 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.614 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -151.8 158.26 43.06 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.885 -178.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.561 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 39.1 tt0 -61.93 121.63 13.44 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.649 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.8 mt -106.34 81.39 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.769 0.795 . . . . 0.0 112.039 -176.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.1 118.85 26.77 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.784 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -34.64 115.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.409 1.099 . . . . 0.0 110.083 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.667 ' CB ' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.419 -1.997 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.746 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.585 HG13 ' HB ' ' A' ' 236' ' ' VAL . 25.0 t . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 19.2 mttt -150.77 -35.92 0.14 Allowed 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.937 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.637 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -92.55 -173.08 3.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 184' ' ' ILE . 6.5 pt -165.04 109.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.207 1.003 . . . . 0.0 109.68 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.69 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -83.69 106.56 15.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.563 -178.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 252' ' ' CYS . 4.3 t -93.82 111.75 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.643 0.777 . . . . 0.0 112.744 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -44.77 -175.98 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -32.59 162.37 0.0 OUTLIER Glycine 0 C--N 1.342 0.876 0 N-CA-C 114.824 0.69 . . . . 0.0 114.824 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.597 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -175.12 -145.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.567 ' N ' HD12 ' A' ' 189' ' ' LEU . 9.1 t -89.32 133.37 35.0 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 110.225 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 53.8 Cg_exo -29.69 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.209 2.606 . . . . 0.0 113.251 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.79 56.97 0.86 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 0.0 111.279 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.538 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 54.0 m -39.48 125.79 1.42 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -53.61 95.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.802 2.334 . . . . 0.0 112.189 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.38 -20.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 66.1 mt-10 -62.79 -39.51 94.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.0 OUTLIER -79.27 -46.66 17.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.611 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.62 -27.0 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.942 177.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.525 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.7 mtp85 -77.75 -28.03 50.57 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.697 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.9 mm-40 -85.8 -60.63 1.96 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.697 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -41.51 -41.49 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.613 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.768 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -99.49 -30.98 11.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.821 -178.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.13 -47.01 91.96 Favored Glycine 0 CA--C 1.504 -0.642 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 176.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -22.48 65.93 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.7 -36.89 85.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.89 0.853 . . . . 0.0 108.74 178.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.04 -138.43 5.29 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.904 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.8 mm-40 -91.89 89.88 7.22 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.023 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.428 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -55.57 139.8 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.572 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 6.0 tt0 -89.66 -47.1 8.17 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 76.3 p -173.48 150.32 1.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.743 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.615 HG21 HD12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -114.59 161.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.329 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -158.9 137.48 10.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.537 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.495 ' CD1' HD22 ' A' ' 189' ' ' LEU . 2.3 mm? . . . . . 0 CA--C 1.533 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.562 ' O ' ' C ' ' A' ' 224' ' ' GLY . 2.7 mtm180 . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.47 81.17 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 O-C-N 124.443 1.089 . . . . 0.0 112.903 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.597 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -143.98 -120.76 0.09 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -163.4 165.08 24.34 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.325 1.06 . . . . 0.0 113.349 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.69 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 3.6 m-85 -150.46 111.32 4.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.729 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.711 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.5 mt -112.49 161.79 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-O 121.144 0.497 . . . . 0.0 110.476 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -136.7 -179.25 5.58 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.408 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 85.2 m-85 -157.07 115.83 3.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.869 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.572 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.38 -36.27 0.53 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.3 mm-40 -89.09 -157.05 0.42 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.759 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.8 pm0 -143.15 12.81 1.81 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.379 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.59 -61.73 0.2 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.788 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 81.1 Cg_exo -49.28 -32.85 26.67 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 N-CA-C 108.946 -1.213 . . . . 0.0 108.946 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.585 ' HB ' HG13 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -66.53 -53.04 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.266 -1.788 . . . . 0.0 110.153 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.7 pttt -52.84 -45.39 67.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.659 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.639 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.84 -53.84 34.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.603 0.716 . . . . 0.0 109.852 177.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.653 ' CG2' ' CG2' ' A' ' 254' ' ' ILE . 0.4 OUTLIER -31.18 -62.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.823 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -48.35 -29.17 3.69 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 238' ' ' LYS . 8.3 mm-40 -65.79 -38.99 90.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.31 20.76 16.25 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.14 177.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.564 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.16 -49.71 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.459 0 O-C-N 124.647 1.217 . . . . 0.0 111.966 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.2 m-85 -84.84 74.59 10.46 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.598 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 9.4 m-70 -76.1 151.42 37.04 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 1.2 m-80 -115.07 80.67 1.45 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.502 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -74.52 108.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.566 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 39.09 -89.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.441 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -97.97 -43.37 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 9.0 m -88.25 147.88 24.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.637 0.732 . . . . 0.0 112.92 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.55 141.11 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.524 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.625 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.17 168.37 26.73 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.465 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 56.6 tt0 -73.31 96.07 2.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.375 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.653 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.4 mt -83.95 81.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.737 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.577 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -94.26 118.04 31.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.64 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -27.88 120.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 122.217 1.008 . . . . 0.0 110.539 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.671 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.43 -1.474 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.105 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 28.6 t . . . . . 0 CA--C 1.495 -1.15 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 18.5 mttt -150.33 -34.39 0.17 Allowed 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.911 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -97.07 -173.59 2.73 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 184' ' ' ILE . 13.2 pt -162.7 117.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.105 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.679 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -91.57 99.54 12.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.78 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.67 HG11 ' HB2' ' A' ' 252' ' ' CYS . 2.7 t -84.84 112.85 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.03 0.932 . . . . 0.0 110.924 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -99.18 120.91 7.03 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 97.47 108.72 2.65 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 177.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.629 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -168.81 -159.22 0.24 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.556 ' N ' HD13 ' A' ' 189' ' ' LEU . 26.3 t -89.04 132.75 36.99 Favored Pre-proline 0 C--N 1.342 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.744 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -31.02 -29.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.872 3.048 . . . . 0.0 113.561 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 190' ' ' SER . 11.4 t70 -148.57 53.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.529 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 7.9 m -39.83 134.15 1.36 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.184 0.516 . . . . 0.0 110.634 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.494 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.7 Cg_endo -52.66 83.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.077 2.518 . . . . 0.0 112.084 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -39.58 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.216 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 194' ' ' PRO . 42.9 mt-10 -63.53 -35.59 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -78.33 -46.45 20.06 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.619 HG23 HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -49.82 -24.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.624 177.504 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.533 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.8 mtp-105 -83.98 -25.96 29.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.69 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.7 OUTLIER -88.06 -35.54 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.044 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.708 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -68.33 -41.12 81.22 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.755 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.9 OUTLIER -97.34 -30.96 12.65 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.894 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.08 -47.28 86.96 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.82 -23.73 61.56 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.783 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.46 -34.1 77.19 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.987 0.898 . . . . 0.0 108.859 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.84 -140.27 6.58 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 113.875 -1.512 . . . . 0.0 109.956 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.4 mm-40 -91.51 90.73 7.76 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.889 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.48 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -54.63 144.12 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.583 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 6.6 tt0 -89.43 -49.34 6.75 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.9 p -173.17 148.99 1.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.236 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.606 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.24 163.81 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.36 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -163.12 126.57 2.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.856 0.36 . . . . 0.0 110.953 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 1.2 mm? . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.146 0.498 . . . . 0.0 111.264 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 23.28 75.63 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 O-C-N 123.635 0.584 . . . . 0.0 111.683 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.629 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.14 -120.4 0.12 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.533 ' HB3' ' CD1' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -169.77 162.95 9.77 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.194 0.997 . . . . 0.0 113.263 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.679 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 4.8 m-85 -144.42 123.94 13.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.634 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.744 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.3 mt -119.85 157.21 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.523 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.3 m -132.77 173.52 11.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.88 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.674 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 93.1 m-85 -148.2 117.4 6.86 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.583 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.48 -37.37 1.06 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.507 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -90.19 -154.87 0.35 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.62 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -142.07 1.98 1.48 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.696 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -83.75 -57.46 0.41 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 75.2 Cg_exo -49.18 -33.29 27.22 Favored 'Trans proline' 0 CA--C 1.492 -1.584 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.575 ' HB ' HG11 ' A' ' 181' ' ' VAL . 1.0 OUTLIER -64.94 -52.07 58.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.419 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.4 mtpt -46.54 -56.45 6.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.659 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.03 -53.58 56.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.6 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.647 HD13 ' CE2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -32.94 -61.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.699 -179.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 30.8 mtm -49.94 -20.12 0.85 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -75.57 -33.31 60.6 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.34 22.83 15.39 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.075 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.582 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -16.05 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 112.332 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.91 72.7 10.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.314 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.3 m-70 -73.55 146.61 44.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.2 m-80 -107.63 79.6 1.31 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.365 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.69 147.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.256 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 7.4 -73.9 0.0 OUTLIER Glycine 0 C--N 1.343 0.941 0 O-C-N 124.032 0.833 . . . . 0.0 113.679 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -116.71 -41.18 3.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.731 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -89.16 152.07 21.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.866 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.87 144.76 39.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.94 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.67 ' HB2' HG11 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.26 168.88 25.36 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 118.739 -1.185 . . . . 0.0 114.093 -177.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.475 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 49.9 tt0 -75.39 93.01 2.87 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.627 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.1 mt -80.18 83.44 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.751 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.578 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.9 OUTLIER -96.04 117.36 30.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.5 p -29.74 117.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 119.703 1.138 . . . . 0.0 110.161 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.649 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.422 -1.828 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.451 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.6 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 42.2 t . . . . . 0 CA--C 1.494 -1.182 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 19.9 mttt -150.57 -35.36 0.15 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 118.889 -1.124 . . . . 0.0 112.042 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.589 ' O ' ' CG1' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -96.46 -173.9 2.9 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.631 HD13 ' CD1' ' A' ' 239' ' ' ILE . 4.9 pt -162.45 115.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.648 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.5 OUTLIER -93.08 92.57 7.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.019 -177.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.603 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.2 t -73.37 148.09 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.546 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -93.84 -167.64 37.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.389 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -23.55 150.11 0.0 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.602 ' HB3' ' SG ' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -176.46 -147.11 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 192' ' ' ASP . 1.3 m -89.41 129.93 45.58 Favored Pre-proline 0 C--N 1.341 0.199 0 CA-C-O 120.96 0.409 . . . . 0.0 110.508 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -32.03 -28.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.391 2.728 . . . . 0.0 113.409 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.8 t0 -149.68 53.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.624 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.551 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 16.9 m -39.91 124.75 1.59 Allowed Pre-proline 0 CA--C 1.519 -0.245 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.087 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.529 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 6.2 Cg_endo -48.58 94.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.56 2.174 . . . . 0.0 111.988 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -45.24 -21.32 0.07 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.707 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -37.65 88.06 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.3 mttp -77.68 -49.09 15.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.624 HG21 HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -47.18 -28.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.931 176.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.547 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 12.0 mtt180 -79.64 -27.99 40.92 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.33 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 5.2 pt-20 -87.47 -53.01 5.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.68 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -51.48 -39.5 57.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.342 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.762 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.3 OUTLIER -98.75 -35.83 10.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.673 -178.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.94 -42.93 99.57 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -66.04 -22.48 70.62 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.762 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -67.21 -37.85 84.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.3 1.048 . . . . 0.0 108.399 178.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.52 -156.67 28.3 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.157 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.5 mt-10 -81.6 90.91 6.32 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.645 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.6 t -53.01 142.75 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.1 tp10 -89.41 -46.97 8.33 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -167.79 169.79 11.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.184 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.647 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -133.49 166.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.471 ' O ' HD13 ' A' ' 213' ' ' LEU . 2.1 tp10 -162.67 148.37 12.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.709 0.29 . . . . 0.0 111.352 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.534 ' CD1' HD21 ' A' ' 189' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.305 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.871 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 23.58 77.87 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.136 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.546 ' CB ' ' C ' ' A' ' 187' ' ' GLY . 7.2 p90 -131.26 -130.6 0.2 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.538 ' CB ' ' HB ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -154.27 162.53 41.12 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.198 0.523 . . . . 0.0 110.355 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.702 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 1.8 m-85 -150.5 118.02 6.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.525 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.661 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.3 mt -119.13 142.35 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 122.051 0.929 . . . . 0.0 110.492 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.0 m -120.09 149.55 42.01 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.284 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 63.8 m-85 -130.71 116.67 18.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -39.39 -36.63 0.37 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.227 1.013 . . . . 0.0 108.299 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.2 mm-40 -88.44 -155.87 0.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.992 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.6 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.3 OUTLIER -144.97 11.4 1.37 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.4 -59.07 0.22 Allowed Pre-proline 0 C--O 1.224 -0.254 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.761 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.0 Cg_exo -51.33 -32.48 41.89 Favored 'Trans proline' 0 CA--C 1.496 -1.388 0 N-CA-C 108.678 -1.316 . . . . 0.0 108.678 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.589 ' CG1' ' O ' ' A' ' 183' ' ' LYS . 0.9 OUTLIER -66.95 -54.5 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.056 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.6 OUTLIER -51.54 -45.25 62.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.84 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.674 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -53.97 31.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.456 0.646 . . . . 0.0 109.74 178.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.679 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -32.69 -65.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.336 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.451 ' HE1' HG23 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -48.71 -25.35 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 238' ' ' LYS . 5.6 mm-40 -67.88 -37.14 81.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -105.52 22.96 14.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.241 178.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.78 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.655 1.222 . . . . 0.0 111.985 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -84.52 72.22 10.67 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.983 0.42 . . . . 0.0 110.742 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.64 ' CE1' HG23 ' A' ' 239' ' ' ILE . 9.0 m-70 -74.23 159.15 32.88 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.393 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.441 ' OD1' ' HG2' ' A' ' 251' ' ' LYS . 5.2 m-80 -119.75 74.26 1.01 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.45 101.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.675 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.65 -87.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.54 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -99.87 -42.34 6.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.158 0.504 . . . . 0.0 110.559 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 247' ' ' VAL . 41.9 m -88.44 143.81 26.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.372 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.02 133.19 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.266 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -153.62 169.35 23.47 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.474 ' CG ' ' HD2' ' A' ' 255' ' ' LYS . 47.8 tt0 -72.9 104.9 4.2 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.004 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.651 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.8 mt -91.12 79.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.643 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.6 mtpt -87.45 119.04 27.33 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.1 p -33.73 115.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.518 1.152 . . . . 0.0 110.644 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.702 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.421 -1.881 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.955 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.608 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.6 t . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 25.6 mttt -151.27 -35.41 0.14 Allowed 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 118.873 -1.131 . . . . 0.0 112.259 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.657 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -92.47 -172.64 3.14 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.657 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.8 pt -166.03 111.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 122.025 0.916 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.684 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -83.57 103.27 12.77 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.046 -178.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.7 t -89.62 106.37 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -98.08 122.71 7.6 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 115.964 1.145 . . . . 0.0 115.964 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.58 107.72 2.85 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.634 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -168.64 -158.89 0.23 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.561 ' N ' HD11 ' A' ' 189' ' ' LEU . 46.3 t -88.85 135.61 31.79 Favored Pre-proline 0 C--N 1.343 0.318 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.878 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HB2' ' OD1' ' A' ' 192' ' ' ASP . 87.8 Cg_exo -29.63 -32.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.669 2.913 . . . . 0.0 113.576 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.8 OUTLIER -150.65 54.75 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.617 0.246 . . . . 0.0 111.195 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.6 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 17.9 m -39.77 134.1 1.34 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 110.819 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 198' ' ' ILE . 11.8 Cg_endo -55.1 89.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.774 2.316 . . . . 0.0 111.75 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.585 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -44.43 -22.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.034 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.51 -35.69 81.78 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.17 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.84 -47.11 17.24 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.62 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -50.02 -24.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.196 177.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.542 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 1.7 mtt180 -82.03 -26.8 33.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.792 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -87.37 -43.86 11.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.874 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.72 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -58.63 -43.25 89.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.441 0.639 . . . . 0.0 110.066 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.774 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 1.2 m-85 -94.97 -32.05 13.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.369 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.3 -44.68 95.13 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.674 -2.171 . . . . 0.0 107.674 175.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.56 -23.36 66.82 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.812 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.29 -34.31 77.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.072 0.939 . . . . 0.0 108.709 177.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.92 -142.4 7.97 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.895 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 18.1 mt-10 -91.18 92.54 8.71 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.7 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -55.66 144.84 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.537 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.4 tp10 -89.76 -50.33 6.12 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 72.2 m -171.77 148.1 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.296 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.642 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.02 158.85 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 211' ' ' ILE . 0.3 OUTLIER -155.23 129.69 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.6 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 4.5 mm? . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.55 0.69 . . . . 0.0 111.322 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.554 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.354 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 8.64 82.26 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.923 0.764 . . . . 0.0 113.062 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.634 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.22 -120.57 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.473 ' SG ' ' SG ' ' A' ' 252' ' ' CYS . 0.1 OUTLIER -168.03 167.47 12.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.143 0.973 . . . . 0.0 112.288 177.018 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.684 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 3.2 m-85 -148.95 113.48 5.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.099 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.723 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.3 mt -109.3 158.58 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.0 m -140.28 155.64 46.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.927 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 70.5 m-85 -131.41 123.0 27.24 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -43.93 -38.22 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mm-40 -90.31 -168.06 2.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.372 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.608 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -131.12 15.57 5.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -92.4 -62.07 0.19 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.812 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.8 Cg_exo -49.03 -31.96 22.21 Favored 'Trans proline' 0 CA--C 1.497 -1.332 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -66.82 -54.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.637 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 30.9 pttt -50.93 -46.77 61.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.549 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.626 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -56.4 11.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.414 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.67 HD13 ' CE2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -28.19 -60.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.028 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.4 mtp -46.23 -31.25 2.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.0 OUTLIER -65.83 -39.54 90.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.17 19.69 14.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.585 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.44 -50.42 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 O-C-N 124.722 1.264 . . . . 0.0 112.114 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.68 72.45 10.57 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.42 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.1 m-70 -73.54 142.19 46.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.965 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -103.54 79.32 1.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.929 0.395 . . . . 0.0 111.394 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -66.88 151.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.171 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 1.82 -69.76 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 O-C-N 124.002 0.814 . . . . 0.0 113.817 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -118.91 -44.3 2.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.093 0.473 . . . . 0.0 110.787 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.545 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -89.82 152.29 21.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.615 -178.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.52 144.35 46.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.169 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.611 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -155.41 164.48 38.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -178.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 44.9 tt0 -72.74 92.01 1.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.453 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.651 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.3 mt -81.38 81.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.935 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.7 OUTLIER -96.64 119.06 34.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -27.87 119.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 122.264 1.031 . . . . 0.0 110.197 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.668 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.424 -1.731 0 CA-C-N 113.186 -1.824 . . . . 0.0 113.323 -175.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.619 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 41.3 t . . . . . 0 CA--C 1.491 -1.304 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 20.2 mttt -150.81 -33.55 0.16 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.81 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.617 ' CD ' ' HB2' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -104.9 -166.96 1.29 Allowed 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.596 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 12.4 pt -164.05 139.1 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.421 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -110.48 98.4 7.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.096 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.625 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.1 t -80.83 148.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.556 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -95.45 -171.74 36.41 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.766 -0.73 . . . . 0.0 114.085 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -21.51 148.44 0.0 OUTLIER Glycine 0 C--N 1.343 0.97 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.609 ' HB3' ' SG ' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -169.9 -144.85 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.549 ' O ' HD12 ' A' ' 189' ' ' LEU . 36.0 m -89.39 129.63 46.71 Favored Pre-proline 0 C--N 1.343 0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -29.66 -31.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.546 2.831 . . . . 0.0 113.532 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 190' ' ' SER . 41.7 m-20 -151.14 54.2 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 24.1 m -41.16 117.46 1.57 Allowed Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.371 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.543 ' HG2' ' CE ' ' A' ' 197' ' ' LYS . 9.0 Cg_endo -49.9 101.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.882 2.388 . . . . 0.0 112.209 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -48.38 -18.28 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.973 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 60.1 mt-10 -63.92 -37.43 87.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.543 ' CE ' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -81.52 -45.88 15.3 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.618 HG22 HD11 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -51.13 -27.59 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.346 176.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.522 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 1.2 mtt180 -77.04 -27.88 54.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.812 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.2 mm-40 -85.76 -62.74 1.46 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.586 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.665 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -41.3 -40.93 1.79 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.756 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -98.11 -34.15 10.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.614 -178.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.36 -45.68 95.45 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 176.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.67 -22.41 68.03 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.756 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -65.82 -36.94 84.89 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 122.521 1.153 . . . . 0.0 108.227 177.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.74 -162.15 35.61 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.863 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.7 mt-10 -76.58 93.09 3.54 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.557 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 209' ' ' GLU . 1.6 t -53.73 142.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.538 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -89.53 -44.05 10.38 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 67.2 m -170.92 172.42 5.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.112 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.667 HG21 HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -137.13 161.08 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.981 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.426 ' OE2' ' C ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -161.33 143.94 12.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.492 HD13 HD23 ' A' ' 189' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 111.319 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.527 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 21.41 78.62 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.472 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.604 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 8.4 p90 -130.1 -130.15 0.21 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.528 ' CB ' ' HB ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.386 0.612 . . . . 0.0 111.375 178.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.703 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 3.0 m-85 -151.02 111.58 4.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.912 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.667 HG12 HG21 ' A' ' 211' ' ' ILE . 1.5 mt -112.8 148.49 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.595 ' N ' HG22 ' A' ' 228' ' ' ILE . 8.4 m -124.56 152.28 43.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.126 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 68.6 m-85 -132.11 119.02 20.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.538 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.21 -38.19 0.74 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.2 mt-10 -89.06 -155.48 0.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.711 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 2.0 pm0 -141.83 4.89 1.72 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.552 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.522 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 14.2 mt-10 -86.63 -56.15 0.36 Allowed Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.741 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 94.0 Cg_exo -51.45 -31.99 41.06 Favored 'Trans proline' 0 CA--C 1.494 -1.482 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.578 ' CG1' ' O ' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -65.41 -50.62 71.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.342 177.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 22.3 mttm -47.93 -58.64 4.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.043 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.669 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.23 -51.99 66.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.155 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.661 HG21 ' CE1' ' A' ' 245' ' ' HIS . 0.7 OUTLIER -36.65 -63.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.114 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.52 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -52.56 -18.17 1.6 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.298 -179.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' LYS . 14.0 mm-40 -76.67 -33.52 58.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.81 24.15 13.51 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.766 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.576 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.34 -47.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.354 1.034 . . . . 0.0 112.122 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 242' ' ' LYS . 23.0 m-85 -84.69 69.87 10.71 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.529 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.661 ' CE1' HG21 ' A' ' 239' ' ' ILE . 9.4 m-70 -70.46 156.22 39.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.832 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -122.04 72.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.639 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -61.55 141.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.446 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 12.14 -76.82 0.0 OUTLIER Glycine 0 C--N 1.338 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 113.899 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.99 -42.5 3.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 247' ' ' VAL . 14.5 m -88.01 145.37 26.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.702 0.763 . . . . 0.0 112.645 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -135.6 133.28 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 107.888 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -152.54 163.53 39.41 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 118.636 -1.226 . . . . 0.0 114.27 -176.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.448 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 42.5 tt0 -67.57 108.66 2.95 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.215 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.656 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.1 mt -98.49 79.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.196 -1.365 . . . . 0.0 112.453 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.39 119.92 28.15 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.557 ' O ' ' CG1' ' A' ' 256' ' ' VAL . 2.9 p -36.25 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 123.051 1.405 . . . . 0.0 110.876 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.703 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.412 -2.368 0 CA-C-N 112.097 -2.32 . . . . 0.0 112.059 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.59 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 29.2 t . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 21.9 mttt -150.31 -35.03 0.16 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.133 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.615 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -94.18 -170.84 2.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.628 HG13 ' O ' ' A' ' 184' ' ' ILE . 11.6 pt -165.33 117.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.709 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -93.06 100.22 12.68 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.879 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.8 t -85.04 111.26 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.067 0.947 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -97.77 119.43 6.42 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.117 1.207 . . . . 0.0 116.117 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 98.72 105.95 2.59 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 114.903 0.721 . . . . 0.0 114.903 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.616 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -166.07 -157.63 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 192' ' ' ASP . 58.8 m -89.25 133.17 35.54 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -29.76 -31.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.695 2.93 . . . . 0.0 113.663 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.8 m-20 -150.41 54.2 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.431 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 32.4 m -40.65 128.49 1.86 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 198' ' ' ILE . 6.3 Cg_endo -49.2 90.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.164 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.576 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.9 OUTLIER -42.43 -23.57 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.511 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.64 -37.56 87.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.1 mmmt -77.36 -48.27 17.74 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.622 HG23 HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.73 -26.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.256 177.286 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.51 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.4 mtt85 -79.67 -27.25 40.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.937 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 pt-20 -86.42 -50.96 6.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.7 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -51.57 -40.24 59.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.541 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.741 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.8 OUTLIER -98.93 -30.31 12.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.176 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.63 -47.36 87.51 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -61.66 -23.57 63.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 176.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.772 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.38 -34.23 77.5 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.044 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.25 -142.53 8.14 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 8.7 mt-10 -90.72 94.67 9.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.256 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -56.59 143.1 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.58 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.5 tp10 -89.27 -47.53 7.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 68.1 m -174.06 147.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.374 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.615 HG23 HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.16 161.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.437 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.3 OUTLIER -160.47 127.76 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 111.226 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.508 ' CD2' HD13 ' A' ' 198' ' ' ILE . 1.5 mm? . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.458 0.647 . . . . 0.0 111.803 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 22.43 76.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 O-C-N 123.705 0.628 . . . . 0.0 112.575 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.616 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -147.58 -123.14 0.06 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.48 ' SG ' HD22 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.08 164.57 20.37 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 113.201 178.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.709 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 4.1 m-85 -148.24 116.05 6.37 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 113.626 -1.625 . . . . 0.0 108.742 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.715 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.3 mt -115.17 159.58 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.621 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.7 m -136.83 169.02 18.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.197 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 86.2 m-85 -145.94 116.64 7.65 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.58 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.6 -36.93 0.65 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.539 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 3.7 pm0 -89.03 -155.97 0.37 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.473 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.59 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 19.1 pt-20 -141.17 -2.59 1.27 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.885 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.7 -57.33 0.83 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 -177.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.772 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.9 Cg_exo -51.04 -34.18 45.89 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.572 ' HB ' HG12 ' A' ' 181' ' ' VAL . 1.1 t -64.72 -51.48 66.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.85 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 16.8 mtpt -44.99 -58.79 2.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.933 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.647 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.67 -52.76 64.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.627 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.652 HD13 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -33.92 -62.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.175 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.533 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.3 mtp -51.3 -20.85 1.84 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.919 0.39 . . . . 0.0 111.251 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -75.72 -34.28 60.33 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.19 22.39 16.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.617 178.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.76 -48.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 0.0 112.29 -179.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 242' ' ' LYS . 23.4 m-30 -84.4 71.79 10.66 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.66 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.2 m-70 -72.75 154.49 40.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.18 79.56 1.36 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.04 152.53 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.575 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 0.79 -68.85 0.0 OUTLIER Glycine 0 C--N 1.343 0.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.899 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -117.3 -43.59 2.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.0 110.997 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 9.1 m -89.77 153.84 20.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.033 0.921 . . . . 0.0 113.283 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.27 139.77 39.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.183 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.671 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.98 169.57 24.52 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 118.613 -1.235 . . . . 0.0 114.157 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.489 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.3 tt0 -75.88 92.15 3.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.738 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.643 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.3 mt -79.93 81.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.837 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.575 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 2.7 mtpt -93.7 116.98 29.5 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.4 p -29.17 119.65 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 122.267 1.032 . . . . 0.0 110.744 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.658 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.428 -1.557 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.47 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.612 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 40.8 t . . . . . 0 CA--C 1.495 -1.151 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 19.6 mttt -148.34 -35.42 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.867 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -94.79 -175.49 3.59 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.639 HD12 ' CD1' ' A' ' 239' ' ' ILE . 5.4 pt -162.38 117.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.675 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -93.4 109.1 20.67 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.415 -177.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.628 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -97.67 115.32 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.757 0.823 . . . . 0.0 112.984 -178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -49.3 -177.14 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 114.796 0.678 . . . . 0.0 114.796 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -31.49 161.74 0.0 OUTLIER Glycine 0 C--N 1.342 0.914 0 N-CA-C 114.653 0.621 . . . . 0.0 114.653 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.6 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -175.42 -143.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.594 ' N ' HD12 ' A' ' 189' ' ' LEU . 1.3 m -88.5 135.4 32.64 Favored Pre-proline 0 C--N 1.343 0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 44.2 Cg_exo -28.78 -39.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.159 2.573 . . . . 0.0 113.033 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.5 56.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.583 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 86.1 m -39.21 127.95 1.3 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.489 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.9 Cg_endo -50.53 96.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.259 2.64 . . . . 0.0 113.808 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.774 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -39.75 -28.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.207 178.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 194' ' ' PRO . 2.9 mm-40 -61.23 -36.78 80.88 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.183 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 200' ' ' GLU . 3.0 mmmt -77.64 -52.29 9.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.774 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.91 -26.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.04 176.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.549 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.1 mtp180 -82.31 -26.84 32.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.101 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.8 OUTLIER -87.48 -41.12 13.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.998 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.684 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.3 t80 -67.14 -38.27 85.25 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.369 0.604 . . . . 0.0 110.358 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.743 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -98.26 -37.06 9.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.396 -178.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.5 -43.69 96.27 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.14 -23.98 66.69 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.79 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -37.52 86.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.084 0.945 . . . . 0.0 108.902 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.88 -140.51 6.41 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 32.6 mt-10 -92.06 94.6 9.33 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.213 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.95 144.91 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.53 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 15.4 tt0 -89.79 -53.14 4.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 66.8 m -171.22 148.43 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.625 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.667 HG23 HD13 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.64 166.84 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.138 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.443 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -165.36 123.69 1.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.067 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.54 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.5 mm? . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 111.439 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.505 -0.782 0 CA-C-O 119.79 -0.147 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.88 81.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.49 0 O-C-N 124.218 0.949 . . . . 0.0 112.212 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.6 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -149.92 -119.85 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.084 -0.558 . . . . 0.0 109.574 -176.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.49 ' SG ' HD21 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -172.62 168.91 5.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.0 0.905 . . . . 0.0 112.805 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.675 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 4.2 m-85 -150.41 125.37 9.88 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.349 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.668 HD11 ' CG ' ' A' ' 202' ' ' PHE . 1.6 mt -119.92 147.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.528 0.68 . . . . 0.0 110.071 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.617 ' N ' HG21 ' A' ' 228' ' ' ILE . 3.1 m -126.09 153.14 44.91 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.1 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 89.1 m-85 -129.01 120.64 26.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.26 -38.99 2.81 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mt-10 -90.13 -167.1 1.75 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.665 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.612 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -132.56 15.56 4.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.64 -64.88 0.15 Allowed Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.79 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 52.7 Cg_exo -46.34 -35.2 15.44 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.573 ' HB ' HG13 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -65.48 -52.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.241 -1.799 . . . . 0.0 110.349 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.6 pttt -52.26 -45.19 65.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.549 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.647 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.23 -54.78 20.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.618 0.723 . . . . 0.0 109.935 177.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.667 HD13 ' CD2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -29.59 -64.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.159 -179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -49.4 -22.33 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.276 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.4 mm-40 -74.29 -37.1 63.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.613 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -100.33 19.84 15.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.375 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.62 -48.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.52 1.137 . . . . 0.0 112.166 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 242' ' ' LYS . 18.5 m-85 -86.66 71.17 10.41 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.351 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.664 ' CE1' HG22 ' A' ' 239' ' ' ILE . 10.7 m-70 -71.68 148.51 46.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.346 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.74 77.23 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.097 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.516 ' O ' ' C ' ' A' ' 248' ' ' GLY . 2.2 t -62.97 171.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.67 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -14.67 -59.27 0.01 OUTLIER Glycine 0 C--N 1.341 0.806 0 O-C-N 123.781 0.676 . . . . 0.0 113.367 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -132.04 -41.61 1.01 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.398 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.52 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -87.94 152.05 22.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.67 0.748 . . . . 0.0 112.755 -177.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.99 135.61 36.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.812 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.628 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.58 157.56 41.2 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.634 -0.826 . . . . 0.0 112.92 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.571 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 64.8 tt0 -60.76 119.16 7.63 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.649 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.7 mt -104.36 82.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.813 0.816 . . . . 0.0 111.85 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.587 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.0 118.72 26.57 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.197 -1.365 . . . . 0.0 107.695 178.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.5 p -33.73 120.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 119.546 1.066 . . . . 0.0 109.777 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.653 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.423 -1.799 0 CA-C-N 113.226 -1.807 . . . . 0.0 113.053 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.596 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 32.0 t . . . . . 0 CA--C 1.497 -1.091 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.516 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.4 mttt -151.44 -35.17 0.14 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.175 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.644 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -91.73 -173.19 3.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 256' ' ' VAL . 7.8 pt -165.86 108.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 122.519 1.152 . . . . 0.0 109.502 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.66 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -81.53 103.59 11.37 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.754 -178.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.608 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 64.3 t -89.87 131.44 37.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.976 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 188' ' ' GLY . . . -64.33 -176.48 4.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -37.82 172.59 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.023 -0.589 . . . . 0.0 114.128 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.668 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.2 OUTLIER 169.63 -139.8 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.361 -0.135 . . . . 0.0 111.123 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 192' ' ' ASP . 6.1 m -88.78 130.69 44.08 Favored Pre-proline 0 C--N 1.339 0.149 0 CA-C-O 120.966 0.412 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -32.63 -30.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.058 2.505 . . . . 0.0 112.931 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -151.29 54.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 198' ' ' ILE . 47.9 m -39.54 128.51 1.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.268 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.553 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.4 Cg_endo -52.29 96.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.803 2.335 . . . . 0.0 111.889 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' A' ' 198' ' ' ILE . 1.1 pm0 -46.31 -17.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 26.9 mt-10 -65.13 -40.47 94.51 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.6 OUTLIER -78.51 -45.72 21.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.604 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.83 -26.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.892 176.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.532 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.9 mtt85 -77.36 -28.41 52.97 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.514 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.0 mm-40 -85.29 -60.64 1.97 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.773 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.703 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -42.21 -42.55 3.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.768 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -97.88 -31.5 12.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.15 -49.77 71.68 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 176.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.64 -23.26 60.55 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.79 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.29 -36.74 85.09 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.825 0.822 . . . . 0.0 108.805 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.62 -139.01 5.62 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.908 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 66.9 mt-10 -91.71 89.7 7.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.996 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -55.57 141.07 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.544 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.6 tp10 -90.08 -48.3 7.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 21.5 m -174.27 149.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.626 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.29 156.92 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.748 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -154.19 125.74 7.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.558 HD22 ' CD1' ' A' ' 198' ' ' ILE . 3.2 mm? . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 121.219 0.533 . . . . 0.0 111.103 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.588 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.67 82.23 0.01 OUTLIER Glycine 0 C--N 1.336 0.547 0 O-C-N 124.114 0.884 . . . . 0.0 112.008 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.668 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -149.93 -116.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.497 ' HB2' HD21 ' A' ' 189' ' ' LEU . 0.5 OUTLIER -174.07 169.26 4.01 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.496 1.141 . . . . 0.0 112.824 177.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.662 ' CE2' ' CB ' ' A' ' 257' ' ' ALA . 3.7 m-85 -151.51 110.6 3.9 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.858 -1.973 . . . . 0.0 108.519 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.706 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.2 mt -108.72 159.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.333 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.8 m -137.38 170.8 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.158 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.8 m-85 -148.02 114.08 5.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.544 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -38.67 -35.34 0.19 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 17.2 mt-10 -88.6 -153.63 0.26 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.772 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.7 OUTLIER -148.44 13.27 0.95 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.075 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.636 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 1.2 mt-10 -94.27 -57.81 0.21 Allowed Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.79 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 87.7 Cg_exo -51.43 -31.94 40.67 Favored 'Trans proline' 0 CA--C 1.496 -1.417 0 N-CA-C 108.793 -1.272 . . . . 0.0 108.793 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.561 HG11 HG22 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -68.01 -55.02 18.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.821 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -50.99 -42.39 60.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.157 -179.179 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.641 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.06 -54.62 10.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.601 0.715 . . . . 0.0 109.957 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.658 ' CG2' ' CG2' ' A' ' 254' ' ' ILE . 0.4 OUTLIER -28.2 -63.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.865 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.487 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 19.2 mtm -45.76 -29.63 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.7 mm-40 -64.78 -40.9 96.03 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.36 20.51 13.56 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.586 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.49 -50.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.635 1.209 . . . . 0.0 112.185 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.5 m-85 -85.58 69.29 10.63 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.2 m-70 -69.18 149.7 48.3 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.74 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -112.62 80.72 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -74.04 100.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.04 -84.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.707 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -105.54 -42.18 5.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 247' ' ' VAL . 56.1 m -88.81 146.84 24.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.721 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.42 138.32 32.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.475 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.608 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.99 153.59 26.33 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.664 -177.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.563 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 28.2 tt0 -57.96 114.55 2.39 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.969 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.658 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.8 mt -103.33 83.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.793 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.573 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -91.86 117.78 30.11 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.351 178.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 4.3 p -30.57 122.75 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 119.376 0.989 . . . . 0.0 109.936 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.662 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.431 -1.421 0 CA-C-N 113.677 -1.602 . . . . 0.0 113.004 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.588 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 28.3 t . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 26.0 mttt -152.55 -34.97 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.717 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -93.58 -179.32 4.99 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.654 179.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 184' ' ' ILE . 5.9 pt -161.1 112.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 122.098 0.952 . . . . 0.0 108.897 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.718 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -87.04 104.7 16.57 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.147 -177.334 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.602 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.6 t -91.02 112.11 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.431 0.693 . . . . 0.0 111.44 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . -52.38 -172.64 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.5 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -28.16 156.95 0.0 OUTLIER Glycine 0 N--CA 1.468 0.794 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -171.08 -145.41 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.57 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.74 132.4 38.66 Favored Pre-proline 0 C--N 1.341 0.215 0 CA-C-O 120.8 0.333 . . . . 0.0 110.213 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 73.4 Cg_exo -29.7 -33.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.298 2.665 . . . . 0.0 113.126 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 190' ' ' SER . 1.9 m-20 -150.92 54.33 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.408 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.537 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 25.5 m -39.95 122.54 1.57 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.582 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 11.2 Cg_endo -53.81 98.56 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.89 2.393 . . . . 0.0 112.22 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.585 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.5 OUTLIER -44.73 -21.39 0.05 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.766 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 2.2 mp0 -62.1 -39.09 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.582 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -80.28 -44.97 18.71 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.59 -28.63 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.172 -1.377 . . . . 0.0 108.899 177.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER -76.07 -27.99 57.44 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.366 177.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mm-40 -84.03 -61.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.898 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.679 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.3 t80 -41.68 -39.38 1.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.284 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.724 ' CG ' HD11 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -100.81 -33.93 10.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.372 -177.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.59 -48.28 82.84 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -62.3 -23.06 63.95 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 176.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.738 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -65.93 -38.15 87.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 122.153 0.978 . . . . 0.0 108.849 177.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.24 -143.01 8.04 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.639 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.6 mt-10 -92.05 97.15 10.76 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.293 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -61.39 143.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.53 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 13.4 tt0 -89.07 -52.45 5.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 60.7 p -169.67 147.47 3.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.628 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.643 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.32 161.68 8.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.449 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.55 128.55 5.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.304 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.492 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 1.5 mm? . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 121.442 0.639 . . . . 0.0 110.996 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.553 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.507 -0.683 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.93 78.08 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 O-C-N 124.005 0.816 . . . . 0.0 112.994 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.604 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.86 -121.21 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.508 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.81 166.5 11.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.099 0.952 . . . . 0.0 112.888 178.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 4.0 m-85 -148.24 119.58 7.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.318 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.724 HD11 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -115.75 146.18 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.631 0.729 . . . . 0.0 110.3 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 3.3 m -124.15 164.52 19.31 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.101 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 96.4 m-85 -139.44 119.85 13.93 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -42.57 -38.93 2.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.4 mm-40 -91.21 -168.04 1.96 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.488 -1.687 . . . . 0.0 110.732 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.588 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 4.8 pt-20 -129.6 16.8 5.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -89.62 -64.49 0.19 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.675 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.9 Cg_exo -46.13 -30.83 8.01 Favored 'Trans proline' 0 CA--C 1.5 -1.182 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.56 ' HB ' HG13 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -72.23 -54.49 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.757 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -51.18 -32.9 25.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.541 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.648 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -83.75 -56.48 3.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.147 178.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.738 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.8 OUTLIER -30.28 -57.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.322 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.522 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.8 mtp -51.24 -19.67 1.32 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.859 0.361 . . . . 0.0 111.733 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.8 mm-40 -79.62 -33.57 41.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.58 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -107.67 21.85 16.84 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.309 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.587 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -18.61 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.218 0.949 . . . . 0.0 112.117 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.587 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 22.0 m-85 -85.84 78.97 9.42 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.747 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.692 ' CE1' HG12 ' A' ' 239' ' ' ILE . 13.9 m-70 -76.18 -170.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.9 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.5 m-80 -151.54 81.32 1.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -81.33 106.59 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.504 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 38.73 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.381 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -95.6 -43.0 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 111.457 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -88.51 150.26 23.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -147.96 133.1 18.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.331 179.347 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.602 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -154.13 173.72 15.69 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.567 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 61.5 tt0 -76.91 97.78 4.7 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.452 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.665 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.8 mt -86.59 83.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.709 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.589 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.3 mtpt -94.99 122.46 37.67 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.7 p -32.91 110.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.631 1.205 . . . . 0.0 110.524 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.658 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.419 -2.021 0 CA-C-N 112.65 -2.068 . . . . 0.0 112.977 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.587 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 38.5 t . . . . . 0 CA--C 1.492 -1.261 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 18.0 mttt -150.32 -34.02 0.17 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.65 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.641 ' HD3' ' CB ' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -103.53 -168.52 1.52 Allowed 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 239' ' ' ILE . 16.7 pt -163.02 138.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.605 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.63 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -108.87 91.13 3.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.112 0.482 . . . . 0.0 112.24 -178.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 252' ' ' CYS . 2.0 t -68.21 138.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.566 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -130.71 111.49 1.13 Allowed Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.995 -1.098 . . . . 0.0 114.483 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.482 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . 108.87 102.97 2.8 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.638 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.597 ' C ' ' CD1' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -170.59 -154.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.498 ' O ' HD11 ' A' ' 189' ' ' LEU . 14.0 m -89.46 136.64 29.59 Favored Pre-proline 0 C--N 1.341 0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.499 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -31.3 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.38 2.72 . . . . 0.0 113.515 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 190' ' ' SER . 8.4 t0 -150.98 56.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.511 ' CG2' HD13 ' A' ' 198' ' ' ILE . 2.6 m -39.13 128.97 1.26 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . 5.2 Cg_endo -47.16 97.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.858 2.372 . . . . 0.0 112.191 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 3.5 pt-20 -48.02 -17.95 0.16 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.11 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.79 -36.93 83.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.7 OUTLIER -80.0 -46.26 16.95 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.622 HG21 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.08 -31.5 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.519 176.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.537 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 5.3 mtp180 -74.13 -28.89 61.55 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.176 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -87.57 -63.76 1.25 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.992 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.659 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -39.65 -37.16 0.48 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.76 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -101.16 -33.25 10.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.222 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.93 -43.6 98.97 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.42 -21.26 72.29 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 176.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.773 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -34.85 79.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 108.7 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.72 -144.9 9.74 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.633 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.6 mm-40 -90.52 91.16 8.32 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 121.881 -0.776 . . . . 0.0 110.539 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.49 141.25 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.498 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.7 tp10 -89.54 -45.72 9.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.433 ' C ' HG12 ' A' ' 211' ' ' ILE . 15.3 m -171.29 173.09 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.298 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.639 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.31 164.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.563 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.505 ' CG ' ' C ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -172.43 128.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 225' ' ' PHE . 3.0 mm? . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.519 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 27.19 78.52 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.136 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 7.5 p90 -140.04 -131.32 0.11 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.539 ' CB ' ' HB ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -151.41 164.17 37.32 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.11 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.715 ' CE2' ' HB3' ' A' ' 257' ' ' ALA . 3.0 m-85 -150.61 113.49 4.77 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.129 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.655 HD12 ' CE1' ' A' ' 202' ' ' PHE . 1.3 mt -115.19 150.69 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 121.724 0.773 . . . . 0.0 110.88 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.4 m -127.17 151.58 48.49 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.929 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 76.5 m-85 -130.92 119.2 21.78 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -40.69 -37.85 0.81 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -88.84 -158.68 0.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.373 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.587 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 15.5 pt-20 -137.63 0.64 2.26 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.058 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 238' ' ' LYS . 3.7 mm-40 -79.2 -58.62 0.67 Allowed Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.773 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 72.5 Cg_exo -50.0 -35.35 40.96 Favored 'Trans proline' 0 CA--C 1.488 -1.797 0 CA-C-N 120.485 1.209 . . . . 0.0 109.023 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.571 ' CG1' ' O ' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -64.12 -51.99 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 113.251 -1.795 . . . . 0.0 108.726 178.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 24.9 mttt -44.62 -58.65 2.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.13 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.668 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.85 -53.47 57.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.825 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -32.16 -64.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.65 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.42 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.6 mtp -48.3 -29.63 4.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 26.3 mm-40 -66.67 -37.39 84.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.67 19.84 17.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.271 177.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.555 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.45 -50.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.646 1.216 . . . . 0.0 112.12 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.4 m-85 -85.35 71.41 10.82 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.258 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.7 m-70 -70.8 152.88 43.28 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.225 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.417 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -114.25 74.21 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.72 100.76 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.794 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.3 -85.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.626 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.548 ' CD2' ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -104.26 -42.09 5.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.299 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 37.5 m -87.8 144.49 26.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.031 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.72 140.15 36.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.348 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.619 ' HB2' HG11 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.75 168.93 24.75 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -177.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.459 ' OE1' ' HE3' ' A' ' 255' ' ' LYS . 43.9 tt0 -73.38 96.64 2.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.648 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.6 mt -85.73 81.97 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -90.91 121.39 32.71 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.558 ' O ' ' CG1' ' A' ' 256' ' ' VAL . 2.0 p -36.11 100.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.286 1.517 . . . . 0.0 111.214 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.715 ' HB3' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.414 -2.233 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.89 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.605 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 21.9 t . . . . . 0 CA--C 1.499 -0.994 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 24.1 mttt -150.41 -35.16 0.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.137 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.1 OUTLIER -94.58 -176.57 3.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 184' ' ' ILE . 4.8 pt -161.08 114.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.057 0.932 . . . . 0.0 109.297 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.703 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -91.75 106.43 18.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.485 -177.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 252' ' ' CYS . 2.8 t -92.17 111.71 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.642 0.777 . . . . 0.0 112.842 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . -45.58 -176.84 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.46 162.86 0.0 OUTLIER Glycine 0 C--N 1.34 0.787 0 N-CA-C 115.019 0.767 . . . . 0.0 115.019 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.656 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -178.82 -143.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.57 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.8 m -89.21 131.32 41.09 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.425 ' C ' ' O ' ' A' ' 190' ' ' SER . 33.0 Cg_exo -27.36 -35.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.47 2.78 . . . . 0.0 113.494 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -150.96 54.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.06 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.554 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 51.9 m -40.23 125.67 1.72 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 110.413 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PRO . . . . . 0.58 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -47.13 101.62 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.399 2.733 . . . . 0.0 113.905 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.792 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.38 -20.41 0.22 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.972 178.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 10.6 mm-40 -66.34 -39.99 89.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 200' ' ' GLU . 2.5 mttp -76.27 -50.53 14.14 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.792 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -45.72 -28.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.692 176.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.5 mtp180 -77.13 -29.84 54.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.358 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.7 pt-20 -86.99 -54.12 4.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.698 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -50.7 -37.8 43.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 110.663 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.731 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -100.44 -34.46 9.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.498 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.2 -44.69 96.71 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.0 -23.98 66.45 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.773 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.01 -35.91 81.84 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 122.032 0.92 . . . . 0.0 108.599 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -142.43 7.83 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.971 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -91.0 94.8 9.8 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.688 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -58.64 144.59 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLU . . . . . 0.549 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 3.9 tp10 -89.86 -50.91 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.1 p -172.04 156.61 4.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.443 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.664 HG22 HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -119.95 167.52 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.002 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -165.02 123.71 1.72 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.684 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 121.287 0.565 . . . . 0.0 111.952 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.586 ' O ' ' C ' ' A' ' 224' ' ' GLY . 3.2 mtp85 . . . . . 0 CA--C 1.502 -0.896 0 CA-C-O 120.212 0.053 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.42 78.93 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 O-C-N 124.588 1.18 . . . . 0.0 111.624 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PHE . . . . . 0.656 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -138.71 -121.38 0.13 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -165.32 163.11 20.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.973 0.892 . . . . 0.0 112.594 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.703 ' CE2' ' HB2' ' A' ' 185' ' ' PHE . 3.4 m-85 -147.83 124.54 11.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.864 -1.517 . . . . 0.0 108.97 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.667 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.6 mt -121.33 150.93 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 CA-C-O 121.555 0.693 . . . . 0.0 109.944 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 228' ' ' ILE . 2.9 m -129.85 152.41 49.36 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.212 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 87.3 m-85 -130.32 117.26 19.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.549 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.72 -37.31 0.73 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . 0.515 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.59 -155.93 0.35 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.494 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.605 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.2 pt-20 -143.12 4.17 1.42 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.51 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.9 OUTLIER -84.53 -58.51 0.36 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PRO . . . . . 0.773 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.6 Cg_exo -49.77 -34.68 36.67 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.574 HG11 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.28 -51.11 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.801 178.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 6.3 mtpt -45.86 -60.13 2.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.933 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.681 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.99 -52.75 64.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.69 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.661 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -34.72 -66.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.259 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.466 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.2 mtp -48.83 -25.56 1.94 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.563 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -69.35 -38.35 78.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.36 21.14 15.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 177.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.51 -49.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.669 1.231 . . . . 0.0 111.878 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.7 m-85 -85.2 71.85 10.82 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.504 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' HIS . . . . . 0.643 ' CE1' HG22 ' A' ' 239' ' ' ILE . 9.6 m-70 -72.62 153.04 41.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.226 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -115.51 76.38 1.0 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -69.14 101.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.149 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.74 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.45 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -101.89 -41.84 6.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.126 0.489 . . . . 0.0 110.892 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 247' ' ' VAL . 21.0 m -88.41 146.82 25.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.514 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.38 139.82 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.75 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' CYS . . . . . 0.612 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 166.06 32.83 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLU . . . . . 0.419 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 48.4 tt0 -71.95 93.58 1.37 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.227 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ILE . . . . . 0.642 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.5 mt -79.78 80.86 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.133 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -87.89 122.58 31.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.0 p -33.82 122.32 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 122.244 1.021 . . . . 0.0 109.912 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.66 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.429 -1.517 0 CA-C-N 113.204 -1.817 . . . . 0.0 113.494 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 30.2 t . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 18.5 mttt -150.14 -35.11 0.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.591 -1.244 . . . . 0.0 112.462 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.652 ' CD ' ' HB1' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -102.55 -167.46 1.4 Allowed 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.603 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 17.3 pt -165.11 139.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.261 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.664 ' CD2' ' C5 ' ' B' ' 3' ' ' ' DA' . 0.8 OUTLIER -109.32 96.75 6.5 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.382 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.638 HG13 ' HB2' ' A' ' 252' ' ' CYS . 2.0 t -79.39 122.09 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.576 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -67.32 -170.34 4.61 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.924 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -26.14 158.03 0.0 OUTLIER Glycine 0 N--CA 1.466 0.675 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -177.24 -143.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.526 ' O ' HD12 ' A' ' 189' ' ' LEU . 10.7 t -89.69 134.52 32.12 Favored Pre-proline 0 C--N 1.344 0.33 0 CA-C-O 121.13 0.49 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 190' ' ' SER . 80.8 Cg_exo -28.65 -35.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.432 2.755 . . . . 0.0 113.22 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 190' ' ' SER . 34.7 p30 -151.36 56.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.158 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 6.1 m -39.4 123.23 1.39 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.549 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 6.6 Cg_endo -48.79 99.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.661 2.24 . . . . 0.0 112.23 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.577 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.45 -19.59 0.18 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.442 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 26.0 mt-10 -64.29 -39.0 93.03 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.549 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -77.56 -46.77 21.24 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.99 -29.79 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.832 176.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.503 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 4.7 mtt180 -75.83 -28.57 58.32 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.86 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -86.12 -63.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.792 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -39.75 -39.16 0.74 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.556 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.748 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -99.64 -34.16 10.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.452 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.42 -45.59 96.09 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.28 -23.29 68.08 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.0 -33.69 76.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 122.053 0.93 . . . . 0.0 108.651 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.24 -139.72 6.29 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.01 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.5 mm-40 -91.57 94.24 9.33 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.097 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.54 142.6 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.557 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 11.3 tt0 -89.6 -52.45 5.0 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.1 p -169.82 152.92 4.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.35 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.657 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.72 167.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.491 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -167.2 130.15 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.478 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.497 ' CD2' HD13 ' A' ' 198' ' ' ILE . 2.3 mm? -118.43 104.5 47.67 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.629 ' HG2' ' CD2' ' A' ' 225' ' ' PHE . 72.6 Cg_exo -48.95 -158.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.508 2.805 . . . . 0.0 113.778 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.49 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER 158.61 125.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.285 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 8.3 p-10 -62.73 71.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.54 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 215' ' ' MET . 18.3 t-20 -130.6 -13.42 3.77 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.805 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.512 ' C ' HG22 ' A' ' 219' ' ' THR . 0.0 OUTLIER -106.16 -22.06 12.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.932 0.396 . . . . 0.0 111.355 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.532 HG21 ' CZ ' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -136.0 -16.13 1.71 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.05 -178.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.4 m120 68.39 48.48 0.86 Allowed 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.572 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -119.35 -156.43 0.66 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.985 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.705 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -85.51 -38.71 18.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 122.421 -0.174 . . . . 0.0 110.578 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.705 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.7 OUTLIER 4.37 -106.36 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 124.305 1.003 . . . . 0.0 111.193 -178.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.53 ' O ' HD13 ' A' ' 189' ' ' LEU . . . 32.21 76.1 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.675 ' CZ ' " H4'" ' B' ' 3' ' ' ' DA' . 8.1 p90 -135.4 -128.95 0.15 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.85 162.44 39.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.64 0.733 . . . . 0.0 111.326 178.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.73 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 2.8 m-85 -149.95 124.62 9.76 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.664 HD11 ' CE1' ' A' ' 202' ' ' PHE . 1.4 mt -122.94 153.06 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.972 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.594 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.6 m -130.03 152.87 49.01 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.016 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.5 m-85 -130.1 120.62 24.93 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -40.81 -37.53 0.79 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.8 mt-10 -90.85 -157.64 0.5 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.572 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -137.53 1.23 2.35 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.04 -60.46 0.49 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.775 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 63.9 Cg_exo -48.89 -33.83 26.77 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.578 ' HB ' HG11 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -64.73 -51.16 70.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.747 178.141 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -46.12 -57.41 4.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.081 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.669 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.19 -52.83 63.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.679 179.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.653 HG22 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -34.2 -64.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.133 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.49 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.0 OUTLIER -48.72 -26.73 2.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.894 0.378 . . . . 0.0 110.588 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.1 mm-40 -68.1 -40.07 82.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.56 13.94 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.345 178.004 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.72 -50.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.562 1.164 . . . . 0.0 111.998 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.6 m-85 -84.29 74.15 10.37 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.449 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.653 ' CE1' HG22 ' A' ' 239' ' ' ILE . 10.0 m-70 -74.81 152.24 38.99 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.388 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 74.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.371 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -66.05 103.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.23 -83.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.86 -41.23 5.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.175 0.512 . . . . 0.0 110.538 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 67.7 m -87.87 145.46 26.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.398 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.98 141.61 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.848 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.638 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.97 167.58 29.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.483 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 44.5 tt0 -73.11 95.09 2.01 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.511 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.643 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.6 mt -83.03 78.96 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.716 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.32 123.67 33.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.571 ' O ' ' CG1' ' A' ' 256' ' ' VAL . 1.9 p -37.41 99.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 123.331 1.538 . . . . 0.0 111.035 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.728 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -44.98 -171.57 0.0 OUTLIER 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.006 -2.361 . . . . 0.0 112.998 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.641 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 171.76 144.06 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.088 -1.869 . . . . 0.0 110.584 178.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.787 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.903 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.837 0 O4'-C1'-C2' 107.203 1.003 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.675 " H4'" ' CZ ' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 N19-C1'-C2' 112.961 -0.774 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.822 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.429 -0.71 0 C4'-C3'-C2' 101.353 -1.847 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.822 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.506 -1.066 0 C4'-C3'-C2' 104.275 1.075 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.614 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 36.7 t . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 22.8 mttt -151.86 -34.83 0.13 Allowed 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.411 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -95.36 -175.11 3.39 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.255 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.614 HD12 ' CD1' ' A' ' 239' ' ' ILE . 8.2 pt -163.08 120.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.704 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -95.68 104.46 16.38 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.389 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.605 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.9 t -90.73 112.76 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.763 0.825 . . . . 0.0 112.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.533 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -48.44 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.632 0.613 . . . . 0.0 114.632 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.92 160.98 0.0 OUTLIER Glycine 0 C--N 1.341 0.846 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.618 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -173.33 -144.8 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.574 ' N ' HD12 ' A' ' 189' ' ' LEU . 70.1 m -88.88 135.59 31.76 Favored Pre-proline 0 C--N 1.342 0.261 0 CA-C-O 120.977 0.418 . . . . 0.0 110.623 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 190' ' ' SER . 56.6 Cg_exo -28.77 -37.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.325 2.684 . . . . 0.0 113.051 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 190' ' ' SER . 62.4 t0 -151.4 54.23 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.08 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.573 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 86.3 m -39.87 123.87 1.57 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.149 0.499 . . . . 0.0 110.75 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.579 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 10.1 Cg_endo -51.2 101.95 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.351 2.701 . . . . 0.0 113.728 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.791 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.2 OUTLIER -45.74 -20.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.145 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.5 mt-10 -65.2 -41.96 94.02 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.579 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 2.2 mttp -75.34 -50.03 17.26 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.791 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.48 -26.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.975 176.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.555 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.4 mtp180 -80.12 -28.65 38.93 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.302 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.9 pt-20 -86.89 -47.56 8.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.597 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.691 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.4 t80 -56.46 -40.73 75.32 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 110.342 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.768 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.9 OUTLIER -97.95 -33.9 11.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.43 -44.22 95.6 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.44 -23.2 68.31 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.768 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -66.4 -36.32 82.53 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.155 0.979 . . . . 0.0 108.88 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.9 -142.78 7.99 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.651 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 27.2 mt-10 -91.09 92.59 8.77 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.976 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.15 143.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.0 tp10 -89.64 -46.9 8.31 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.419 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 3.0 p -175.16 152.64 1.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.788 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.671 HG23 HD12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -116.02 161.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.956 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.571 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.5 OUTLIER -159.02 125.64 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.922 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.504 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 1.0 OUTLIER -108.86 94.02 13.63 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 121.473 0.654 . . . . 0.0 111.054 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.577 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 71.4 Cg_exo -47.81 -167.22 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.737 2.958 . . . . 0.0 113.333 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.578 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 154.67 120.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.087 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -35.43 85.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.777 -179.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 215' ' ' MET . 20.6 t-20 -139.92 -13.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.517 ' C ' HG21 ' A' ' 219' ' ' THR . 23.0 mmmt -119.99 -12.74 9.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.74 0.305 . . . . 0.0 111.704 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.517 HG21 ' C ' ' A' ' 218' ' ' LYS . 0.1 OUTLIER -143.24 -13.19 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 219' ' ' THR . 25.7 m-20 66.33 44.45 2.45 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.564 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -117.9 -155.3 0.59 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.101 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.642 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -86.47 -40.04 15.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.75 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.642 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.7 OUTLIER 10.87 -93.4 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.907 0.754 . . . . 0.0 111.204 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 20.9 76.46 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 O-C-N 123.906 0.754 . . . . 0.0 112.032 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.618 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -144.27 -121.73 0.08 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -178.068 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.504 ' HB3' ' CD1' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -166.37 164.3 17.46 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.153 0.978 . . . . 0.0 113.251 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.798 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.8 m-85 -147.83 117.0 6.86 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.764 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.742 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -114.35 147.57 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.606 0.717 . . . . 0.0 110.354 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.592 ' N ' HG21 ' A' ' 228' ' ' ILE . 1.2 m -120.21 172.36 7.84 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.43 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 95.4 m-85 -150.63 111.83 4.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -39.33 -37.13 0.41 Allowed 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 230' ' ' PHE . 21.8 mt-10 -89.09 -155.56 0.35 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.776 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.614 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.4 pt-20 -142.33 -0.93 1.22 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.953 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.13 -58.93 0.56 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.766 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 50.9 Cg_exo -48.09 -36.32 28.07 Favored 'Trans proline' 0 CA--C 1.491 -1.654 0 N-CA-C 108.845 -1.252 . . . . 0.0 108.845 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 183' ' ' LYS . 1.0 OUTLIER -63.14 -51.79 67.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.177 -1.829 . . . . 0.0 108.921 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -45.04 -59.45 2.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.126 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.667 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.28 -54.23 49.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.539 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.661 HD12 ' CE2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -33.42 -64.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.142 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.488 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -48.04 -36.18 12.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 238' ' ' LYS . 12.1 mt-10 -60.52 -38.85 85.76 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -103.28 21.65 15.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.558 177.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.53 -50.08 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 O-C-N 124.493 1.12 . . . . 0.0 112.069 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.6 m-85 -83.44 74.91 10.04 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.627 ' CE1' HG23 ' A' ' 239' ' ' ILE . 8.1 m170 -76.65 159.35 30.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 7.4 m-80 -123.01 79.13 1.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.167 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.67 107.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 37.25 -88.18 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.611 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -95.52 -44.93 7.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 247' ' ' VAL . 5.4 m -88.9 148.09 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.24 140.39 30.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.372 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.605 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.25 166.81 30.5 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.523 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 51.7 tt0 -71.42 97.44 1.63 Allowed 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.411 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.649 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.4 mt -86.55 80.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.968 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.2 OUTLIER -89.18 122.63 32.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.4 p -34.52 116.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 122.434 1.112 . . . . 0.0 110.036 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.669 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -72.93 -177.63 2.47 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.518 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.559 ' HG3' ' N1 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -152.34 -151.25 0.37 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.703 -1.59 . . . . 0.0 111.16 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.85 -179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.767 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.798 0 C3'-C2'-C1' 104.247 1.105 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.971 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.804 0 C3'-C2'-C1' 101.78 -0.657 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.971 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.518 -1.021 0 C4'-C3'-C2' 100.993 -2.207 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.553 ' C6 ' ' N7 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.955 0 O4'-C4'-C3' 106.136 0.536 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.591 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 37.6 t . . . . . 0 CA--C 1.497 -1.074 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 23.8 mttt -151.2 -34.9 0.14 Allowed 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.073 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.652 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -92.08 -172.47 3.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.188 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.665 HG13 ' O ' ' A' ' 184' ' ' ILE . 5.9 pt -166.45 111.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 122.12 0.962 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.709 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -87.16 107.74 18.6 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.593 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.608 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.9 t -94.42 109.55 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.461 0.704 . . . . 0.0 112.299 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.33 -176.77 0.01 OUTLIER Glycine 0 N--CA 1.476 1.366 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -30.68 160.36 0.0 OUTLIER Glycine 0 C--N 1.344 1.025 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.618 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -174.07 -142.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.537 ' N ' HD11 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -89.04 132.1 39.0 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 110.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -31.96 -33.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.152 2.568 . . . . 0.0 113.01 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 190' ' ' SER . 16.5 t0 -150.99 53.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.623 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.545 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 52.2 m -40.21 121.68 1.63 Allowed Pre-proline 0 C--N 1.33 -0.246 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -52.01 94.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.634 2.223 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.577 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -41.91 -24.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.296 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 194' ' ' PRO . 36.2 mt-10 -61.22 -34.79 75.68 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.568 ' HD3' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -86.11 -35.05 20.45 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.619 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.6 OUTLIER -62.08 -25.24 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.614 176.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.527 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 19.2 mtp180 -77.61 -25.73 50.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 197' ' ' LYS . 3.7 mt-10 -86.07 -60.01 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.928 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.709 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -43.3 -40.63 3.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.761 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.768 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -99.6 -30.66 12.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 -178.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -46.22 92.42 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.84 -22.8 66.8 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.785 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.66 -36.47 84.38 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.961 0.886 . . . . 0.0 108.726 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -138.26 5.21 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 231' ' ' LYS . 1.7 mt-10 -91.95 89.99 7.23 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.813 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -56.33 142.96 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.559 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.2 tp10 -90.25 -49.05 6.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.447 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 5.8 p -172.75 156.75 3.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.543 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.621 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -122.78 153.81 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.237 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -154.41 133.04 12.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.073 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.545 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 4.4 mm? -112.11 99.37 45.88 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 121.229 0.537 . . . . 0.0 111.842 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.618 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 70.0 Cg_exo -50.51 -167.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.47 0.147 0 C-N-CA 123.628 2.885 . . . . 0.0 113.392 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.529 ' CG ' ' C ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 160.09 138.27 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.552 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 5.4 p-10 -63.53 82.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.601 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.47 2.96 1.47 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.504 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 4.7 mmtt -138.85 0.32 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.57 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.1 p -152.3 -26.91 0.17 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.57 ' HB2' ' O ' ' A' ' 219' ' ' THR . 4.5 m120 76.86 50.82 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.562 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.41 177.49 7.31 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.583 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -65.42 -36.85 85.17 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.001 -178.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.583 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.1 OUTLIER 13.93 -85.23 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 124.255 0.972 . . . . 0.0 110.47 -177.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 11.79 80.52 0.01 OUTLIER Glycine 0 C--N 1.336 0.546 0 O-C-N 123.982 0.801 . . . . 0.0 112.416 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.618 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -145.87 -119.98 0.07 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.533 ' SG ' ' CD1' ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.47 169.15 14.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.247 1.022 . . . . 0.0 112.798 178.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.771 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.5 m-85 -152.17 111.92 3.98 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.908 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.718 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -110.79 161.58 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.3 m -138.14 168.98 18.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.165 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.642 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.5 m-85 -146.74 115.61 6.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.2 OUTLIER -39.64 -35.3 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.531 ' O ' ' O ' ' A' ' 230' ' ' PHE . 7.9 mm-40 -88.89 -156.74 0.4 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.998 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.591 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.5 pm0 -144.16 12.77 1.6 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.615 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -92.29 -63.29 0.17 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.785 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 95.2 Cg_exo -48.47 -32.26 20.13 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.553 HG11 HG22 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.97 -53.43 34.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.372 -1.74 . . . . 0.0 110.209 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.4 OUTLIER -51.6 -46.58 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.609 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.647 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -64.89 -54.29 33.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.69 0.757 . . . . 0.0 109.933 177.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.657 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -30.84 -64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.531 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -46.19 -31.96 2.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 238' ' ' LYS . 30.4 mm-40 -62.71 -45.04 94.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -94.01 19.77 8.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.14 177.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.563 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.97 -50.31 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.625 1.203 . . . . 0.0 111.928 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.1 m-85 -84.84 71.29 10.89 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.621 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 9.3 m-70 -72.99 153.03 41.09 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.75 82.34 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.3 t -75.01 97.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.749 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.06 -80.91 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.752 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.82 -43.45 4.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.44 148.32 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.625 0.726 . . . . 0.0 112.344 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -145.54 140.69 27.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.8 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.608 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.23 169.44 24.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.464 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 76.4 tt0 -75.35 91.58 2.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.58 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.642 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.3 mt -77.99 80.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.534 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.605 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.4 mtpt -91.67 120.09 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -30.55 120.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-O 122.29 1.043 . . . . 0.0 110.367 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.676 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -77.92 172.3 13.68 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 113.19 -1.823 . . . . 0.0 112.342 -176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.469 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -139.0 -166.22 1.98 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.804 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.843 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.583 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C3'--C2' 1.51 -0.838 0 C4'-C3'-C2' 101.814 -1.386 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.631 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 C3'-C2'-C1' 101.832 -0.62 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.771 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.881 0 C4'-C3'-C2' 101.198 -2.002 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.588 ' C8 ' " H2'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.51 -0.789 0 C1'-O4'-C4' 110.415 0.511 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.595 HG12 ' HB ' ' A' ' 236' ' ' VAL . 23.1 t . . . . . 0 CA--C 1.499 -1.004 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 19.7 mttt -150.21 -36.46 0.15 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.064 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.1 OUTLIER -94.17 -171.54 2.57 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.633 HD11 ' CD1' ' A' ' 239' ' ' ILE . 10.2 pt -164.62 121.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.687 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -96.02 109.51 21.9 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.357 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.615 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -97.71 112.71 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.708 0.803 . . . . 0.0 113.103 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.41 -178.38 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -31.53 161.41 0.0 OUTLIER Glycine 0 C--N 1.342 0.861 0 N-CA-C 114.607 0.603 . . . . 0.0 114.607 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -174.67 -144.67 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.556 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.541 ' N ' HD13 ' A' ' 189' ' ' LEU . 49.2 m -89.44 133.32 34.92 Favored Pre-proline 0 C--N 1.338 0.069 0 CA-C-O 121.018 0.437 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 84.7 Cg_exo -28.18 -36.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.5 2.8 . . . . 0.0 113.116 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.0 t70 -150.85 56.45 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.551 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 21.7 m -38.8 132.57 1.09 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.067 0.461 . . . . 0.0 110.308 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.505 ' O ' HG13 ' A' ' 198' ' ' ILE . 14.7 Cg_endo -56.42 92.29 0.05 OUTLIER 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 123.025 2.483 . . . . 0.0 112.381 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.557 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.31 -24.53 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 8.7 mm-40 -62.94 -36.65 84.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.917 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 200' ' ' GLU . 22.7 mmmt -78.12 -49.23 14.3 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.4 -28.81 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.471 176.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.522 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 0.0 OUTLIER -77.1 -28.61 54.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.737 178.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.2 mm-40 -85.61 -63.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.668 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.705 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.1 t80 -40.17 -39.33 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.732 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -100.34 -33.3 10.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.48 -178.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.89 -45.99 95.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.47 -23.12 66.43 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.77 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.6 -34.18 77.64 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.014 0.911 . . . . 0.0 108.818 178.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.35 -141.04 7.02 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.045 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 77.3 mm-40 -91.82 91.54 7.98 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.757 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.6 142.24 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.561 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.5 tp10 -88.96 -48.64 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 26.7 m -175.96 150.02 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.344 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.654 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.34 167.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.556 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -166.34 125.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.809 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.551 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 4.4 mm? -107.67 101.57 40.66 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.628 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 49.2 Cg_exo -46.0 -164.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.863 3.042 . . . . 0.0 113.2 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.3 OUTLIER 158.78 129.68 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.007 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.418 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 31.3 p-10 -61.82 72.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.249 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 215' ' ' MET . 1.5 t-20 -131.83 -10.57 3.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.746 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.464 ' HD2' " H4'" ' B' ' 5' ' ' ' DG' . 2.6 mmpt? -121.45 -0.12 9.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.774 0.321 . . . . 0.0 111.424 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.584 ' CG2' ' NH2' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -151.49 -25.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 219' ' ' THR . 18.0 m-20 72.41 44.52 0.41 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.616 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -117.96 -155.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.475 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.654 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -86.87 -39.22 16.02 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.654 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 8.01 -96.47 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 124.352 1.032 . . . . 0.0 111.401 -178.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 23.87 75.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 O-C-N 123.673 0.608 . . . . 0.0 111.807 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.664 ' CE1' " C5'" ' B' ' 3' ' ' ' DA' . 0.2 OUTLIER -138.38 -120.2 0.14 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.533 ' SG ' ' CD1' ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.72 169.87 13.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.449 1.119 . . . . 0.0 113.02 178.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.729 ' CE1' ' C2 ' ' B' ' 4' ' ' ' DG' . 5.6 m-85 -151.79 125.21 8.84 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.614 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.681 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.6 mt -122.3 156.57 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.539 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.1 m -134.33 160.31 38.33 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.947 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.637 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.2 m-85 -137.86 115.76 11.54 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.561 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -38.51 -36.59 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.301 1.048 . . . . 0.0 108.265 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.1 mt-10 -88.82 -153.88 0.27 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.647 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.1 pt-20 -144.54 4.46 1.18 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.355 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -84.84 -58.19 0.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.77 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 88.6 Cg_exo -50.4 -33.53 37.94 Favored 'Trans proline' 0 CA--C 1.492 -1.605 0 N-CA-C 108.763 -1.283 . . . . 0.0 108.763 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.595 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -64.94 -51.91 60.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.618 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.9 mttt -45.71 -57.4 4.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.031 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.674 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.94 -52.49 65.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.605 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -34.72 -63.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.237 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.539 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -50.83 -19.16 0.9 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -77.55 -37.22 51.24 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.92 13.36 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.582 178.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.582 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -15.43 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.517 1.135 . . . . 0.0 112.433 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.1 m-85 -86.0 72.46 10.45 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.366 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.653 ' CE1' HG23 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.52 141.64 46.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.262 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -105.26 75.5 1.17 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.354 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -67.05 138.36 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.139 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 15.22 -77.62 0.0 OUTLIER Glycine 0 C--N 1.342 0.895 0 O-C-N 123.932 0.77 . . . . 0.0 113.729 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.07 -40.54 3.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.312 0.577 . . . . 0.0 110.529 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.472 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.75 152.92 21.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.886 -178.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.07 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.942 179.174 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.615 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 156.47 29.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.995 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.551 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 41.6 tt0 -60.88 120.27 9.84 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.657 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.2 mt -104.52 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.746 0.784 . . . . 0.0 112.428 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.59 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.06 119.47 28.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.465 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.7 p -33.62 122.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.149 0.976 . . . . 0.0 110.055 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.663 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -77.55 176.09 9.25 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.405 -1.725 . . . . 0.0 113.049 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -151.15 -148.63 0.27 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.63 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 C3'-C2'-C1' 100.528 -1.552 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.948 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.929 0 C4'-C3'-C2' 104.891 1.691 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.948 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.837 0 C4'-C3'-C2' 100.725 -2.475 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.741 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.858 0 O4'-C4'-C3' 106.276 0.676 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 20.5 t . . . . . 0 CA--C 1.499 -0.981 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 21.1 mttt -150.04 -34.58 0.17 Allowed 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.149 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.67 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -89.78 -171.4 3.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.67 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.1 pt -168.75 110.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.941 0.877 . . . . 0.0 108.92 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.666 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -83.08 101.76 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.733 -177.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 252' ' ' CYS . 2.5 t -87.68 111.22 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.32 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.573 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -101.39 120.5 6.89 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.563 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 97.04 109.92 2.7 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.59 ' C ' ' CD1' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.56 -157.66 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.564 ' N ' HD11 ' A' ' 189' ' ' LEU . 3.4 m -89.03 133.65 34.94 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.197 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -32.46 -29.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.43 2.754 . . . . 0.0 113.473 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 47.8 t0 -149.38 52.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.532 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 17.6 m -43.08 126.79 3.36 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.494 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -53.1 94.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.677 2.251 . . . . 0.0 112.068 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.589 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.9 OUTLIER -45.13 -20.67 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 8.0 mt-10 -64.96 -36.55 84.75 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.12 -47.65 17.75 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.631 HG21 HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.25 -28.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.847 176.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 211' ' ' ILE . 11.3 mtp180 -76.41 -28.86 56.84 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 mt-10 -85.27 -61.94 1.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.811 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.705 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -39.56 -42.65 1.18 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.727 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 1.0 OUTLIER -97.75 -31.49 12.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.728 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.21 -46.85 93.09 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.41 -24.27 65.55 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.775 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.65 -34.21 77.74 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.11 -139.8 6.36 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.833 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.6 mt-10 -91.86 95.3 9.76 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.854 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.443 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -57.31 144.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.576 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 10.5 tt0 -90.6 -50.58 5.85 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 73.1 m -172.42 147.18 1.88 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.914 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.31 162.08 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.629 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -157.79 123.86 4.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 0.0 111.596 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.511 ' O ' ' O ' ' A' ' 214' ' ' PRO . 2.0 mm? -108.8 92.93 11.26 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 121.372 0.606 . . . . 0.0 111.028 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.623 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 72.0 Cg_exo -43.81 -165.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 124.577 3.518 . . . . 0.0 114.182 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.542 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 155.94 119.94 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.052 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 18.1 p-10 -44.8 83.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.887 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 215' ' ' MET . 1.9 m-20 -144.16 4.06 1.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.953 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.518 ' C ' HG22 ' A' ' 219' ' ' THR . 17.4 mmmt -132.79 -19.04 2.35 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.518 HG22 ' C ' ' A' ' 218' ' ' LYS . 0.1 OUTLIER -141.97 -9.31 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.0 m120 68.31 48.16 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.574 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -126.78 -177.52 4.05 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -69.5 -37.39 77.19 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.639 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.587 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER 15.81 -83.16 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 124.445 1.09 . . . . 0.0 109.994 -176.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.59 80.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 O-C-N 123.906 0.754 . . . . 0.0 112.505 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.623 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -151.02 -121.04 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.475 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -167.5 164.58 14.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.347 1.07 . . . . 0.0 113.074 178.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.75 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.9 m-85 -149.18 114.91 5.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.071 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.717 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.6 mt -112.98 161.58 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.344 0.592 . . . . 0.0 110.588 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.8 m -138.7 172.36 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.537 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 89.1 m-85 -145.23 119.8 9.75 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.576 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.38 -37.3 0.99 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.8 mt-10 -89.42 -155.59 0.36 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.57 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.6 pt-20 -143.02 5.27 1.5 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.495 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 1.0 OUTLIER -86.9 -57.28 0.32 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.775 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 99.3 Cg_exo -49.74 -33.22 31.54 Favored 'Trans proline' 0 CA--C 1.493 -1.573 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.7 -51.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 112.988 -1.915 . . . . 0.0 109.065 178.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 12.4 mttt -46.3 -57.6 4.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.276 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.626 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.13 -54.74 42.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.673 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.646 ' CG2' ' CG2' ' A' ' 254' ' ' ILE . 0.4 OUTLIER -28.95 -63.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.029 -179.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 9.9 mtp -45.73 -31.32 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 111.139 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.3 mm-40 -63.33 -43.09 98.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -96.56 19.96 11.47 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.268 178.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.546 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.18 -50.55 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.696 1.247 . . . . 0.0 111.716 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.9 m-85 -85.51 71.03 10.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.271 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.675 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.9 m-70 -70.49 146.41 50.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.029 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.41 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 4.6 m-80 -107.43 79.75 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -69.12 149.48 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.71 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 6.59 -72.08 0.0 OUTLIER Glycine 0 C--N 1.343 0.953 0 O-C-N 124.014 0.821 . . . . 0.0 113.682 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -119.64 -41.88 2.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.076 0.465 . . . . 0.0 110.454 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.546 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 2.0 m -88.89 148.54 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.689 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -131.76 147.62 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.054 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.625 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -160.34 161.85 33.32 Favored 'General case' 0 C--O 1.228 -0.042 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.238 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 185' ' ' PHE . 56.7 tt0 -69.86 93.12 0.73 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.609 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.646 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.4 mt -83.92 82.73 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.591 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.592 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.7 mtpt -98.4 118.91 36.12 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.8 p -28.72 110.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-O 122.612 1.196 . . . . 0.0 110.594 -177.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.652 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -67.65 179.16 1.43 Allowed 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 112.634 -2.076 . . . . 0.0 112.758 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.561 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 4.1 mtm -150.02 -151.75 0.41 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.693 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.954 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.896 0 O4'-C1'-C2' 106.957 0.779 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.782 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C1'-O4'-C4' 110.378 0.484 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.782 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C4'-C3'-C2' 101.002 -2.198 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.497 ' OP2' " H2'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.921 0 C3'-C2'-C1' 102.164 -0.383 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.606 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 29.9 t . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 22.0 mttt -152.19 -35.66 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.575 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -94.91 -177.94 4.34 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.37 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 202' ' ' PHE . 4.6 pt -161.82 111.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 122.245 1.022 . . . . 0.0 109.57 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.723 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -85.41 101.79 12.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.551 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.621 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.6 t -87.27 106.21 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.246 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.636 ' HA3' ' C2 ' ' B' ' 2' ' ' ' DT' . . . -97.43 122.1 7.33 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.45 106.66 2.73 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.676 0.631 . . . . 0.0 114.676 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.617 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -168.08 -157.16 0.2 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.571 ' N ' HD13 ' A' ' 189' ' ' LEU . 71.0 m -88.6 134.38 34.22 Favored Pre-proline 0 C--N 1.345 0.372 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.187 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -29.29 -32.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.789 2.993 . . . . 0.0 113.919 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.72 54.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.482 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.531 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 14.3 m -40.17 123.74 1.68 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.927 0.394 . . . . 0.0 110.537 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.493 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 8.2 Cg_endo -50.32 92.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.745 2.297 . . . . 0.0 112.077 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.568 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -42.16 -23.67 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 194' ' ' PRO . 10.0 mt-10 -63.87 -33.5 75.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -85.76 -34.45 21.17 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.605 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.7 OUTLIER -62.33 -20.87 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.863 176.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.537 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.7 mtt180 -85.39 -25.03 27.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.293 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -88.99 -31.2 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.878 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.697 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -72.99 -38.7 66.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.749 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 1.0 OUTLIER -100.43 -30.99 11.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.449 -178.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.92 -46.26 92.01 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.63 64.51 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.794 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.22 -34.68 78.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.968 0.89 . . . . 0.0 108.916 178.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.26 -139.99 6.37 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.063 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.6 mt-10 -91.43 90.47 7.69 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.993 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -55.36 143.59 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.585 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 9.7 tt0 -89.71 -50.33 6.12 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 50.3 m -172.03 147.25 2.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.293 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.613 HG21 HD12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.34 159.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.466 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.478 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.3 OUTLIER -155.5 124.67 6.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.34 . . . . 0.0 111.372 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 214' ' ' PRO . 1.4 mm? -105.4 93.96 7.65 Favored Pre-proline 0 N--CA 1.454 -0.238 0 CA-C-O 121.414 0.626 . . . . 0.0 111.066 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.626 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 50.4 Cg_exo -43.05 -169.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 124.348 3.365 . . . . 0.0 113.864 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.509 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 158.02 121.72 0.0 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.039 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.515 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 17.3 p-10 -51.99 85.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 215' ' ' MET . 0.1 OUTLIER -145.19 9.33 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.654 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.56 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 22.3 mmtt -136.78 -27.42 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -132.99 -14.68 2.68 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 219' ' ' THR . 4.1 m120 71.85 53.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.556 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -128.2 -171.0 2.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.577 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -76.59 -37.42 56.49 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.792 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.577 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 17.65 -85.46 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 124.369 1.043 . . . . 0.0 109.992 -177.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.06 79.64 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 O-C-N 123.994 0.809 . . . . 0.0 112.857 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.626 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -150.78 -121.16 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.508 ' HA ' ' CD ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -167.23 162.19 14.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.987 0.899 . . . . 0.0 112.587 177.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.753 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 2.9 m-85 -144.34 113.84 7.09 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.709 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.732 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -111.47 159.13 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-O 121.498 0.666 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.5 m -135.04 178.05 7.33 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.338 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 92.0 m-85 -152.56 117.22 5.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.585 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.93 -37.54 1.34 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -89.49 -155.84 0.37 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.606 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -141.43 1.86 1.6 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.716 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -81.62 -58.42 0.48 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.794 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 84.9 Cg_exo -48.91 -35.34 31.27 Favored 'Trans proline' 0 CA--C 1.494 -1.501 0 N-CA-C 109.035 -1.179 . . . . 0.0 109.035 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.568 HG11 HG23 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.66 -51.74 66.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.774 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -44.94 -55.35 5.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.482 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.62 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.0 -54.19 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.107 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.649 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -29.95 -62.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.06 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -49.24 -27.13 3.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.889 0.376 . . . . 0.0 111.255 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 238' ' ' LYS . 11.5 mm-40 -68.59 -34.98 76.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.09 20.57 18.75 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.458 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.587 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.77 -49.54 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.516 1.135 . . . . 0.0 112.009 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.0 m-85 -85.0 72.83 10.78 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.488 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.2 m-70 -73.04 150.34 42.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.248 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.94 80.94 1.36 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 249' ' ' LEU . 0.9 OUTLIER -75.84 103.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.658 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 47.64 -85.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.486 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -106.01 -44.94 4.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.976 0.417 . . . . 0.0 110.907 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.498 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.21 147.21 24.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.765 0.793 . . . . 0.0 112.372 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.02 145.65 46.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.058 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.621 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.9 163.24 36.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.568 -1.253 . . . . 0.0 114.204 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.487 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 64.2 tt0 -71.55 91.34 1.06 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.471 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.64 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.3 mt -80.76 80.19 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.512 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.624 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.3 OUTLIER -93.13 120.46 33.45 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -30.54 116.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.941 1.246 . . . . 0.0 109.972 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.648 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -78.16 -173.06 3.04 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 112.971 -1.922 . . . . 0.0 113.369 -175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.512 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER 170.03 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.198 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.823 179.708 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.704 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.767 0 O4'-C4'-C3' 104.082 -1.518 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.999 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 C3'-C2'-C1' 101.936 -0.546 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.999 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.801 0 C4'-C3'-C2' 101.164 -2.036 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.56 " C3'" ' HG3' ' A' ' 218' ' ' LYS . . . . . . . . 0 C2'--C1' 1.509 -0.827 0 O4'-C4'-C3' 106.19 0.59 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.613 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.2 t . . . . . 0 CA--C 1.497 -1.092 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.531 ' HA ' HG22 ' A' ' 236' ' ' VAL . 26.3 mttt -151.26 -36.38 0.13 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.727 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -93.57 -176.8 4.2 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 184' ' ' ILE . 4.5 pt -161.34 114.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 122.15 0.976 . . . . 0.0 109.118 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.677 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -91.12 110.54 21.81 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.098 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.628 HG12 ' HB2' ' A' ' 252' ' ' CYS . 3.0 t -100.15 108.72 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.37 -179.87 0.01 OUTLIER Glycine 0 CA--C 1.531 1.065 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.42 161.59 0.0 OUTLIER Glycine 0 C--N 1.344 0.988 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.592 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -173.93 -143.67 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.551 ' N ' HD13 ' A' ' 189' ' ' LEU . 33.1 m -89.18 132.93 36.22 Favored Pre-proline 0 C--N 1.34 0.165 0 CA-C-O 121.037 0.446 . . . . 0.0 110.88 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 72.1 Cg_exo -27.8 -36.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.588 2.859 . . . . 0.0 113.301 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.59 54.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.576 0.226 . . . . 0.0 111.084 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.535 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 8.1 m -39.68 120.7 1.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.394 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.569 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -50.35 99.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.717 2.278 . . . . 0.0 112.275 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.582 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -45.88 -21.72 0.15 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.379 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 34.5 mt-10 -60.76 -37.87 83.31 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.569 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.2 mttp -79.73 -46.86 16.27 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.622 HG22 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.98 -26.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.897 177.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.541 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 5.3 mtt180 -80.56 -27.1 37.6 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.836 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.4 mt-10 -85.36 -59.85 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.719 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -44.89 -41.56 7.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.58 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.751 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -97.29 -35.08 10.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.997 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.51 -47.04 92.3 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.01 -22.79 65.2 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.787 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.53 -37.86 87.97 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.044 0.926 . . . . 0.0 108.837 178.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.93 -142.0 7.3 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.7 mm-40 -91.66 92.64 8.54 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.874 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.35 143.54 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.533 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.6 tp10 -89.45 -51.02 5.76 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.408 ' OG ' ' OE2' ' A' ' 212' ' ' GLU . 5.0 p -170.34 155.48 5.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.1 178.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.644 HG23 HD13 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -120.34 159.48 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.121 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.408 ' OE2' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -157.77 132.75 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.534 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 1.6 mm? -115.7 98.24 50.51 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 121.428 0.632 . . . . 0.0 111.001 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.637 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 71.4 Cg_exo -49.14 -161.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.472 0.213 0 C-N-CA 123.86 3.04 . . . . 0.0 113.399 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.546 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 153.95 131.29 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.466 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 1.0 OUTLIER -58.43 75.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.453 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 215' ' ' MET . 26.9 t30 -145.4 4.64 1.05 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.507 ' C ' ' CG2' ' A' ' 219' ' ' THR . 6.9 mmmt -142.5 3.96 1.53 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.655 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 8.3 p -151.73 -37.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.099 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.655 ' HB2' ' O ' ' A' ' 219' ' ' THR . 77.6 m-20 91.32 57.77 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.524 ' CD ' ' OG1' ' A' ' 219' ' ' THR . 0.0 OUTLIER -143.91 -164.42 1.88 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 119.779 -0.769 . . . . 0.0 111.579 178.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.621 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -83.16 -38.19 22.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.621 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 7.41 -87.39 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 124.235 0.959 . . . . 0.0 111.25 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 17.28 75.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.77 0 O-C-N 124.015 0.822 . . . . 0.0 111.362 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.641 ' CZ ' " C5'" ' B' ' 3' ' ' ' DA' . 0.2 OUTLIER -140.54 -119.64 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.611 -0.795 . . . . 0.0 108.923 -176.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -166.4 163.58 17.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.905 0.859 . . . . 0.0 112.487 178.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.762 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.0 m-85 -148.54 118.09 6.99 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.963 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.67 HD11 ' CG ' ' A' ' 202' ' ' PHE . 1.5 mt -113.23 152.85 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.6 m -131.04 152.97 49.77 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.072 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 87.8 m-85 -131.95 116.77 17.57 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.533 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.44 -37.75 0.73 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.2 mm-40 -89.21 -158.24 0.49 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.788 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.613 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 16.5 pt-20 -141.09 11.6 2.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.856 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.5 OUTLIER -89.84 -62.75 0.21 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.787 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 66.9 Cg_exo -47.55 -34.08 19.32 Favored 'Trans proline' 0 CA--C 1.494 -1.498 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.563 ' HB ' HG11 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -64.92 -52.69 50.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.611 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 8.0 pttt -52.8 -49.64 65.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.422 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.66 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -61.45 -53.55 55.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.671 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -34.13 -64.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.333 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.486 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 2.3 mtp -49.23 -22.15 0.96 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.137 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 4.0 mm-40 -73.57 -36.9 65.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.619 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.16 20.88 15.88 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.312 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.583 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.96 -48.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.634 1.209 . . . . 0.0 112.416 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.3 m-85 -86.55 73.91 9.99 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.466 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 9.1 m-70 -77.0 147.34 36.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.156 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.436 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -111.48 81.35 1.43 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.987 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.41 96.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.8 -78.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.61 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.81 -43.48 3.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 0.0 110.922 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.32 148.53 24.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.512 0.672 . . . . 0.0 112.209 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.76 145.71 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.628 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -161.6 155.02 21.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.751 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.537 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 47.6 tt0 -59.75 120.47 9.59 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.663 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.3 mt -105.06 84.6 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.749 0.785 . . . . 0.0 112.214 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.573 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.68 120.45 30.08 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 114.234 -1.348 . . . . 0.0 107.893 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -35.21 120.39 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 119.457 1.026 . . . . 0.0 109.696 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.656 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -77.94 -178.44 5.5 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.14 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.528 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.1 OUTLIER 173.84 -90.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.245 -1.798 . . . . 0.0 110.449 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.3 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 179.775 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.619 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 C4'-C3'-C2' 102.247 -0.953 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.996 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 O4'-C4'-C3' 106.188 0.588 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.996 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.783 0 C4'-C3'-C2' 101.195 -2.005 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.498 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.822 0 C3'-C2'-C1' 102.121 -0.413 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.632 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.1 t . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 25.9 mttt -151.63 -35.35 0.13 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.148 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.653 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -93.13 -171.79 2.78 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.656 HG13 ' O ' ' A' ' 184' ' ' ILE . 6.0 pt -166.46 110.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 122.197 0.998 . . . . 0.0 109.318 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.702 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -84.71 104.14 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.643 -178.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.634 HG12 ' HB2' ' A' ' 252' ' ' CYS . 3.8 t -89.82 114.46 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.716 0.806 . . . . 0.0 112.735 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.534 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -46.21 -177.21 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.936 0.735 . . . . 0.0 114.936 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -33.32 163.5 0.01 OUTLIER Glycine 0 C--N 1.341 0.832 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.573 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.1 OUTLIER -177.7 -146.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.526 ' N ' HD13 ' A' ' 189' ' ' LEU . 39.7 m -89.03 133.13 35.98 Favored Pre-proline 0 C--N 1.34 0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 111.105 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.72 -33.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.498 2.799 . . . . 0.0 113.181 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.2 m-20 -151.45 55.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.53 0.205 . . . . 0.0 111.461 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.581 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 24.3 m -39.19 123.21 1.31 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.484 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.2 Cg_endo -49.51 88.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 0.0 111.682 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.57 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -39.74 -25.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 194' ' ' PRO . 49.7 mt-10 -61.32 -33.42 73.56 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -88.21 -31.28 19.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.608 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.9 OUTLIER -66.22 -21.95 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.621 176.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.547 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 13.9 mtp180 -82.44 -25.24 33.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.365 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 197' ' ' LYS . 4.3 pt-20 -88.91 -37.77 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.842 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.694 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -65.36 -37.69 87.8 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.121 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.748 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -100.69 -30.72 11.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.18 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.97 -44.93 93.81 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.61 -23.53 67.06 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.773 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.36 -35.89 82.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 122.182 0.991 . . . . 0.0 108.849 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 162.77 -138.93 5.61 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.981 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.9 mm-40 -91.46 92.09 8.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.643 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -58.07 142.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.547 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.61 -47.74 7.49 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 12.3 m -175.41 150.14 1.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.809 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.613 HG22 HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.23 158.62 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.833 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.441 ' HG2' ' C ' ' A' ' 211' ' ' ILE . 0.8 OUTLIER -156.14 129.22 8.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 111.289 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 213' ' ' LEU . 4.4 mm? -111.7 99.07 43.63 Favored Pre-proline 0 CA--C 1.529 0.162 0 CA-C-O 121.09 0.471 . . . . 0.0 111.428 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.661 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 83.6 Cg_exo -43.07 -165.39 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 124.461 3.441 . . . . 0.0 114.25 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 156.93 117.09 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.409 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 36.8 p-10 -51.73 81.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.052 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 215' ' ' MET . 9.8 t-20 -139.4 3.75 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.207 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.566 ' HG3' " C4'" ' B' ' 5' ' ' ' DG' . 7.1 mmmt -136.36 1.59 2.66 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.2 OUTLIER -151.95 -20.13 0.18 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.552 ' HB2' ' O ' ' A' ' 219' ' ' THR . 34.7 m-20 74.74 42.77 0.27 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.619 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -119.65 -152.66 0.51 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.056 178.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.555 ' O ' ' C ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -105.8 -27.04 11.5 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.619 ' HG2' ' CD ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER 12.48 -82.17 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 124.639 1.212 . . . . 0.0 109.949 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 20.76 79.96 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.05 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.661 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -142.91 -118.76 0.1 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 213' ' ' LEU . 0.4 OUTLIER -167.69 169.24 11.95 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.209 1.004 . . . . 0.0 112.442 177.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.733 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.3 m-85 -150.66 110.52 4.08 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.886 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.71 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -108.17 160.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.514 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.4 m -138.94 167.63 21.61 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.251 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.659 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 82.8 m-85 -144.05 119.82 10.54 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.547 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.36 -39.4 3.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.6 mt-10 -92.45 -176.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.894 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.632 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.9 pt-20 -119.05 3.83 11.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.485 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 0.8 OUTLIER -79.86 -61.41 0.46 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.773 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 57.8 Cg_exo -47.59 -35.69 23.16 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 CA-C-N 120.422 1.186 . . . . 0.0 109.203 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.588 HG11 HG22 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -62.68 -50.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.017 178.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 11.2 mttt -46.78 -59.85 2.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.12 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.643 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -58.46 -51.97 67.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.629 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.655 HD13 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -33.62 -65.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.339 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.446 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 0.1 OUTLIER -47.94 -28.12 2.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.574 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 238' ' ' LYS . 25.6 mm-40 -66.46 -42.15 88.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -98.88 21.64 11.28 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.258 177.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.56 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.46 -49.69 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 O-C-N 124.632 1.207 . . . . 0.0 111.846 -179.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.603 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.7 m-85 -85.12 72.57 10.76 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.653 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 9.7 m-70 -73.06 152.18 41.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -114.77 80.88 1.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.892 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -74.93 97.5 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.767 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.37 -83.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.568 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.31 -43.57 4.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.964 0.412 . . . . 0.0 110.687 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 1.2 m -88.33 145.34 25.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.695 0.759 . . . . 0.0 112.357 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -140.33 140.57 35.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.855 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.634 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.85 166.42 33.42 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 53.2 tt0 -72.68 93.54 1.65 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.774 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.4 mt -81.47 82.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.604 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.567 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -93.8 120.29 33.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -31.01 118.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.373 1.082 . . . . 0.0 110.431 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.672 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -76.4 175.31 9.27 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.072 -1.876 . . . . 0.0 112.343 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -147.41 -151.41 0.38 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.736 -1.575 . . . . 0.0 111.144 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.797 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.959 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O4'--C4' 1.437 -0.788 0 C3'-C2'-C1' 104.872 1.551 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 1.008 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C4'-C3'-C2' 104.77 1.57 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 1.008 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C2'--C1' 1.533 0.89 0 C4'-C3'-C2' 100.62 -2.58 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.869 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -0.986 0 C4'-C3'-C2' 104.12 0.92 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.619 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 38.6 t . . . . . 0 CA--C 1.499 -0.995 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 20.7 mttt -152.56 -35.48 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.736 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.1 OUTLIER -94.24 -174.61 3.42 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.641 HG13 ' O ' ' A' ' 184' ' ' ILE . 6.5 pt -163.64 114.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.988 0.899 . . . . 0.0 108.878 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.701 ' HB2' ' CE1' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -89.38 110.07 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.864 -177.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 252' ' ' CYS . 2.7 t -100.35 107.66 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.15 -179.56 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -30.06 160.3 0.0 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.589 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -172.15 -145.04 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.542 ' N ' HD11 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -89.23 130.51 43.82 Favored Pre-proline 0 C--N 1.339 0.121 0 CA-C-O 120.898 0.38 . . . . 0.0 110.644 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -30.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.236 2.624 . . . . 0.0 112.979 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 190' ' ' SER . 15.1 t70 -150.43 52.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.266 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.531 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 55.1 m -42.9 124.51 3.15 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.271 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.465 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.9 Cg_endo -52.17 92.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.761 2.307 . . . . 0.0 112.286 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.562 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.1 OUTLIER -39.75 -27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 199' ' ' ARG . 2.6 mp0 -61.49 -37.23 82.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 200' ' ' GLU . 20.4 mmmt -73.99 -50.03 21.73 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.628 HG22 HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -51.72 -27.43 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 113.142 -1.844 . . . . 0.0 107.556 175.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.559 ' HD3' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -75.72 -30.92 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.813 178.146 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -85.59 -64.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.805 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.721 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -39.35 -39.06 0.61 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.407 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.758 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -99.92 -34.26 10.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.831 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.5 -46.08 94.53 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.63 -22.42 67.96 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.79 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.62 -37.57 86.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.962 0.887 . . . . 0.0 108.834 178.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.07 -142.85 7.86 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.997 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mm-40 -91.48 89.79 7.37 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.809 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.427 ' O ' ' HE2' ' A' ' 231' ' ' LYS . 1.8 t -53.19 141.88 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.546 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.4 -48.04 7.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 17.9 m -175.8 150.91 1.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.169 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.659 HG21 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -115.62 158.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.701 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -155.56 124.76 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.76 0.314 . . . . 0.0 111.018 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.48 HD23 ' CD1' ' A' ' 198' ' ' ILE . 1.7 mm? -108.16 94.79 13.8 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.443 0.64 . . . . 0.0 111.438 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.617 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 74.1 Cg_exo -46.71 -165.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 123.813 3.008 . . . . 0.0 113.795 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.534 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 156.46 130.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.721 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 3.9 p30 -50.13 82.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 111.645 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 215' ' ' MET . 32.5 t30 -135.57 -5.91 2.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.735 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.46 ' C ' HG21 ' A' ' 219' ' ' THR . 17.7 mmmt -128.75 -3.89 5.26 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.4 OUTLIER -151.21 -20.43 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 219' ' ' THR . 4.0 m-80 71.35 45.94 0.45 Allowed 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.604 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -116.65 -154.42 0.55 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.562 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.665 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -89.17 -37.87 14.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.199 -0.313 . . . . 0.0 110.431 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.665 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.4 OUTLIER 6.87 -98.78 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 124.143 0.902 . . . . 0.0 111.536 -178.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.52 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 25.28 74.68 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.617 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.4 OUTLIER -138.49 -123.26 0.13 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.484 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -159.51 162.8 35.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.08 0.943 . . . . 0.0 112.692 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.751 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 2.9 m-85 -149.66 109.95 4.18 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 113.602 -1.636 . . . . 0.0 108.28 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.667 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.6 mt -106.87 157.88 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.723 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 6.6 m -138.38 154.18 48.92 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.527 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 68.9 m-85 -132.37 120.55 22.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.546 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -42.13 -38.26 1.65 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 230' ' ' PHE . 31.3 mt-10 -89.32 -164.0 1.08 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.657 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 25.8 pt-20 -134.67 16.93 3.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.6 -63.06 0.17 Allowed Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.015 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.79 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 76.4 Cg_exo -48.03 -34.9 24.28 Favored 'Trans proline' 0 CA--C 1.494 -1.487 0 N-CA-C 108.94 -1.215 . . . . 0.0 108.94 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.573 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -65.82 -54.06 31.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.221 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 37.3 pttt -51.37 -41.83 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.022 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.65 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.22 -55.17 8.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.574 0.702 . . . . 0.0 110.048 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.662 HD13 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -29.8 -60.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.846 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.531 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -51.89 -18.21 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 111.801 -178.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.4 mm-40 -79.5 -33.47 42.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -104.71 20.87 17.89 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.946 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.59 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.05 -47.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.394 1.059 . . . . 0.0 112.148 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.609 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.6 m-85 -85.73 71.2 10.72 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.359 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.643 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 11.3 m-70 -73.12 144.71 46.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.147 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -107.6 78.37 1.2 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -68.77 152.74 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.349 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 2.87 -70.87 0.0 OUTLIER Glycine 0 C--N 1.343 0.949 0 O-C-N 123.97 0.794 . . . . 0.0 113.854 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -120.91 -40.01 2.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.519 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.9 OUTLIER -88.94 152.41 21.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.81 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.0 134.55 28.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.575 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.614 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -151.8 158.26 43.06 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.885 -178.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.561 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 39.1 tt0 -61.93 121.63 13.44 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.649 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.8 mt -106.34 81.39 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.769 0.795 . . . . 0.0 112.039 -176.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.1 118.85 26.77 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.784 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.2 p -34.64 115.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.409 1.099 . . . . 0.0 110.083 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.667 ' CB ' ' CE1' ' A' ' 227' ' ' PHE . . . -69.09 178.73 2.15 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.746 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.588 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -170.19 139.66 1.81 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.41 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.054 0.454 . . . . 0.0 111.133 -179.675 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.626 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.425 -0.92 0 C3'-C2'-C1' 100.782 -1.37 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.68 ' N7 ' ' CE2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 O4'-C1'-C2' 107.044 0.858 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.751 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.52 -0.847 0 C4'-C3'-C2' 100.835 -2.365 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.598 ' C6 ' ' N7 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 O4'-C1'-N19 108.1 0.375 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.585 HG13 ' HB ' ' A' ' 236' ' ' VAL . 25.0 t . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 19.2 mttt -150.77 -35.92 0.14 Allowed 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.937 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.637 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -92.55 -173.08 3.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 184' ' ' ILE . 6.5 pt -165.04 109.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.207 1.003 . . . . 0.0 109.68 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.694 ' CD2' ' C6 ' ' B' ' 3' ' ' ' DA' . 0.1 OUTLIER -83.69 106.56 15.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.563 -178.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.625 HG13 ' HB2' ' A' ' 252' ' ' CYS . 4.3 t -93.82 111.75 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.643 0.777 . . . . 0.0 112.744 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -44.77 -175.98 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -32.59 162.37 0.0 OUTLIER Glycine 0 C--N 1.342 0.876 0 N-CA-C 114.824 0.69 . . . . 0.0 114.824 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.597 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -175.12 -145.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.567 ' N ' HD12 ' A' ' 189' ' ' LEU . 9.1 t -89.32 133.37 35.0 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 110.225 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 53.8 Cg_exo -29.69 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.209 2.606 . . . . 0.0 113.251 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.79 56.97 0.86 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 0.0 111.279 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.538 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 54.0 m -39.48 125.79 1.42 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.537 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -53.61 95.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.802 2.334 . . . . 0.0 112.189 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.569 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.38 -20.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 66.1 mt-10 -62.79 -39.51 94.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.0 OUTLIER -79.27 -46.66 17.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.611 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.62 -27.0 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.942 177.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.525 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.7 mtp85 -77.75 -28.03 50.57 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.697 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.9 mm-40 -85.8 -60.63 1.96 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.697 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -41.51 -41.49 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.613 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.768 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -99.49 -30.98 11.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.821 -178.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.13 -47.01 91.96 Favored Glycine 0 CA--C 1.504 -0.642 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 176.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -22.48 65.93 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.7 -36.89 85.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.89 0.853 . . . . 0.0 108.74 178.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.04 -138.43 5.29 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.904 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.8 mm-40 -91.89 89.88 7.22 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.023 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.428 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -55.57 139.8 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.572 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 6.0 tt0 -89.66 -47.1 8.17 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 76.3 p -173.48 150.32 1.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.743 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.615 HG21 HD12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -114.59 161.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.329 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -158.9 137.48 10.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.537 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.495 ' CD1' HD22 ' A' ' 189' ' ' LEU . 2.3 mm? -125.44 111.62 25.84 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.599 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 1.8 Cg_endo -85.75 -162.44 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.783 2.989 . . . . 0.0 113.474 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.527 ' HA ' ' CA ' ' A' ' 224' ' ' GLY . 2.9 ptp 164.43 172.17 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.939 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 0.5 OUTLIER -83.43 75.41 10.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' A' ' 218' ' ' LYS . 11.0 m120 -144.89 8.47 1.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.453 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.488 ' HG3' ' OP2' ' B' ' 5' ' ' ' DG' . 20.0 mmtp -123.98 -36.91 2.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.371 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.529 HG23 ' NH2' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -138.92 -2.9 1.66 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.1 -177.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.8 m120 71.22 55.09 0.22 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.591 ' CE ' ' CZ ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.41 163.52 26.73 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.141 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.634 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -59.48 -36.43 76.0 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.979 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.634 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 2.7 mtm180 6.39 -84.99 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 124.501 1.126 . . . . 0.0 109.659 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.47 81.17 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 O-C-N 124.443 1.089 . . . . 0.0 112.903 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.612 ' CZ ' H5'' ' B' ' 4' ' ' ' DG' . 0.1 OUTLIER -143.98 -120.76 0.09 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -163.4 165.08 24.34 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.325 1.06 . . . . 0.0 113.349 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.778 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.6 m-85 -150.46 111.32 4.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.729 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.711 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.5 mt -112.49 161.79 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-O 121.144 0.497 . . . . 0.0 110.476 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -136.7 -179.25 5.58 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.408 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.643 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 85.2 m-85 -157.07 115.83 3.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.869 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.572 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.38 -36.27 0.53 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.3 mm-40 -89.09 -157.05 0.42 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.759 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.8 pm0 -143.15 12.81 1.81 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.379 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.59 -61.73 0.2 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.788 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 81.1 Cg_exo -49.28 -32.85 26.67 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 N-CA-C 108.946 -1.213 . . . . 0.0 108.946 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.585 ' HB ' HG13 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -66.53 -53.04 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.266 -1.788 . . . . 0.0 110.153 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.7 pttt -52.84 -45.39 67.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.659 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.639 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.84 -53.84 34.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.603 0.716 . . . . 0.0 109.852 177.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.653 ' CG2' ' CG2' ' A' ' 254' ' ' ILE . 0.4 OUTLIER -31.18 -62.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.823 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -48.35 -29.17 3.69 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 238' ' ' LYS . 8.3 mm-40 -65.79 -38.99 90.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.31 20.76 16.25 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.14 177.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.564 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.16 -49.71 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.459 0 O-C-N 124.647 1.217 . . . . 0.0 111.966 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.2 m-85 -84.84 74.59 10.46 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.598 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 9.4 m-70 -76.1 151.42 37.04 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 1.2 m-80 -115.07 80.67 1.45 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.502 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -74.52 108.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.566 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 39.09 -89.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.441 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -97.97 -43.37 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 9.0 m -88.25 147.88 24.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.637 0.732 . . . . 0.0 112.92 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.55 141.11 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.524 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.625 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.17 168.37 26.73 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.465 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 56.6 tt0 -73.31 96.07 2.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.375 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.653 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.4 mt -83.95 81.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.737 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.577 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -94.26 118.04 31.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.64 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -27.88 120.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 122.217 1.008 . . . . 0.0 110.539 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.671 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -80.44 174.04 12.0 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.105 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.29 150.36 14.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.138 -1.846 . . . . 0.0 110.924 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.574 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.731 0 O4'-C4'-C3' 104.367 -1.233 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.895 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 C3'-C2'-C1' 104.951 1.608 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 1.075 " H5'" ' N3 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.535 1.011 0 C4'-C3'-C2' 100.82 -2.38 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.849 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.836 0 O4'-C1'-C2' 106.701 0.547 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 28.6 t . . . . . 0 CA--C 1.495 -1.15 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 18.5 mttt -150.33 -34.39 0.17 Allowed 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.911 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -97.07 -173.59 2.73 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 184' ' ' ILE . 13.2 pt -162.7 117.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.105 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.679 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -91.57 99.54 12.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.78 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.67 HG11 ' HB2' ' A' ' 252' ' ' CYS . 2.7 t -84.84 112.85 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.03 0.932 . . . . 0.0 110.924 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.603 ' O ' ' C5 ' ' B' ' 2' ' ' ' DT' . . . -99.18 120.91 7.03 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.551 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 97.47 108.72 2.65 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 177.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.629 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -168.81 -159.22 0.24 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.556 ' N ' HD13 ' A' ' 189' ' ' LEU . 26.3 t -89.04 132.75 36.99 Favored Pre-proline 0 C--N 1.342 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.744 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -31.02 -29.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.872 3.048 . . . . 0.0 113.561 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 190' ' ' SER . 11.4 t70 -148.57 53.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.529 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 7.9 m -39.83 134.15 1.36 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.184 0.516 . . . . 0.0 110.634 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.494 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.7 Cg_endo -52.66 83.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.077 2.518 . . . . 0.0 112.084 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -39.58 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.216 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 194' ' ' PRO . 42.9 mt-10 -63.53 -35.59 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -78.33 -46.45 20.06 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.619 HG23 HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -49.82 -24.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.624 177.504 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.533 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 7.8 mtp-105 -83.98 -25.96 29.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.69 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.7 OUTLIER -88.06 -35.54 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.044 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.708 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -68.33 -41.12 81.22 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.755 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.9 OUTLIER -97.34 -30.96 12.65 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.894 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.08 -47.28 86.96 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.82 -23.73 61.56 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.783 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.46 -34.1 77.19 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.987 0.898 . . . . 0.0 108.859 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.84 -140.27 6.58 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 113.875 -1.512 . . . . 0.0 109.956 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.4 mm-40 -91.51 90.73 7.76 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.889 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.48 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -54.63 144.12 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.583 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 6.6 tt0 -89.43 -49.34 6.75 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.9 p -173.17 148.99 1.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.236 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.606 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.24 163.81 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.36 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -163.12 126.57 2.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.856 0.36 . . . . 0.0 110.953 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 1.2 mm? -109.94 98.37 33.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.146 0.498 . . . . 0.0 111.264 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.583 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 53.4 Cg_exo -48.18 -161.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.691 2.927 . . . . 0.0 113.269 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 155.86 122.53 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.714 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.487 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 8.8 p-10 -59.81 74.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.26 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 215' ' ' MET . 3.6 t-20 -131.05 -2.48 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.365 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.497 ' HG3' H5'' ' B' ' 5' ' ' ' DG' . 4.0 mmmt -132.1 5.73 4.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.965 0.412 . . . . 0.0 111.76 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -151.86 -24.98 0.19 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.305 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.568 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.8 m120 75.06 40.99 0.32 Allowed 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.628 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -116.12 -155.82 0.59 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.306 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.648 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -91.08 -37.02 13.68 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 122.256 -0.278 . . . . 0.0 110.267 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.648 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.3 OUTLIER 7.47 -96.29 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 124.084 0.865 . . . . 0.0 111.573 -178.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 23.28 75.63 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 O-C-N 123.635 0.584 . . . . 0.0 111.683 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.629 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.14 -120.4 0.12 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.101 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.533 ' HB3' ' CD1' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -169.77 162.95 9.77 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.194 0.997 . . . . 0.0 113.263 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.785 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 4.8 m-85 -144.42 123.94 13.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.634 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.744 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.3 mt -119.85 157.21 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.523 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.3 m -132.77 173.52 11.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.88 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.674 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 93.1 m-85 -148.2 117.4 6.86 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.583 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.48 -37.37 1.06 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.507 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -90.19 -154.87 0.35 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.62 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -142.07 1.98 1.48 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.696 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -83.75 -57.46 0.41 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.783 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 75.2 Cg_exo -49.18 -33.29 27.22 Favored 'Trans proline' 0 CA--C 1.492 -1.584 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.575 ' HB ' HG11 ' A' ' 181' ' ' VAL . 1.0 OUTLIER -64.94 -52.07 58.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.419 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.581 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.4 mtpt -46.54 -56.45 6.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.659 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.03 -53.58 56.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.6 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.647 HD13 ' CE2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -32.94 -61.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.699 -179.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.559 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 30.8 mtm -49.94 -20.12 0.85 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -75.57 -33.31 60.6 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.34 22.83 15.39 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.075 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.582 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -16.05 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 112.332 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.91 72.7 10.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.314 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.3 m-70 -73.55 146.61 44.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.2 m-80 -107.63 79.6 1.31 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.365 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.69 147.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.256 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 7.4 -73.9 0.0 OUTLIER Glycine 0 C--N 1.343 0.941 0 O-C-N 124.032 0.833 . . . . 0.0 113.679 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -116.71 -41.18 3.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.731 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -89.16 152.07 21.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.866 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.87 144.76 39.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.94 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.67 ' HB2' HG11 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.26 168.88 25.36 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 118.739 -1.185 . . . . 0.0 114.093 -177.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.475 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 49.9 tt0 -75.39 93.01 2.87 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.627 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.1 mt -80.18 83.44 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.751 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.578 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.9 OUTLIER -96.04 117.36 30.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.626 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.5 p -29.74 117.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 119.703 1.138 . . . . 0.0 110.161 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.649 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -75.46 -173.16 2.02 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.451 -175.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.436 ' HG2' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -175.93 142.21 0.51 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.763 -2.017 . . . . 0.0 110.63 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.789 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.683 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 C3'-C2'-C1' 101.71 -0.707 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 1.015 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.868 0 O4'-C4'-C3' 106.215 0.615 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 1.015 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.854 0 C4'-C3'-C2' 100.849 -2.351 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.887 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.505 -1.123 0 C4'-C3'-C2' 104.218 1.018 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.6 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 42.2 t . . . . . 0 CA--C 1.494 -1.182 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 19.9 mttt -150.57 -35.36 0.15 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 118.889 -1.124 . . . . 0.0 112.042 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.589 ' O ' ' CG1' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -96.46 -173.9 2.9 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.631 HD13 ' CD1' ' A' ' 239' ' ' ILE . 4.9 pt -162.45 115.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.706 ' CD2' ' C6 ' ' B' ' 3' ' ' ' DA' . 0.5 OUTLIER -93.08 92.57 7.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.019 -177.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.603 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.2 t -73.37 148.09 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.546 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -93.84 -167.64 37.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.389 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -23.55 150.11 0.0 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.602 ' HB3' ' SG ' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -176.46 -147.11 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 192' ' ' ASP . 1.3 m -89.41 129.93 45.58 Favored Pre-proline 0 C--N 1.341 0.199 0 CA-C-O 120.96 0.409 . . . . 0.0 110.508 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -32.03 -28.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.391 2.728 . . . . 0.0 113.409 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.8 t0 -149.68 53.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.624 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.551 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 16.9 m -39.91 124.75 1.59 Allowed Pre-proline 0 CA--C 1.519 -0.245 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.087 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.529 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 6.2 Cg_endo -48.58 94.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.56 2.174 . . . . 0.0 111.988 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.575 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -45.24 -21.32 0.07 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.707 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -37.65 88.06 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.3 mttp -77.68 -49.09 15.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.624 HG21 HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -47.18 -28.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.931 176.805 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.547 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 12.0 mtt180 -79.64 -27.99 40.92 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.33 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 5.2 pt-20 -87.47 -53.01 5.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.68 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -51.48 -39.5 57.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.342 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.762 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.3 OUTLIER -98.75 -35.83 10.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.673 -178.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.94 -42.93 99.57 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -66.04 -22.48 70.62 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.762 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -67.21 -37.85 84.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.3 1.048 . . . . 0.0 108.399 178.011 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.52 -156.67 28.3 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.157 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.5 mt-10 -81.6 90.91 6.32 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.645 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.6 t -53.01 142.75 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.536 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.1 tp10 -89.41 -46.97 8.33 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -167.79 169.79 11.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.184 178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.647 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -133.49 166.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.63 ' HG2' ' C8 ' ' B' ' 4' ' ' ' DG' . 2.1 tp10 -162.67 148.37 12.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.709 0.29 . . . . 0.0 111.352 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.534 ' CD1' HD21 ' A' ' 189' ' ' LEU . 2.8 mm? -140.25 106.1 6.65 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.305 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.6 ' HG2' ' CE2' ' A' ' 225' ' ' PHE . 21.0 Cg_exo -69.64 -172.32 0.55 Allowed 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 124.005 3.137 . . . . 0.0 113.68 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 156.08 107.14 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.054 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 215' ' ' MET . 33.9 p-10 -14.91 78.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.828 0.705 . . . . 0.0 112.749 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 215' ' ' MET . 3.3 t-20 -137.25 -4.14 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.478 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.442 ' C ' HG21 ' A' ' 219' ' ' THR . 5.2 mmmt -147.03 3.49 0.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.6 ' CG2' ' NH2' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -151.01 -5.37 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 219' ' ' THR . 19.6 m-20 70.69 2.83 4.3 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 0.4 OUTLIER -94.78 158.26 15.58 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.459 -178.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -56.77 -42.43 79.39 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.6 ' NH2' ' CG2' ' A' ' 219' ' ' THR . 0.0 OUTLIER 26.36 -91.41 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 124.641 1.213 . . . . 0.0 108.918 -177.261 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 23.58 77.87 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.136 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.609 ' CD1' ' OP2' ' B' ' 3' ' ' ' DA' . 7.2 p90 -131.26 -130.6 0.2 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.538 ' CB ' ' HB ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -154.27 162.53 41.12 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.198 0.523 . . . . 0.0 110.355 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.755 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 1.8 m-85 -150.5 118.02 6.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.525 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.661 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.3 mt -119.13 142.35 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 122.051 0.929 . . . . 0.0 110.492 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.0 m -120.09 149.55 42.01 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.284 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 63.8 m-85 -130.71 116.67 18.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -39.39 -36.63 0.37 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.227 1.013 . . . . 0.0 108.299 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.2 mm-40 -88.44 -155.87 0.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.992 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.6 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.3 OUTLIER -144.97 11.4 1.37 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.4 -59.07 0.22 Allowed Pre-proline 0 C--O 1.224 -0.254 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.761 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.0 Cg_exo -51.33 -32.48 41.89 Favored 'Trans proline' 0 CA--C 1.496 -1.388 0 N-CA-C 108.678 -1.316 . . . . 0.0 108.678 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.589 ' CG1' ' O ' ' A' ' 183' ' ' LYS . 0.9 OUTLIER -66.95 -54.5 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.056 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.6 OUTLIER -51.54 -45.25 62.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.84 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.674 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -53.97 31.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.456 0.646 . . . . 0.0 109.74 178.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.679 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -32.69 -65.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.336 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.451 ' HE1' HG23 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -48.71 -25.35 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 238' ' ' LYS . 5.6 mm-40 -67.88 -37.14 81.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -105.52 22.96 14.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.241 178.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.588 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.78 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.655 1.222 . . . . 0.0 111.985 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -84.52 72.22 10.67 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.983 0.42 . . . . 0.0 110.742 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.64 ' CE1' HG23 ' A' ' 239' ' ' ILE . 9.0 m-70 -74.23 159.15 32.88 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.393 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.441 ' OD1' ' HG2' ' A' ' 251' ' ' LYS . 5.2 m-80 -119.75 74.26 1.01 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.45 101.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.675 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.65 -87.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.54 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -99.87 -42.34 6.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.158 0.504 . . . . 0.0 110.559 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 247' ' ' VAL . 41.9 m -88.44 143.81 26.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.372 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.02 133.19 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.266 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -153.62 169.35 23.47 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.474 ' CG ' ' HD2' ' A' ' 255' ' ' LYS . 47.8 tt0 -72.9 104.9 4.2 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.004 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.651 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.8 mt -91.12 79.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.643 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.6 mtpt -87.45 119.04 27.33 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.1 p -33.73 115.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.518 1.152 . . . . 0.0 110.644 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.702 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -67.9 -179.96 1.31 Allowed 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.955 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.485 ' CG ' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER 176.9 149.52 0.14 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.289 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.471 ' HB2' ' O6 ' ' B' ' 4' ' ' ' DG' . 1.8 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 111.207 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.908 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.881 0 C4'-C3'-C2' 103.938 0.738 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.706 ' C6 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.849 0 O4'-C1'-N19 108.388 0.735 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.755 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.835 0 C4'-C3'-C2' 101.094 -2.106 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.566 ' P ' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 C2'--C1' 1.507 -1.021 0 C4'-C3'-C2' 104.515 1.315 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.608 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.6 t . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 25.6 mttt -151.27 -35.41 0.14 Allowed 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 118.873 -1.131 . . . . 0.0 112.259 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.657 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -92.47 -172.64 3.14 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.657 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 6.8 pt -166.03 111.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 122.025 0.916 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.684 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -83.57 103.27 12.77 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.046 -178.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.7 t -89.62 106.37 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.638 ' HA3' ' C2 ' ' B' ' 2' ' ' ' DT' . . . -98.08 122.71 7.6 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 115.964 1.145 . . . . 0.0 115.964 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.58 107.72 2.85 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.634 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -168.64 -158.89 0.23 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.561 ' N ' HD11 ' A' ' 189' ' ' LEU . 46.3 t -88.85 135.61 31.79 Favored Pre-proline 0 C--N 1.343 0.318 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.878 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HB2' ' OD1' ' A' ' 192' ' ' ASP . 87.8 Cg_exo -29.63 -32.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.669 2.913 . . . . 0.0 113.576 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.8 OUTLIER -150.65 54.75 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.617 0.246 . . . . 0.0 111.195 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.6 ' HB ' ' CD1' ' A' ' 213' ' ' LEU . 17.9 m -39.77 134.1 1.34 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 110.819 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.502 ' O ' HG13 ' A' ' 198' ' ' ILE . 11.8 Cg_endo -55.1 89.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.774 2.316 . . . . 0.0 111.75 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.585 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -44.43 -22.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.034 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.51 -35.69 81.78 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.17 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.84 -47.11 17.24 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.62 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.5 OUTLIER -50.02 -24.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.196 177.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.542 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 1.7 mtt180 -82.03 -26.8 33.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.792 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -87.37 -43.86 11.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.874 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.72 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -58.63 -43.25 89.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.441 0.639 . . . . 0.0 110.066 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.774 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 1.2 m-85 -94.97 -32.05 13.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.369 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.3 -44.68 95.13 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.674 -2.171 . . . . 0.0 107.674 175.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.56 -23.36 66.82 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.812 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.29 -34.31 77.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.072 0.939 . . . . 0.0 108.709 177.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.92 -142.4 7.97 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.895 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 18.1 mt-10 -91.18 92.54 8.71 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.7 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -55.66 144.84 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.537 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.4 tp10 -89.76 -50.33 6.12 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 72.2 m -171.77 148.1 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.296 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.642 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.02 158.85 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.3 OUTLIER -155.23 129.69 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.6 ' CD1' ' HB ' ' A' ' 193' ' ' THR . 4.5 mm? -110.29 92.03 12.73 Favored Pre-proline 0 N--CA 1.455 -0.183 0 CA-C-O 121.55 0.69 . . . . 0.0 111.322 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.595 ' HA ' ' P ' ' B' ' 5' ' ' ' DG' . 84.4 Cg_exo -48.06 -170.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 124.109 3.206 . . . . 0.0 113.909 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.534 ' HG2' ' OP1' ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER 157.7 141.2 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.656 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.504 ' HA ' ' HD3' ' A' ' 223' ' ' ARG . 3.8 p-10 -51.03 87.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.214 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 215' ' ' MET . 2.8 t30 -147.39 6.3 0.85 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.508 ' C ' HG23 ' A' ' 219' ' ' THR . 0.0 OUTLIER -135.59 -25.97 1.26 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -143.54 -6.89 0.78 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 219' ' ' THR . 6.9 m-20 71.42 52.29 0.24 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.555 ' CD ' ' HD2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -126.83 172.54 10.3 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.506 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -60.74 -35.69 77.01 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.497 -179.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.555 ' HD2' ' CD ' ' A' ' 221' ' ' LYS . 0.4 OUTLIER 17.41 -81.83 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 124.548 1.155 . . . . 0.0 110.35 -177.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 8.64 82.26 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.923 0.764 . . . . 0.0 113.062 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.634 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.22 -120.57 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.539 ' HA ' ' CD ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -168.03 167.47 12.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.143 0.973 . . . . 0.0 112.288 177.018 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.741 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.2 m-85 -148.95 113.48 5.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.099 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.723 HD13 ' CG ' ' A' ' 202' ' ' PHE . 2.3 mt -109.3 158.58 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.0 m -140.28 155.64 46.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.927 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 70.5 m-85 -131.41 123.0 27.24 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.537 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -43.93 -38.22 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mm-40 -90.31 -168.06 2.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.372 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.608 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -131.12 15.57 5.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -92.4 -62.07 0.19 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.735 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.812 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.8 Cg_exo -49.03 -31.96 22.21 Favored 'Trans proline' 0 CA--C 1.497 -1.332 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -66.82 -54.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.637 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 30.9 pttt -50.93 -46.77 61.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.549 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.626 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -56.4 11.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.414 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.67 HD13 ' CE2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -28.19 -60.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.028 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.472 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.4 mtp -46.23 -31.25 2.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.0 OUTLIER -65.83 -39.54 90.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.17 19.69 14.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.585 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.44 -50.42 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 O-C-N 124.722 1.264 . . . . 0.0 112.114 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.68 72.45 10.57 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.42 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.1 m-70 -73.54 142.19 46.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.965 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -103.54 79.32 1.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.929 0.395 . . . . 0.0 111.394 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -66.88 151.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.171 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 1.82 -69.76 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 O-C-N 124.002 0.814 . . . . 0.0 113.817 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -118.91 -44.3 2.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.093 0.473 . . . . 0.0 110.787 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.545 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -89.82 152.29 21.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.615 -178.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.52 144.35 46.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.169 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.611 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -155.41 164.48 38.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -178.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.48 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 44.9 tt0 -72.74 92.01 1.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.453 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.651 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.3 mt -81.38 81.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.935 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.7 OUTLIER -96.64 119.06 34.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -27.87 119.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 122.264 1.031 . . . . 0.0 110.197 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.668 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -80.06 174.47 11.56 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 113.186 -1.824 . . . . 0.0 113.323 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.416 ' O ' ' HB3' ' A' ' 259' ' ' SER . 0.0 OUTLIER 176.68 -87.01 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.746 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 258' ' ' MET . 9.0 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.648 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.785 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C4'--C3' 1.52 -0.835 0 O4'-C4'-C3' 104.23 -1.37 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.593 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.846 0 C3'-C2'-C1' 102.108 -0.423 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.741 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.521 -0.732 0 C4'-C3'-C2' 100.959 -2.241 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.718 ' C6 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.901 0 C3'-C2'-C1' 101.989 -0.508 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.619 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 41.3 t . . . . . 0 CA--C 1.491 -1.304 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 20.2 mttt -150.81 -33.55 0.16 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.81 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.617 ' CD ' ' HB2' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -104.9 -166.96 1.29 Allowed 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.596 ' CG2' ' O ' ' A' ' 183' ' ' LYS . 12.4 pt -164.05 139.1 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.421 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -110.48 98.4 7.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.096 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.625 ' CG1' HG12 ' A' ' 254' ' ' ILE . 2.1 t -80.83 148.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.556 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -95.45 -171.74 36.41 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.766 -0.73 . . . . 0.0 114.085 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -21.51 148.44 0.0 OUTLIER Glycine 0 C--N 1.343 0.97 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.609 ' HB3' ' SG ' ' A' ' 252' ' ' CYS . 0.0 OUTLIER -169.9 -144.85 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.549 ' O ' HD12 ' A' ' 189' ' ' LEU . 36.0 m -89.39 129.63 46.71 Favored Pre-proline 0 C--N 1.343 0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -29.66 -31.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.546 2.831 . . . . 0.0 113.532 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 190' ' ' SER . 41.7 m-20 -151.14 54.2 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.555 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 24.1 m -41.16 117.46 1.57 Allowed Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.371 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.543 ' HG2' ' CE ' ' A' ' 197' ' ' LYS . 9.0 Cg_endo -49.9 101.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.882 2.388 . . . . 0.0 112.209 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.571 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -48.38 -18.28 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.973 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 60.1 mt-10 -63.92 -37.43 87.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.543 ' CE ' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -81.52 -45.88 15.3 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.618 HG22 HD11 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -51.13 -27.59 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.346 176.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.522 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 1.2 mtt180 -77.04 -27.88 54.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.812 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.2 mm-40 -85.76 -62.74 1.46 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.586 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.665 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -41.3 -40.93 1.79 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.756 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -98.11 -34.15 10.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.614 -178.398 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.36 -45.68 95.45 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 176.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.67 -22.41 68.03 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.756 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -65.82 -36.94 84.89 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 122.521 1.153 . . . . 0.0 108.227 177.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.74 -162.15 35.61 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.863 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.7 mt-10 -76.58 93.09 3.54 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.557 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 209' ' ' GLU . 1.6 t -53.73 142.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.538 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -89.53 -44.05 10.38 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 67.2 m -170.92 172.42 5.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.112 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.667 HG21 HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -137.13 161.08 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.981 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.578 ' HG2' ' C8 ' ' B' ' 4' ' ' ' DG' . 0.3 OUTLIER -161.33 143.94 12.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.492 HD13 HD23 ' A' ' 189' ' ' LEU . 3.3 mm? -134.1 107.82 11.46 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 111.319 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.61 ' HA ' ' P ' ' B' ' 5' ' ' ' DG' . 73.4 Cg_exo -50.49 -164.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.436 2.757 . . . . 0.0 113.619 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.498 ' N ' ' OP2' ' B' ' 5' ' ' ' DG' . 6.9 ptt? 161.75 128.33 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.646 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 51.9 p-10 -58.19 80.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.602 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 215' ' ' MET . 44.1 m-20 -147.23 11.46 1.03 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.211 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.559 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 4.9 mmtt -134.15 -30.22 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.538 HG23 ' NH2' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -135.76 -7.04 2.16 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 219' ' ' THR . 20.4 m-80 70.39 46.44 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.579 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -128.59 161.13 30.34 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.07 178.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -55.52 -42.0 73.91 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.218 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.579 ' HG2' ' HG2' ' A' ' 221' ' ' LYS . 0.0 OUTLIER 23.51 -89.55 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.541 1.151 . . . . 0.0 109.574 -177.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 21.41 78.62 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.472 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.635 ' CE1' " H4'" ' B' ' 3' ' ' ' DA' . 8.4 p90 -130.1 -130.15 0.21 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.528 ' CB ' ' HB ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.386 0.612 . . . . 0.0 111.375 178.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.736 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.0 m-85 -151.02 111.58 4.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.912 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.667 HG12 HG21 ' A' ' 211' ' ' ILE . 1.5 mt -112.8 148.49 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.595 ' N ' HG22 ' A' ' 228' ' ' ILE . 8.4 m -124.56 152.28 43.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.126 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.618 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 68.6 m-85 -132.11 119.02 20.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.538 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.21 -38.19 0.74 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.2 mt-10 -89.06 -155.48 0.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.711 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 2.0 pm0 -141.83 4.89 1.72 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.552 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.522 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 14.2 mt-10 -86.63 -56.15 0.36 Allowed Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.741 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 94.0 Cg_exo -51.45 -31.99 41.06 Favored 'Trans proline' 0 CA--C 1.494 -1.482 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.578 ' CG1' ' O ' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -65.41 -50.62 71.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.342 177.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 22.3 mttm -47.93 -58.64 4.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.043 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.669 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.23 -51.99 66.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.155 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.661 HG21 ' CE1' ' A' ' 245' ' ' HIS . 0.7 OUTLIER -36.65 -63.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.114 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.52 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -52.56 -18.17 1.6 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.298 -179.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' LYS . 14.0 mm-40 -76.67 -33.52 58.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.81 24.15 13.51 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.766 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.576 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.34 -47.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.354 1.034 . . . . 0.0 112.122 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 242' ' ' LYS . 23.0 m-85 -84.69 69.87 10.71 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.529 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.661 ' CE1' HG21 ' A' ' 239' ' ' ILE . 9.4 m-70 -70.46 156.22 39.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.832 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -122.04 72.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.639 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -61.55 141.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.446 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 12.14 -76.82 0.0 OUTLIER Glycine 0 C--N 1.338 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 113.899 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.99 -42.5 3.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 247' ' ' VAL . 14.5 m -88.01 145.37 26.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.702 0.763 . . . . 0.0 112.645 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.525 ' CB ' ' HA ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -135.6 133.28 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 107.888 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -152.54 163.53 39.41 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 118.636 -1.226 . . . . 0.0 114.27 -176.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.492 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 42.5 tt0 -67.57 108.66 2.95 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.215 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.656 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 2.1 mt -98.49 79.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.196 -1.365 . . . . 0.0 112.453 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.39 119.92 28.15 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.557 ' O ' ' CG1' ' A' ' 256' ' ' VAL . 2.9 p -36.25 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 123.051 1.405 . . . . 0.0 110.876 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.703 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -45.38 -171.91 0.0 OUTLIER 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 112.097 -2.32 . . . . 0.0 112.059 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.597 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -162.7 -156.0 0.38 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.572 -1.649 . . . . 0.0 110.981 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.884 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.793 0 C4'-C3'-C2' 104.092 0.892 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.635 " H4'" ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 N19-C1'-C2' 112.908 -0.808 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.736 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 C4'-C3'-C2' 101.235 -1.965 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.61 ' P ' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 C2'--C1' 1.506 -1.063 0 C4'-C3'-C2' 104.769 1.569 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.59 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 29.2 t . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 21.9 mttt -150.31 -35.03 0.16 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.133 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.615 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -94.18 -170.84 2.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.628 HG13 ' O ' ' A' ' 184' ' ' ILE . 11.6 pt -165.33 117.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.709 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -93.06 100.22 12.68 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.879 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.8 t -85.04 111.26 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.067 0.947 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.591 ' HA3' ' C2 ' ' B' ' 2' ' ' ' DT' . . . -97.77 119.43 6.42 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.117 1.207 . . . . 0.0 116.117 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.535 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 98.72 105.95 2.59 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 114.903 0.721 . . . . 0.0 114.903 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.616 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -166.07 -157.63 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 192' ' ' ASP . 58.8 m -89.25 133.17 35.54 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -29.76 -31.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.695 2.93 . . . . 0.0 113.663 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.8 m-20 -150.41 54.2 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.431 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 32.4 m -40.65 128.49 1.86 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 198' ' ' ILE . 6.3 Cg_endo -49.2 90.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.164 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.576 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.9 OUTLIER -42.43 -23.57 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.511 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.64 -37.56 87.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.1 mmmt -77.36 -48.27 17.74 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.622 HG23 HD13 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.73 -26.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.256 177.286 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.51 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 10.4 mtt85 -79.67 -27.25 40.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.937 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 pt-20 -86.42 -50.96 6.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.7 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -51.57 -40.24 59.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.541 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.741 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.8 OUTLIER -98.93 -30.31 12.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.176 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.63 -47.36 87.51 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -61.66 -23.57 63.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 176.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.772 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.38 -34.23 77.5 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.044 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.25 -142.53 8.14 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 8.7 mt-10 -90.72 94.67 9.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.256 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -56.59 143.1 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.58 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.5 tp10 -89.27 -47.53 7.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 68.1 m -174.06 147.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.374 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.615 HG23 HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.16 161.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.437 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.3 OUTLIER -160.47 127.76 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 111.226 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.508 ' CD2' HD13 ' A' ' 198' ' ' ILE . 1.5 mm? -109.55 97.68 28.66 Favored Pre-proline 0 N--CA 1.456 -0.126 0 CA-C-O 121.458 0.647 . . . . 0.0 111.803 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.619 ' HA ' ' P ' ' B' ' 5' ' ' ' DG' . 60.9 Cg_exo -48.41 -167.26 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 123.902 3.068 . . . . 0.0 113.332 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.8 OUTLIER 154.82 125.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.992 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.493 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 14.4 p-10 -51.25 83.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.443 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 215' ' ' MET . 3.1 t-20 -146.08 6.12 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.493 ' C ' ' CG2' ' A' ' 219' ' ' THR . 4.1 mmmt -141.86 -0.88 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.607 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -152.46 -26.49 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 219' ' ' THR . 22.2 m-20 78.88 53.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.562 ' HG2' ' N ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -129.35 -158.65 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.862 178.39 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.645 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -87.52 -40.87 13.92 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 118.189 0.449 . . . . 0.0 109.851 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.645 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.5 OUTLIER 19.07 -94.56 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 123.787 0.679 . . . . 0.0 110.615 -178.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 22.43 76.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 O-C-N 123.705 0.628 . . . . 0.0 112.575 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.616 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -147.58 -123.14 0.06 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.357 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.48 ' SG ' HD22 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.08 164.57 20.37 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 113.201 178.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.779 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 4.1 m-85 -148.24 116.05 6.37 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 113.626 -1.625 . . . . 0.0 108.742 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.715 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.3 mt -115.17 159.58 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.621 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.7 m -136.83 169.02 18.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.197 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.672 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 86.2 m-85 -145.94 116.64 7.65 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.58 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.6 -36.93 0.65 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.539 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 3.7 pm0 -89.03 -155.97 0.37 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.473 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.59 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 19.1 pt-20 -141.17 -2.59 1.27 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.885 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.7 -57.33 0.83 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 -177.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.772 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.9 Cg_exo -51.04 -34.18 45.89 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.572 ' HB ' HG12 ' A' ' 181' ' ' VAL . 1.1 t -64.72 -51.48 66.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.85 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 16.8 mtpt -44.99 -58.79 2.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.933 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.647 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.67 -52.76 64.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.627 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.652 HD13 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -33.92 -62.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.175 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.533 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.3 mtp -51.3 -20.85 1.84 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.919 0.39 . . . . 0.0 111.251 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -75.72 -34.28 60.33 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.19 22.39 16.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.617 178.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.595 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.76 -48.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 0.0 112.29 -179.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 242' ' ' LYS . 23.4 m-30 -84.4 71.79 10.66 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.66 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.2 m-70 -72.75 154.49 40.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.18 79.56 1.36 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.04 152.53 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.575 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 0.79 -68.85 0.0 OUTLIER Glycine 0 C--N 1.343 0.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.899 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -117.3 -43.59 2.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.0 110.997 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 9.1 m -89.77 153.84 20.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.033 0.921 . . . . 0.0 113.283 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.27 139.77 39.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.183 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.671 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.98 169.57 24.52 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 118.613 -1.235 . . . . 0.0 114.157 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.489 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.3 tt0 -75.88 92.15 3.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.738 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.643 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.3 mt -79.93 81.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.837 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.575 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 2.7 mtpt -93.7 116.98 29.5 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.4 p -29.17 119.65 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 122.267 1.032 . . . . 0.0 110.744 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.658 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -78.25 174.66 10.97 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.47 -175.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.86 148.39 6.07 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.51 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 91.9 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 111.252 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.614 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C3'--C2' 1.51 -0.751 0 C4'-C3'-C2' 101.728 -1.472 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.911 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.825 0 C3'-C2'-C1' 101.918 -0.559 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.911 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.822 0 C4'-C3'-C2' 101.097 -2.103 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.619 ' P ' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.83 0 C5'-C4'-O4' 108.576 -0.515 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.612 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 40.8 t . . . . . 0 CA--C 1.495 -1.151 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 19.6 mttt -148.34 -35.42 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.867 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -94.79 -175.49 3.59 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.639 HD12 ' CD1' ' A' ' 239' ' ' ILE . 5.4 pt -162.38 117.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.675 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -93.4 109.1 20.67 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.415 -177.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.628 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.4 t -97.67 115.32 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.757 0.823 . . . . 0.0 112.984 -178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.528 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -49.3 -177.14 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 114.796 0.678 . . . . 0.0 114.796 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -31.49 161.74 0.0 OUTLIER Glycine 0 C--N 1.342 0.914 0 N-CA-C 114.653 0.621 . . . . 0.0 114.653 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.6 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -175.42 -143.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.594 ' N ' HD12 ' A' ' 189' ' ' LEU . 1.3 m -88.5 135.4 32.64 Favored Pre-proline 0 C--N 1.343 0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 44.2 Cg_exo -28.78 -39.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.159 2.573 . . . . 0.0 113.033 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.5 56.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.583 ' CG2' ' CD1' ' A' ' 198' ' ' ILE . 86.1 m -39.21 127.95 1.3 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.489 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.9 Cg_endo -50.53 96.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.259 2.64 . . . . 0.0 113.808 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.774 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -39.75 -28.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.207 178.245 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 194' ' ' PRO . 2.9 mm-40 -61.23 -36.78 80.88 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.183 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 200' ' ' GLU . 3.0 mmmt -77.64 -52.29 9.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.774 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -46.91 -26.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.04 176.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.549 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 8.1 mtp180 -82.31 -26.84 32.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.101 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.8 OUTLIER -87.48 -41.12 13.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.998 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.684 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.3 t80 -67.14 -38.27 85.25 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.369 0.604 . . . . 0.0 110.358 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.743 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -98.26 -37.06 9.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.396 -178.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.5 -43.69 96.27 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.14 -23.98 66.69 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.79 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -37.52 86.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.084 0.945 . . . . 0.0 108.902 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.88 -140.51 6.41 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 32.6 mt-10 -92.06 94.6 9.33 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.213 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.95 144.91 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.53 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 15.4 tt0 -89.79 -53.14 4.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 66.8 m -171.22 148.43 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.625 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.667 HG23 HD13 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.64 166.84 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.138 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.474 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -165.36 123.69 1.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.067 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.54 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.5 mm? -105.72 98.94 19.29 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 111.439 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.616 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 74.4 Cg_exo -51.44 -160.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.209 3.273 . . . . 0.0 114.438 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 153.39 127.52 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.672 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.515 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 17.5 p-10 -54.62 82.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.767 0.318 . . . . 0.0 111.786 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 215' ' ' MET . 6.4 t-20 -139.92 0.52 1.78 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.801 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.479 ' HG3' " H3'" ' B' ' 5' ' ' ' DG' . 0.1 OUTLIER -133.68 0.45 3.27 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 111.553 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.7 OUTLIER -152.12 -24.8 0.18 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.58 ' HB2' ' O ' ' A' ' 219' ' ' THR . 6.7 m-80 75.29 41.28 0.29 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.575 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -116.37 -158.96 0.71 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.896 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -87.61 -35.22 18.19 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.313 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.1 OUTLIER 12.76 -79.41 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 124.587 1.18 . . . . 0.0 110.648 -178.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 10.88 81.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.49 0 O-C-N 124.218 0.949 . . . . 0.0 112.212 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.616 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -149.92 -119.85 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.084 -0.558 . . . . 0.0 109.574 -176.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.536 ' HA ' ' CD ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -172.62 168.91 5.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.0 0.905 . . . . 0.0 112.805 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.772 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 4.2 m-85 -150.41 125.37 9.88 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.349 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.668 HD11 ' CG ' ' A' ' 202' ' ' PHE . 1.6 mt -119.92 147.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.528 0.68 . . . . 0.0 110.071 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.617 ' N ' HG21 ' A' ' 228' ' ' ILE . 3.1 m -126.09 153.14 44.91 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.1 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 89.1 m-85 -129.01 120.64 26.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.26 -38.99 2.81 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mt-10 -90.13 -167.1 1.75 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.665 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.612 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -132.56 15.56 4.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.64 -64.88 0.15 Allowed Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.79 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 52.7 Cg_exo -46.34 -35.2 15.44 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.573 ' HB ' HG13 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -65.48 -52.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.241 -1.799 . . . . 0.0 110.349 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.6 pttt -52.26 -45.19 65.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.549 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.647 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.23 -54.78 20.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.618 0.723 . . . . 0.0 109.935 177.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.667 HD13 ' CD2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -29.59 -64.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.159 -179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.477 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -49.4 -22.33 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.276 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.4 mm-40 -74.29 -37.1 63.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.613 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -100.33 19.84 15.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.375 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.62 -48.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.52 1.137 . . . . 0.0 112.166 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 242' ' ' LYS . 18.5 m-85 -86.66 71.17 10.41 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.351 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.664 ' CE1' HG22 ' A' ' 239' ' ' ILE . 10.7 m-70 -71.68 148.51 46.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.346 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.74 77.23 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.097 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.516 ' O ' ' C ' ' A' ' 248' ' ' GLY . 2.2 t -62.97 171.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.67 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . -14.67 -59.27 0.01 OUTLIER Glycine 0 C--N 1.341 0.806 0 O-C-N 123.781 0.676 . . . . 0.0 113.367 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -132.04 -41.61 1.01 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.398 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.52 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -87.94 152.05 22.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.67 0.748 . . . . 0.0 112.755 -177.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.99 135.61 36.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.812 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.628 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.58 157.56 41.2 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.634 -0.826 . . . . 0.0 112.92 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.571 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 64.8 tt0 -60.76 119.16 7.63 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.649 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.7 mt -104.36 82.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.813 0.816 . . . . 0.0 111.85 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.587 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.0 118.72 26.57 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.197 -1.365 . . . . 0.0 107.695 178.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.5 p -33.73 120.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 119.546 1.066 . . . . 0.0 109.777 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.653 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -75.46 -177.26 3.52 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 113.226 -1.807 . . . . 0.0 113.053 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.418 ' CG ' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -164.18 -156.43 0.34 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.319 -1.764 . . . . 0.0 110.595 -179.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.81 0.338 . . . . 0.0 110.893 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.608 ' OP2' ' C6 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C3'-C2'-C1' 100.413 -1.634 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.617 ' OP2' ' CE1' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.805 0 C3'-C2'-C1' 101.936 -0.546 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.94 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 C4'--C3' 1.519 -0.864 0 C4'-C3'-C2' 100.629 -2.571 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.94 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 O4'-C4'-C3' 106.215 0.615 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.596 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 32.0 t . . . . . 0 CA--C 1.497 -1.091 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.516 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.4 mttt -151.44 -35.17 0.14 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.175 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.644 ' O ' ' CG2' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -91.73 -173.19 3.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.653 ' HA ' ' HA ' ' A' ' 256' ' ' VAL . 7.8 pt -165.86 108.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 122.519 1.152 . . . . 0.0 109.502 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.677 ' CD2' ' C6 ' ' B' ' 3' ' ' ' DA' . 0.2 OUTLIER -81.53 103.59 11.37 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.754 -178.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.608 ' CG1' ' HB2' ' A' ' 252' ' ' CYS . 64.3 t -89.87 131.44 37.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.976 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 188' ' ' GLY . . . -64.33 -176.48 4.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -37.82 172.59 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.023 -0.589 . . . . 0.0 114.128 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.668 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.2 OUTLIER 169.63 -139.8 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.361 -0.135 . . . . 0.0 111.123 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 192' ' ' ASP . 6.1 m -88.78 130.69 44.08 Favored Pre-proline 0 C--N 1.339 0.149 0 CA-C-O 120.966 0.412 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -32.63 -30.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.058 2.505 . . . . 0.0 112.931 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -151.29 54.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.531 HG21 ' CD1' ' A' ' 198' ' ' ILE . 47.9 m -39.54 128.51 1.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.268 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.553 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.4 Cg_endo -52.29 96.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.803 2.335 . . . . 0.0 111.889 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.59 ' HA ' HG13 ' A' ' 198' ' ' ILE . 1.1 pm0 -46.31 -17.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 26.9 mt-10 -65.13 -40.47 94.51 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.6 OUTLIER -78.51 -45.72 21.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.604 ' CG2' ' CD1' ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.83 -26.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.892 176.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.532 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.9 mtt85 -77.36 -28.41 52.97 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.514 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.0 mm-40 -85.29 -60.64 1.97 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.773 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.703 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -42.21 -42.55 3.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.768 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -97.88 -31.5 12.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.15 -49.77 71.68 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 176.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.64 -23.26 60.55 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.79 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.29 -36.74 85.09 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.825 0.822 . . . . 0.0 108.805 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.62 -139.01 5.62 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.908 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 66.9 mt-10 -91.71 89.7 7.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.996 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -55.57 141.07 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.544 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.6 tp10 -90.08 -48.3 7.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 21.5 m -174.27 149.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.626 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.643 HG21 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.29 156.92 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.748 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.482 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -154.19 125.74 7.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.558 HD22 ' CD1' ' A' ' 198' ' ' ILE . 3.2 mm? -107.34 96.37 15.77 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 121.219 0.533 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.652 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 87.1 Cg_exo -49.47 -167.19 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.386 2.724 . . . . 0.0 113.057 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.533 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 155.99 130.96 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.74 -179.312 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 0.6 OUTLIER -52.87 83.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.116 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 215' ' ' MET . 0.8 OUTLIER -138.91 -4.15 1.57 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.549 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 3.7 mmtt -138.53 1.32 2.14 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.8 OUTLIER -151.69 -25.26 0.19 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.378 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 219' ' ' THR . 11.6 m-20 73.86 43.52 0.32 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.56 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -122.09 -178.43 3.86 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.623 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -65.6 -43.62 89.08 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.566 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.588 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER 20.87 -83.36 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 O-C-N 124.785 1.303 . . . . 0.0 109.702 -176.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 10.67 82.23 0.01 OUTLIER Glycine 0 C--N 1.336 0.547 0 O-C-N 124.114 0.884 . . . . 0.0 112.008 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.668 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -149.93 -116.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.092 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.536 ' HA ' ' CD ' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -174.07 169.26 4.01 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.496 1.141 . . . . 0.0 112.824 177.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.769 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.7 m-85 -151.51 110.6 3.9 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.858 -1.973 . . . . 0.0 108.519 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.706 HD12 ' CG ' ' A' ' 202' ' ' PHE . 2.2 mt -108.72 159.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.333 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.8 m -137.38 170.8 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.158 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.8 m-85 -148.02 114.08 5.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.544 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -38.67 -35.34 0.19 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 17.2 mt-10 -88.6 -153.63 0.26 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.772 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.7 OUTLIER -148.44 13.27 0.95 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.075 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.636 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 1.2 mt-10 -94.27 -57.81 0.21 Allowed Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.79 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 87.7 Cg_exo -51.43 -31.94 40.67 Favored 'Trans proline' 0 CA--C 1.496 -1.417 0 N-CA-C 108.793 -1.272 . . . . 0.0 108.793 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.561 HG11 HG22 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -68.01 -55.02 18.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.821 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -50.99 -42.39 60.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.157 -179.179 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.641 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.06 -54.62 10.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.601 0.715 . . . . 0.0 109.957 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.658 ' CG2' ' CG2' ' A' ' 254' ' ' ILE . 0.4 OUTLIER -28.2 -63.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.865 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.487 ' SD ' ' HB ' ' A' ' 256' ' ' VAL . 19.2 mtm -45.76 -29.63 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.7 mm-40 -64.78 -40.9 96.03 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.36 20.51 13.56 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.586 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.49 -50.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.635 1.209 . . . . 0.0 112.185 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.5 m-85 -85.58 69.29 10.63 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.2 m-70 -69.18 149.7 48.3 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.74 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -112.62 80.72 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -74.04 100.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.04 -84.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.707 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.539 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -105.54 -42.18 5.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 247' ' ' VAL . 56.1 m -88.81 146.84 24.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.721 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.42 138.32 32.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.475 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.608 ' HB2' ' CG1' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.99 153.59 26.33 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.664 -177.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.563 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 28.2 tt0 -57.96 114.55 2.39 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.969 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.658 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.8 mt -103.33 83.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.793 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.573 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -91.86 117.78 30.11 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.351 178.755 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 4.3 p -30.57 122.75 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 119.376 0.989 . . . . 0.0 109.936 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.662 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -82.17 177.31 8.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.677 -1.602 . . . . 0.0 113.004 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.08 135.44 7.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.307 -1.77 . . . . 0.0 110.241 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.426 ' HB3' ' O6 ' ' B' ' 4' ' ' ' DG' . 26.5 p . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.101 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.883 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.73 0 O4'-C1'-C2' 107.035 0.85 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.677 ' C6 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.941 0 C3'-C2'-C1' 101.996 -0.503 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.769 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.52 -0.787 0 C4'-C3'-C2' 100.93 -2.27 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.559 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.766 0 O4'-C4'-C3' 106.115 0.515 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.588 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 28.3 t . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 26.0 mttt -152.55 -34.97 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.717 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.0 OUTLIER -93.58 -179.32 4.99 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.654 179.094 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 184' ' ' ILE . 5.9 pt -161.1 112.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 122.098 0.952 . . . . 0.0 108.897 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.718 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -87.04 104.7 16.57 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.147 -177.334 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.602 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.6 t -91.02 112.11 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.431 0.693 . . . . 0.0 111.44 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . -52.38 -172.64 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.5 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -28.16 156.95 0.0 OUTLIER Glycine 0 N--CA 1.468 0.794 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -171.08 -145.41 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.57 ' N ' HD12 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.74 132.4 38.66 Favored Pre-proline 0 C--N 1.341 0.215 0 CA-C-O 120.8 0.333 . . . . 0.0 110.213 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 73.4 Cg_exo -29.7 -33.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.298 2.665 . . . . 0.0 113.126 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 190' ' ' SER . 1.9 m-20 -150.92 54.33 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.408 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.537 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 25.5 m -39.95 122.54 1.57 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.582 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 11.2 Cg_endo -53.81 98.56 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.89 2.393 . . . . 0.0 112.22 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.585 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.5 OUTLIER -44.73 -21.39 0.05 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.766 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 2.2 mp0 -62.1 -39.09 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.582 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.2 OUTLIER -80.28 -44.97 18.71 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.624 HG22 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.59 -28.63 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.172 -1.377 . . . . 0.0 108.899 177.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 0.1 OUTLIER -76.07 -27.99 57.44 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.366 177.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mm-40 -84.03 -61.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.898 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.679 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.3 t80 -41.68 -39.38 1.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.284 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.724 ' CG ' HD11 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -100.81 -33.93 10.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.372 -177.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.59 -48.28 82.84 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -62.3 -23.06 63.95 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 176.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.738 ' CE2' HG13 ' A' ' 239' ' ' ILE . 0.1 OUTLIER -65.93 -38.15 87.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 122.153 0.978 . . . . 0.0 108.849 177.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.24 -143.01 8.04 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.639 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.6 mt-10 -92.05 97.15 10.76 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.293 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -61.39 143.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.53 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 13.4 tt0 -89.07 -52.45 5.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 60.7 p -169.67 147.47 3.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.628 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.643 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.32 161.68 8.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.449 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -159.55 128.55 5.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.304 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.492 ' O ' ' O ' ' A' ' 214' ' ' PRO . 1.5 mm? -109.41 95.77 20.05 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 121.442 0.639 . . . . 0.0 110.996 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.639 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 88.5 Cg_exo -44.01 -166.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 124.558 3.505 . . . . 0.0 114.263 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 159.13 132.81 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.105 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 15.2 p-10 -65.28 81.77 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.642 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 217' ' ' ASN . 8.5 t30 -141.16 2.36 1.69 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.724 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.472 ' C ' ' CG2' ' A' ' 219' ' ' THR . 19.2 mmtt -138.11 1.56 2.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.751 0.31 . . . . 0.0 111.818 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.8 OUTLIER -152.0 -26.36 0.18 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 219' ' ' THR . 31.3 m-20 73.93 52.0 0.11 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.568 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.03 -166.58 1.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.574 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -78.69 -39.37 36.83 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.146 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.574 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.5 OUTLIER 17.63 -86.01 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 124.319 1.012 . . . . 0.0 109.645 -177.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.93 78.08 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 O-C-N 124.005 0.816 . . . . 0.0 112.994 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.639 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -150.86 -121.21 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.508 ' SG ' ' CD2' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.81 166.5 11.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.099 0.952 . . . . 0.0 112.888 178.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.786 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 4.0 m-85 -148.24 119.58 7.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.318 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.724 HD11 ' CG ' ' A' ' 202' ' ' PHE . 2.4 mt -115.75 146.18 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.631 0.729 . . . . 0.0 110.3 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 3.3 m -124.15 164.52 19.31 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.101 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 96.4 m-85 -139.44 119.85 13.93 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.53 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -42.57 -38.93 2.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.4 mm-40 -91.21 -168.04 1.96 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.488 -1.687 . . . . 0.0 110.732 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.588 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 4.8 pt-20 -129.6 16.8 5.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -89.62 -64.49 0.19 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.675 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.9 Cg_exo -46.13 -30.83 8.01 Favored 'Trans proline' 0 CA--C 1.5 -1.182 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.56 ' HB ' HG13 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -72.23 -54.49 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.757 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.635 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -51.18 -32.9 25.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.541 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.648 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -83.75 -56.48 3.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.147 178.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.738 HG13 ' CE2' ' A' ' 205' ' ' PHE . 0.8 OUTLIER -30.28 -57.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.322 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.522 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.8 mtp -51.24 -19.67 1.32 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.859 0.361 . . . . 0.0 111.733 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.8 mm-40 -79.62 -33.57 41.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.58 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -107.67 21.85 16.84 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.309 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.587 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -18.61 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.218 0.949 . . . . 0.0 112.117 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.587 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 22.0 m-85 -85.84 78.97 9.42 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.747 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.692 ' CE1' HG12 ' A' ' 239' ' ' ILE . 13.9 m-70 -76.18 -170.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.9 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.5 m-80 -151.54 81.32 1.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -81.33 106.59 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.504 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 38.73 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.381 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -95.6 -43.0 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 111.457 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -88.51 150.26 23.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -147.96 133.1 18.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.331 179.347 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.602 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -154.13 173.72 15.69 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.567 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 61.5 tt0 -76.91 97.78 4.7 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.452 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.665 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.8 mt -86.59 83.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.709 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.589 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.3 mtpt -94.99 122.46 37.67 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.573 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.7 p -32.91 110.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.631 1.205 . . . . 0.0 110.524 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.658 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -67.71 -174.9 0.48 Allowed 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 112.65 -2.068 . . . . 0.0 112.977 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.424 ' CG ' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -179.52 -94.08 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.467 179.508 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.93 0.395 . . . . 0.0 111.423 179.841 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.902 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.833 0 O4'-C1'-C2' 107.129 0.936 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.734 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 O4'-C4'-C3' 106.185 0.585 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.786 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.52 -0.767 0 C4'-C3'-C2' 100.926 -2.274 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.774 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.506 -1.105 0 C4'-C3'-C2' 103.819 0.619 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.587 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 38.5 t . . . . . 0 CA--C 1.492 -1.261 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 18.0 mttt -150.32 -34.02 0.17 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.65 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.641 ' HD3' ' CB ' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -103.53 -168.52 1.52 Allowed 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 239' ' ' ILE . 16.7 pt -163.02 138.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.605 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.63 ' CD1' ' CE1' ' A' ' 227' ' ' PHE . 0.7 OUTLIER -108.87 91.13 3.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.112 0.482 . . . . 0.0 112.24 -178.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.619 HG11 ' HB2' ' A' ' 252' ' ' CYS . 2.0 t -68.21 138.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.602 ' O ' ' C5 ' ' B' ' 2' ' ' ' DT' . . . -130.71 111.49 1.13 Allowed Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.995 -1.098 . . . . 0.0 114.483 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.482 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . 108.87 102.97 2.8 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.638 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.597 ' C ' ' CD1' ' A' ' 189' ' ' LEU . 0.0 OUTLIER -170.59 -154.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.498 ' O ' HD11 ' A' ' 189' ' ' LEU . 14.0 m -89.46 136.64 29.59 Favored Pre-proline 0 C--N 1.341 0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.499 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -31.3 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.38 2.72 . . . . 0.0 113.515 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 190' ' ' SER . 8.4 t0 -150.98 56.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.511 ' CG2' HD13 ' A' ' 198' ' ' ILE . 2.6 m -39.13 128.97 1.26 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . 5.2 Cg_endo -47.16 97.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.858 2.372 . . . . 0.0 112.191 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.576 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 3.5 pt-20 -48.02 -17.95 0.16 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.11 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.79 -36.93 83.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.7 OUTLIER -80.0 -46.26 16.95 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.622 HG21 HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.08 -31.5 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.519 176.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.537 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 5.3 mtp180 -74.13 -28.89 61.55 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.176 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -87.57 -63.76 1.25 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.992 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.659 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -39.65 -37.16 0.48 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.76 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.4 OUTLIER -101.16 -33.25 10.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.222 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.93 -43.6 98.97 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.42 -21.26 72.29 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 176.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.773 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -34.85 79.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 108.7 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.72 -144.9 9.74 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.633 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.6 mm-40 -90.52 91.16 8.32 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 121.881 -0.776 . . . . 0.0 110.539 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.49 141.25 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.498 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.7 tp10 -89.54 -45.72 9.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.433 ' C ' HG12 ' A' ' 211' ' ' ILE . 15.3 m -171.29 173.09 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.298 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.639 HG22 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.31 164.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.563 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.558 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.0 OUTLIER -172.43 128.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 225' ' ' PHE . 3.0 mm? -113.59 122.32 35.42 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.663 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 51.9 Cg_exo -56.68 -162.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.519 2.813 . . . . 0.0 113.622 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 159.67 106.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.972 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.491 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 8.4 p-10 -40.22 84.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.062 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 215' ' ' MET . 1.6 m-20 -148.4 4.19 0.69 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.491 ' HG3' " C5'" ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER -135.96 -4.41 2.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.4 OUTLIER -151.58 -18.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 219' ' ' THR . 7.6 m-80 74.18 49.27 0.12 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.527 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -129.72 178.06 6.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.328 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -70.72 -41.16 72.27 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.826 -179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.6 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 26.04 -97.34 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 27.19 78.52 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.136 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.663 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 7.5 p90 -140.04 -131.32 0.11 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.539 ' CB ' ' HB ' ' A' ' 186' ' ' VAL . 0.0 OUTLIER -151.41 164.17 37.32 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.11 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.72 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.0 m-85 -150.61 113.49 4.77 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.129 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.655 HD12 ' CE1' ' A' ' 202' ' ' PHE . 1.3 mt -115.19 150.69 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 121.724 0.773 . . . . 0.0 110.88 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.4 m -127.17 151.58 48.49 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.929 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 76.5 m-85 -130.92 119.2 21.78 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -40.69 -37.85 0.81 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.546 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -88.84 -158.68 0.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.373 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.587 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 15.5 pt-20 -137.63 0.64 2.26 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.058 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 238' ' ' LYS . 3.7 mm-40 -79.2 -58.62 0.67 Allowed Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.773 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 72.5 Cg_exo -50.0 -35.35 40.96 Favored 'Trans proline' 0 CA--C 1.488 -1.797 0 CA-C-N 120.485 1.209 . . . . 0.0 109.023 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.571 ' CG1' ' O ' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -64.12 -51.99 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 113.251 -1.795 . . . . 0.0 108.726 178.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 24.9 mttt -44.62 -58.65 2.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.13 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.668 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.85 -53.47 57.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.825 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.641 HD11 ' CD2' ' A' ' 205' ' ' PHE . 0.5 OUTLIER -32.16 -64.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.65 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.42 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.6 mtp -48.3 -29.63 4.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 26.3 mm-40 -66.67 -37.39 84.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.67 19.84 17.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.271 177.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.555 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.45 -50.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.646 1.216 . . . . 0.0 112.12 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.4 m-85 -85.35 71.41 10.82 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.258 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.645 ' HB3' ' CZ ' ' A' ' 201' ' ' TYR . 10.7 m-70 -70.8 152.88 43.28 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.225 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.417 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -114.25 74.21 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.72 100.76 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.794 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.3 -85.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.626 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.548 ' CD2' ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -104.26 -42.09 5.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.299 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.547 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 37.5 m -87.8 144.49 26.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.031 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.72 140.15 36.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.348 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.619 ' HB2' HG11 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.75 168.93 24.75 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -177.51 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.459 ' OE1' ' HE3' ' A' ' 255' ' ' LYS . 43.9 tt0 -73.38 96.64 2.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.648 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.636 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.6 mt -85.73 81.97 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -90.91 121.39 32.71 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.558 ' O ' ' CG1' ' A' ' 256' ' ' VAL . 2.0 p -36.11 100.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.286 1.517 . . . . 0.0 111.214 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.715 ' HB3' ' CE2' ' A' ' 227' ' ' PHE . . . -45.37 -171.08 0.0 OUTLIER 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.89 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.583 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 173.46 148.67 0.06 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.253 -1.794 . . . . 0.0 110.886 179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' SER . . . . . 0.459 ' OG ' ' C6 ' ' B' ' 4' ' ' ' DG' . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.972 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C3'-C2'-C1' 104.876 1.554 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.529 " H1'" ' OP2' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.774 0 C3'-C2'-C1' 105.275 1.839 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.72 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.93 0 C4'-C3'-C2' 101.091 -2.109 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.587 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.914 0 C4'-C3'-C2' 104.795 1.595 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.605 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 21.9 t . . . . . 0 CA--C 1.499 -0.994 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 24.1 mttt -150.41 -35.16 0.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.137 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 229' ' ' THR . 0.1 OUTLIER -94.58 -176.57 3.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 184' ' ' ILE . 4.8 pt -161.08 114.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.057 0.932 . . . . 0.0 109.297 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.703 ' HB2' ' CE2' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -91.75 106.43 18.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.485 -177.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.612 HG13 ' HB2' ' A' ' 252' ' ' CYS . 2.8 t -92.17 111.71 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.642 0.777 . . . . 0.0 112.842 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 252' ' ' CYS . . . -45.58 -176.84 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.46 162.86 0.0 OUTLIER Glycine 0 C--N 1.34 0.787 0 N-CA-C 115.019 0.767 . . . . 0.0 115.019 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.656 ' CD1' ' HA ' ' A' ' 225' ' ' PHE . 0.0 OUTLIER -178.82 -143.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.57 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.8 m -89.21 131.32 41.09 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.425 ' C ' ' O ' ' A' ' 190' ' ' SER . 33.0 Cg_exo -27.36 -35.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.47 2.78 . . . . 0.0 113.494 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -150.96 54.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.06 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.554 ' OG1' ' CD2' ' A' ' 189' ' ' LEU . 51.9 m -40.23 125.67 1.72 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 110.413 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . 0.58 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -47.13 101.62 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.399 2.733 . . . . 0.0 113.905 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.792 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.38 -20.41 0.22 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.972 178.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 10.6 mm-40 -66.34 -39.99 89.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 200' ' ' GLU . 2.5 mttp -76.27 -50.53 14.14 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.792 ' CG1' ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -45.72 -28.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.692 176.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.5 mtp180 -77.13 -29.84 54.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.358 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.7 pt-20 -86.99 -54.12 4.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.698 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -50.7 -37.8 43.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 110.663 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.731 ' HA ' ' HB2' ' A' ' 205' ' ' PHE . 0.7 OUTLIER -100.44 -34.46 9.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.498 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.2 -44.69 96.71 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.0 -23.98 66.45 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.773 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.01 -35.91 81.84 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 122.032 0.92 . . . . 0.0 108.599 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -142.43 7.83 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.971 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -91.0 94.8 9.8 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.688 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -58.64 144.59 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLU . . . . . 0.549 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 3.9 tp10 -89.86 -50.91 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.1 p -172.04 156.61 4.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.443 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.664 HG22 HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -119.95 167.52 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.002 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -165.02 123.71 1.72 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.684 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 226' ' ' CYS . 0.9 OUTLIER -110.48 101.13 47.7 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 121.287 0.565 . . . . 0.0 111.952 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.559 ' HG3' " O4'" ' B' ' 4' ' ' ' DG' . 25.5 Cg_exo -66.66 -167.0 0.12 Allowed 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 124.056 3.171 . . . . 0.0 112.675 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.528 ' HA ' ' CA ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER 167.69 164.7 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.215 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 221' ' ' LYS . 19.9 t0 -81.89 13.01 3.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.172 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -109.48 -2.71 17.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.63 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.482 ' C ' ' CG2' ' A' ' 219' ' ' THR . 4.3 mmtp -124.77 1.48 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.865 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.603 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -151.75 -16.52 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.603 ' HB2' ' O ' ' A' ' 219' ' ' THR . 0.8 OUTLIER 77.35 20.83 1.1 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' LYS . . . . . 0.553 ' CE ' ' NH1' ' A' ' 223' ' ' ARG . 4.0 mppt? -129.4 179.08 6.0 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.698 -0.401 . . . . 0.0 112.014 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.615 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -70.39 -39.86 74.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.615 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 3.2 mtp85 2.05 -80.02 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 124.34 1.025 . . . . 0.0 111.057 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.586 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.42 78.93 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 O-C-N 124.588 1.18 . . . . 0.0 111.624 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PHE . . . . . 0.656 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -138.71 -121.38 0.13 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 213' ' ' LEU . 0.0 OUTLIER -165.32 163.11 20.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.973 0.892 . . . . 0.0 112.594 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.75 ' CZ ' ' N2 ' ' B' ' 4' ' ' ' DG' . 3.4 m-85 -147.83 124.54 11.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.864 -1.517 . . . . 0.0 108.97 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.667 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.6 mt -121.33 150.93 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 CA-C-O 121.555 0.693 . . . . 0.0 109.944 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.616 ' N ' HG23 ' A' ' 228' ' ' ILE . 2.9 m -129.85 152.41 49.36 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.212 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 87.3 m-85 -130.32 117.26 19.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.549 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.72 -37.31 0.73 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.515 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.59 -155.93 0.35 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.494 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.605 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.2 pt-20 -143.12 4.17 1.42 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.51 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.9 OUTLIER -84.53 -58.51 0.36 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . 0.773 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.6 Cg_exo -49.77 -34.68 36.67 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.574 HG11 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.28 -51.11 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.801 178.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 6.3 mtpt -45.86 -60.13 2.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.933 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.681 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.99 -52.75 64.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.69 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.661 HD12 ' CD2' ' A' ' 205' ' ' PHE . 0.6 OUTLIER -34.72 -66.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.259 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.466 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.2 mtp -48.83 -25.56 1.94 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.563 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -69.35 -38.35 78.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.36 21.14 15.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 177.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.571 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.51 -49.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.669 1.231 . . . . 0.0 111.878 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.7 m-85 -85.2 71.85 10.82 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.504 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' HIS . . . . . 0.643 ' CE1' HG22 ' A' ' 239' ' ' ILE . 9.6 m-70 -72.62 153.04 41.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.226 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -115.51 76.38 1.0 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -69.14 101.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.149 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.74 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.45 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -101.89 -41.84 6.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.126 0.489 . . . . 0.0 110.892 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 247' ' ' VAL . 21.0 m -88.41 146.82 25.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.514 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.38 139.82 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.75 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' CYS . . . . . 0.612 ' HB2' HG13 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 166.06 32.83 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLU . . . . . 0.419 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 48.4 tt0 -71.95 93.58 1.37 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.227 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . 0.642 ' CG2' ' CG2' ' A' ' 239' ' ' ILE . 1.5 mt -79.78 80.86 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.133 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -87.89 122.58 31.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.0 p -33.82 122.32 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 122.244 1.021 . . . . 0.0 109.912 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.66 ' CB ' ' CE2' ' A' ' 227' ' ' PHE . . . -82.12 -179.49 7.42 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.204 -1.817 . . . . 0.0 113.494 -175.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' MET . . . . . 0.524 ' N ' ' HE3' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 175.81 153.95 0.17 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.037 -1.892 . . . . 0.0 110.554 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.739 179.756 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' DT' . . . . . 0.827 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C2'--C1' 1.508 -0.946 0 C4'-C3'-C2' 104.037 0.837 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' DA' . . . . . 0.61 ' C5 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.935 0 O4'-C1'-C2' 106.767 0.607 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' DG' . . . . . 0.75 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.428 -0.763 0 C4'-C3'-C2' 101.454 -1.746 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' DG' . . . . . 0.459 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.827 0 O4'-C4'-C3' 106.062 0.462 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.738 HG12 ' HB ' ' A' ' 236' ' ' VAL . 30.2 t . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.5 mttt -150.14 -35.11 0.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.591 -1.244 . . . . 0.0 112.462 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -102.55 -167.46 1.4 Allowed 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.064 HD13 HD12 ' A' ' 239' ' ' ILE . 17.3 pt -165.11 139.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.261 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.763 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -109.32 96.75 6.5 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.382 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.902 HG13 HG12 ' A' ' 254' ' ' ILE . 2.0 t -79.39 122.09 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -67.32 -170.34 4.61 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.924 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.555 ' N ' ' HB3' ' A' ' 225' ' ' PHE . . . -26.14 158.03 0.0 OUTLIER Glycine 0 N--CA 1.466 0.675 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.966 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -177.24 -143.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.681 ' N ' HD13 ' A' ' 189' ' ' LEU . 10.7 t -89.69 134.52 32.12 Favored Pre-proline 0 C--N 1.344 0.33 0 CA-C-O 121.13 0.49 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 190' ' ' SER . 80.8 Cg_exo -28.65 -35.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.432 2.755 . . . . 0.0 113.22 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 190' ' ' SER . 34.7 p30 -151.36 56.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.158 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.966 ' OG1' HD22 ' A' ' 189' ' ' LEU . 6.1 m -39.4 123.23 1.39 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.567 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 6.6 Cg_endo -48.79 99.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.661 2.24 . . . . 0.0 112.23 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.45 -19.59 0.18 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.442 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 26.0 mt-10 -64.29 -39.0 93.03 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.567 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -77.56 -46.77 21.24 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.128 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.99 -29.79 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.832 176.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.637 ' HG2' HD11 ' A' ' 211' ' ' ILE . 4.7 mtt180 -75.83 -28.57 58.32 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.86 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -86.12 -63.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.792 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.681 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -39.75 -39.16 0.74 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.556 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.076 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -99.64 -34.16 10.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.452 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.42 -45.59 96.09 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.28 -23.29 68.08 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.82 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.0 -33.69 76.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 122.053 0.93 . . . . 0.0 108.651 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.24 -139.72 6.29 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.01 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.5 mm-40 -91.57 94.24 9.33 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.097 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.54 142.6 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 229' ' ' THR . 11.3 tt0 -89.6 -52.45 5.0 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.1 p -169.82 152.92 4.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.35 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.717 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.72 167.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.491 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -167.2 130.15 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.478 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.063 HD21 HD12 ' A' ' 198' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.529 0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.477 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.261 0.077 . . . . 0.0 111.193 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.72 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 32.21 76.1 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.658 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 8.1 p90 -135.4 -128.95 0.15 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.747 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.85 162.44 39.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.64 0.733 . . . . 0.0 111.326 178.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.118 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 2.8 m-85 -149.95 124.62 9.76 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.128 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.4 mt -122.94 153.06 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.972 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.6 m -130.03 152.87 49.01 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.016 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.5 m-85 -130.1 120.62 24.93 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.579 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -40.81 -37.53 0.79 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.8 mt-10 -90.85 -157.64 0.5 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.572 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -137.53 1.23 2.35 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.04 -60.46 0.49 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.82 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 63.9 Cg_exo -48.89 -33.83 26.77 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.764 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.73 -51.16 70.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.747 178.141 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -46.12 -57.41 4.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.081 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.683 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.19 -52.83 63.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.679 179.401 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.064 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.2 -64.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.133 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.508 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.0 OUTLIER -48.72 -26.73 2.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.894 0.378 . . . . 0.0 110.588 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.1 mm-40 -68.1 -40.07 82.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.56 13.94 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.345 178.004 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.543 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.72 -50.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.562 1.164 . . . . 0.0 111.998 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.6 m-85 -84.29 74.15 10.37 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.449 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.918 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.0 m-70 -74.81 152.24 38.99 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.388 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 74.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.371 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -66.05 103.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.23 -83.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.86 -41.23 5.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.175 0.512 . . . . 0.0 110.538 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 67.7 m -87.87 145.46 26.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.398 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.98 141.61 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.848 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.842 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.97 167.58 29.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.499 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 44.5 tt0 -73.11 95.09 2.01 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.511 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.902 HG12 HG13 ' A' ' 186' ' ' VAL . 2.6 mt -83.03 78.96 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.716 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.32 123.67 33.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 256' ' ' VAL . 1.9 p -37.41 99.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 123.331 1.538 . . . . 0.0 111.035 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.118 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.412 -2.35 0 CA-C-N 112.006 -2.361 . . . . 0.0 112.998 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.67 HG12 ' HB ' ' A' ' 236' ' ' VAL . 36.7 t . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 236' ' ' VAL . 22.8 mttt -151.86 -34.83 0.13 Allowed 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.411 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -95.36 -175.11 3.39 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.255 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.037 HD13 HD12 ' A' ' 239' ' ' ILE . 8.2 pt -163.08 120.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.84 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -95.68 104.46 16.38 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.389 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.95 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.9 t -90.73 112.76 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.763 0.825 . . . . 0.0 112.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -48.44 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.632 0.613 . . . . 0.0 114.632 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.92 160.98 0.0 OUTLIER Glycine 0 C--N 1.341 0.846 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 1.039 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -173.33 -144.8 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.658 ' N ' HD13 ' A' ' 189' ' ' LEU . 70.1 m -88.88 135.59 31.76 Favored Pre-proline 0 C--N 1.342 0.261 0 CA-C-O 120.977 0.418 . . . . 0.0 110.623 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 190' ' ' SER . 56.6 Cg_exo -28.77 -37.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.325 2.684 . . . . 0.0 113.051 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 190' ' ' SER . 62.4 t0 -151.4 54.23 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.08 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.039 ' OG1' HD22 ' A' ' 189' ' ' LEU . 86.3 m -39.87 123.87 1.57 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.149 0.499 . . . . 0.0 110.75 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.607 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 10.1 Cg_endo -51.2 101.95 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.351 2.701 . . . . 0.0 113.728 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.815 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.2 OUTLIER -45.74 -20.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.145 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.5 mt-10 -65.2 -41.96 94.02 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.728 ' HE2' HD21 ' A' ' 249' ' ' LEU . 2.2 mttp -75.34 -50.03 17.26 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.109 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -46.48 -26.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.975 176.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.561 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.4 mtp180 -80.12 -28.65 38.93 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.302 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.9 pt-20 -86.89 -47.56 8.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.597 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.685 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.4 t80 -56.46 -40.73 75.32 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 110.342 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.85 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -97.95 -33.9 11.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.43 -44.22 95.6 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.44 -23.2 68.31 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.811 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -66.4 -36.32 82.53 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.155 0.979 . . . . 0.0 108.88 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.9 -142.78 7.99 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.651 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 27.2 mt-10 -91.09 92.59 8.77 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.976 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.15 143.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.557 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.0 tp10 -89.64 -46.9 8.31 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 3.0 p -175.16 152.64 1.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.788 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -116.02 161.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.956 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.486 ' OE1' ' NZ ' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -159.02 125.64 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.922 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 189' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 121.473 0.654 . . . . 0.0 111.054 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.539 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 111.204 0.075 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 20.9 76.46 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 O-C-N 123.906 0.754 . . . . 0.0 112.032 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.651 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -144.27 -121.73 0.08 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -178.068 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.664 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -166.37 164.3 17.46 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.153 0.978 . . . . 0.0 113.251 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.041 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.8 m-85 -147.83 117.0 6.86 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.764 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.109 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -114.35 147.57 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.606 0.717 . . . . 0.0 110.354 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.691 HG23 ' HG2' ' A' ' 183' ' ' LYS . 1.2 m -120.21 172.36 7.84 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.43 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 95.4 m-85 -150.63 111.83 4.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -39.33 -37.13 0.41 Allowed 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 230' ' ' PHE . 21.8 mt-10 -89.09 -155.56 0.35 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.776 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.614 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.4 pt-20 -142.33 -0.93 1.22 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.953 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.13 -58.93 0.56 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.342 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.804 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 50.9 Cg_exo -48.09 -36.32 28.07 Favored 'Trans proline' 0 CA--C 1.491 -1.654 0 N-CA-C 108.845 -1.252 . . . . 0.0 108.845 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.823 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.14 -51.79 67.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.177 -1.829 . . . . 0.0 108.921 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -45.04 -59.45 2.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.126 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.675 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.28 -54.23 49.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.539 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.037 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.42 -64.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.142 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.509 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -48.04 -36.18 12.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 238' ' ' LYS . 12.1 mt-10 -60.52 -38.85 85.76 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -103.28 21.65 15.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.558 177.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.53 -50.08 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 O-C-N 124.493 1.12 . . . . 0.0 112.069 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.6 m-85 -83.44 74.91 10.04 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.969 ' CE1' HD13 ' A' ' 239' ' ' ILE . 8.1 m170 -76.65 159.35 30.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 7.4 m-80 -123.01 79.13 1.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.167 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.67 107.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 37.25 -88.18 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.611 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.728 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -95.52 -44.93 7.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 247' ' ' VAL . 5.4 m -88.9 148.09 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.24 140.39 30.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.372 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.95 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.25 166.81 30.5 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.514 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 51.7 tt0 -71.42 97.44 1.63 Allowed 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.411 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.902 HG12 HG13 ' A' ' 186' ' ' VAL . 2.4 mt -86.55 80.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.968 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.2 OUTLIER -89.18 122.63 32.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.438 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.4 p -34.52 116.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 122.434 1.112 . . . . 0.0 110.036 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.041 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.418 -2.045 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.518 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.681 HG12 ' HB ' ' A' ' 236' ' ' VAL . 37.6 t . . . . . 0 CA--C 1.497 -1.074 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.564 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.8 mttt -151.2 -34.9 0.14 Allowed 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.073 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.848 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.08 -172.47 3.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.188 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 239' ' ' ILE . 5.9 pt -166.45 111.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 122.12 0.962 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.879 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -87.16 107.74 18.6 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.593 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.982 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.9 t -94.42 109.55 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.461 0.704 . . . . 0.0 112.299 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.33 -176.77 0.01 OUTLIER Glycine 0 N--CA 1.476 1.366 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.68 160.36 0.0 OUTLIER Glycine 0 C--N 1.344 1.025 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.918 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -174.07 -142.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.676 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -89.04 132.1 39.0 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 110.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -31.96 -33.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.152 2.568 . . . . 0.0 113.01 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 190' ' ' SER . 16.5 t0 -150.99 53.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.623 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.918 ' OG1' HD22 ' A' ' 189' ' ' LEU . 52.2 m -40.21 121.68 1.63 Allowed Pre-proline 0 C--N 1.33 -0.246 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -52.01 94.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.634 2.223 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.598 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -41.91 -24.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.296 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 194' ' ' PRO . 36.2 mt-10 -61.22 -34.79 75.68 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.688 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -86.11 -35.05 20.45 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.126 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -62.08 -25.24 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.614 176.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.603 ' HA ' HD11 ' A' ' 211' ' ' ILE . 19.2 mtp180 -77.61 -25.73 50.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 197' ' ' LYS . 3.7 mt-10 -86.07 -60.01 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.928 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.705 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -43.3 -40.63 3.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.761 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.88 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -99.6 -30.66 12.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 -178.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -46.22 92.42 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.84 -22.8 66.8 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.838 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.66 -36.47 84.38 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.961 0.886 . . . . 0.0 108.726 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -138.26 5.21 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.7 mt-10 -91.95 89.99 7.23 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.813 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.497 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -56.33 142.96 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.581 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.2 tp10 -90.25 -49.05 6.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.453 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 5.8 p -172.75 156.75 3.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.543 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.63 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -122.78 153.81 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.237 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -154.41 133.04 12.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.073 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.927 HD21 HD12 ' A' ' 198' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.333 -0.125 0 CA-C-O 121.229 0.537 . . . . 0.0 111.842 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.571 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.511 -0.52 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 11.79 80.52 0.01 OUTLIER Glycine 0 C--N 1.336 0.546 0 O-C-N 123.982 0.801 . . . . 0.0 112.416 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.68 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -145.87 -119.98 0.07 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.707 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.47 169.15 14.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.247 1.022 . . . . 0.0 112.798 178.063 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.046 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.5 m-85 -152.17 111.92 3.98 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.908 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.126 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -110.79 161.58 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.3 m -138.14 168.98 18.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.165 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.5 m-85 -146.74 115.61 6.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.581 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.2 OUTLIER -39.64 -35.3 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.531 ' O ' ' O ' ' A' ' 230' ' ' PHE . 7.9 mm-40 -88.89 -156.74 0.4 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.998 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.591 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.5 pm0 -144.16 12.77 1.6 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.615 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.664 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -92.29 -63.29 0.17 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.838 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 95.2 Cg_exo -48.47 -32.26 20.13 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.808 HG13 HG23 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.97 -53.43 34.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.372 -1.74 . . . . 0.0 110.209 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.4 OUTLIER -51.6 -46.58 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.609 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.655 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -64.89 -54.29 33.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.69 0.757 . . . . 0.0 109.933 177.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.972 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -30.84 -64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.531 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.479 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -46.19 -31.96 2.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 238' ' ' LYS . 30.4 mm-40 -62.71 -45.04 94.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -94.01 19.77 8.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.14 177.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.97 -50.31 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.625 1.203 . . . . 0.0 111.928 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.1 m-85 -84.84 71.29 10.89 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.621 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.3 m-70 -72.99 153.03 41.09 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.75 82.34 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.688 HG12 ' CE ' ' A' ' 197' ' ' LYS . 1.3 t -75.01 97.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.749 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.06 -80.91 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.752 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.82 -43.45 4.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.44 148.32 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.625 0.726 . . . . 0.0 112.344 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -145.54 140.69 27.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.8 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.982 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.23 169.44 24.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 76.4 tt0 -75.35 91.58 2.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.58 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.982 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -77.99 80.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.534 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.62 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.4 mtpt -91.67 120.09 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -30.55 120.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-O 122.29 1.043 . . . . 0.0 110.367 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.046 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.42 -1.966 0 CA-C-N 113.19 -1.823 . . . . 0.0 112.342 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.742 HG12 ' HB ' ' A' ' 236' ' ' VAL . 23.1 t . . . . . 0 CA--C 1.499 -1.004 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.7 mttt -150.21 -36.46 0.15 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.064 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.17 -171.54 2.57 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.967 HD13 HD12 ' A' ' 239' ' ' ILE . 10.2 pt -164.62 121.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.808 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -96.02 109.51 21.9 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.357 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.929 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.5 t -97.71 112.71 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.708 0.803 . . . . 0.0 113.103 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.41 -178.38 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -31.53 161.41 0.0 OUTLIER Glycine 0 C--N 1.342 0.861 0 N-CA-C 114.607 0.603 . . . . 0.0 114.607 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 1.029 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -174.67 -144.67 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.556 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 189' ' ' LEU . 49.2 m -89.44 133.32 34.92 Favored Pre-proline 0 C--N 1.338 0.069 0 CA-C-O 121.018 0.437 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 84.7 Cg_exo -28.18 -36.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.5 2.8 . . . . 0.0 113.116 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.0 t70 -150.85 56.45 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.029 ' OG1' HD22 ' A' ' 189' ' ' LEU . 21.7 m -38.8 132.57 1.09 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.067 0.461 . . . . 0.0 110.308 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.522 ' O ' HG13 ' A' ' 198' ' ' ILE . 14.7 Cg_endo -56.42 92.29 0.05 OUTLIER 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 123.025 2.483 . . . . 0.0 112.381 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.573 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.31 -24.53 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 8.7 mm-40 -62.94 -36.65 84.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.917 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 200' ' ' GLU . 22.7 mmmt -78.12 -49.23 14.3 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.168 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.4 -28.81 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.471 176.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.558 ' HG2' HD11 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -77.1 -28.61 54.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.737 178.076 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.2 mm-40 -85.61 -63.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.668 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.702 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.1 t80 -40.17 -39.33 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.984 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -100.34 -33.3 10.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.48 -178.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.89 -45.99 95.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.47 -23.12 66.43 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.826 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.6 -34.18 77.64 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.014 0.911 . . . . 0.0 108.818 178.239 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.35 -141.04 7.02 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.045 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 77.3 mm-40 -91.82 91.54 7.98 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.757 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -55.6 142.24 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.586 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.5 tp10 -88.96 -48.64 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 26.7 m -175.96 150.02 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.344 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.67 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.34 167.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.556 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -166.34 125.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.809 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.966 HD21 HD12 ' A' ' 198' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.963 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.524 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 111.401 0.148 . . . . 0.0 111.401 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 23.87 75.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 O-C-N 123.673 0.608 . . . . 0.0 111.807 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.661 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -138.38 -120.2 0.14 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.679 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.72 169.87 13.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.449 1.119 . . . . 0.0 113.02 178.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.027 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.6 m-85 -151.79 125.21 8.84 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.614 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.168 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -122.3 156.57 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.539 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.1 m -134.33 160.31 38.33 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.947 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.2 m-85 -137.86 115.76 11.54 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.586 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -38.51 -36.59 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.301 1.048 . . . . 0.0 108.265 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.1 mt-10 -88.82 -153.88 0.27 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.647 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.1 pt-20 -144.54 4.46 1.18 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.355 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -84.84 -58.19 0.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.826 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 88.6 Cg_exo -50.4 -33.53 37.94 Favored 'Trans proline' 0 CA--C 1.492 -1.605 0 N-CA-C 108.763 -1.283 . . . . 0.0 108.763 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -64.94 -51.91 60.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.618 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.9 mttt -45.71 -57.4 4.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.031 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.685 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.94 -52.49 65.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.605 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.967 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.72 -63.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.237 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.563 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -50.83 -19.16 0.9 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -77.55 -37.22 51.24 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.92 13.36 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.582 178.154 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.605 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -15.43 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.517 1.135 . . . . 0.0 112.433 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.1 m-85 -86.0 72.46 10.45 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.366 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.52 141.64 46.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.262 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.3 OUTLIER -105.26 75.5 1.17 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.354 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -67.05 138.36 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.139 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 15.22 -77.62 0.0 OUTLIER Glycine 0 C--N 1.342 0.895 0 O-C-N 123.932 0.77 . . . . 0.0 113.729 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.07 -40.54 3.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.312 0.577 . . . . 0.0 110.529 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.75 152.92 21.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.886 -178.452 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.07 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.942 179.174 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.929 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 156.47 29.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.995 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 41.6 tt0 -60.88 120.27 9.84 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.927 HG12 HG13 ' A' ' 186' ' ' VAL . 2.2 mt -104.52 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.746 0.784 . . . . 0.0 112.428 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.591 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.06 119.47 28.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.465 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.7 p -33.62 122.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.149 0.976 . . . . 0.0 110.055 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.027 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.426 -1.649 0 CA-C-N 113.405 -1.725 . . . . 0.0 113.049 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' A' ' 236' ' ' VAL . 20.5 t . . . . . 0 CA--C 1.499 -0.981 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 21.1 mttt -150.04 -34.58 0.17 Allowed 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.149 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -89.78 -171.4 3.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.056 HD13 HD12 ' A' ' 239' ' ' ILE . 6.1 pt -168.75 110.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.941 0.877 . . . . 0.0 108.92 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.871 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -83.08 101.76 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.733 -177.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.966 HG13 HG12 ' A' ' 254' ' ' ILE . 2.5 t -87.68 111.22 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.32 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.617 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -101.39 120.5 6.89 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 97.04 109.92 2.7 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.97 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -165.56 -157.66 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.638 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.4 m -89.03 133.65 34.94 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.197 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -32.46 -29.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.43 2.754 . . . . 0.0 113.473 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 47.8 t0 -149.38 52.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.97 ' OG1' HD22 ' A' ' 189' ' ' LEU . 17.6 m -43.08 126.79 3.36 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.507 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -53.1 94.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.677 2.251 . . . . 0.0 112.068 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.603 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.9 OUTLIER -45.13 -20.67 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 8.0 mt-10 -64.96 -36.55 84.75 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.12 -47.65 17.75 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.153 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.25 -28.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.847 176.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.609 ' HA ' HD11 ' A' ' 211' ' ' ILE . 11.3 mtp180 -76.41 -28.86 56.84 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 mt-10 -85.27 -61.94 1.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.811 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.698 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -39.56 -42.65 1.18 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.882 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.0 OUTLIER -97.75 -31.49 12.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.728 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.21 -46.85 93.09 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.41 -24.27 65.55 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.828 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.65 -34.21 77.74 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.11 -139.8 6.36 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.833 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.6 mt-10 -91.86 95.3 9.76 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.854 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -57.31 144.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.647 ' CD ' HG21 ' A' ' 229' ' ' THR . 10.5 tt0 -90.6 -50.58 5.85 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 73.1 m -172.42 147.18 1.88 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.914 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.623 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.31 162.08 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.629 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -157.79 123.86 4.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 0.0 111.596 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.021 HD21 HD12 ' A' ' 198' ' ' ILE . 2.0 mm? . . . . . 0 C--N 1.333 -0.125 0 CA-C-O 121.372 0.606 . . . . 0.0 111.028 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.587 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.59 80.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 O-C-N 123.906 0.754 . . . . 0.0 112.505 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.643 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.02 -121.04 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.637 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -167.5 164.58 14.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.347 1.07 . . . . 0.0 113.074 178.219 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.024 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.9 m-85 -149.18 114.91 5.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.071 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.153 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.6 mt -112.98 161.58 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.344 0.592 . . . . 0.0 110.588 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.647 HG21 ' CD ' ' A' ' 209' ' ' GLU . 1.8 m -138.7 172.36 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.537 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 89.1 m-85 -145.23 119.8 9.75 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.597 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.38 -37.3 0.99 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.8 mt-10 -89.42 -155.59 0.36 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.57 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.6 pt-20 -143.02 5.27 1.5 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.495 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -86.9 -57.28 0.32 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.828 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 99.3 Cg_exo -49.74 -33.22 31.54 Favored 'Trans proline' 0 CA--C 1.493 -1.573 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.87 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.7 -51.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 112.988 -1.915 . . . . 0.0 109.065 178.17 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 12.4 mttt -46.3 -57.6 4.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.276 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.634 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.13 -54.74 42.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.673 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.056 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.95 -63.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.029 -179.016 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 9.9 mtp -45.73 -31.32 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 111.139 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.3 mm-40 -63.33 -43.09 98.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -96.56 19.96 11.47 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.268 178.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.18 -50.55 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.696 1.247 . . . . 0.0 111.716 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.9 m-85 -85.51 71.03 10.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.271 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.975 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.9 m-70 -70.49 146.41 50.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.029 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 4.6 m-80 -107.43 79.75 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -69.12 149.48 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.71 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 6.59 -72.08 0.0 OUTLIER Glycine 0 C--N 1.343 0.953 0 O-C-N 124.014 0.821 . . . . 0.0 113.682 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -119.64 -41.88 2.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.076 0.465 . . . . 0.0 110.454 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.57 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 2.0 m -88.89 148.54 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.689 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -131.76 147.62 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.054 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.909 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -160.34 161.85 33.32 Favored 'General case' 0 C--O 1.228 -0.042 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.238 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 185' ' ' PHE . 56.7 tt0 -69.86 93.12 0.73 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.609 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.966 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -83.92 82.73 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.591 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.7 mtpt -98.4 118.91 36.12 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.8 p -28.72 110.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-O 122.612 1.196 . . . . 0.0 110.594 -177.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.024 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.418 -2.026 0 CA-C-N 112.634 -2.076 . . . . 0.0 112.758 -176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.619 HG12 ' HB ' ' A' ' 236' ' ' VAL . 29.9 t . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 22.0 mttt -152.19 -35.66 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.575 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.867 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -94.91 -177.94 4.34 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.37 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.945 HD13 HD12 ' A' ' 239' ' ' ILE . 4.6 pt -161.82 111.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 122.245 1.022 . . . . 0.0 109.57 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.906 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -85.41 101.79 12.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.551 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.99 HG13 HG12 ' A' ' 254' ' ' ILE . 2.6 t -87.27 106.21 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.246 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.62 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -97.43 122.1 7.33 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.45 106.66 2.73 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.676 0.631 . . . . 0.0 114.676 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.973 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.08 -157.16 0.2 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.65 ' N ' HD13 ' A' ' 189' ' ' LEU . 71.0 m -88.6 134.38 34.22 Favored Pre-proline 0 C--N 1.345 0.372 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.187 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -29.29 -32.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.789 2.993 . . . . 0.0 113.919 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.72 54.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.482 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.973 ' OG1' HD22 ' A' ' 189' ' ' LEU . 14.3 m -40.17 123.74 1.68 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.927 0.394 . . . . 0.0 110.537 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 8.2 Cg_endo -50.32 92.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.745 2.297 . . . . 0.0 112.077 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.59 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -42.16 -23.67 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 194' ' ' PRO . 10.0 mt-10 -63.87 -33.5 75.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.573 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -85.76 -34.45 21.17 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.109 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -62.33 -20.87 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.863 176.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.544 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.7 mtt180 -85.39 -25.03 27.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.293 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -88.99 -31.2 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.878 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.697 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -72.99 -38.7 66.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.882 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.0 OUTLIER -100.43 -30.99 11.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.449 -178.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.92 -46.26 92.01 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.63 64.51 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.835 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.22 -34.68 78.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.968 0.89 . . . . 0.0 108.916 178.218 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.26 -139.99 6.37 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.063 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.6 mt-10 -91.43 90.47 7.69 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.993 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.492 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -55.36 143.59 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.694 ' CD ' HG21 ' A' ' 229' ' ' THR . 9.7 tt0 -89.71 -50.33 6.12 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 50.3 m -172.03 147.25 2.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.293 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.595 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.34 159.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.466 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.3 OUTLIER -155.5 124.67 6.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.34 . . . . 0.0 111.372 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.773 HD21 HD12 ' A' ' 198' ' ' ILE . 1.4 mm? . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.414 0.626 . . . . 0.0 111.066 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.564 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.682 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.06 79.64 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 O-C-N 123.994 0.809 . . . . 0.0 112.857 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.664 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.78 -121.16 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.601 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -167.23 162.19 14.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.987 0.899 . . . . 0.0 112.587 177.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.027 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 2.9 m-85 -144.34 113.84 7.09 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.709 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.109 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -111.47 159.13 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-O 121.498 0.666 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.719 HG23 ' HG3' ' A' ' 183' ' ' LYS . 1.5 m -135.04 178.05 7.33 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.338 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 92.0 m-85 -152.56 117.22 5.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.607 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.93 -37.54 1.34 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -89.49 -155.84 0.37 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.606 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -141.43 1.86 1.6 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.716 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -81.62 -58.42 0.48 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.835 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 84.9 Cg_exo -48.91 -35.34 31.27 Favored 'Trans proline' 0 CA--C 1.494 -1.501 0 N-CA-C 109.035 -1.179 . . . . 0.0 109.035 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.879 HG13 HG23 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.66 -51.74 66.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.774 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -44.94 -55.35 5.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.482 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.633 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.0 -54.19 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.107 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.965 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -29.95 -62.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.06 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -49.24 -27.13 3.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.889 0.376 . . . . 0.0 111.255 -179.115 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 238' ' ' LYS . 11.5 mm-40 -68.59 -34.98 76.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.09 20.57 18.75 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.458 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.77 -49.54 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.516 1.135 . . . . 0.0 112.009 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.0 m-85 -85.0 72.83 10.78 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.488 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.965 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -73.04 150.34 42.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.248 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.94 80.94 1.36 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.573 HG12 ' CE ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -75.84 103.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.658 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.456 ' C ' HD23 ' A' ' 249' ' ' LEU . . . 47.64 -85.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.486 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -106.01 -44.94 4.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.976 0.417 . . . . 0.0 110.907 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.21 147.21 24.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.765 0.793 . . . . 0.0 112.372 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.02 145.65 46.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.058 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.93 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.9 163.24 36.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.568 -1.253 . . . . 0.0 114.204 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.493 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.2 tt0 -71.55 91.34 1.06 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.471 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.99 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -80.76 80.19 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.512 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.646 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.3 OUTLIER -93.13 120.46 33.45 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.4 p -30.54 116.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.941 1.246 . . . . 0.0 109.972 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.027 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.426 -1.662 0 CA-C-N 112.971 -1.922 . . . . 0.0 113.369 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.703 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.2 t . . . . . 0 CA--C 1.497 -1.092 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 236' ' ' VAL . 26.3 mttt -151.26 -36.38 0.13 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.727 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.882 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -93.57 -176.8 4.2 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.988 ' CD1' HD12 ' A' ' 239' ' ' ILE . 4.5 pt -161.34 114.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 122.15 0.976 . . . . 0.0 109.118 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.883 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.12 110.54 21.81 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.098 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.929 HG12 ' SG ' ' A' ' 252' ' ' CYS . 3.0 t -100.15 108.72 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.37 -179.87 0.01 OUTLIER Glycine 0 CA--C 1.531 1.065 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.42 161.59 0.0 OUTLIER Glycine 0 C--N 1.344 0.988 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.987 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -173.93 -143.67 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.703 ' N ' HD13 ' A' ' 189' ' ' LEU . 33.1 m -89.18 132.93 36.22 Favored Pre-proline 0 C--N 1.34 0.165 0 CA-C-O 121.037 0.446 . . . . 0.0 110.88 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 72.1 Cg_exo -27.8 -36.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.588 2.859 . . . . 0.0 113.301 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.59 54.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.576 0.226 . . . . 0.0 111.084 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.987 ' OG1' HD22 ' A' ' 189' ' ' LEU . 8.1 m -39.68 120.7 1.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.394 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.59 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -50.35 99.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.717 2.278 . . . . 0.0 112.275 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.6 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -45.88 -21.72 0.15 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.379 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 34.5 mt-10 -60.76 -37.87 83.31 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.59 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.2 mttp -79.73 -46.86 16.27 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.157 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.98 -26.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.897 177.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.558 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 5.3 mtt180 -80.56 -27.1 37.6 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.836 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.4 mt-10 -85.36 -59.85 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.716 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -44.89 -41.56 7.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.58 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.06 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -97.29 -35.08 10.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.997 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.51 -47.04 92.3 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.01 -22.79 65.2 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.83 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.53 -37.86 87.97 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.044 0.926 . . . . 0.0 108.837 178.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.93 -142.0 7.3 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.7 mm-40 -91.66 92.64 8.54 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.874 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.412 HG21 ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.35 143.54 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.555 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.6 tp10 -89.45 -51.02 5.76 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.0 p -170.34 155.48 5.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.1 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.729 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -120.34 159.48 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.121 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.77 132.75 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.089 HD21 HD12 ' A' ' 198' ' ' ILE . 1.6 mm? . . . . . 0 C--N 1.333 -0.15 0 CA-C-O 121.428 0.632 . . . . 0.0 111.001 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.579 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.581 0 CA-C-O 119.841 -0.123 . . . . 0.0 111.25 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 17.28 75.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.77 0 O-C-N 124.015 0.822 . . . . 0.0 111.362 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.655 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.54 -119.64 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.611 -0.795 . . . . 0.0 108.923 -176.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -166.4 163.58 17.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.905 0.859 . . . . 0.0 112.487 178.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.03 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -148.54 118.09 6.99 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.963 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.157 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.5 mt -113.23 152.85 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.792 HG23 ' HG3' ' A' ' 183' ' ' LYS . 2.6 m -131.04 152.97 49.77 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.072 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 87.8 m-85 -131.95 116.77 17.57 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.44 -37.75 0.73 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.2 mm-40 -89.21 -158.24 0.49 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.788 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.613 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 16.5 pt-20 -141.09 11.6 2.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.856 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.5 OUTLIER -89.84 -62.75 0.21 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.83 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 66.9 Cg_exo -47.55 -34.08 19.32 Favored 'Trans proline' 0 CA--C 1.494 -1.498 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.821 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.92 -52.69 50.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.611 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 8.0 pttt -52.8 -49.64 65.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.422 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.666 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -61.45 -53.55 55.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.988 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.13 -64.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.333 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.506 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 2.3 mtp -49.23 -22.15 0.96 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.137 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 4.0 mm-40 -73.57 -36.9 65.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.619 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.16 20.88 15.88 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.312 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.61 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.96 -48.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.634 1.209 . . . . 0.0 112.416 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.3 m-85 -86.55 73.91 9.99 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.466 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.931 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.1 m-70 -77.0 147.34 36.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.156 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.48 81.35 1.43 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.987 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.41 96.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.8 -78.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.61 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.81 -43.48 3.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 0.0 110.922 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.32 148.53 24.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.512 0.672 . . . . 0.0 112.209 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.76 145.71 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.929 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -161.6 155.02 21.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.751 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.552 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 47.6 tt0 -59.75 120.47 9.59 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.933 HG21 HD12 ' A' ' 184' ' ' ILE . 2.3 mt -105.06 84.6 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.749 0.785 . . . . 0.0 112.214 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.68 120.45 30.08 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 114.234 -1.348 . . . . 0.0 107.893 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.9 p -35.21 120.39 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 119.457 1.026 . . . . 0.0 109.696 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.03 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.426 -1.649 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.14 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.632 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.1 t . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' HA ' HG21 ' A' ' 236' ' ' VAL . 25.9 mttt -151.63 -35.35 0.13 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.148 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.852 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.13 -171.79 2.78 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 239' ' ' ILE . 6.0 pt -166.46 110.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 122.197 0.998 . . . . 0.0 109.318 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.893 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -84.71 104.14 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.643 -178.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.961 HG13 HG12 ' A' ' 254' ' ' ILE . 3.8 t -89.82 114.46 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.716 0.806 . . . . 0.0 112.735 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -46.21 -177.21 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.936 0.735 . . . . 0.0 114.936 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -33.32 163.5 0.01 OUTLIER Glycine 0 C--N 1.341 0.832 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.95 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -177.7 -146.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.665 ' N ' HD13 ' A' ' 189' ' ' LEU . 39.7 m -89.03 133.13 35.98 Favored Pre-proline 0 C--N 1.34 0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 111.105 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.72 -33.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.498 2.799 . . . . 0.0 113.181 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.2 m-20 -151.45 55.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.53 0.205 . . . . 0.0 111.461 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.95 ' OG1' HD22 ' A' ' 189' ' ' LEU . 24.3 m -39.19 123.21 1.31 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.484 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.519 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.2 Cg_endo -49.51 88.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 0.0 111.682 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -39.74 -25.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 194' ' ' PRO . 49.7 mt-10 -61.32 -33.42 73.56 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.606 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.21 -31.28 19.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.09 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -66.22 -21.95 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.621 176.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.608 ' HG2' HD11 ' A' ' 211' ' ' ILE . 13.9 mtp180 -82.44 -25.24 33.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.365 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 197' ' ' LYS . 4.3 pt-20 -88.91 -37.77 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.842 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.691 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -65.36 -37.69 87.8 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.121 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.895 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -100.69 -30.72 11.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.18 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.97 -44.93 93.81 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.61 -23.53 67.06 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.809 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.36 -35.89 82.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 122.182 0.991 . . . . 0.0 108.849 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 162.77 -138.93 5.61 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.981 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.9 mm-40 -91.46 92.09 8.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.643 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.522 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -58.07 142.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.568 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.61 -47.74 7.49 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.3 m -175.41 150.14 1.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.809 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -113.23 158.62 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.833 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.43 ' HG2' ' C ' ' A' ' 211' ' ' ILE . 0.8 OUTLIER -156.14 129.22 8.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 111.289 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.823 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.4 mm? . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 121.09 0.471 . . . . 0.0 111.428 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.689 0 CA-C-O 120.934 0.397 . . . . 0.0 109.949 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 20.76 79.96 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.05 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.633 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -142.91 -118.76 0.1 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.671 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -167.69 169.24 11.95 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.209 1.004 . . . . 0.0 112.442 177.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.042 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.3 m-85 -150.66 110.52 4.08 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.886 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.09 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -108.17 160.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.514 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.4 m -138.94 167.63 21.61 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.251 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 82.8 m-85 -144.05 119.82 10.54 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.36 -39.4 3.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.6 mt-10 -92.45 -176.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.894 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.632 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.9 pt-20 -119.05 3.83 11.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -79.86 -61.41 0.46 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.809 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 57.8 Cg_exo -47.59 -35.69 23.16 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 CA-C-N 120.422 1.186 . . . . 0.0 109.203 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.831 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -62.68 -50.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.017 178.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 11.2 mttt -46.78 -59.85 2.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.12 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.653 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -58.46 -51.97 67.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.629 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.972 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.62 -65.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.339 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -47.94 -28.12 2.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.574 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 238' ' ' LYS . 25.6 mm-40 -66.46 -42.15 88.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -98.88 21.64 11.28 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.258 177.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.46 -49.69 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 O-C-N 124.632 1.207 . . . . 0.0 111.846 -179.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.603 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.7 m-85 -85.12 72.57 10.76 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.653 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.93 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.7 m-70 -73.06 152.18 41.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.77 80.88 1.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.892 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.606 HG12 ' CE ' ' A' ' 197' ' ' LYS . 1.4 t -74.93 97.5 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.767 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.37 -83.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.568 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.31 -43.57 4.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.964 0.412 . . . . 0.0 110.687 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 1.2 m -88.33 145.34 25.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.695 0.759 . . . . 0.0 112.357 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -140.33 140.57 35.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.855 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.926 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.85 166.42 33.42 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 53.2 tt0 -72.68 93.54 1.65 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.774 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.961 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -81.47 82.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.604 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.573 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -93.8 120.29 33.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -31.01 118.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.373 1.082 . . . . 0.0 110.431 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.042 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.423 -1.823 0 CA-C-N 113.072 -1.876 . . . . 0.0 112.343 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.705 HG12 ' HB ' ' A' ' 236' ' ' VAL . 38.6 t . . . . . 0 CA--C 1.499 -0.995 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.595 ' HA ' HG21 ' A' ' 236' ' ' VAL . 20.7 mttt -152.56 -35.48 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.736 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.24 -174.61 3.42 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.946 ' CD1' HD12 ' A' ' 239' ' ' ILE . 6.5 pt -163.64 114.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.988 0.899 . . . . 0.0 108.878 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.846 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -89.38 110.07 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.864 -177.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.948 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.7 t -100.35 107.66 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.15 -179.56 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.06 160.3 0.0 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 1.041 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -172.15 -145.04 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.684 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -89.23 130.51 43.82 Favored Pre-proline 0 C--N 1.339 0.121 0 CA-C-O 120.898 0.38 . . . . 0.0 110.644 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -30.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.236 2.624 . . . . 0.0 112.979 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 190' ' ' SER . 15.1 t70 -150.43 52.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.266 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.041 ' OG1' HD22 ' A' ' 189' ' ' LEU . 55.1 m -42.9 124.51 3.15 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.271 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.9 Cg_endo -52.17 92.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.761 2.307 . . . . 0.0 112.286 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.65 ' OE1' HD23 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -39.75 -27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 199' ' ' ARG . 2.6 mp0 -61.49 -37.23 82.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 200' ' ' GLU . 20.4 mmmt -73.99 -50.03 21.73 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.168 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -51.72 -27.43 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 113.142 -1.844 . . . . 0.0 107.556 175.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.588 ' HD3' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -75.72 -30.92 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.813 178.146 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -85.59 -64.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.805 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.72 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -39.35 -39.06 0.61 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.407 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.044 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -99.92 -34.26 10.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.831 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.5 -46.08 94.53 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.63 -22.42 67.96 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.836 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.62 -37.57 86.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.962 0.887 . . . . 0.0 108.834 178.191 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.07 -142.85 7.86 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.997 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mm-40 -91.48 89.79 7.37 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.809 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.424 ' O ' ' HE2' ' A' ' 231' ' ' LYS . 1.8 t -53.19 141.88 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.568 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.4 -48.04 7.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 17.9 m -175.8 150.91 1.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.169 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -115.62 158.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.701 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.56 124.76 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.76 0.314 . . . . 0.0 111.018 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.971 HD21 HD12 ' A' ' 198' ' ' ILE . 1.7 mm? . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.443 0.64 . . . . 0.0 111.438 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.52 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.53 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 25.28 74.68 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.636 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.4 OUTLIER -138.49 -123.26 0.13 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -159.51 162.8 35.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.08 0.943 . . . . 0.0 112.692 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.018 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 2.9 m-85 -149.66 109.95 4.18 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 113.602 -1.636 . . . . 0.0 108.28 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.168 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -106.87 157.88 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.723 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 6.6 m -138.38 154.18 48.92 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.527 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.671 ' CD1' HG22 ' A' ' 236' ' ' VAL . 68.9 m-85 -132.37 120.55 22.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -42.13 -38.26 1.65 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 230' ' ' PHE . 31.3 mt-10 -89.32 -164.0 1.08 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.657 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 25.8 pt-20 -134.67 16.93 3.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.6 -63.06 0.17 Allowed Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.015 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.836 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 76.4 Cg_exo -48.03 -34.9 24.28 Favored 'Trans proline' 0 CA--C 1.494 -1.487 0 N-CA-C 108.94 -1.215 . . . . 0.0 108.94 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.832 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -65.82 -54.06 31.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.221 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 37.3 pttt -51.37 -41.83 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.022 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.664 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.22 -55.17 8.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.574 0.702 . . . . 0.0 110.048 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.946 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -29.8 -60.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.846 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -51.89 -18.21 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 111.801 -178.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.4 mm-40 -79.5 -33.47 42.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -104.71 20.87 17.89 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.946 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.617 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.05 -47.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.394 1.059 . . . . 0.0 112.148 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.617 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 20.6 m-85 -85.73 71.2 10.72 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.359 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.935 ' CE1' HD13 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.12 144.71 46.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.147 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -107.6 78.37 1.2 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -68.77 152.74 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.349 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 2.87 -70.87 0.0 OUTLIER Glycine 0 C--N 1.343 0.949 0 O-C-N 123.97 0.794 . . . . 0.0 113.854 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -120.91 -40.01 2.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.9 OUTLIER -88.94 152.41 21.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.81 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.0 134.55 28.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.575 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.948 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -151.8 158.26 43.06 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.885 -178.384 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.578 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 39.1 tt0 -61.93 121.63 13.44 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.923 HG21 HD12 ' A' ' 184' ' ' ILE . 1.8 mt -106.34 81.39 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.769 0.795 . . . . 0.0 112.039 -176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.1 118.85 26.77 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.784 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.2 p -34.64 115.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.409 1.099 . . . . 0.0 110.083 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.018 ' HB1' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.419 -1.997 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.746 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.72 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.0 t . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.592 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.2 mttt -150.77 -35.92 0.14 Allowed 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.937 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.55 -173.08 3.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.971 HD13 HD12 ' A' ' 239' ' ' ILE . 6.5 pt -165.04 109.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.207 1.003 . . . . 0.0 109.68 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.898 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -83.69 106.56 15.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.563 -178.44 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.95 HG13 HG12 ' A' ' 254' ' ' ILE . 4.3 t -93.82 111.75 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.643 0.777 . . . . 0.0 112.744 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -44.77 -175.98 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -32.59 162.37 0.0 OUTLIER Glycine 0 C--N 1.342 0.876 0 N-CA-C 114.824 0.69 . . . . 0.0 114.824 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.975 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -175.12 -145.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.656 ' N ' HD13 ' A' ' 189' ' ' LEU . 9.1 t -89.32 133.37 35.0 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 110.225 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 53.8 Cg_exo -29.69 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.209 2.606 . . . . 0.0 113.251 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.79 56.97 0.86 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 0.0 111.279 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.975 ' OG1' HD22 ' A' ' 189' ' ' LEU . 54.0 m -39.48 125.79 1.42 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.558 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -53.61 95.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.802 2.334 . . . . 0.0 112.189 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.6 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.38 -20.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 66.1 mt-10 -62.79 -39.51 94.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.806 ' HE2' HD21 ' A' ' 249' ' ' LEU . 1.0 OUTLIER -79.27 -46.66 17.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.097 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.62 -27.0 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.942 177.084 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.621 ' HA ' HD11 ' A' ' 211' ' ' ILE . 6.7 mtp85 -77.75 -28.03 50.57 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.697 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.9 mm-40 -85.8 -60.63 1.96 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.695 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -41.51 -41.49 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.613 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.925 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -99.49 -30.98 11.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.821 -178.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.13 -47.01 91.96 Favored Glycine 0 CA--C 1.504 -0.642 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 176.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -22.48 65.93 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.7 -36.89 85.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.89 0.853 . . . . 0.0 108.74 178.176 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.04 -138.43 5.29 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.904 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.8 mm-40 -91.89 89.88 7.22 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.023 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.47 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -55.57 139.8 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.711 ' CD ' HG21 ' A' ' 229' ' ' THR . 6.0 tt0 -89.66 -47.1 8.17 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 76.3 p -173.48 150.32 1.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.743 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.1 OUTLIER -114.59 161.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.329 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -158.9 137.48 10.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.537 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 198' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.533 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.562 ' O ' ' C ' ' A' ' 224' ' ' GLY . 2.7 mtm180 . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.47 81.17 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 O-C-N 124.443 1.089 . . . . 0.0 112.903 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.646 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -143.98 -120.76 0.09 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.15 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.648 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -163.4 165.08 24.34 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.325 1.06 . . . . 0.0 113.349 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.051 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.6 m-85 -150.46 111.32 4.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.729 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.097 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.5 mt -112.49 161.79 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-O 121.144 0.497 . . . . 0.0 110.476 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.711 HG21 ' CD ' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -136.7 -179.25 5.58 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.408 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 85.2 m-85 -157.07 115.83 3.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.869 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.38 -36.27 0.53 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.3 mm-40 -89.09 -157.05 0.42 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.759 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.8 pm0 -143.15 12.81 1.81 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.379 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.59 -61.73 0.2 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.842 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 81.1 Cg_exo -49.28 -32.85 26.67 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 N-CA-C 108.946 -1.213 . . . . 0.0 108.946 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.832 HG13 HG23 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.53 -53.04 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.266 -1.788 . . . . 0.0 110.153 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.7 pttt -52.84 -45.39 67.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.659 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.649 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.84 -53.84 34.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.603 0.716 . . . . 0.0 109.852 177.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.971 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -31.18 -62.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.823 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.493 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -48.35 -29.17 3.69 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 238' ' ' LYS . 8.3 mm-40 -65.79 -38.99 90.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.31 20.76 16.25 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.14 177.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.16 -49.71 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.459 0 O-C-N 124.647 1.217 . . . . 0.0 111.966 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.2 m-85 -84.84 74.59 10.46 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.598 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.961 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.4 m-70 -76.1 151.42 37.04 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 5.1 m120 -115.07 80.67 1.45 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.502 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -74.52 108.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.566 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 39.09 -89.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.441 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.806 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -97.97 -43.37 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 9.0 m -88.25 147.88 24.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.637 0.732 . . . . 0.0 112.92 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.55 141.11 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.524 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.944 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.17 168.37 26.73 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 56.6 tt0 -73.31 96.07 2.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.375 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.95 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -83.95 81.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.737 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.583 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -94.26 118.04 31.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -27.88 120.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 122.217 1.008 . . . . 0.0 110.539 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.051 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.43 -1.474 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.105 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.708 HG12 ' HB ' ' A' ' 236' ' ' VAL . 28.6 t . . . . . 0 CA--C 1.495 -1.15 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.5 mttt -150.33 -34.39 0.17 Allowed 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.911 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -97.07 -173.59 2.73 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.345 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.001 HD13 HD12 ' A' ' 239' ' ' ILE . 13.2 pt -162.7 117.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.105 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.855 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.57 99.54 12.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.78 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.012 HG13 HG12 ' A' ' 254' ' ' ILE . 2.7 t -84.84 112.85 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.03 0.932 . . . . 0.0 110.924 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -99.18 120.91 7.03 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 97.47 108.72 2.65 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 177.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.941 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.81 -159.22 0.24 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.602 ' N ' HD13 ' A' ' 189' ' ' LEU . 26.3 t -89.04 132.75 36.99 Favored Pre-proline 0 C--N 1.342 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.744 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 190' ' ' SER . 28.2 Cg_exo -31.02 -29.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.872 3.048 . . . . 0.0 113.561 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 190' ' ' SER . 11.4 t70 -148.57 53.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.969 HG22 HD11 ' A' ' 198' ' ' ILE . 7.9 m -39.83 134.15 1.36 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.184 0.516 . . . . 0.0 110.634 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.7 Cg_endo -52.66 83.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.077 2.518 . . . . 0.0 112.084 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.581 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -39.58 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.216 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 194' ' ' PRO . 42.9 mt-10 -63.53 -35.59 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -78.33 -46.45 20.06 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.13 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -49.82 -24.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.624 177.504 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.569 ' HG2' HD11 ' A' ' 211' ' ' ILE . 7.8 mtp-105 -83.98 -25.96 29.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.69 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.7 OUTLIER -88.06 -35.54 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.044 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.708 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -68.33 -41.12 81.22 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.833 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -97.34 -30.96 12.65 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.894 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.08 -47.28 86.96 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.82 -23.73 61.56 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.834 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.46 -34.1 77.19 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.987 0.898 . . . . 0.0 108.859 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.84 -140.27 6.58 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 113.875 -1.512 . . . . 0.0 109.956 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.4 mm-40 -91.51 90.73 7.76 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.889 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -54.63 144.12 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.688 ' CD ' HG21 ' A' ' 229' ' ' THR . 6.6 tt0 -89.43 -49.34 6.75 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.9 p -173.17 148.99 1.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.236 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.589 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.24 163.81 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.36 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -163.12 126.57 2.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.856 0.36 . . . . 0.0 110.953 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.948 HD21 HD12 ' A' ' 198' ' ' ILE . 1.2 mm? . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.146 0.498 . . . . 0.0 111.264 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 23.28 75.63 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 O-C-N 123.635 0.584 . . . . 0.0 111.683 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.681 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.14 -120.4 0.12 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.101 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.63 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -169.77 162.95 9.77 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.194 0.997 . . . . 0.0 113.263 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.031 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.8 m-85 -144.42 123.94 13.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.634 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.13 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -119.85 157.21 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.523 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.688 HG21 ' CD ' ' A' ' 209' ' ' GLU . 1.3 m -132.77 173.52 11.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.88 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 93.1 m-85 -148.2 117.4 6.86 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.609 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.48 -37.37 1.06 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.507 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -90.19 -154.87 0.35 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.62 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -142.07 1.98 1.48 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.696 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -83.75 -57.46 0.41 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.834 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 75.2 Cg_exo -49.18 -33.29 27.22 Favored 'Trans proline' 0 CA--C 1.492 -1.584 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.795 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -64.94 -52.07 58.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.419 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.4 mtpt -46.54 -56.45 6.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.03 -53.58 56.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.6 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.006 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -32.94 -61.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.699 -179.505 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.582 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 30.8 mtm -49.94 -20.12 0.85 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -75.57 -33.31 60.6 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.34 22.83 15.39 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.075 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -16.05 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 112.332 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.91 72.7 10.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.314 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 1.006 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.3 m-70 -73.55 146.61 44.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.2 m-80 -107.63 79.6 1.31 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.365 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.69 147.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.256 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 7.4 -73.9 0.0 OUTLIER Glycine 0 C--N 1.343 0.941 0 O-C-N 124.032 0.833 . . . . 0.0 113.679 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -116.71 -41.18 3.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.731 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -89.16 152.07 21.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.866 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.87 144.76 39.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.94 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.879 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.26 168.88 25.36 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 118.739 -1.185 . . . . 0.0 114.093 -177.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 49.9 tt0 -75.39 93.01 2.87 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 1.012 HG12 HG13 ' A' ' 186' ' ' VAL . 1.1 mt -80.18 83.44 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.751 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.588 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.9 OUTLIER -96.04 117.36 30.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.5 p -29.74 117.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 119.703 1.138 . . . . 0.0 110.161 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.031 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.422 -1.828 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.451 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.764 HG12 ' HB ' ' A' ' 236' ' ' VAL . 42.2 t . . . . . 0 CA--C 1.494 -1.182 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.9 mttt -150.57 -35.36 0.15 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 118.889 -1.124 . . . . 0.0 112.042 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.941 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -96.46 -173.9 2.9 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.058 HD13 HD12 ' A' ' 239' ' ' ILE . 4.9 pt -162.45 115.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.831 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -93.08 92.57 7.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.019 -177.25 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.054 HG13 HG12 ' A' ' 254' ' ' ILE . 2.2 t -73.37 148.09 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.546 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -93.84 -167.64 37.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.389 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -23.55 150.11 0.0 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 1.051 HD21 HD12 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -176.46 -147.11 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.669 ' N ' HD13 ' A' ' 189' ' ' LEU . 1.3 m -89.41 129.93 45.58 Favored Pre-proline 0 C--N 1.341 0.199 0 CA-C-O 120.96 0.409 . . . . 0.0 110.508 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -32.03 -28.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.391 2.728 . . . . 0.0 113.409 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.8 t0 -149.68 53.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.624 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.974 ' OG1' HD22 ' A' ' 189' ' ' LEU . 16.9 m -39.91 124.75 1.59 Allowed Pre-proline 0 CA--C 1.519 -0.245 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.087 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 6.2 Cg_endo -48.58 94.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.56 2.174 . . . . 0.0 111.988 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.601 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -45.24 -21.32 0.07 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.707 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -37.65 88.06 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.763 ' HE2' HD21 ' A' ' 249' ' ' LEU . 1.3 mttp -77.68 -49.09 15.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.129 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -47.18 -28.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.931 176.805 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.674 ' HG2' HD11 ' A' ' 211' ' ' ILE . 12.0 mtt180 -79.64 -27.99 40.92 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.33 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 5.2 pt-20 -87.47 -53.01 5.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.677 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -51.48 -39.5 57.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.342 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.131 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -98.75 -35.83 10.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.673 -178.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.94 -42.93 99.57 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -66.04 -22.48 70.62 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.823 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.21 -37.85 84.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.3 1.048 . . . . 0.0 108.399 178.011 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.52 -156.67 28.3 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.157 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.5 mt-10 -81.6 90.91 6.32 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.645 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.6 t -53.01 142.75 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.559 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.1 tp10 -89.41 -46.97 8.33 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.4 ' C ' HG12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -167.79 169.79 11.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.184 178.066 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.674 HD11 ' HG2' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -133.49 166.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.763 ' C ' HD22 ' A' ' 213' ' ' LEU . 2.1 tp10 -162.67 148.37 12.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.709 0.29 . . . . 0.0 111.352 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.051 HD12 HD21 ' A' ' 189' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.305 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.871 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 23.58 77.87 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.136 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 7.2 p90 -131.26 -130.6 0.2 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.744 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -154.27 162.53 41.12 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.198 0.523 . . . . 0.0 110.355 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.161 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 1.8 m-85 -150.5 118.02 6.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.525 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.131 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.3 mt -119.13 142.35 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 122.051 0.929 . . . . 0.0 110.492 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.0 m -120.09 149.55 42.01 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.284 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.66 ' CD1' HG22 ' A' ' 236' ' ' VAL . 63.8 m-85 -130.71 116.67 18.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -39.39 -36.63 0.37 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.227 1.013 . . . . 0.0 108.299 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.2 mm-40 -88.44 -155.87 0.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.992 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.6 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.3 OUTLIER -144.97 11.4 1.37 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.4 -59.07 0.22 Allowed Pre-proline 0 C--O 1.224 -0.254 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.823 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.0 Cg_exo -51.33 -32.48 41.89 Favored 'Trans proline' 0 CA--C 1.496 -1.388 0 N-CA-C 108.678 -1.316 . . . . 0.0 108.678 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.764 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -66.95 -54.5 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.056 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.6 OUTLIER -51.54 -45.25 62.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.84 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.688 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -53.97 31.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.456 0.646 . . . . 0.0 109.74 178.112 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.058 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -32.69 -65.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.336 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -48.71 -25.35 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 238' ' ' LYS . 5.6 mm-40 -67.88 -37.14 81.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -105.52 22.96 14.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.241 178.145 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.609 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.78 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.655 1.222 . . . . 0.0 111.985 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -84.52 72.22 10.67 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.983 0.42 . . . . 0.0 110.742 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.924 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.0 m-70 -74.23 159.15 32.88 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.393 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 251' ' ' LYS . 5.2 m-80 -119.75 74.26 1.01 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.45 101.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.675 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.65 -87.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.54 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.763 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -99.87 -42.34 6.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.158 0.504 . . . . 0.0 110.559 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 247' ' ' VAL . 41.9 m -88.44 143.81 26.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.372 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.02 133.19 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.266 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.039 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -153.62 169.35 23.47 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.408 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.483 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 47.8 tt0 -72.9 104.9 4.2 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.004 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 1.054 HG12 HG13 ' A' ' 186' ' ' VAL . 1.8 mt -91.12 79.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.643 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.6 mtpt -87.45 119.04 27.33 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.1 p -33.73 115.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.518 1.152 . . . . 0.0 110.644 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.161 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.421 -1.881 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.955 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.689 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.6 t . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 25.6 mttt -151.27 -35.41 0.14 Allowed 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 118.873 -1.131 . . . . 0.0 112.259 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -92.47 -172.64 3.14 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.041 HD13 HD12 ' A' ' 239' ' ' ILE . 6.8 pt -166.03 111.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 122.025 0.916 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.935 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -83.57 103.27 12.77 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.046 -178.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.95 HG13 HG12 ' A' ' 254' ' ' ILE . 2.7 t -89.62 106.37 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.638 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -98.08 122.71 7.6 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 115.964 1.145 . . . . 0.0 115.964 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.58 107.72 2.85 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.973 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.64 -158.89 0.23 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.6 ' N ' HD13 ' A' ' 189' ' ' LEU . 46.3 t -88.85 135.61 31.79 Favored Pre-proline 0 C--N 1.343 0.318 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.878 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 192' ' ' ASP . 87.8 Cg_exo -29.63 -32.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.669 2.913 . . . . 0.0 113.576 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.8 OUTLIER -150.65 54.75 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.617 0.246 . . . . 0.0 111.195 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.973 ' OG1' HD22 ' A' ' 189' ' ' LEU . 17.9 m -39.77 134.1 1.34 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 110.819 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.52 ' O ' HG13 ' A' ' 198' ' ' ILE . 11.8 Cg_endo -55.1 89.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.774 2.316 . . . . 0.0 111.75 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.594 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -44.43 -22.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.034 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.51 -35.69 81.78 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.17 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.84 -47.11 17.24 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.691 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.128 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -50.02 -24.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.196 177.116 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.559 ' HG2' HD11 ' A' ' 211' ' ' ILE . 1.7 mtt180 -82.03 -26.8 33.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.792 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -87.37 -43.86 11.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.874 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.721 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -58.63 -43.25 89.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.441 0.639 . . . . 0.0 110.066 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.849 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.2 m-85 -94.97 -32.05 13.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.369 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.3 -44.68 95.13 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.674 -2.171 . . . . 0.0 107.674 175.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -23.36 66.82 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.869 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.29 -34.31 77.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.072 0.939 . . . . 0.0 108.709 177.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.92 -142.4 7.97 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.895 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 18.1 mt-10 -91.18 92.54 8.71 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.7 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -55.66 144.84 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.558 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.4 tp10 -89.76 -50.33 6.12 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 72.2 m -171.77 148.1 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.296 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.02 158.85 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 211' ' ' ILE . 0.3 OUTLIER -155.23 129.69 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.969 HD21 HD12 ' A' ' 198' ' ' ILE . 4.5 mm? . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.55 0.69 . . . . 0.0 111.322 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.554 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.354 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 8.64 82.26 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.923 0.764 . . . . 0.0 113.062 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.71 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.22 -120.57 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.03 167.47 12.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.143 0.973 . . . . 0.0 112.288 177.018 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.058 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.2 m-85 -148.95 113.48 5.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.099 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.128 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -109.3 158.58 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.0 m -140.28 155.64 46.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.927 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 70.5 m-85 -131.41 123.0 27.24 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -43.93 -38.22 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mm-40 -90.31 -168.06 2.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.372 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.608 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -131.12 15.57 5.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -92.4 -62.07 0.19 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.735 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.869 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.8 Cg_exo -49.03 -31.96 22.21 Favored 'Trans proline' 0 CA--C 1.497 -1.332 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -66.82 -54.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.637 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 30.9 pttt -50.93 -46.77 61.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.549 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.641 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -56.4 11.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.414 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.041 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.19 -60.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.028 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.49 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.4 mtp -46.23 -31.25 2.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.0 OUTLIER -65.83 -39.54 90.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.17 19.69 14.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.585 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.44 -50.42 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 O-C-N 124.722 1.264 . . . . 0.0 112.114 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.68 72.45 10.57 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.42 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 1.027 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.1 m-70 -73.54 142.19 46.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.965 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -103.54 79.32 1.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.929 0.395 . . . . 0.0 111.394 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -66.88 151.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.171 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 1.82 -69.76 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 O-C-N 124.002 0.814 . . . . 0.0 113.817 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -118.91 -44.3 2.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.093 0.473 . . . . 0.0 110.787 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.568 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -89.82 152.29 21.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.615 -178.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.52 144.35 46.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.169 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.941 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -155.41 164.48 38.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -178.169 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 44.9 tt0 -72.74 92.01 1.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.453 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.95 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -81.38 81.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.935 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.7 OUTLIER -96.64 119.06 34.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -27.87 119.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 122.264 1.031 . . . . 0.0 110.197 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.058 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.424 -1.731 0 CA-C-N 113.186 -1.824 . . . . 0.0 113.323 -175.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.734 HG12 ' HB ' ' A' ' 236' ' ' VAL . 41.3 t . . . . . 0 CA--C 1.491 -1.304 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 236' ' ' VAL . 20.2 mttt -150.81 -33.55 0.16 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.81 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.893 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -104.9 -166.96 1.29 Allowed 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.043 HD13 HD12 ' A' ' 239' ' ' ILE . 12.4 pt -164.05 139.1 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.421 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.706 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -110.48 98.4 7.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.096 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 1.082 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.1 t -80.83 148.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.556 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -95.45 -171.74 36.41 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.766 -0.73 . . . . 0.0 114.085 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -21.51 148.44 0.0 OUTLIER Glycine 0 C--N 1.343 0.97 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.996 HD21 HD12 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -169.9 -144.85 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.734 ' N ' HD13 ' A' ' 189' ' ' LEU . 36.0 m -89.39 129.63 46.71 Favored Pre-proline 0 C--N 1.343 0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -29.66 -31.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.546 2.831 . . . . 0.0 113.532 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 190' ' ' SER . 41.7 m-20 -151.14 54.2 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.987 ' OG1' HD22 ' A' ' 189' ' ' LEU . 24.1 m -41.16 117.46 1.57 Allowed Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.371 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.578 ' HG2' ' CE ' ' A' ' 197' ' ' LYS . 9.0 Cg_endo -49.9 101.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.882 2.388 . . . . 0.0 112.209 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.599 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -48.38 -18.28 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.973 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 60.1 mt-10 -63.92 -37.43 87.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.578 ' CE ' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -81.52 -45.88 15.3 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.14 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -51.13 -27.59 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.346 176.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.621 ' HG2' HD11 ' A' ' 211' ' ' ILE . 1.2 mtt180 -77.04 -27.88 54.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.812 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.2 mm-40 -85.76 -62.74 1.46 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.586 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.666 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -41.3 -40.93 1.79 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.067 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -98.11 -34.15 10.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.614 -178.398 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.36 -45.68 95.45 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 176.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.67 -22.41 68.03 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.803 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.82 -36.94 84.89 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 122.521 1.153 . . . . 0.0 108.227 177.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.74 -162.15 35.61 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.863 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.7 mt-10 -76.58 93.09 3.54 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.557 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 202' ' ' PHE . 1.6 t -53.73 142.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.56 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -89.53 -44.05 10.38 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 211' ' ' ILE . 67.2 m -170.92 172.42 5.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.112 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -137.13 161.08 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.981 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.838 ' C ' HD22 ' A' ' 213' ' ' LEU . 0.3 OUTLIER -161.33 143.94 12.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.996 HD12 HD21 ' A' ' 189' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 111.319 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.527 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.714 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 21.41 78.62 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.472 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 8.4 p90 -130.1 -130.15 0.21 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.716 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.386 0.612 . . . . 0.0 111.375 178.448 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.121 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -151.02 111.58 4.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.912 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.14 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.5 mt -112.8 148.49 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 8.4 m -124.56 152.28 43.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.126 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 68.6 m-85 -132.11 119.02 20.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.56 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.21 -38.19 0.74 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.2 mt-10 -89.06 -155.48 0.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.711 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 2.0 pm0 -141.83 4.89 1.72 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.552 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 14.2 mt-10 -86.63 -56.15 0.36 Allowed Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.803 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 94.0 Cg_exo -51.45 -31.99 41.06 Favored 'Trans proline' 0 CA--C 1.494 -1.482 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.734 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -65.41 -50.62 71.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.342 177.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 22.3 mttm -47.93 -58.64 4.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.043 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.685 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.23 -51.99 66.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.155 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.043 HD12 HD13 ' A' ' 184' ' ' ILE . 0.7 OUTLIER -36.65 -63.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.114 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -52.56 -18.17 1.6 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.298 -179.034 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' LYS . 14.0 mm-40 -76.67 -33.52 58.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.81 24.15 13.51 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.766 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.599 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.34 -47.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.354 1.034 . . . . 0.0 112.122 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.599 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 23.0 m-85 -84.69 69.87 10.71 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.529 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.861 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.4 m-70 -70.46 156.22 39.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.832 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -122.04 72.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.639 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -61.55 141.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.446 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 12.14 -76.82 0.0 OUTLIER Glycine 0 C--N 1.338 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 113.899 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.99 -42.5 3.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 14.5 m -88.01 145.37 26.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.702 0.763 . . . . 0.0 112.645 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.6 133.28 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 107.888 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 1.082 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.54 163.53 39.41 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 118.636 -1.226 . . . . 0.0 114.27 -176.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.462 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 42.5 tt0 -67.57 108.66 2.95 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.215 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.972 HG12 HG13 ' A' ' 186' ' ' VAL . 2.1 mt -98.49 79.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.196 -1.365 . . . . 0.0 112.453 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.629 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.39 119.92 28.15 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 256' ' ' VAL . 2.9 p -36.25 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 123.051 1.405 . . . . 0.0 110.876 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.121 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.412 -2.368 0 CA-C-N 112.097 -2.32 . . . . 0.0 112.059 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.702 HG12 ' HB ' ' A' ' 236' ' ' VAL . 29.2 t . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HA ' HG21 ' A' ' 236' ' ' VAL . 21.9 mttt -150.31 -35.03 0.16 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.133 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.18 -170.84 2.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.032 HD13 HD12 ' A' ' 239' ' ' ILE . 11.6 pt -165.33 117.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.825 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.06 100.22 12.68 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.879 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.965 HG13 HG12 ' A' ' 254' ' ' ILE . 2.8 t -85.04 111.26 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.067 0.947 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -97.77 119.43 6.42 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.117 1.207 . . . . 0.0 116.117 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . 98.72 105.95 2.59 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 114.903 0.721 . . . . 0.0 114.903 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.943 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -166.07 -157.63 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.631 ' N ' HD13 ' A' ' 189' ' ' LEU . 58.8 m -89.25 133.17 35.54 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -29.76 -31.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.695 2.93 . . . . 0.0 113.663 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.8 m-20 -150.41 54.2 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.431 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.943 ' OG1' HD22 ' A' ' 189' ' ' LEU . 32.4 m -40.65 128.49 1.86 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.511 ' O ' HG13 ' A' ' 198' ' ' ILE . 6.3 Cg_endo -49.2 90.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.164 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.681 ' OE1' HD23 ' A' ' 213' ' ' LEU . 0.9 OUTLIER -42.43 -23.57 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.511 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.64 -37.56 87.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.1 mmmt -77.36 -48.27 17.74 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.118 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.73 -26.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.256 177.286 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.56 ' HA ' HD11 ' A' ' 211' ' ' ILE . 10.4 mtt85 -79.67 -27.25 40.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.937 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 pt-20 -86.42 -50.96 6.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.694 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -51.57 -40.24 59.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.541 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.889 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -98.93 -30.31 12.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.176 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.63 -47.36 87.51 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -61.66 -23.57 63.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.826 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.38 -34.23 77.5 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.044 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.25 -142.53 8.14 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 8.7 mt-10 -90.72 94.67 9.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.256 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -56.59 143.1 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.604 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.5 tp10 -89.27 -47.53 7.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 68.1 m -174.06 147.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.374 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.598 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.16 161.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.437 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.3 OUTLIER -160.47 127.76 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 111.226 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 1.073 HD21 HD12 ' A' ' 198' ' ' ILE . 1.5 mm? . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.458 0.647 . . . . 0.0 111.803 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 22.43 76.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 O-C-N 123.705 0.628 . . . . 0.0 112.575 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.651 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -147.58 -123.14 0.06 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.357 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.625 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.08 164.57 20.37 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 113.201 178.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.018 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.1 m-85 -148.24 116.05 6.37 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 113.626 -1.625 . . . . 0.0 108.742 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.118 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -115.17 159.58 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.621 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.7 m -136.83 169.02 18.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.197 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 86.2 m-85 -145.94 116.64 7.65 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.604 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.6 -36.93 0.65 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.572 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 3.7 pm0 -89.03 -155.97 0.37 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.473 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.59 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 19.1 pt-20 -141.17 -2.59 1.27 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.885 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.7 -57.33 0.83 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 -177.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.826 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.9 Cg_exo -51.04 -34.18 45.89 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.829 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.1 t -64.72 -51.48 66.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.85 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 16.8 mtpt -44.99 -58.79 2.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.933 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.67 -52.76 64.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.627 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.032 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.92 -62.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.175 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.3 mtp -51.3 -20.85 1.84 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.919 0.39 . . . . 0.0 111.251 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -75.72 -34.28 60.33 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.19 22.39 16.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.617 178.266 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.76 -48.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 0.0 112.29 -179.546 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 242' ' ' LYS . 23.4 m-30 -84.4 71.79 10.66 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.66 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.953 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -72.75 154.49 40.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.18 79.56 1.36 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.04 152.53 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.575 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 0.79 -68.85 0.0 OUTLIER Glycine 0 C--N 1.343 0.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.899 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -117.3 -43.59 2.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.0 110.997 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.561 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 9.1 m -89.77 153.84 20.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.033 0.921 . . . . 0.0 113.283 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.27 139.77 39.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.183 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.872 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.98 169.57 24.52 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 118.613 -1.235 . . . . 0.0 114.157 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.3 tt0 -75.88 92.15 3.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.738 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.965 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -79.93 81.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.837 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.58 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 2.7 mtpt -93.7 116.98 29.5 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.4 p -29.17 119.65 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 122.267 1.032 . . . . 0.0 110.744 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.018 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.428 -1.557 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.47 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' A' ' 236' ' ' VAL . 40.8 t . . . . . 0 CA--C 1.495 -1.151 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.695 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.6 mttt -148.34 -35.42 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.867 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -94.79 -175.49 3.59 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.301 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.978 ' CD1' HD12 ' A' ' 239' ' ' ILE . 5.4 pt -162.38 117.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.837 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.4 109.1 20.67 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.415 -177.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.924 HG13 HG12 ' A' ' 254' ' ' ILE . 2.4 t -97.67 115.32 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.757 0.823 . . . . 0.0 112.984 -178.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -49.3 -177.14 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 114.796 0.678 . . . . 0.0 114.796 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -31.49 161.74 0.0 OUTLIER Glycine 0 C--N 1.342 0.914 0 N-CA-C 114.653 0.621 . . . . 0.0 114.653 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.978 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -175.42 -143.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 189' ' ' LEU . 1.3 m -88.5 135.4 32.64 Favored Pre-proline 0 C--N 1.343 0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 44.2 Cg_exo -28.78 -39.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.159 2.573 . . . . 0.0 113.033 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.5 56.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.978 ' OG1' HD22 ' A' ' 189' ' ' LEU . 86.1 m -39.21 127.95 1.3 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.498 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.9 Cg_endo -50.53 96.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.259 2.64 . . . . 0.0 113.808 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.783 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -39.75 -28.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.207 178.245 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 194' ' ' PRO . 2.9 mm-40 -61.23 -36.78 80.88 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.183 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 200' ' ' GLU . 3.0 mmmt -77.64 -52.29 9.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.166 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -46.91 -26.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.04 176.847 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.708 ' HG2' HD11 ' A' ' 211' ' ' ILE . 8.1 mtp180 -82.31 -26.84 32.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.101 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.8 OUTLIER -87.48 -41.12 13.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.998 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.3 t80 -67.14 -38.27 85.25 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.369 0.604 . . . . 0.0 110.358 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.99 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -98.26 -37.06 9.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.396 -178.511 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.5 -43.69 96.27 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.14 -23.98 66.69 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.834 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -37.52 86.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.084 0.945 . . . . 0.0 108.902 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.88 -140.51 6.41 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 32.6 mt-10 -92.06 94.6 9.33 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.213 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -60.95 144.91 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.588 ' CD ' HG21 ' A' ' 229' ' ' THR . 15.4 tt0 -89.79 -53.14 4.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.8 m -171.22 148.43 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.625 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.746 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.64 166.84 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.138 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -165.36 123.69 1.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.067 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.834 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.5 mm? . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 111.439 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.505 -0.782 0 CA-C-O 119.79 -0.147 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.88 81.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.49 0 O-C-N 124.218 0.949 . . . . 0.0 112.212 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.617 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -149.92 -119.85 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.084 -0.558 . . . . 0.0 109.574 -176.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.589 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -172.62 168.91 5.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.0 0.905 . . . . 0.0 112.805 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.026 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.2 m-85 -150.41 125.37 9.88 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.349 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.166 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -119.92 147.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.528 0.68 . . . . 0.0 110.071 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 3.1 m -126.09 153.14 44.91 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.1 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.659 ' CD1' HG22 ' A' ' 236' ' ' VAL . 89.1 m-85 -129.01 120.64 26.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.547 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.26 -38.99 2.81 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mt-10 -90.13 -167.1 1.75 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.665 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.612 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -132.56 15.56 4.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.64 -64.88 0.15 Allowed Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.834 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 52.7 Cg_exo -46.34 -35.2 15.44 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.801 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -65.48 -52.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.241 -1.799 . . . . 0.0 110.349 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.6 pttt -52.26 -45.19 65.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.549 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.654 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.23 -54.78 20.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.618 0.723 . . . . 0.0 109.935 177.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.978 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -29.59 -64.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.159 -179.671 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -49.4 -22.33 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.276 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.4 mm-40 -74.29 -37.1 63.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.613 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -100.33 19.84 15.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.375 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.62 -48.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.52 1.137 . . . . 0.0 112.166 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 242' ' ' LYS . 18.5 m-85 -86.66 71.17 10.41 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.351 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.876 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.7 m-70 -71.68 148.51 46.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.346 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.74 77.23 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.097 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 248' ' ' GLY . 2.2 t -62.97 171.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.67 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.706 ' C ' HD23 ' A' ' 249' ' ' LEU . . . -14.67 -59.27 0.01 OUTLIER Glycine 0 C--N 1.341 0.806 0 O-C-N 123.781 0.676 . . . . 0.0 113.367 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.706 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -132.04 -41.61 1.01 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.398 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -87.94 152.05 22.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.67 0.748 . . . . 0.0 112.755 -177.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.99 135.61 36.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.812 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.921 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.58 157.56 41.2 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.634 -0.826 . . . . 0.0 112.92 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.585 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 64.8 tt0 -60.76 119.16 7.63 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.963 HG21 HD12 ' A' ' 184' ' ' ILE . 1.7 mt -104.36 82.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.813 0.816 . . . . 0.0 111.85 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.586 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.0 118.72 26.57 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.197 -1.365 . . . . 0.0 107.695 178.295 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.5 p -33.73 120.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 119.546 1.066 . . . . 0.0 109.777 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.026 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.423 -1.799 0 CA-C-N 113.226 -1.807 . . . . 0.0 113.053 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.67 HG12 ' HB ' ' A' ' 236' ' ' VAL . 32.0 t . . . . . 0 CA--C 1.497 -1.091 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.6 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.4 mttt -151.44 -35.17 0.14 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.175 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.871 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.73 -173.19 3.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.015 HD13 HD12 ' A' ' 239' ' ' ILE . 7.8 pt -165.86 108.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 122.519 1.152 . . . . 0.0 109.502 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.901 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -81.53 103.59 11.37 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.754 -178.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 254' ' ' ILE . 64.3 t -89.87 131.44 37.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.976 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.512 ' C ' ' HB2' ' A' ' 225' ' ' PHE . . . -64.33 -176.48 4.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -37.82 172.59 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.023 -0.589 . . . . 0.0 114.128 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 225' ' ' PHE . 0.2 OUTLIER 169.63 -139.8 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.361 -0.135 . . . . 0.0 111.123 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.574 ' N ' HD13 ' A' ' 189' ' ' LEU . 6.1 m -88.78 130.69 44.08 Favored Pre-proline 0 C--N 1.339 0.149 0 CA-C-O 120.966 0.412 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -32.63 -30.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.058 2.505 . . . . 0.0 112.931 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -151.29 54.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.861 ' HB ' HD11 ' A' ' 213' ' ' LEU . 47.9 m -39.54 128.51 1.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.268 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.576 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.4 Cg_endo -52.29 96.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.803 2.335 . . . . 0.0 111.889 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.612 ' HA ' HG13 ' A' ' 198' ' ' ILE . 1.1 pm0 -46.31 -17.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 26.9 mt-10 -65.13 -40.47 94.51 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.576 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -78.51 -45.72 21.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.093 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.83 -26.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.892 176.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.576 ' HA ' HD11 ' A' ' 211' ' ' ILE . 2.9 mtt85 -77.36 -28.41 52.97 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.514 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.0 mm-40 -85.29 -60.64 1.97 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.773 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.696 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -42.21 -42.55 3.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.905 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -97.88 -31.5 12.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.15 -49.77 71.68 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 176.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.64 -23.26 60.55 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.29 -36.74 85.09 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.825 0.822 . . . . 0.0 108.805 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.62 -139.01 5.62 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.908 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 66.9 mt-10 -91.71 89.7 7.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.996 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -55.57 141.07 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.566 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.6 tp10 -90.08 -48.3 7.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 21.5 m -174.27 149.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.626 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -113.29 156.92 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.748 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -154.19 125.74 7.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.991 HD21 ' CD1' ' A' ' 198' ' ' ILE . 3.2 mm? . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 121.219 0.533 . . . . 0.0 111.103 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.588 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.67 82.23 0.01 OUTLIER Glycine 0 C--N 1.336 0.547 0 O-C-N 124.114 0.884 . . . . 0.0 112.008 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.779 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -149.93 -116.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.092 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.563 ' SG ' HD22 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -174.07 169.26 4.01 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.496 1.141 . . . . 0.0 112.824 177.157 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.034 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m-85 -151.51 110.6 3.9 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.858 -1.973 . . . . 0.0 108.519 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.093 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.2 mt -108.72 159.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.333 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.8 m -137.38 170.8 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.158 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.655 ' CD1' HG22 ' A' ' 236' ' ' VAL . 75.8 m-85 -148.02 114.08 5.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.566 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -38.67 -35.34 0.19 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 17.2 mt-10 -88.6 -153.63 0.26 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.772 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.7 OUTLIER -148.44 13.27 0.95 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.075 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 1.2 mt-10 -94.27 -57.81 0.21 Allowed Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.842 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 87.7 Cg_exo -51.43 -31.94 40.67 Favored 'Trans proline' 0 CA--C 1.496 -1.417 0 N-CA-C 108.793 -1.272 . . . . 0.0 108.793 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -68.01 -55.02 18.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.821 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -50.99 -42.39 60.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.157 -179.179 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.655 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.06 -54.62 10.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.601 0.715 . . . . 0.0 109.957 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.015 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.2 -63.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.865 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.584 ' HE3' ' O ' ' A' ' 236' ' ' VAL . 19.2 mtm -45.76 -29.63 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.7 mm-40 -64.78 -40.9 96.03 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.36 20.51 13.56 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.586 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.49 -50.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.635 1.209 . . . . 0.0 112.185 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.5 m-85 -85.58 69.29 10.63 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.994 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -69.18 149.7 48.3 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.74 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.62 80.72 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -74.04 100.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.04 -84.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.707 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.54 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -105.54 -42.18 5.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 247' ' ' VAL . 56.1 m -88.81 146.84 24.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.721 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.42 138.32 32.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.475 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.657 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.99 153.59 26.33 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.664 -177.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.574 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 28.2 tt0 -57.96 114.55 2.39 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.969 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.895 ' CG2' HD12 ' A' ' 184' ' ' ILE . 1.8 mt -103.33 83.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.793 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -91.86 117.78 30.11 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.351 178.755 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.3 p -30.57 122.75 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 119.376 0.989 . . . . 0.0 109.936 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.034 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.431 -1.421 0 CA-C-N 113.677 -1.602 . . . . 0.0 113.004 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.66 HG12 ' HB ' ' A' ' 236' ' ' VAL . 28.3 t . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 236' ' ' VAL . 26.0 mttt -152.55 -34.97 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.717 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -93.58 -179.32 4.99 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.654 179.094 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.01 HD12 HG21 ' A' ' 254' ' ' ILE . 5.9 pt -161.1 112.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 122.098 0.952 . . . . 0.0 108.897 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.873 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -87.04 104.7 16.57 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.147 -177.334 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.975 HG13 HG12 ' A' ' 254' ' ' ILE . 2.6 t -91.02 112.11 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.431 0.693 . . . . 0.0 111.44 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -52.38 -172.64 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.5 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -28.16 156.95 0.0 OUTLIER Glycine 0 N--CA 1.468 0.794 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.993 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -171.08 -145.41 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.663 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.74 132.4 38.66 Favored Pre-proline 0 C--N 1.341 0.215 0 CA-C-O 120.8 0.333 . . . . 0.0 110.213 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 73.4 Cg_exo -29.7 -33.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.298 2.665 . . . . 0.0 113.126 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 190' ' ' SER . 1.9 m-20 -150.92 54.33 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.408 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.993 ' OG1' HD22 ' A' ' 189' ' ' LEU . 25.5 m -39.95 122.54 1.57 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.608 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 11.2 Cg_endo -53.81 98.56 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.89 2.393 . . . . 0.0 112.22 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.605 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.5 OUTLIER -44.73 -21.39 0.05 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.766 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 2.2 mp0 -62.1 -39.09 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.787 ' HE2' HD21 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.28 -44.97 18.71 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.521 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.121 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.59 -28.63 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.172 -1.377 . . . . 0.0 108.899 177.103 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.565 ' HA ' HD11 ' A' ' 211' ' ' ILE . 0.1 OUTLIER -76.07 -27.99 57.44 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.366 177.715 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mm-40 -84.03 -61.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.898 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.671 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.3 t80 -41.68 -39.38 1.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.284 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.857 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -100.81 -33.93 10.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.372 -177.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.59 -48.28 82.84 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.3 -23.06 63.95 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.774 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -65.93 -38.15 87.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 122.153 0.978 . . . . 0.0 108.849 177.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.24 -143.01 8.04 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.639 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.6 mt-10 -92.05 97.15 10.76 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.293 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -61.39 143.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.689 ' CD ' HG21 ' A' ' 229' ' ' THR . 13.4 tt0 -89.07 -52.45 5.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 60.7 p -169.67 147.47 3.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.628 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.666 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.32 161.68 8.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.449 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -159.55 128.55 5.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.304 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.77 HD21 HD12 ' A' ' 198' ' ' ILE . 1.5 mm? . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 121.442 0.639 . . . . 0.0 110.996 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.553 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.507 -0.683 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.93 78.08 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 O-C-N 124.005 0.816 . . . . 0.0 112.994 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.654 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.86 -121.21 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.702 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.81 166.5 11.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.099 0.952 . . . . 0.0 112.888 178.698 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.034 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.0 m-85 -148.24 119.58 7.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.318 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.121 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -115.75 146.18 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.631 0.729 . . . . 0.0 110.3 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.689 HG21 ' CD ' ' A' ' 209' ' ' GLU . 3.3 m -124.15 164.52 19.31 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.101 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 96.4 m-85 -139.44 119.85 13.93 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -42.57 -38.93 2.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.4 mm-40 -91.21 -168.04 1.96 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.488 -1.687 . . . . 0.0 110.732 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.588 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 4.8 pt-20 -129.6 16.8 5.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.656 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -89.62 -64.49 0.19 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.937 ' O ' HD12 ' A' ' 239' ' ' ILE . 82.9 Cg_exo -46.13 -30.83 8.01 Favored 'Trans proline' 0 CA--C 1.5 -1.182 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.858 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -72.23 -54.49 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.757 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -51.18 -32.9 25.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.541 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.664 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -83.75 -56.48 3.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.147 178.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.937 HD12 ' O ' ' A' ' 235' ' ' PRO . 0.8 OUTLIER -30.28 -57.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.322 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.8 mtp -51.24 -19.67 1.32 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.859 0.361 . . . . 0.0 111.733 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 3.8 mm-40 -79.62 -33.57 41.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.58 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -107.67 21.85 16.84 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.309 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.613 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -18.61 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.218 0.949 . . . . 0.0 112.117 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.613 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 22.0 m-85 -85.84 78.97 9.42 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.747 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.816 ' CG ' HD12 ' A' ' 254' ' ' ILE . 13.9 m-70 -76.18 -170.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.9 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 4.7 m120 -151.54 81.32 1.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -81.33 106.59 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.504 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 38.73 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.381 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.787 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -95.6 -43.0 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 111.457 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -88.51 150.26 23.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -147.96 133.1 18.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.331 179.347 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.962 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -154.13 173.72 15.69 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.551 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 61.5 tt0 -76.91 97.78 4.7 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.452 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 1.01 HG21 HD12 ' A' ' 184' ' ' ILE . 1.8 mt -86.59 83.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.709 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.607 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.3 mtpt -94.99 122.46 37.67 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.7 p -32.91 110.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.631 1.205 . . . . 0.0 110.524 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.034 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.419 -2.021 0 CA-C-N 112.65 -2.068 . . . . 0.0 112.977 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.74 HG12 ' HB ' ' A' ' 236' ' ' VAL . 38.5 t . . . . . 0 CA--C 1.492 -1.261 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.0 mttt -150.32 -34.02 0.17 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.65 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -103.53 -168.52 1.52 Allowed 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 1.071 HD13 HD12 ' A' ' 239' ' ' ILE . 16.7 pt -163.02 138.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.605 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.749 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -108.87 91.13 3.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.112 0.482 . . . . 0.0 112.24 -178.237 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.927 HG13 HG12 ' A' ' 254' ' ' ILE . 2.0 t -68.21 138.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.585 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -130.71 111.49 1.13 Allowed Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.995 -1.098 . . . . 0.0 114.483 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.555 ' H ' ' HB3' ' A' ' 225' ' ' PHE . . . 108.87 102.97 2.8 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.638 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.752 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -170.59 -154.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.61 ' N ' HD13 ' A' ' 189' ' ' LEU . 14.0 m -89.46 136.64 29.59 Favored Pre-proline 0 C--N 1.341 0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.499 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -31.3 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.38 2.72 . . . . 0.0 113.515 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 190' ' ' SER . 8.4 t0 -150.98 56.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.759 HG22 HD11 ' A' ' 198' ' ' ILE . 2.6 m -39.13 128.97 1.26 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 5.2 Cg_endo -47.16 97.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.858 2.372 . . . . 0.0 112.191 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 198' ' ' ILE . 3.5 pt-20 -48.02 -17.95 0.16 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.11 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.79 -36.93 83.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.629 ' HE2' HD21 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -80.0 -46.26 16.95 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.141 HG22 ' CD1' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.08 -31.5 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.519 176.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' A' ' 211' ' ' ILE . 5.3 mtp180 -74.13 -28.89 61.55 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.176 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -87.57 -63.76 1.25 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.992 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.656 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -39.65 -37.16 0.48 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 1.123 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -101.16 -33.25 10.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.222 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.93 -43.6 98.97 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.42 -21.26 72.29 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 176.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.813 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -34.85 79.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 108.7 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.72 -144.9 9.74 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.633 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.6 mm-40 -90.52 91.16 8.32 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 121.881 -0.776 . . . . 0.0 110.539 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.49 141.25 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.515 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.7 tp10 -89.54 -45.72 9.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.45 ' C ' HG12 ' A' ' 211' ' ' ILE . 15.3 m -171.29 173.09 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.298 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.727 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.31 164.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.563 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.505 ' CG ' ' C ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -172.43 128.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.823 HD21 HD12 ' A' ' 198' ' ' ILE . 3.0 mm? . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.519 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.617 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 27.19 78.52 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.136 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 7.5 p90 -140.04 -131.32 0.11 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.668 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -151.41 164.17 37.32 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.11 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.13 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -150.61 113.49 4.77 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.129 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.141 ' CD1' HG22 ' A' ' 198' ' ' ILE . 1.3 mt -115.19 150.69 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 121.724 0.773 . . . . 0.0 110.88 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.644 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.4 m -127.17 151.58 48.49 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.929 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 76.5 m-85 -130.92 119.2 21.78 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -40.69 -37.85 0.81 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.553 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -88.84 -158.68 0.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.373 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.587 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 15.5 pt-20 -137.63 0.64 2.26 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.058 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 238' ' ' LYS . 3.7 mm-40 -79.2 -58.62 0.67 Allowed Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.813 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 72.5 Cg_exo -50.0 -35.35 40.96 Favored 'Trans proline' 0 CA--C 1.488 -1.797 0 CA-C-N 120.485 1.209 . . . . 0.0 109.023 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.759 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.12 -51.99 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 113.251 -1.795 . . . . 0.0 108.726 178.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 24.9 mttt -44.62 -58.65 2.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.13 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.675 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.85 -53.47 57.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.825 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 1.071 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -32.16 -64.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.65 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.6 mtp -48.3 -29.63 4.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 26.3 mm-40 -66.67 -37.39 84.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.67 19.84 17.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.271 177.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.577 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.45 -50.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.646 1.216 . . . . 0.0 112.12 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.4 m-85 -85.35 71.41 10.82 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.258 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.933 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.7 m-70 -70.8 152.88 43.28 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.225 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 4.6 m120 -114.25 74.21 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 250' ' ' SER . 2.1 t -66.72 100.76 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.794 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.3 -85.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.626 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.629 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -104.26 -42.09 5.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.299 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 37.5 m -87.8 144.49 26.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.031 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.72 140.15 36.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.348 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.835 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.75 168.93 24.75 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -177.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 255' ' ' LYS . 43.9 tt0 -73.38 96.64 2.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.648 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.927 HG12 HG13 ' A' ' 186' ' ' VAL . 1.6 mt -85.73 81.97 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -90.91 121.39 32.71 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.55 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 256' ' ' VAL . 2.0 p -36.11 100.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.286 1.517 . . . . 0.0 111.214 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.13 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.414 -2.233 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.89 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.675 HG12 ' HB ' ' A' ' 236' ' ' VAL . 21.9 t . . . . . 0 CA--C 1.499 -0.994 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 236' ' ' VAL . 24.1 mttt -150.41 -35.16 0.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.137 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.58 -176.57 3.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.958 ' CD1' HD12 ' A' ' 239' ' ' ILE . 4.8 pt -161.08 114.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.057 0.932 . . . . 0.0 109.297 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.915 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.75 106.43 18.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.485 -177.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.966 HG13 HG12 ' A' ' 254' ' ' ILE . 2.8 t -92.17 111.71 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.642 0.777 . . . . 0.0 112.842 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.58 -176.84 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.46 162.86 0.0 OUTLIER Glycine 0 C--N 1.34 0.787 0 N-CA-C 115.019 0.767 . . . . 0.0 115.019 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 1.019 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -178.82 -143.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.303 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.696 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.8 m -89.21 131.32 41.09 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.425 ' C ' ' O ' ' A' ' 190' ' ' SER . 33.0 Cg_exo -27.36 -35.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.47 2.78 . . . . 0.0 113.494 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -150.96 54.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.06 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . 1.019 ' OG1' HD22 ' A' ' 189' ' ' LEU . 51.9 m -40.23 125.67 1.72 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 110.413 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PRO . . . . . 0.605 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -47.13 101.62 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.399 2.733 . . . . 0.0 113.905 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.38 -20.41 0.22 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.972 178.358 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 10.6 mm-40 -66.34 -39.99 89.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.605 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 2.5 mttp -76.27 -50.53 14.14 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 1.164 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -45.72 -28.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.692 176.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.5 mtp180 -77.13 -29.84 54.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.358 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.7 pt-20 -86.99 -54.12 4.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.696 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -50.7 -37.8 43.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 110.663 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.98 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -100.44 -34.46 9.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.498 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.2 -44.69 96.71 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.0 -23.98 66.45 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.829 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.01 -35.91 81.84 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 122.032 0.92 . . . . 0.0 108.599 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -142.43 7.83 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.971 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -91.0 94.8 9.8 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.688 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -58.64 144.59 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLU . . . . . 0.57 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 3.9 tp10 -89.86 -50.91 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.1 p -172.04 156.61 4.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.443 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.721 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -119.95 167.52 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.002 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -165.02 123.71 1.72 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.684 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.771 HD12 HD21 ' A' ' 189' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 121.287 0.565 . . . . 0.0 111.952 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.586 ' O ' ' C ' ' A' ' 224' ' ' GLY . 3.2 mtp85 . . . . . 0 CA--C 1.502 -0.896 0 CA-C-O 120.212 0.053 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 10.42 78.93 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 O-C-N 124.588 1.18 . . . . 0.0 111.624 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PHE . . . . . 0.654 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -138.71 -121.38 0.13 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 226' ' ' CYS . . . . . 0.666 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.32 163.11 20.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.973 0.892 . . . . 0.0 112.594 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 1.035 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.4 m-85 -147.83 124.54 11.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.864 -1.517 . . . . 0.0 108.97 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 1.164 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -121.33 150.93 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 CA-C-O 121.555 0.693 . . . . 0.0 109.944 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.751 HG23 ' HG3' ' A' ' 183' ' ' LYS . 2.9 m -129.85 152.41 49.36 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.212 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 87.3 m-85 -130.32 117.26 19.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.57 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.72 -37.31 0.73 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLU . . . . . 0.515 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.59 -155.93 0.35 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.494 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.605 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.2 pt-20 -143.12 4.17 1.42 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.51 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.9 OUTLIER -84.53 -58.51 0.36 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.432 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PRO . . . . . 0.829 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.6 Cg_exo -49.77 -34.68 36.67 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.843 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.28 -51.11 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.801 178.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 6.3 mtpt -45.86 -60.13 2.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.933 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.692 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.99 -52.75 64.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.69 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.958 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -34.72 -66.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.259 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.2 mtp -48.83 -25.56 1.94 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.563 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -69.35 -38.35 78.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.36 21.14 15.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 177.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.594 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.51 -49.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.669 1.231 . . . . 0.0 111.878 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.7 m-85 -85.2 71.85 10.82 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.504 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' HIS . . . . . 0.896 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.6 m-70 -72.62 153.04 41.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.226 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.51 76.38 1.0 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -69.14 101.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.149 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.74 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.45 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.671 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -101.89 -41.84 6.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.126 0.489 . . . . 0.0 110.892 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 247' ' ' VAL . 21.0 m -88.41 146.82 25.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.514 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.38 139.82 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.75 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 252' ' ' CYS . . . . . 0.947 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 166.06 32.83 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 255' ' ' LYS . 48.4 tt0 -71.95 93.58 1.37 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.227 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ILE . . . . . 0.966 HG12 HG13 ' A' ' 186' ' ' VAL . 1.5 mt -79.78 80.86 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.133 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -87.89 122.58 31.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.183 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.0 p -33.82 122.32 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 122.244 1.021 . . . . 0.0 109.912 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 1.035 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.429 -1.517 0 CA-C-N 113.204 -1.817 . . . . 0.0 113.494 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.738 HG12 ' HB ' ' A' ' 236' ' ' VAL . 30.2 t . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.5 mttt -150.14 -35.11 0.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.591 -1.244 . . . . 0.0 112.462 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -102.55 -167.46 1.4 Allowed 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.064 HD13 HD12 ' A' ' 239' ' ' ILE . 17.3 pt -165.11 139.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.261 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.763 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -109.32 96.75 6.5 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.382 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.902 HG13 HG12 ' A' ' 254' ' ' ILE . 2.0 t -79.39 122.09 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -67.32 -170.34 4.61 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.924 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.564 ' H ' " H1'" ' B' ' 2' ' ' ' DT' . . . -26.14 158.03 0.0 OUTLIER Glycine 0 N--CA 1.466 0.675 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.966 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -177.24 -143.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.681 ' N ' HD13 ' A' ' 189' ' ' LEU . 10.7 t -89.69 134.52 32.12 Favored Pre-proline 0 C--N 1.344 0.33 0 CA-C-O 121.13 0.49 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 190' ' ' SER . 80.8 Cg_exo -28.65 -35.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.432 2.755 . . . . 0.0 113.22 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 190' ' ' SER . 34.7 p30 -151.36 56.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.158 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.966 ' OG1' HD22 ' A' ' 189' ' ' LEU . 6.1 m -39.4 123.23 1.39 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.567 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 6.6 Cg_endo -48.79 99.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.661 2.24 . . . . 0.0 112.23 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.45 -19.59 0.18 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.442 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 26.0 mt-10 -64.29 -39.0 93.03 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.567 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -77.56 -46.77 21.24 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.128 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.99 -29.79 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.832 176.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.637 ' HG2' HD11 ' A' ' 211' ' ' ILE . 4.7 mtt180 -75.83 -28.57 58.32 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.86 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -86.12 -63.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.792 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.681 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -39.75 -39.16 0.74 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.556 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.076 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -99.64 -34.16 10.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.452 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.42 -45.59 96.09 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.28 -23.29 68.08 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.82 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.0 -33.69 76.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 122.053 0.93 . . . . 0.0 108.651 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.24 -139.72 6.29 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.01 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.5 mm-40 -91.57 94.24 9.33 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.097 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.54 142.6 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 229' ' ' THR . 11.3 tt0 -89.6 -52.45 5.0 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.1 p -169.82 152.92 4.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.35 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.717 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.72 167.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.491 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -167.2 130.15 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.478 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.063 HD21 HD12 ' A' ' 198' ' ' ILE . 2.3 mm? -118.43 104.5 47.67 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.658 ' HG2' ' CD2' ' A' ' 225' ' ' PHE . 72.6 Cg_exo -48.95 -158.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.508 2.805 . . . . 0.0 113.778 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.49 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER 158.61 125.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.285 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 8.3 p-10 -62.73 71.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.54 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 215' ' ' MET . 0.2 OUTLIER -130.6 -13.42 3.77 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.805 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.16 -22.06 12.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.932 0.396 . . . . 0.0 111.355 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -136.0 -16.13 1.71 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.05 -178.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.4 m120 68.39 48.48 0.86 Allowed 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.585 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -119.35 -156.43 0.66 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.985 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.698 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -85.51 -38.71 18.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 122.421 -0.174 . . . . 0.0 110.578 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.698 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.7 OUTLIER 4.37 -106.36 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 124.305 1.003 . . . . 0.0 111.193 -178.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.72 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 32.21 76.1 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.679 ' CZ ' " H4'" ' B' ' 3' ' ' ' DA' . 8.1 p90 -135.4 -128.95 0.15 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.747 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.85 162.44 39.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.64 0.733 . . . . 0.0 111.326 178.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.118 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 2.8 m-85 -149.95 124.62 9.76 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.128 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.4 mt -122.94 153.06 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.972 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.6 m -130.03 152.87 49.01 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.016 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.5 m-85 -130.1 120.62 24.93 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.579 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -40.81 -37.53 0.79 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.8 mt-10 -90.85 -157.64 0.5 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.572 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -137.53 1.23 2.35 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.04 -60.46 0.49 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.82 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 63.9 Cg_exo -48.89 -33.83 26.77 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.764 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.73 -51.16 70.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.747 178.141 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -46.12 -57.41 4.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.081 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.683 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.19 -52.83 63.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.679 179.401 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.064 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.2 -64.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.133 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.508 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.0 OUTLIER -48.72 -26.73 2.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.894 0.378 . . . . 0.0 110.588 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.1 mm-40 -68.1 -40.07 82.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.56 13.94 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.345 178.004 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.543 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.72 -50.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.562 1.164 . . . . 0.0 111.998 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.6 m-85 -84.29 74.15 10.37 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.449 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.918 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.0 m-70 -74.81 152.24 38.99 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.388 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 74.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.371 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -66.05 103.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.23 -83.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.86 -41.23 5.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.175 0.512 . . . . 0.0 110.538 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 67.7 m -87.87 145.46 26.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.398 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.98 141.61 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.848 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.842 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.97 167.58 29.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.505 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 44.5 tt0 -73.11 95.09 2.01 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.511 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.902 HG12 HG13 ' A' ' 186' ' ' VAL . 2.6 mt -83.03 78.96 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.716 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.32 123.67 33.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 256' ' ' VAL . 1.9 p -37.41 99.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 123.331 1.538 . . . . 0.0 111.035 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.118 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -44.98 -171.57 0.0 OUTLIER 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.006 -2.361 . . . . 0.0 112.998 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.666 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 171.76 144.06 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.088 -1.869 . . . . 0.0 110.584 178.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.787 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.911 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.837 0 O4'-C1'-C2' 107.203 1.003 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.679 " H4'" ' CZ ' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 N19-C1'-C2' 112.961 -0.774 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.801 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.429 -0.71 0 C4'-C3'-C2' 101.353 -1.847 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.801 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.506 -1.066 0 C4'-C3'-C2' 104.275 1.075 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.67 HG12 ' HB ' ' A' ' 236' ' ' VAL . 36.7 t . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 236' ' ' VAL . 22.8 mttt -151.86 -34.83 0.13 Allowed 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.411 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -95.36 -175.11 3.39 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.255 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.037 HD13 HD12 ' A' ' 239' ' ' ILE . 8.2 pt -163.08 120.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.84 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -95.68 104.46 16.38 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.389 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.95 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.9 t -90.73 112.76 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.763 0.825 . . . . 0.0 112.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -48.44 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.632 0.613 . . . . 0.0 114.632 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.92 160.98 0.0 OUTLIER Glycine 0 C--N 1.341 0.846 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.039 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -173.33 -144.8 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.658 ' N ' HD13 ' A' ' 189' ' ' LEU . 70.1 m -88.88 135.59 31.76 Favored Pre-proline 0 C--N 1.342 0.261 0 CA-C-O 120.977 0.418 . . . . 0.0 110.623 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 190' ' ' SER . 56.6 Cg_exo -28.77 -37.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.325 2.684 . . . . 0.0 113.051 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 190' ' ' SER . 62.4 t0 -151.4 54.23 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.08 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.039 ' OG1' HD22 ' A' ' 189' ' ' LEU . 86.3 m -39.87 123.87 1.57 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.149 0.499 . . . . 0.0 110.75 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.607 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 10.1 Cg_endo -51.2 101.95 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.351 2.701 . . . . 0.0 113.728 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.815 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.2 OUTLIER -45.74 -20.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.145 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.5 mt-10 -65.2 -41.96 94.02 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.728 ' HE2' HD21 ' A' ' 249' ' ' LEU . 2.2 mttp -75.34 -50.03 17.26 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.109 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -46.48 -26.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.975 176.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.561 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.4 mtp180 -80.12 -28.65 38.93 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.302 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.9 pt-20 -86.89 -47.56 8.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.597 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.685 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.4 t80 -56.46 -40.73 75.32 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 110.342 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.85 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -97.95 -33.9 11.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.43 -44.22 95.6 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.44 -23.2 68.31 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.811 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -66.4 -36.32 82.53 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.155 0.979 . . . . 0.0 108.88 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.9 -142.78 7.99 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.651 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 27.2 mt-10 -91.09 92.59 8.77 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.976 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.15 143.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.557 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.0 tp10 -89.64 -46.9 8.31 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 3.0 p -175.16 152.64 1.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.788 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -116.02 161.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.956 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.571 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.5 OUTLIER -159.02 125.64 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.922 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 189' ' ' LEU . 1.0 OUTLIER -108.86 94.02 13.63 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 121.473 0.654 . . . . 0.0 111.054 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.577 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 71.4 Cg_exo -47.81 -167.22 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.737 2.958 . . . . 0.0 113.333 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.578 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 154.67 120.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.087 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -35.43 85.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.777 -179.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 215' ' ' MET . 20.6 t-20 -139.92 -13.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -119.99 -12.74 9.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.74 0.305 . . . . 0.0 111.704 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -143.24 -13.19 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.611 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 219' ' ' THR . 25.7 m-20 66.33 44.45 2.45 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.587 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -117.9 -155.3 0.59 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.101 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.643 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -86.47 -40.04 15.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.75 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.643 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.7 OUTLIER 10.87 -93.4 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.907 0.754 . . . . 0.0 111.204 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 20.9 76.46 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 O-C-N 123.906 0.754 . . . . 0.0 112.032 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.651 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -144.27 -121.73 0.08 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -178.068 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.664 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -166.37 164.3 17.46 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.153 0.978 . . . . 0.0 113.251 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.041 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.8 m-85 -147.83 117.0 6.86 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.764 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.109 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -114.35 147.57 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.606 0.717 . . . . 0.0 110.354 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.691 HG23 ' HG2' ' A' ' 183' ' ' LYS . 1.2 m -120.21 172.36 7.84 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.43 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 95.4 m-85 -150.63 111.83 4.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -39.33 -37.13 0.41 Allowed 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 230' ' ' PHE . 21.8 mt-10 -89.09 -155.56 0.35 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.776 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.614 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.4 pt-20 -142.33 -0.93 1.22 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.953 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.13 -58.93 0.56 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.342 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.804 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 50.9 Cg_exo -48.09 -36.32 28.07 Favored 'Trans proline' 0 CA--C 1.491 -1.654 0 N-CA-C 108.845 -1.252 . . . . 0.0 108.845 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.823 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.14 -51.79 67.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.177 -1.829 . . . . 0.0 108.921 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -45.04 -59.45 2.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.126 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.675 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.28 -54.23 49.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.539 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.037 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.42 -64.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.142 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.509 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -48.04 -36.18 12.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 238' ' ' LYS . 12.1 mt-10 -60.52 -38.85 85.76 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -103.28 21.65 15.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.558 177.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.53 -50.08 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 O-C-N 124.493 1.12 . . . . 0.0 112.069 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.6 m-85 -83.44 74.91 10.04 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.969 ' CE1' HD13 ' A' ' 239' ' ' ILE . 8.1 m170 -76.65 159.35 30.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 7.4 m-80 -123.01 79.13 1.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.167 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.67 107.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 37.25 -88.18 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.611 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.728 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -95.52 -44.93 7.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 247' ' ' VAL . 5.4 m -88.9 148.09 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.24 140.39 30.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.372 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.95 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.25 166.81 30.5 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.514 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 51.7 tt0 -71.42 97.44 1.63 Allowed 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.411 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.902 HG12 HG13 ' A' ' 186' ' ' VAL . 2.4 mt -86.55 80.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.968 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.2 OUTLIER -89.18 122.63 32.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.4 p -34.52 116.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 122.434 1.112 . . . . 0.0 110.036 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.041 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -72.93 -177.63 2.47 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.518 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.558 ' HG3' ' N1 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -152.34 -151.25 0.37 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.703 -1.59 . . . . 0.0 111.16 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.85 -179.911 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.778 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.798 0 C3'-C2'-C1' 104.247 1.105 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.98 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.804 0 C3'-C2'-C1' 101.78 -0.657 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.98 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.518 -1.021 0 C4'-C3'-C2' 100.993 -2.207 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.553 ' C6 ' ' N7 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.955 0 O4'-C4'-C3' 106.136 0.536 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.681 HG12 ' HB ' ' A' ' 236' ' ' VAL . 37.6 t . . . . . 0 CA--C 1.497 -1.074 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.564 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.8 mttt -151.2 -34.9 0.14 Allowed 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.073 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.848 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.08 -172.47 3.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.188 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 239' ' ' ILE . 5.9 pt -166.45 111.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 122.12 0.962 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.879 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -87.16 107.74 18.6 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.593 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.982 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.9 t -94.42 109.55 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.461 0.704 . . . . 0.0 112.299 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.33 -176.77 0.01 OUTLIER Glycine 0 N--CA 1.476 1.366 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.68 160.36 0.0 OUTLIER Glycine 0 C--N 1.344 1.025 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.918 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -174.07 -142.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.676 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -89.04 132.1 39.0 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 110.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -31.96 -33.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.152 2.568 . . . . 0.0 113.01 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 190' ' ' SER . 16.5 t0 -150.99 53.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.623 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.918 ' OG1' HD22 ' A' ' 189' ' ' LEU . 52.2 m -40.21 121.68 1.63 Allowed Pre-proline 0 C--N 1.33 -0.246 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -52.01 94.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.634 2.223 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.598 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -41.91 -24.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.296 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 194' ' ' PRO . 36.2 mt-10 -61.22 -34.79 75.68 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.688 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -86.11 -35.05 20.45 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.126 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -62.08 -25.24 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.614 176.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.603 ' HA ' HD11 ' A' ' 211' ' ' ILE . 19.2 mtp180 -77.61 -25.73 50.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 197' ' ' LYS . 3.7 mt-10 -86.07 -60.01 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.928 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.705 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -43.3 -40.63 3.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.761 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.88 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -99.6 -30.66 12.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 -178.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -46.22 92.42 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.84 -22.8 66.8 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.838 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.66 -36.47 84.38 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.961 0.886 . . . . 0.0 108.726 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -138.26 5.21 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.7 mt-10 -91.95 89.99 7.23 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.813 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.497 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -56.33 142.96 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.581 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.2 tp10 -90.25 -49.05 6.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.453 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 5.8 p -172.75 156.75 3.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.543 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.63 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -122.78 153.81 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.237 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -154.41 133.04 12.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.073 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.927 HD21 HD12 ' A' ' 198' ' ' ILE . 4.4 mm? -112.11 99.37 45.88 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 121.229 0.537 . . . . 0.0 111.842 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.618 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 70.0 Cg_exo -50.51 -167.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.47 0.147 0 C-N-CA 123.628 2.885 . . . . 0.0 113.392 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.529 ' CG ' ' C ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 160.09 138.27 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.552 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 5.4 p-10 -63.53 82.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.601 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.47 2.96 1.47 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.498 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 4.7 mmtt -138.85 0.32 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.1 p -152.3 -26.91 0.17 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 219' ' ' THR . 4.5 m120 76.86 50.82 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.558 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.41 177.49 7.31 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.582 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -65.42 -36.85 85.17 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.001 -178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.582 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.1 OUTLIER 13.93 -85.23 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 124.255 0.972 . . . . 0.0 110.47 -177.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 11.79 80.52 0.01 OUTLIER Glycine 0 C--N 1.336 0.546 0 O-C-N 123.982 0.801 . . . . 0.0 112.416 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.68 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -145.87 -119.98 0.07 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.707 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.47 169.15 14.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.247 1.022 . . . . 0.0 112.798 178.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.046 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.5 m-85 -152.17 111.92 3.98 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.908 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.126 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -110.79 161.58 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.3 m -138.14 168.98 18.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.165 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.5 m-85 -146.74 115.61 6.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.581 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.2 OUTLIER -39.64 -35.3 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.531 ' O ' ' O ' ' A' ' 230' ' ' PHE . 7.9 mm-40 -88.89 -156.74 0.4 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.998 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.591 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.5 pm0 -144.16 12.77 1.6 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.615 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.664 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -92.29 -63.29 0.17 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.838 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 95.2 Cg_exo -48.47 -32.26 20.13 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.808 HG13 HG23 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.97 -53.43 34.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.372 -1.74 . . . . 0.0 110.209 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.4 OUTLIER -51.6 -46.58 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.609 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.655 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -64.89 -54.29 33.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.69 0.757 . . . . 0.0 109.933 177.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.972 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -30.84 -64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.531 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.479 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -46.19 -31.96 2.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 238' ' ' LYS . 30.4 mm-40 -62.71 -45.04 94.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -94.01 19.77 8.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.14 177.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.97 -50.31 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.625 1.203 . . . . 0.0 111.928 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.1 m-85 -84.84 71.29 10.89 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.621 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.3 m-70 -72.99 153.03 41.09 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.75 82.34 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.688 HG12 ' CE ' ' A' ' 197' ' ' LYS . 1.3 t -75.01 97.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.749 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.06 -80.91 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.752 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.82 -43.45 4.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.44 148.32 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.625 0.726 . . . . 0.0 112.344 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -145.54 140.69 27.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.8 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.982 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.23 169.44 24.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 76.4 tt0 -75.35 91.58 2.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.58 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.982 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -77.99 80.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.534 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.62 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.4 mtpt -91.67 120.09 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -30.55 120.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-O 122.29 1.043 . . . . 0.0 110.367 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.046 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.92 172.3 13.68 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 113.19 -1.823 . . . . 0.0 112.342 -176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.483 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -139.0 -166.22 1.98 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.804 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.843 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.583 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C3'--C2' 1.51 -0.838 0 C4'-C3'-C2' 101.814 -1.386 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.612 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 C3'-C2'-C1' 101.832 -0.62 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.771 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.881 0 C4'-C3'-C2' 101.198 -2.002 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.601 ' C8 ' " H2'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.51 -0.789 0 C1'-O4'-C4' 110.415 0.511 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.742 HG12 ' HB ' ' A' ' 236' ' ' VAL . 23.1 t . . . . . 0 CA--C 1.499 -1.004 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.7 mttt -150.21 -36.46 0.15 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.064 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.17 -171.54 2.57 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.967 HD13 HD12 ' A' ' 239' ' ' ILE . 10.2 pt -164.62 121.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.808 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -96.02 109.51 21.9 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.357 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.929 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.5 t -97.71 112.71 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.708 0.803 . . . . 0.0 113.103 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.41 -178.38 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -31.53 161.41 0.0 OUTLIER Glycine 0 C--N 1.342 0.861 0 N-CA-C 114.607 0.603 . . . . 0.0 114.607 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.029 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -174.67 -144.67 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.556 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 189' ' ' LEU . 49.2 m -89.44 133.32 34.92 Favored Pre-proline 0 C--N 1.338 0.069 0 CA-C-O 121.018 0.437 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 84.7 Cg_exo -28.18 -36.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.5 2.8 . . . . 0.0 113.116 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.0 t70 -150.85 56.45 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.029 ' OG1' HD22 ' A' ' 189' ' ' LEU . 21.7 m -38.8 132.57 1.09 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.067 0.461 . . . . 0.0 110.308 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.522 ' O ' HG13 ' A' ' 198' ' ' ILE . 14.7 Cg_endo -56.42 92.29 0.05 OUTLIER 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 123.025 2.483 . . . . 0.0 112.381 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.573 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.31 -24.53 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 8.7 mm-40 -62.94 -36.65 84.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.917 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 200' ' ' GLU . 22.7 mmmt -78.12 -49.23 14.3 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.168 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.4 -28.81 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.471 176.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.558 ' HG2' HD11 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -77.1 -28.61 54.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.737 178.076 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.2 mm-40 -85.61 -63.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.668 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.702 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.1 t80 -40.17 -39.33 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.984 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -100.34 -33.3 10.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.48 -178.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.89 -45.99 95.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.47 -23.12 66.43 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.826 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.6 -34.18 77.64 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.014 0.911 . . . . 0.0 108.818 178.239 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.35 -141.04 7.02 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.045 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 77.3 mm-40 -91.82 91.54 7.98 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.757 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -55.6 142.24 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.586 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.5 tp10 -88.96 -48.64 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 26.7 m -175.96 150.02 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.344 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.67 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.34 167.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.556 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -166.34 125.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.809 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.966 HD21 HD12 ' A' ' 198' ' ' ILE . 4.4 mm? -107.67 101.57 40.66 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.645 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 49.2 Cg_exo -46.0 -164.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.863 3.042 . . . . 0.0 113.2 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.3 OUTLIER 158.78 129.68 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.007 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 31.3 p-10 -61.82 72.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.249 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 215' ' ' MET . 1.5 t-20 -131.83 -10.57 3.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.746 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.478 ' HD2' " H4'" ' B' ' 5' ' ' ' DG' . 2.6 mmpt? -121.45 -0.12 9.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.774 0.321 . . . . 0.0 111.424 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.614 HG23 ' NH2' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -151.49 -25.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 219' ' ' THR . 18.0 m-20 72.41 44.52 0.41 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.621 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -117.96 -155.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.475 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.653 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -86.87 -39.22 16.02 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.653 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 8.01 -96.47 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 124.352 1.032 . . . . 0.0 111.401 -178.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 23.87 75.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 O-C-N 123.673 0.608 . . . . 0.0 111.807 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.664 ' CE1' " C5'" ' B' ' 3' ' ' ' DA' . 0.2 OUTLIER -138.38 -120.2 0.14 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.679 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.72 169.87 13.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.449 1.119 . . . . 0.0 113.02 178.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.027 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.6 m-85 -151.79 125.21 8.84 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.614 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.168 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -122.3 156.57 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.539 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.1 m -134.33 160.31 38.33 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.947 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.2 m-85 -137.86 115.76 11.54 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.586 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -38.51 -36.59 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.301 1.048 . . . . 0.0 108.265 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.1 mt-10 -88.82 -153.88 0.27 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.647 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.1 pt-20 -144.54 4.46 1.18 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.355 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -84.84 -58.19 0.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.826 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 88.6 Cg_exo -50.4 -33.53 37.94 Favored 'Trans proline' 0 CA--C 1.492 -1.605 0 N-CA-C 108.763 -1.283 . . . . 0.0 108.763 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -64.94 -51.91 60.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.618 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.9 mttt -45.71 -57.4 4.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.031 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.685 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.94 -52.49 65.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.605 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.967 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.72 -63.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.237 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.563 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -50.83 -19.16 0.9 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -77.55 -37.22 51.24 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.92 13.36 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.582 178.154 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.605 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -15.43 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.517 1.135 . . . . 0.0 112.433 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.1 m-85 -86.0 72.46 10.45 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.366 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.52 141.64 46.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.262 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.3 OUTLIER -105.26 75.5 1.17 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.354 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -67.05 138.36 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.139 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 15.22 -77.62 0.0 OUTLIER Glycine 0 C--N 1.342 0.895 0 O-C-N 123.932 0.77 . . . . 0.0 113.729 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.07 -40.54 3.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.312 0.577 . . . . 0.0 110.529 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.75 152.92 21.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.886 -178.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.07 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.942 179.174 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.929 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 156.47 29.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.995 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 41.6 tt0 -60.88 120.27 9.84 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.927 HG12 HG13 ' A' ' 186' ' ' VAL . 2.2 mt -104.52 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.746 0.784 . . . . 0.0 112.428 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.591 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.06 119.47 28.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.465 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.7 p -33.62 122.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.149 0.976 . . . . 0.0 110.055 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.027 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.55 176.09 9.25 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.405 -1.725 . . . . 0.0 113.049 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -151.15 -148.63 0.27 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.63 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 C3'-C2'-C1' 100.528 -1.552 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.945 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.929 0 C4'-C3'-C2' 104.891 1.691 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.945 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.837 0 C4'-C3'-C2' 100.725 -2.475 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.717 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.858 0 O4'-C4'-C3' 106.276 0.676 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' A' ' 236' ' ' VAL . 20.5 t . . . . . 0 CA--C 1.499 -0.981 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 21.1 mttt -150.04 -34.58 0.17 Allowed 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.149 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -89.78 -171.4 3.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.056 HD13 HD12 ' A' ' 239' ' ' ILE . 6.1 pt -168.75 110.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.941 0.877 . . . . 0.0 108.92 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.871 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -83.08 101.76 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.733 -177.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.966 HG13 HG12 ' A' ' 254' ' ' ILE . 2.5 t -87.68 111.22 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.32 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.617 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -101.39 120.5 6.89 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.675 ' HA3' ' H72' ' B' ' 2' ' ' ' DT' . . . 97.04 109.92 2.7 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.97 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -165.56 -157.66 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.638 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.4 m -89.03 133.65 34.94 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.197 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -32.46 -29.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.43 2.754 . . . . 0.0 113.473 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 47.8 t0 -149.38 52.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.97 ' OG1' HD22 ' A' ' 189' ' ' LEU . 17.6 m -43.08 126.79 3.36 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.507 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -53.1 94.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.677 2.251 . . . . 0.0 112.068 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.603 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.9 OUTLIER -45.13 -20.67 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 8.0 mt-10 -64.96 -36.55 84.75 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.12 -47.65 17.75 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.153 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.25 -28.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.847 176.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.609 ' HA ' HD11 ' A' ' 211' ' ' ILE . 11.3 mtp180 -76.41 -28.86 56.84 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 mt-10 -85.27 -61.94 1.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.811 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.698 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -39.56 -42.65 1.18 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.882 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.0 OUTLIER -97.75 -31.49 12.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.728 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.21 -46.85 93.09 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.41 -24.27 65.55 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.828 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.65 -34.21 77.74 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.11 -139.8 6.36 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.833 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.6 mt-10 -91.86 95.3 9.76 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.854 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -57.31 144.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.647 ' CD ' HG21 ' A' ' 229' ' ' THR . 10.5 tt0 -90.6 -50.58 5.85 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 73.1 m -172.42 147.18 1.88 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.914 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.623 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.31 162.08 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.629 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -157.79 123.86 4.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 0.0 111.596 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.021 HD21 HD12 ' A' ' 198' ' ' ILE . 2.0 mm? -108.8 92.93 11.26 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 121.372 0.606 . . . . 0.0 111.028 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.639 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 72.0 Cg_exo -43.81 -165.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 124.577 3.518 . . . . 0.0 114.182 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.542 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 155.94 119.94 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.052 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 18.1 p-10 -44.8 83.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.887 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 215' ' ' MET . 1.9 m-20 -144.16 4.06 1.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.953 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.401 ' CG ' HH12 ' A' ' 223' ' ' ARG . 17.4 mmmt -132.79 -19.04 2.35 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -141.97 -9.31 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.0 m120 68.31 48.16 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.594 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -126.78 -177.52 4.05 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -69.5 -37.39 77.19 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.639 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.594 ' HG2' ' HG2' ' A' ' 221' ' ' LYS . 0.2 OUTLIER 15.81 -83.16 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 124.445 1.09 . . . . 0.0 109.994 -176.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.59 80.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 O-C-N 123.906 0.754 . . . . 0.0 112.505 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.643 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.02 -121.04 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.637 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -167.5 164.58 14.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.347 1.07 . . . . 0.0 113.074 178.219 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.024 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.9 m-85 -149.18 114.91 5.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.071 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.153 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.6 mt -112.98 161.58 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.344 0.592 . . . . 0.0 110.588 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.647 HG21 ' CD ' ' A' ' 209' ' ' GLU . 1.8 m -138.7 172.36 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.537 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 89.1 m-85 -145.23 119.8 9.75 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.597 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.38 -37.3 0.99 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.8 mt-10 -89.42 -155.59 0.36 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.57 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.6 pt-20 -143.02 5.27 1.5 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.495 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -86.9 -57.28 0.32 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.828 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 99.3 Cg_exo -49.74 -33.22 31.54 Favored 'Trans proline' 0 CA--C 1.493 -1.573 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.87 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.7 -51.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 112.988 -1.915 . . . . 0.0 109.065 178.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 12.4 mttt -46.3 -57.6 4.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.276 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.634 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.13 -54.74 42.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.673 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.056 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.95 -63.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.029 -179.016 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 9.9 mtp -45.73 -31.32 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 111.139 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.3 mm-40 -63.33 -43.09 98.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -96.56 19.96 11.47 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.268 178.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.18 -50.55 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.696 1.247 . . . . 0.0 111.716 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.9 m-85 -85.51 71.03 10.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.271 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.975 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.9 m-70 -70.49 146.41 50.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.029 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 4.6 m-80 -107.43 79.75 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -69.12 149.48 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.71 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 6.59 -72.08 0.0 OUTLIER Glycine 0 C--N 1.343 0.953 0 O-C-N 124.014 0.821 . . . . 0.0 113.682 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -119.64 -41.88 2.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.076 0.465 . . . . 0.0 110.454 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.57 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 2.0 m -88.89 148.54 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.689 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -131.76 147.62 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.054 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.909 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -160.34 161.85 33.32 Favored 'General case' 0 C--O 1.228 -0.042 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.238 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 185' ' ' PHE . 56.7 tt0 -69.86 93.12 0.73 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.609 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.966 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -83.92 82.73 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.591 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.7 mtpt -98.4 118.91 36.12 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.8 p -28.72 110.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-O 122.612 1.196 . . . . 0.0 110.594 -177.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.024 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -67.65 179.16 1.43 Allowed 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 112.634 -2.076 . . . . 0.0 112.758 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.559 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 4.1 mtm -150.02 -151.75 0.41 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.693 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.963 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.896 0 O4'-C1'-C2' 106.957 0.779 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.775 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C1'-O4'-C4' 110.378 0.484 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.775 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C4'-C3'-C2' 101.002 -2.198 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.583 " H5'" " H1'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.921 0 C3'-C2'-C1' 102.164 -0.383 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.619 HG12 ' HB ' ' A' ' 236' ' ' VAL . 29.9 t . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 22.0 mttt -152.19 -35.66 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.575 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.867 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -94.91 -177.94 4.34 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.37 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.945 HD13 HD12 ' A' ' 239' ' ' ILE . 4.6 pt -161.82 111.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 122.245 1.022 . . . . 0.0 109.57 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.906 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -85.41 101.79 12.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.551 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.99 HG13 HG12 ' A' ' 254' ' ' ILE . 2.6 t -87.27 106.21 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.246 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.641 ' HA3' ' C2 ' ' B' ' 2' ' ' ' DT' . . . -97.43 122.1 7.33 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.45 106.66 2.73 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.676 0.631 . . . . 0.0 114.676 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.973 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.08 -157.16 0.2 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.65 ' N ' HD13 ' A' ' 189' ' ' LEU . 71.0 m -88.6 134.38 34.22 Favored Pre-proline 0 C--N 1.345 0.372 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.187 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -29.29 -32.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.789 2.993 . . . . 0.0 113.919 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.72 54.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.482 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.973 ' OG1' HD22 ' A' ' 189' ' ' LEU . 14.3 m -40.17 123.74 1.68 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.927 0.394 . . . . 0.0 110.537 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 8.2 Cg_endo -50.32 92.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.745 2.297 . . . . 0.0 112.077 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.59 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -42.16 -23.67 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 194' ' ' PRO . 10.0 mt-10 -63.87 -33.5 75.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.573 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -85.76 -34.45 21.17 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.109 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -62.33 -20.87 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.863 176.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.544 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.7 mtt180 -85.39 -25.03 27.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.293 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -88.99 -31.2 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.878 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.697 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -72.99 -38.7 66.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.882 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.0 OUTLIER -100.43 -30.99 11.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.449 -178.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.92 -46.26 92.01 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.63 64.51 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.835 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.22 -34.68 78.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.968 0.89 . . . . 0.0 108.916 178.218 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.26 -139.99 6.37 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.063 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.6 mt-10 -91.43 90.47 7.69 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.993 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.492 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -55.36 143.59 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.694 ' CD ' HG21 ' A' ' 229' ' ' THR . 9.7 tt0 -89.71 -50.33 6.12 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 50.3 m -172.03 147.25 2.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.293 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.595 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.34 159.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.466 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.3 OUTLIER -155.5 124.67 6.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.34 . . . . 0.0 111.372 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.773 HD21 HD12 ' A' ' 198' ' ' ILE . 1.4 mm? -105.4 93.96 7.65 Favored Pre-proline 0 N--CA 1.454 -0.238 0 CA-C-O 121.414 0.626 . . . . 0.0 111.066 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.644 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 50.4 Cg_exo -43.05 -169.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 124.348 3.365 . . . . 0.0 113.864 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.509 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 158.02 121.72 0.0 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.039 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 17.3 p-10 -51.99 85.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 215' ' ' MET . 0.1 OUTLIER -145.19 9.33 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.654 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.561 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 22.3 mmtt -136.78 -27.42 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -132.99 -14.68 2.68 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 219' ' ' THR . 4.1 m120 71.85 53.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.577 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -128.2 -171.0 2.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.574 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -76.59 -37.42 56.49 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.792 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 221' ' ' LYS . 0.2 OUTLIER 17.65 -85.46 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 124.369 1.043 . . . . 0.0 109.992 -177.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.06 79.64 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 O-C-N 123.994 0.809 . . . . 0.0 112.857 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.664 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.78 -121.16 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.601 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -167.23 162.19 14.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.987 0.899 . . . . 0.0 112.587 177.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.027 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 2.9 m-85 -144.34 113.84 7.09 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.709 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.109 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -111.47 159.13 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-O 121.498 0.666 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.719 HG23 ' HG3' ' A' ' 183' ' ' LYS . 1.5 m -135.04 178.05 7.33 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.338 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 92.0 m-85 -152.56 117.22 5.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.607 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.93 -37.54 1.34 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -89.49 -155.84 0.37 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.606 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -141.43 1.86 1.6 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.716 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -81.62 -58.42 0.48 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.835 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 84.9 Cg_exo -48.91 -35.34 31.27 Favored 'Trans proline' 0 CA--C 1.494 -1.501 0 N-CA-C 109.035 -1.179 . . . . 0.0 109.035 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.879 HG13 HG23 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.66 -51.74 66.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.774 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -44.94 -55.35 5.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.482 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.633 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.0 -54.19 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.107 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.965 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -29.95 -62.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.06 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -49.24 -27.13 3.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.889 0.376 . . . . 0.0 111.255 -179.115 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 238' ' ' LYS . 11.5 mm-40 -68.59 -34.98 76.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.09 20.57 18.75 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.458 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.77 -49.54 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.516 1.135 . . . . 0.0 112.009 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.0 m-85 -85.0 72.83 10.78 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.488 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.965 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -73.04 150.34 42.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.248 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.94 80.94 1.36 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.573 HG12 ' CE ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -75.84 103.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.658 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.456 ' C ' HD23 ' A' ' 249' ' ' LEU . . . 47.64 -85.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.486 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -106.01 -44.94 4.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.976 0.417 . . . . 0.0 110.907 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.21 147.21 24.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.765 0.793 . . . . 0.0 112.372 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.02 145.65 46.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.058 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.93 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.9 163.24 36.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.568 -1.253 . . . . 0.0 114.204 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.493 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.2 tt0 -71.55 91.34 1.06 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.471 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.99 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -80.76 80.19 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.512 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.646 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.3 OUTLIER -93.13 120.46 33.45 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.4 p -30.54 116.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.941 1.246 . . . . 0.0 109.972 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.027 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.16 -173.06 3.04 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 112.971 -1.922 . . . . 0.0 113.369 -175.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.53 ' N ' ' HE3' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 170.03 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.198 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.823 179.708 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.719 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.767 0 O4'-C4'-C3' 104.082 -1.518 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.99 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 C3'-C2'-C1' 101.936 -0.546 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.99 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.801 0 C4'-C3'-C2' 101.164 -2.036 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.57 ' P ' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 C2'--C1' 1.509 -0.827 0 O4'-C4'-C3' 106.19 0.59 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.703 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.2 t . . . . . 0 CA--C 1.497 -1.092 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 236' ' ' VAL . 26.3 mttt -151.26 -36.38 0.13 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.727 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.882 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -93.57 -176.8 4.2 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.988 ' CD1' HD12 ' A' ' 239' ' ' ILE . 4.5 pt -161.34 114.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 122.15 0.976 . . . . 0.0 109.118 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.883 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.12 110.54 21.81 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.098 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.929 HG12 ' SG ' ' A' ' 252' ' ' CYS . 3.0 t -100.15 108.72 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.37 -179.87 0.01 OUTLIER Glycine 0 CA--C 1.531 1.065 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.42 161.59 0.0 OUTLIER Glycine 0 C--N 1.344 0.988 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.987 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -173.93 -143.67 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.703 ' N ' HD13 ' A' ' 189' ' ' LEU . 33.1 m -89.18 132.93 36.22 Favored Pre-proline 0 C--N 1.34 0.165 0 CA-C-O 121.037 0.446 . . . . 0.0 110.88 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 72.1 Cg_exo -27.8 -36.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.588 2.859 . . . . 0.0 113.301 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.59 54.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.576 0.226 . . . . 0.0 111.084 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.987 ' OG1' HD22 ' A' ' 189' ' ' LEU . 8.1 m -39.68 120.7 1.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.394 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.59 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -50.35 99.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.717 2.278 . . . . 0.0 112.275 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.6 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -45.88 -21.72 0.15 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.379 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 34.5 mt-10 -60.76 -37.87 83.31 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.59 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.2 mttp -79.73 -46.86 16.27 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.157 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.98 -26.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.897 177.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.558 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 5.3 mtt180 -80.56 -27.1 37.6 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.836 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.4 mt-10 -85.36 -59.85 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.716 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -44.89 -41.56 7.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.58 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.06 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -97.29 -35.08 10.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.997 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.51 -47.04 92.3 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.01 -22.79 65.2 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.83 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.53 -37.86 87.97 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.044 0.926 . . . . 0.0 108.837 178.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.93 -142.0 7.3 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.7 mm-40 -91.66 92.64 8.54 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.874 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.412 HG21 ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.35 143.54 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.555 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.6 tp10 -89.45 -51.02 5.76 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.0 p -170.34 155.48 5.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.1 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.729 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -120.34 159.48 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.121 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.77 132.75 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.089 HD21 HD12 ' A' ' 198' ' ' ILE . 1.6 mm? -115.7 98.24 50.51 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 121.428 0.632 . . . . 0.0 111.001 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.647 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 71.4 Cg_exo -49.14 -161.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.472 0.213 0 C-N-CA 123.86 3.04 . . . . 0.0 113.399 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.546 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 153.95 131.29 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.466 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 1.0 OUTLIER -58.43 75.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.453 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 215' ' ' MET . 26.9 t30 -145.4 4.64 1.05 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.507 ' C ' ' CG2' ' A' ' 219' ' ' THR . 6.9 mmmt -142.5 3.96 1.53 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.666 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 8.3 p -151.73 -37.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.099 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 219' ' ' THR . 77.6 m-20 91.32 57.77 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.524 ' CD ' ' OG1' ' A' ' 219' ' ' THR . 0.0 OUTLIER -143.91 -164.42 1.88 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 119.779 -0.769 . . . . 0.0 111.579 178.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.613 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -83.16 -38.19 22.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.613 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 7.41 -87.39 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 124.235 0.959 . . . . 0.0 111.25 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 17.28 75.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.77 0 O-C-N 124.015 0.822 . . . . 0.0 111.362 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.655 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.54 -119.64 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.611 -0.795 . . . . 0.0 108.923 -176.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -166.4 163.58 17.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.905 0.859 . . . . 0.0 112.487 178.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.03 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -148.54 118.09 6.99 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.963 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.157 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.5 mt -113.23 152.85 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.792 HG23 ' HG3' ' A' ' 183' ' ' LYS . 2.6 m -131.04 152.97 49.77 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.072 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 87.8 m-85 -131.95 116.77 17.57 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.44 -37.75 0.73 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.2 mm-40 -89.21 -158.24 0.49 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.788 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.613 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 16.5 pt-20 -141.09 11.6 2.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.856 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.5 OUTLIER -89.84 -62.75 0.21 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.83 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 66.9 Cg_exo -47.55 -34.08 19.32 Favored 'Trans proline' 0 CA--C 1.494 -1.498 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.821 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.92 -52.69 50.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.611 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 8.0 pttt -52.8 -49.64 65.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.422 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.666 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -61.45 -53.55 55.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.988 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.13 -64.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.333 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.506 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 2.3 mtp -49.23 -22.15 0.96 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.137 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 4.0 mm-40 -73.57 -36.9 65.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.619 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.16 20.88 15.88 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.312 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.61 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.96 -48.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.634 1.209 . . . . 0.0 112.416 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.3 m-85 -86.55 73.91 9.99 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.466 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.931 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.1 m-70 -77.0 147.34 36.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.156 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.48 81.35 1.43 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.987 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.41 96.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.8 -78.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.61 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.81 -43.48 3.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 0.0 110.922 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.32 148.53 24.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.512 0.672 . . . . 0.0 112.209 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.76 145.71 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.929 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -161.6 155.02 21.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.751 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.552 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 47.6 tt0 -59.75 120.47 9.59 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.933 HG21 HD12 ' A' ' 184' ' ' ILE . 2.3 mt -105.06 84.6 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.749 0.785 . . . . 0.0 112.214 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.68 120.45 30.08 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 114.234 -1.348 . . . . 0.0 107.893 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.9 p -35.21 120.39 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 119.457 1.026 . . . . 0.0 109.696 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.03 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.94 -178.44 5.5 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.14 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.542 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.1 OUTLIER 173.84 -90.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.245 -1.798 . . . . 0.0 110.449 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.3 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 179.775 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.619 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 C4'-C3'-C2' 102.247 -0.953 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.991 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 O4'-C4'-C3' 106.188 0.588 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.991 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.783 0 C4'-C3'-C2' 101.195 -2.005 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.513 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.822 0 C3'-C2'-C1' 102.121 -0.413 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.632 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.1 t . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' HA ' HG21 ' A' ' 236' ' ' VAL . 25.9 mttt -151.63 -35.35 0.13 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.148 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.852 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.13 -171.79 2.78 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 239' ' ' ILE . 6.0 pt -166.46 110.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 122.197 0.998 . . . . 0.0 109.318 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.893 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -84.71 104.14 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.643 -178.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.961 HG13 HG12 ' A' ' 254' ' ' ILE . 3.8 t -89.82 114.46 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.716 0.806 . . . . 0.0 112.735 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -46.21 -177.21 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.936 0.735 . . . . 0.0 114.936 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -33.32 163.5 0.01 OUTLIER Glycine 0 C--N 1.341 0.832 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.95 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -177.7 -146.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.665 ' N ' HD13 ' A' ' 189' ' ' LEU . 39.7 m -89.03 133.13 35.98 Favored Pre-proline 0 C--N 1.34 0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 111.105 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.72 -33.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.498 2.799 . . . . 0.0 113.181 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.2 m-20 -151.45 55.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.53 0.205 . . . . 0.0 111.461 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.95 ' OG1' HD22 ' A' ' 189' ' ' LEU . 24.3 m -39.19 123.21 1.31 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.484 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.519 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.2 Cg_endo -49.51 88.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 0.0 111.682 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -39.74 -25.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 194' ' ' PRO . 49.7 mt-10 -61.32 -33.42 73.56 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.606 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.21 -31.28 19.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.09 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -66.22 -21.95 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.621 176.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.608 ' HG2' HD11 ' A' ' 211' ' ' ILE . 13.9 mtp180 -82.44 -25.24 33.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.365 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 197' ' ' LYS . 4.3 pt-20 -88.91 -37.77 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.842 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.691 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -65.36 -37.69 87.8 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.121 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.895 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -100.69 -30.72 11.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.18 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.97 -44.93 93.81 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.61 -23.53 67.06 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.809 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.36 -35.89 82.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 122.182 0.991 . . . . 0.0 108.849 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 162.77 -138.93 5.61 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.981 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.9 mm-40 -91.46 92.09 8.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.643 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.522 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -58.07 142.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.568 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.61 -47.74 7.49 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.3 m -175.41 150.14 1.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.809 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -113.23 158.62 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.833 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.43 ' HG2' ' C ' ' A' ' 211' ' ' ILE . 0.8 OUTLIER -156.14 129.22 8.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 111.289 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.823 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.4 mm? -111.7 99.07 43.63 Favored Pre-proline 0 CA--C 1.529 0.162 0 CA-C-O 121.09 0.471 . . . . 0.0 111.428 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.68 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 83.6 Cg_exo -43.07 -165.39 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 124.461 3.441 . . . . 0.0 114.25 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 156.93 117.09 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.409 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 36.8 p-10 -51.73 81.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.052 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 215' ' ' MET . 9.8 t-20 -139.4 3.75 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.207 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.576 ' HG3' " C4'" ' B' ' 5' ' ' ' DG' . 7.1 mmmt -136.36 1.59 2.66 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.2 OUTLIER -151.95 -20.13 0.18 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 219' ' ' THR . 34.7 m-20 74.74 42.77 0.27 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.624 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -119.65 -152.66 0.51 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.056 178.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.555 ' O ' ' C ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -105.8 -27.04 11.5 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.624 ' HG2' ' CD ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER 12.48 -82.17 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 124.639 1.212 . . . . 0.0 109.949 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 20.76 79.96 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.05 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.68 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -142.91 -118.76 0.1 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.671 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -167.69 169.24 11.95 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.209 1.004 . . . . 0.0 112.442 177.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.042 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.3 m-85 -150.66 110.52 4.08 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.886 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.09 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -108.17 160.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.514 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.4 m -138.94 167.63 21.61 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.251 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 82.8 m-85 -144.05 119.82 10.54 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.36 -39.4 3.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.6 mt-10 -92.45 -176.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.894 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.632 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.9 pt-20 -119.05 3.83 11.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -79.86 -61.41 0.46 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.809 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 57.8 Cg_exo -47.59 -35.69 23.16 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 CA-C-N 120.422 1.186 . . . . 0.0 109.203 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.831 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -62.68 -50.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.017 178.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 11.2 mttt -46.78 -59.85 2.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.12 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.653 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -58.46 -51.97 67.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.629 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.972 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.62 -65.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.339 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -47.94 -28.12 2.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.574 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 238' ' ' LYS . 25.6 mm-40 -66.46 -42.15 88.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -98.88 21.64 11.28 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.258 177.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.46 -49.69 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 O-C-N 124.632 1.207 . . . . 0.0 111.846 -179.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.603 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.7 m-85 -85.12 72.57 10.76 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.653 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.93 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.7 m-70 -73.06 152.18 41.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.77 80.88 1.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.892 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.606 HG12 ' CE ' ' A' ' 197' ' ' LYS . 1.4 t -74.93 97.5 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.767 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.37 -83.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.568 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.31 -43.57 4.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.964 0.412 . . . . 0.0 110.687 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 1.2 m -88.33 145.34 25.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.695 0.759 . . . . 0.0 112.357 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -140.33 140.57 35.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.855 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.926 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.85 166.42 33.42 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 53.2 tt0 -72.68 93.54 1.65 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.774 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.961 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -81.47 82.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.604 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.573 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -93.8 120.29 33.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -31.01 118.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.373 1.082 . . . . 0.0 110.431 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.042 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.4 175.31 9.27 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.072 -1.876 . . . . 0.0 112.343 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -147.41 -151.41 0.38 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.736 -1.575 . . . . 0.0 111.144 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.797 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.973 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O4'--C4' 1.437 -0.788 0 C3'-C2'-C1' 104.872 1.551 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.989 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C4'-C3'-C2' 104.77 1.57 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.989 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C2'--C1' 1.533 0.89 0 C4'-C3'-C2' 100.62 -2.58 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.863 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -0.986 0 C4'-C3'-C2' 104.12 0.92 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.705 HG12 ' HB ' ' A' ' 236' ' ' VAL . 38.6 t . . . . . 0 CA--C 1.499 -0.995 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.595 ' HA ' HG21 ' A' ' 236' ' ' VAL . 20.7 mttt -152.56 -35.48 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.736 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.24 -174.61 3.42 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.946 ' CD1' HD12 ' A' ' 239' ' ' ILE . 6.5 pt -163.64 114.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.988 0.899 . . . . 0.0 108.878 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.846 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -89.38 110.07 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.864 -177.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.948 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.7 t -100.35 107.66 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.15 -179.56 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.06 160.3 0.0 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.041 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -172.15 -145.04 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.684 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -89.23 130.51 43.82 Favored Pre-proline 0 C--N 1.339 0.121 0 CA-C-O 120.898 0.38 . . . . 0.0 110.644 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -30.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.236 2.624 . . . . 0.0 112.979 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 190' ' ' SER . 15.1 t70 -150.43 52.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.266 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.041 ' OG1' HD22 ' A' ' 189' ' ' LEU . 55.1 m -42.9 124.51 3.15 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.271 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.9 Cg_endo -52.17 92.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.761 2.307 . . . . 0.0 112.286 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.65 ' OE1' HD23 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -39.75 -27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 199' ' ' ARG . 2.6 mp0 -61.49 -37.23 82.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 200' ' ' GLU . 20.4 mmmt -73.99 -50.03 21.73 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.168 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -51.72 -27.43 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 113.142 -1.844 . . . . 0.0 107.556 175.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.588 ' HD3' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -75.72 -30.92 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.813 178.146 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -85.59 -64.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.805 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.72 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -39.35 -39.06 0.61 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.407 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.044 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -99.92 -34.26 10.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.831 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.5 -46.08 94.53 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.63 -22.42 67.96 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.836 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.62 -37.57 86.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.962 0.887 . . . . 0.0 108.834 178.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.07 -142.85 7.86 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.997 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mm-40 -91.48 89.79 7.37 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.809 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.424 ' O ' ' HE2' ' A' ' 231' ' ' LYS . 1.8 t -53.19 141.88 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.568 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.4 -48.04 7.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 17.9 m -175.8 150.91 1.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.169 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -115.62 158.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.701 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.489 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -155.56 124.76 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.76 0.314 . . . . 0.0 111.018 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.971 HD21 HD12 ' A' ' 198' ' ' ILE . 1.7 mm? -108.16 94.79 13.8 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.443 0.64 . . . . 0.0 111.438 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.619 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 74.1 Cg_exo -46.71 -165.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 123.813 3.008 . . . . 0.0 113.795 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.539 ' HG2' ' OP1' ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER 156.46 130.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.721 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 220' ' ' ASN . 3.9 p30 -50.13 82.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 111.645 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 215' ' ' MET . 32.5 t30 -135.57 -5.91 2.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.735 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.439 ' C ' ' CG2' ' A' ' 219' ' ' THR . 17.7 mmmt -128.75 -3.89 5.26 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.4 OUTLIER -151.21 -20.43 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 219' ' ' THR . 4.0 m-80 71.35 45.94 0.45 Allowed 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.606 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -116.65 -154.42 0.55 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.562 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -89.17 -37.87 14.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.199 -0.313 . . . . 0.0 110.431 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.656 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.4 OUTLIER 6.87 -98.78 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 124.143 0.902 . . . . 0.0 111.536 -178.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.53 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 25.28 74.68 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.636 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.4 OUTLIER -138.49 -123.26 0.13 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -159.51 162.8 35.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.08 0.943 . . . . 0.0 112.692 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.018 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 2.9 m-85 -149.66 109.95 4.18 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 113.602 -1.636 . . . . 0.0 108.28 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.168 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -106.87 157.88 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.723 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 6.6 m -138.38 154.18 48.92 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.527 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.671 ' CD1' HG22 ' A' ' 236' ' ' VAL . 68.9 m-85 -132.37 120.55 22.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -42.13 -38.26 1.65 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 230' ' ' PHE . 31.3 mt-10 -89.32 -164.0 1.08 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.657 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 25.8 pt-20 -134.67 16.93 3.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.6 -63.06 0.17 Allowed Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.015 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.836 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 76.4 Cg_exo -48.03 -34.9 24.28 Favored 'Trans proline' 0 CA--C 1.494 -1.487 0 N-CA-C 108.94 -1.215 . . . . 0.0 108.94 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.832 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -65.82 -54.06 31.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.221 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 37.3 pttt -51.37 -41.83 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.022 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.664 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.22 -55.17 8.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.574 0.702 . . . . 0.0 110.048 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.946 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -29.8 -60.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.846 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -51.89 -18.21 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 111.801 -178.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.4 mm-40 -79.5 -33.47 42.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -104.71 20.87 17.89 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.946 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.617 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.05 -47.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.394 1.059 . . . . 0.0 112.148 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.617 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 20.6 m-85 -85.73 71.2 10.72 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.359 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.935 ' CE1' HD13 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.12 144.71 46.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.147 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -107.6 78.37 1.2 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -68.77 152.74 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.349 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 2.87 -70.87 0.0 OUTLIER Glycine 0 C--N 1.343 0.949 0 O-C-N 123.97 0.794 . . . . 0.0 113.854 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -120.91 -40.01 2.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.9 OUTLIER -88.94 152.41 21.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.81 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.0 134.55 28.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.575 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.948 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -151.8 158.26 43.06 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.885 -178.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.578 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 39.1 tt0 -61.93 121.63 13.44 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.923 HG21 HD12 ' A' ' 184' ' ' ILE . 1.8 mt -106.34 81.39 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.769 0.795 . . . . 0.0 112.039 -176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.1 118.85 26.77 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.784 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.2 p -34.64 115.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.409 1.099 . . . . 0.0 110.083 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.018 ' HB1' ' CE1' ' A' ' 227' ' ' PHE . . . -69.09 178.73 2.15 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.746 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.589 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -170.19 139.66 1.81 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.41 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.054 0.454 . . . . 0.0 111.133 -179.675 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.626 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.425 -0.92 0 C3'-C2'-C1' 100.782 -1.37 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.68 ' N7 ' ' CE2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 O4'-C1'-C2' 107.044 0.858 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.751 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.52 -0.847 0 C4'-C3'-C2' 100.835 -2.365 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.598 ' C6 ' ' N7 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 O4'-C1'-N19 108.1 0.375 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.72 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.0 t . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.592 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.2 mttt -150.77 -35.92 0.14 Allowed 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.937 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.55 -173.08 3.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.971 HD13 HD12 ' A' ' 239' ' ' ILE . 6.5 pt -165.04 109.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.207 1.003 . . . . 0.0 109.68 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.898 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -83.69 106.56 15.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.563 -178.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.95 HG13 HG12 ' A' ' 254' ' ' ILE . 4.3 t -93.82 111.75 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.643 0.777 . . . . 0.0 112.744 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -44.77 -175.98 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -32.59 162.37 0.0 OUTLIER Glycine 0 C--N 1.342 0.876 0 N-CA-C 114.824 0.69 . . . . 0.0 114.824 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.975 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -175.12 -145.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.656 ' N ' HD13 ' A' ' 189' ' ' LEU . 9.1 t -89.32 133.37 35.0 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 110.225 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 53.8 Cg_exo -29.69 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.209 2.606 . . . . 0.0 113.251 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.79 56.97 0.86 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 0.0 111.279 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.975 ' OG1' HD22 ' A' ' 189' ' ' LEU . 54.0 m -39.48 125.79 1.42 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.558 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -53.61 95.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.802 2.334 . . . . 0.0 112.189 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.6 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.38 -20.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 66.1 mt-10 -62.79 -39.51 94.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.806 ' HE2' HD21 ' A' ' 249' ' ' LEU . 1.0 OUTLIER -79.27 -46.66 17.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.097 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.62 -27.0 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.942 177.084 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.621 ' HA ' HD11 ' A' ' 211' ' ' ILE . 6.7 mtp85 -77.75 -28.03 50.57 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.697 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.9 mm-40 -85.8 -60.63 1.96 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.695 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -41.51 -41.49 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.613 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.925 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -99.49 -30.98 11.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.821 -178.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.13 -47.01 91.96 Favored Glycine 0 CA--C 1.504 -0.642 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 176.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -22.48 65.93 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.7 -36.89 85.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.89 0.853 . . . . 0.0 108.74 178.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.04 -138.43 5.29 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.904 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.8 mm-40 -91.89 89.88 7.22 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.023 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.47 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -55.57 139.8 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.711 ' CD ' HG21 ' A' ' 229' ' ' THR . 6.0 tt0 -89.66 -47.1 8.17 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 76.3 p -173.48 150.32 1.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.743 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.1 OUTLIER -114.59 161.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.329 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -158.9 137.48 10.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.537 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 198' ' ' ILE . 2.3 mm? -125.44 111.62 25.84 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.605 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 1.8 Cg_endo -85.75 -162.44 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.783 2.989 . . . . 0.0 113.474 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.538 ' HA ' ' CA ' ' A' ' 224' ' ' GLY . 2.9 ptp 164.43 172.17 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.939 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 0.5 OUTLIER -83.43 75.41 10.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 218' ' ' LYS . 11.0 m120 -144.89 8.47 1.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.453 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.517 ' HG3' ' OP2' ' B' ' 5' ' ' ' DG' . 20.0 mmtp -123.98 -36.91 2.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.371 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -138.92 -2.9 1.66 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.1 -177.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.8 m120 71.22 55.09 0.22 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.591 ' CE ' ' CZ ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.41 163.52 26.73 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.141 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.637 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -59.48 -36.43 76.0 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.979 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.637 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 2.7 mtm180 6.39 -84.99 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 124.501 1.126 . . . . 0.0 109.659 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.47 81.17 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 O-C-N 124.443 1.089 . . . . 0.0 112.903 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.646 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -143.98 -120.76 0.09 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.648 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -163.4 165.08 24.34 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.325 1.06 . . . . 0.0 113.349 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.051 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.6 m-85 -150.46 111.32 4.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.729 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.097 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.5 mt -112.49 161.79 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-O 121.144 0.497 . . . . 0.0 110.476 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.711 HG21 ' CD ' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -136.7 -179.25 5.58 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.408 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 85.2 m-85 -157.07 115.83 3.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.869 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.38 -36.27 0.53 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.3 mm-40 -89.09 -157.05 0.42 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.759 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.8 pm0 -143.15 12.81 1.81 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.379 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.59 -61.73 0.2 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.842 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 81.1 Cg_exo -49.28 -32.85 26.67 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 N-CA-C 108.946 -1.213 . . . . 0.0 108.946 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.832 HG13 HG23 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.53 -53.04 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.266 -1.788 . . . . 0.0 110.153 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.7 pttt -52.84 -45.39 67.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.659 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.649 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.84 -53.84 34.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.603 0.716 . . . . 0.0 109.852 177.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.971 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -31.18 -62.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.823 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.493 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -48.35 -29.17 3.69 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 238' ' ' LYS . 8.3 mm-40 -65.79 -38.99 90.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.31 20.76 16.25 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.14 177.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.16 -49.71 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.459 0 O-C-N 124.647 1.217 . . . . 0.0 111.966 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.2 m-85 -84.84 74.59 10.46 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.598 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.961 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.4 m-70 -76.1 151.42 37.04 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 5.1 m120 -115.07 80.67 1.45 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.502 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -74.52 108.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.566 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 39.09 -89.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.441 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.806 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -97.97 -43.37 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 9.0 m -88.25 147.88 24.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.637 0.732 . . . . 0.0 112.92 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.55 141.11 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.524 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.944 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.17 168.37 26.73 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 56.6 tt0 -73.31 96.07 2.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.375 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.95 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -83.95 81.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.737 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.583 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -94.26 118.04 31.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -27.88 120.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 122.217 1.008 . . . . 0.0 110.539 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.051 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -80.44 174.04 12.0 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.105 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.29 150.36 14.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.138 -1.846 . . . . 0.0 110.924 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.578 " C4'" ' HD3' ' A' ' 222' ' ' ARG . . . . . . . . 0 O5'--C5' 1.428 -0.731 0 O4'-C4'-C3' 104.367 -1.233 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.87 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 C3'-C2'-C1' 104.951 1.608 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 1.087 ' N3 ' " H5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.535 1.011 0 C4'-C3'-C2' 100.82 -2.38 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.838 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.836 0 O4'-C1'-C2' 106.701 0.547 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.708 HG12 ' HB ' ' A' ' 236' ' ' VAL . 28.6 t . . . . . 0 CA--C 1.495 -1.15 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.5 mttt -150.33 -34.39 0.17 Allowed 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.911 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -97.07 -173.59 2.73 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.345 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.001 HD13 HD12 ' A' ' 239' ' ' ILE . 13.2 pt -162.7 117.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.105 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.855 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.57 99.54 12.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.78 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.012 HG13 HG12 ' A' ' 254' ' ' ILE . 2.7 t -84.84 112.85 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.03 0.932 . . . . 0.0 110.924 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.603 ' O ' ' C5 ' ' B' ' 2' ' ' ' DT' . . . -99.18 120.91 7.03 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.563 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 97.47 108.72 2.65 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 177.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.941 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.81 -159.22 0.24 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.602 ' N ' HD13 ' A' ' 189' ' ' LEU . 26.3 t -89.04 132.75 36.99 Favored Pre-proline 0 C--N 1.342 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.744 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 190' ' ' SER . 28.2 Cg_exo -31.02 -29.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.872 3.048 . . . . 0.0 113.561 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 190' ' ' SER . 11.4 t70 -148.57 53.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.969 HG22 HD11 ' A' ' 198' ' ' ILE . 7.9 m -39.83 134.15 1.36 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.184 0.516 . . . . 0.0 110.634 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.7 Cg_endo -52.66 83.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.077 2.518 . . . . 0.0 112.084 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.581 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -39.58 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.216 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 194' ' ' PRO . 42.9 mt-10 -63.53 -35.59 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -78.33 -46.45 20.06 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.13 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -49.82 -24.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.624 177.504 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.569 ' HG2' HD11 ' A' ' 211' ' ' ILE . 7.8 mtp-105 -83.98 -25.96 29.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.69 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.7 OUTLIER -88.06 -35.54 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.044 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.708 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -68.33 -41.12 81.22 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.833 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -97.34 -30.96 12.65 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.894 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.08 -47.28 86.96 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.82 -23.73 61.56 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.834 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.46 -34.1 77.19 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.987 0.898 . . . . 0.0 108.859 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.84 -140.27 6.58 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 113.875 -1.512 . . . . 0.0 109.956 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.4 mm-40 -91.51 90.73 7.76 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.889 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -54.63 144.12 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.688 ' CD ' HG21 ' A' ' 229' ' ' THR . 6.6 tt0 -89.43 -49.34 6.75 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.9 p -173.17 148.99 1.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.236 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.589 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.24 163.81 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.36 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -163.12 126.57 2.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.856 0.36 . . . . 0.0 110.953 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.948 HD21 HD12 ' A' ' 198' ' ' ILE . 1.2 mm? -109.94 98.37 33.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.146 0.498 . . . . 0.0 111.264 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 53.4 Cg_exo -48.18 -161.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.691 2.927 . . . . 0.0 113.269 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 155.86 122.53 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.714 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.495 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 8.8 p-10 -59.81 74.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.26 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 215' ' ' MET . 0.4 OUTLIER -131.05 -2.48 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.365 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.507 ' HG3' H5'' ' B' ' 5' ' ' ' DG' . 4.0 mmmt -132.1 5.73 4.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.965 0.412 . . . . 0.0 111.76 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -151.86 -24.98 0.19 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.305 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.8 m120 75.06 40.99 0.32 Allowed 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.63 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -116.12 -155.82 0.59 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.306 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.639 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -91.08 -37.02 13.68 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 122.256 -0.278 . . . . 0.0 110.267 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.639 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.3 OUTLIER 7.47 -96.29 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 124.084 0.865 . . . . 0.0 111.573 -178.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 23.28 75.63 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 O-C-N 123.635 0.584 . . . . 0.0 111.683 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.681 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.14 -120.4 0.12 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.101 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.63 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -169.77 162.95 9.77 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.194 0.997 . . . . 0.0 113.263 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.031 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.8 m-85 -144.42 123.94 13.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.634 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.13 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -119.85 157.21 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.523 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.688 HG21 ' CD ' ' A' ' 209' ' ' GLU . 1.3 m -132.77 173.52 11.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.88 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 93.1 m-85 -148.2 117.4 6.86 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.609 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.48 -37.37 1.06 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.507 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -90.19 -154.87 0.35 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.62 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -142.07 1.98 1.48 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.696 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -83.75 -57.46 0.41 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.834 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 75.2 Cg_exo -49.18 -33.29 27.22 Favored 'Trans proline' 0 CA--C 1.492 -1.584 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.795 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -64.94 -52.07 58.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.419 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.4 mtpt -46.54 -56.45 6.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.03 -53.58 56.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.6 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.006 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -32.94 -61.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.699 -179.505 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.582 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 30.8 mtm -49.94 -20.12 0.85 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -75.57 -33.31 60.6 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.34 22.83 15.39 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.075 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -16.05 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 112.332 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.91 72.7 10.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.314 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 1.006 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.3 m-70 -73.55 146.61 44.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.2 m-80 -107.63 79.6 1.31 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.365 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.69 147.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.256 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 7.4 -73.9 0.0 OUTLIER Glycine 0 C--N 1.343 0.941 0 O-C-N 124.032 0.833 . . . . 0.0 113.679 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -116.71 -41.18 3.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.731 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -89.16 152.07 21.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.866 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.87 144.76 39.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.94 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.879 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.26 168.88 25.36 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 118.739 -1.185 . . . . 0.0 114.093 -177.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 49.9 tt0 -75.39 93.01 2.87 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 1.012 HG12 HG13 ' A' ' 186' ' ' VAL . 1.1 mt -80.18 83.44 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.751 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.588 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.9 OUTLIER -96.04 117.36 30.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.5 p -29.74 117.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 119.703 1.138 . . . . 0.0 110.161 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.031 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.46 -173.16 2.02 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.451 -175.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.452 ' HG2' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -175.93 142.21 0.51 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.763 -2.017 . . . . 0.0 110.63 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.789 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.699 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 C3'-C2'-C1' 101.71 -0.707 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.992 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.868 0 O4'-C4'-C3' 106.215 0.615 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.992 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.854 0 C4'-C3'-C2' 100.849 -2.351 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.859 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.505 -1.123 0 C4'-C3'-C2' 104.218 1.018 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.764 HG12 ' HB ' ' A' ' 236' ' ' VAL . 42.2 t . . . . . 0 CA--C 1.494 -1.182 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.9 mttt -150.57 -35.36 0.15 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 118.889 -1.124 . . . . 0.0 112.042 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.941 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -96.46 -173.9 2.9 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.058 HD13 HD12 ' A' ' 239' ' ' ILE . 4.9 pt -162.45 115.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.831 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -93.08 92.57 7.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.019 -177.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.054 HG13 HG12 ' A' ' 254' ' ' ILE . 2.2 t -73.37 148.09 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.546 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -93.84 -167.64 37.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.389 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -23.55 150.11 0.0 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.051 HD21 HD12 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -176.46 -147.11 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.669 ' N ' HD13 ' A' ' 189' ' ' LEU . 1.3 m -89.41 129.93 45.58 Favored Pre-proline 0 C--N 1.341 0.199 0 CA-C-O 120.96 0.409 . . . . 0.0 110.508 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -32.03 -28.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.391 2.728 . . . . 0.0 113.409 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.8 t0 -149.68 53.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.624 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.974 ' OG1' HD22 ' A' ' 189' ' ' LEU . 16.9 m -39.91 124.75 1.59 Allowed Pre-proline 0 CA--C 1.519 -0.245 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.087 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 6.2 Cg_endo -48.58 94.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.56 2.174 . . . . 0.0 111.988 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.601 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -45.24 -21.32 0.07 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.707 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -37.65 88.06 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.763 ' HE2' HD21 ' A' ' 249' ' ' LEU . 1.3 mttp -77.68 -49.09 15.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.129 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -47.18 -28.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.931 176.805 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.674 ' HG2' HD11 ' A' ' 211' ' ' ILE . 12.0 mtt180 -79.64 -27.99 40.92 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.33 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 5.2 pt-20 -87.47 -53.01 5.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.677 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -51.48 -39.5 57.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.342 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.131 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -98.75 -35.83 10.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.673 -178.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.94 -42.93 99.57 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -66.04 -22.48 70.62 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.823 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.21 -37.85 84.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.3 1.048 . . . . 0.0 108.399 178.011 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.52 -156.67 28.3 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.157 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.5 mt-10 -81.6 90.91 6.32 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.645 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.6 t -53.01 142.75 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.559 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.1 tp10 -89.41 -46.97 8.33 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.4 ' C ' HG12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -167.79 169.79 11.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.184 178.066 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.674 HD11 ' HG2' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -133.49 166.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.763 ' C ' HD22 ' A' ' 213' ' ' LEU . 2.1 tp10 -162.67 148.37 12.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.709 0.29 . . . . 0.0 111.352 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.051 HD12 HD21 ' A' ' 189' ' ' LEU . 2.8 mm? -140.25 106.1 6.65 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.305 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.636 ' HG2' ' CE2' ' A' ' 225' ' ' PHE . 21.0 Cg_exo -69.64 -172.32 0.55 Allowed 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 124.005 3.137 . . . . 0.0 113.68 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 156.08 107.14 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.054 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 215' ' ' MET . 33.9 p-10 -14.91 78.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.828 0.705 . . . . 0.0 112.749 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 215' ' ' MET . 3.3 t-20 -137.25 -4.14 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.478 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.437 ' C ' ' CG2' ' A' ' 219' ' ' THR . 5.2 mmmt -147.03 3.49 0.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.629 HG23 ' NH2' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -151.01 -5.37 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 219' ' ' THR . 19.6 m-20 70.69 2.83 4.3 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 0.4 OUTLIER -94.78 158.26 15.58 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.459 -178.22 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -56.77 -42.43 79.39 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.629 ' NH2' HG23 ' A' ' 219' ' ' THR . 0.0 OUTLIER 26.36 -91.41 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 124.641 1.213 . . . . 0.0 108.918 -177.261 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 23.58 77.87 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.136 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.636 ' CE2' ' HG2' ' A' ' 214' ' ' PRO . 7.2 p90 -131.26 -130.6 0.2 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.744 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -154.27 162.53 41.12 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.198 0.523 . . . . 0.0 110.355 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.161 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 1.8 m-85 -150.5 118.02 6.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.525 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.131 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.3 mt -119.13 142.35 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 122.051 0.929 . . . . 0.0 110.492 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.0 m -120.09 149.55 42.01 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.284 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.66 ' CD1' HG22 ' A' ' 236' ' ' VAL . 63.8 m-85 -130.71 116.67 18.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -39.39 -36.63 0.37 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.227 1.013 . . . . 0.0 108.299 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.2 mm-40 -88.44 -155.87 0.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.992 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.6 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.3 OUTLIER -144.97 11.4 1.37 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.4 -59.07 0.22 Allowed Pre-proline 0 C--O 1.224 -0.254 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.823 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.0 Cg_exo -51.33 -32.48 41.89 Favored 'Trans proline' 0 CA--C 1.496 -1.388 0 N-CA-C 108.678 -1.316 . . . . 0.0 108.678 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.764 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -66.95 -54.5 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.056 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.6 OUTLIER -51.54 -45.25 62.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.84 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.688 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -53.97 31.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.456 0.646 . . . . 0.0 109.74 178.112 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.058 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -32.69 -65.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.336 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -48.71 -25.35 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 238' ' ' LYS . 5.6 mm-40 -67.88 -37.14 81.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -105.52 22.96 14.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.241 178.145 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.609 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.78 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.655 1.222 . . . . 0.0 111.985 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -84.52 72.22 10.67 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.983 0.42 . . . . 0.0 110.742 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.924 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.0 m-70 -74.23 159.15 32.88 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.393 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 251' ' ' LYS . 5.2 m-80 -119.75 74.26 1.01 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.45 101.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.675 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.65 -87.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.54 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.763 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -99.87 -42.34 6.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.158 0.504 . . . . 0.0 110.559 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 247' ' ' VAL . 41.9 m -88.44 143.81 26.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.372 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.02 133.19 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.266 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.039 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -153.62 169.35 23.47 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.483 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 47.8 tt0 -72.9 104.9 4.2 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.004 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 1.054 HG12 HG13 ' A' ' 186' ' ' VAL . 1.8 mt -91.12 79.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.643 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.6 mtpt -87.45 119.04 27.33 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.1 p -33.73 115.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.518 1.152 . . . . 0.0 110.644 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.161 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -67.9 -179.96 1.31 Allowed 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.955 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.485 ' CG ' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER 176.9 149.52 0.14 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.289 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.475 ' HB2' ' O6 ' ' B' ' 4' ' ' ' DG' . 1.8 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 111.207 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.914 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.881 0 C4'-C3'-C2' 103.938 0.738 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.706 ' C6 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.849 0 O4'-C1'-N19 108.388 0.735 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.755 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.835 0 C4'-C3'-C2' 101.094 -2.106 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.552 ' C6 ' ' N7 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -1.021 0 C4'-C3'-C2' 104.515 1.315 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.689 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.6 t . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 25.6 mttt -151.27 -35.41 0.14 Allowed 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 118.873 -1.131 . . . . 0.0 112.259 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -92.47 -172.64 3.14 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.041 HD13 HD12 ' A' ' 239' ' ' ILE . 6.8 pt -166.03 111.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 122.025 0.916 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.935 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -83.57 103.27 12.77 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.046 -178.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.95 HG13 HG12 ' A' ' 254' ' ' ILE . 2.7 t -89.62 106.37 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.645 ' HA3' ' C2 ' ' B' ' 2' ' ' ' DT' . . . -98.08 122.71 7.6 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 115.964 1.145 . . . . 0.0 115.964 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.58 107.72 2.85 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.973 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.64 -158.89 0.23 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.6 ' N ' HD13 ' A' ' 189' ' ' LEU . 46.3 t -88.85 135.61 31.79 Favored Pre-proline 0 C--N 1.343 0.318 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.878 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 192' ' ' ASP . 87.8 Cg_exo -29.63 -32.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.669 2.913 . . . . 0.0 113.576 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.8 OUTLIER -150.65 54.75 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.617 0.246 . . . . 0.0 111.195 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.973 ' OG1' HD22 ' A' ' 189' ' ' LEU . 17.9 m -39.77 134.1 1.34 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 110.819 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.52 ' O ' HG13 ' A' ' 198' ' ' ILE . 11.8 Cg_endo -55.1 89.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.774 2.316 . . . . 0.0 111.75 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.594 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -44.43 -22.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.034 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.51 -35.69 81.78 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.17 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.84 -47.11 17.24 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.128 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -50.02 -24.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.196 177.116 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.559 ' HG2' HD11 ' A' ' 211' ' ' ILE . 1.7 mtt180 -82.03 -26.8 33.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.792 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -87.37 -43.86 11.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.874 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.721 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -58.63 -43.25 89.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.441 0.639 . . . . 0.0 110.066 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.849 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.2 m-85 -94.97 -32.05 13.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.369 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.3 -44.68 95.13 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.674 -2.171 . . . . 0.0 107.674 175.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -23.36 66.82 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.869 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.29 -34.31 77.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.072 0.939 . . . . 0.0 108.709 177.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.92 -142.4 7.97 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.895 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 18.1 mt-10 -91.18 92.54 8.71 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.7 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -55.66 144.84 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.558 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.4 tp10 -89.76 -50.33 6.12 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 72.2 m -171.77 148.1 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.296 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.02 158.85 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.3 OUTLIER -155.23 129.69 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.969 HD21 HD12 ' A' ' 198' ' ' ILE . 4.5 mm? -110.29 92.03 12.73 Favored Pre-proline 0 N--CA 1.455 -0.183 0 CA-C-O 121.55 0.69 . . . . 0.0 111.322 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.604 ' HA ' ' P ' ' B' ' 5' ' ' ' DG' . 84.4 Cg_exo -48.06 -170.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 124.109 3.206 . . . . 0.0 113.909 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.542 ' HG2' ' OP1' ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER 157.7 141.2 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.656 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 223' ' ' ARG . 3.8 p-10 -51.03 87.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.214 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 215' ' ' MET . 2.8 t30 -147.39 6.3 0.85 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.487 ' HD2' ' OP2' ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER -135.59 -25.97 1.26 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.522 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.789 HG23 ' NH1' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -143.54 -6.89 0.78 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 219' ' ' THR . 6.9 m-20 71.42 52.29 0.24 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.556 ' CD ' ' HD2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -126.83 172.54 10.3 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.506 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -60.74 -35.69 77.01 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.497 -179.095 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.789 ' NH1' HG23 ' A' ' 219' ' ' THR . 0.4 OUTLIER 17.41 -81.83 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 124.548 1.155 . . . . 0.0 110.35 -177.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 8.64 82.26 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.923 0.764 . . . . 0.0 113.062 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.71 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.22 -120.57 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.03 167.47 12.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.143 0.973 . . . . 0.0 112.288 177.018 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.058 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.2 m-85 -148.95 113.48 5.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.099 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.128 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -109.3 158.58 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.0 m -140.28 155.64 46.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.927 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 70.5 m-85 -131.41 123.0 27.24 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -43.93 -38.22 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mm-40 -90.31 -168.06 2.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.372 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.608 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -131.12 15.57 5.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -92.4 -62.07 0.19 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.869 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.8 Cg_exo -49.03 -31.96 22.21 Favored 'Trans proline' 0 CA--C 1.497 -1.332 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -66.82 -54.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.637 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 30.9 pttt -50.93 -46.77 61.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.549 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.641 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -56.4 11.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.414 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.041 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.19 -60.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.028 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.49 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.4 mtp -46.23 -31.25 2.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.0 OUTLIER -65.83 -39.54 90.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.17 19.69 14.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.585 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.44 -50.42 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 O-C-N 124.722 1.264 . . . . 0.0 112.114 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.68 72.45 10.57 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.42 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 1.027 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.1 m-70 -73.54 142.19 46.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.965 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -103.54 79.32 1.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.929 0.395 . . . . 0.0 111.394 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -66.88 151.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.171 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 1.82 -69.76 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 O-C-N 124.002 0.814 . . . . 0.0 113.817 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -118.91 -44.3 2.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.093 0.473 . . . . 0.0 110.787 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.568 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -89.82 152.29 21.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.615 -178.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.52 144.35 46.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.169 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.941 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -155.41 164.48 38.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -178.169 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 44.9 tt0 -72.74 92.01 1.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.453 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.95 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -81.38 81.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.935 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.7 OUTLIER -96.64 119.06 34.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -27.87 119.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 122.264 1.031 . . . . 0.0 110.197 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.058 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -80.06 174.47 11.56 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 113.186 -1.824 . . . . 0.0 113.323 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.41 ' O ' ' CB ' ' A' ' 259' ' ' SER . 0.0 OUTLIER 176.68 -87.01 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.746 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 258' ' ' MET . 9.0 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.648 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.797 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C4'--C3' 1.52 -0.835 0 O4'-C4'-C3' 104.23 -1.37 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.579 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.846 0 C3'-C2'-C1' 102.108 -0.423 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.741 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.521 -0.732 0 C4'-C3'-C2' 100.959 -2.241 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.718 ' C6 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.901 0 C3'-C2'-C1' 101.989 -0.508 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.734 HG12 ' HB ' ' A' ' 236' ' ' VAL . 41.3 t . . . . . 0 CA--C 1.491 -1.304 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 236' ' ' VAL . 20.2 mttt -150.81 -33.55 0.16 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.81 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.893 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -104.9 -166.96 1.29 Allowed 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.043 HD13 HD12 ' A' ' 239' ' ' ILE . 12.4 pt -164.05 139.1 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.421 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.706 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -110.48 98.4 7.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.096 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 1.082 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.1 t -80.83 148.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.556 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -95.45 -171.74 36.41 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.766 -0.73 . . . . 0.0 114.085 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -21.51 148.44 0.0 OUTLIER Glycine 0 C--N 1.343 0.97 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.996 HD21 HD12 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -169.9 -144.85 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.734 ' N ' HD13 ' A' ' 189' ' ' LEU . 36.0 m -89.39 129.63 46.71 Favored Pre-proline 0 C--N 1.343 0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -29.66 -31.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.546 2.831 . . . . 0.0 113.532 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 190' ' ' SER . 41.7 m-20 -151.14 54.2 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.987 ' OG1' HD22 ' A' ' 189' ' ' LEU . 24.1 m -41.16 117.46 1.57 Allowed Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.371 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.578 ' HG2' ' CE ' ' A' ' 197' ' ' LYS . 9.0 Cg_endo -49.9 101.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.882 2.388 . . . . 0.0 112.209 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.599 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -48.38 -18.28 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.973 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 60.1 mt-10 -63.92 -37.43 87.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.578 ' CE ' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -81.52 -45.88 15.3 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.14 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -51.13 -27.59 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.346 176.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.621 ' HG2' HD11 ' A' ' 211' ' ' ILE . 1.2 mtt180 -77.04 -27.88 54.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.812 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.2 mm-40 -85.76 -62.74 1.46 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.586 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.666 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -41.3 -40.93 1.79 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.067 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -98.11 -34.15 10.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.614 -178.398 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.36 -45.68 95.45 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 176.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.67 -22.41 68.03 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.803 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.82 -36.94 84.89 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 122.521 1.153 . . . . 0.0 108.227 177.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.74 -162.15 35.61 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.863 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.7 mt-10 -76.58 93.09 3.54 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.557 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 202' ' ' PHE . 1.6 t -53.73 142.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.56 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -89.53 -44.05 10.38 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 211' ' ' ILE . 67.2 m -170.92 172.42 5.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.112 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -137.13 161.08 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.981 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.838 ' C ' HD22 ' A' ' 213' ' ' LEU . 0.3 OUTLIER -161.33 143.94 12.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.996 HD12 HD21 ' A' ' 189' ' ' LEU . 3.3 mm? -134.1 107.82 11.46 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 111.319 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.636 ' HA ' ' P ' ' B' ' 5' ' ' ' DG' . 73.4 Cg_exo -50.49 -164.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.436 2.757 . . . . 0.0 113.619 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.51 ' H ' ' HD3' ' A' ' 223' ' ' ARG . 6.9 ptt? 161.75 128.33 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.646 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 51.9 p-10 -58.19 80.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.602 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 215' ' ' MET . 44.1 m-20 -147.23 11.46 1.03 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.211 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.562 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 4.9 mmtt -134.15 -30.22 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -135.76 -7.04 2.16 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 219' ' ' THR . 20.4 m-80 70.39 46.44 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -128.59 161.13 30.34 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.07 178.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -55.52 -42.0 73.91 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.218 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 221' ' ' LYS . 0.0 OUTLIER 23.51 -89.55 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.541 1.151 . . . . 0.0 109.574 -177.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.714 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 21.41 78.62 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.472 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.657 ' CE1' " H4'" ' B' ' 3' ' ' ' DA' . 8.4 p90 -130.1 -130.15 0.21 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.716 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.386 0.612 . . . . 0.0 111.375 178.448 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.121 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -151.02 111.58 4.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.912 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.14 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.5 mt -112.8 148.49 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 8.4 m -124.56 152.28 43.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.126 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 68.6 m-85 -132.11 119.02 20.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.56 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.21 -38.19 0.74 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.2 mt-10 -89.06 -155.48 0.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.711 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 2.0 pm0 -141.83 4.89 1.72 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.552 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 14.2 mt-10 -86.63 -56.15 0.36 Allowed Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.803 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 94.0 Cg_exo -51.45 -31.99 41.06 Favored 'Trans proline' 0 CA--C 1.494 -1.482 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.734 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -65.41 -50.62 71.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.342 177.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 22.3 mttm -47.93 -58.64 4.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.043 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.685 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.23 -51.99 66.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.155 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.043 HD12 HD13 ' A' ' 184' ' ' ILE . 0.7 OUTLIER -36.65 -63.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.114 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -52.56 -18.17 1.6 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.298 -179.034 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' LYS . 14.0 mm-40 -76.67 -33.52 58.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.81 24.15 13.51 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.766 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.599 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.34 -47.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.354 1.034 . . . . 0.0 112.122 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.599 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 23.0 m-85 -84.69 69.87 10.71 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.529 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.861 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.4 m-70 -70.46 156.22 39.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.832 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -122.04 72.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.639 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -61.55 141.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.446 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 12.14 -76.82 0.0 OUTLIER Glycine 0 C--N 1.338 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 113.899 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.99 -42.5 3.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 14.5 m -88.01 145.37 26.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.702 0.763 . . . . 0.0 112.645 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.6 133.28 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 107.888 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 1.082 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.54 163.53 39.41 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 118.636 -1.226 . . . . 0.0 114.27 -176.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.519 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 42.5 tt0 -67.57 108.66 2.95 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.215 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.972 HG12 HG13 ' A' ' 186' ' ' VAL . 2.1 mt -98.49 79.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.196 -1.365 . . . . 0.0 112.453 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.629 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.39 119.92 28.15 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 256' ' ' VAL . 2.9 p -36.25 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 123.051 1.405 . . . . 0.0 110.876 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.121 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -45.38 -171.91 0.0 OUTLIER 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 112.097 -2.32 . . . . 0.0 112.059 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.618 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -162.7 -156.0 0.38 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.572 -1.649 . . . . 0.0 110.981 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.89 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.793 0 C4'-C3'-C2' 104.092 0.892 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.657 " H4'" ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 N19-C1'-C2' 112.908 -0.808 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.736 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 C4'-C3'-C2' 101.235 -1.965 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.636 ' P ' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 C2'--C1' 1.506 -1.063 0 C4'-C3'-C2' 104.769 1.569 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.702 HG12 ' HB ' ' A' ' 236' ' ' VAL . 29.2 t . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HA ' HG21 ' A' ' 236' ' ' VAL . 21.9 mttt -150.31 -35.03 0.16 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.133 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.18 -170.84 2.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.032 HD13 HD12 ' A' ' 239' ' ' ILE . 11.6 pt -165.33 117.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.825 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.06 100.22 12.68 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.879 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.965 HG13 HG12 ' A' ' 254' ' ' ILE . 2.8 t -85.04 111.26 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.067 0.947 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.594 ' HA3' ' C2 ' ' B' ' 2' ' ' ' DT' . . . -97.77 119.43 6.42 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.117 1.207 . . . . 0.0 116.117 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.637 ' HA3' ' H72' ' B' ' 2' ' ' ' DT' . . . 98.72 105.95 2.59 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 114.903 0.721 . . . . 0.0 114.903 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.943 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -166.07 -157.63 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.631 ' N ' HD13 ' A' ' 189' ' ' LEU . 58.8 m -89.25 133.17 35.54 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -29.76 -31.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.695 2.93 . . . . 0.0 113.663 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.8 m-20 -150.41 54.2 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.431 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.943 ' OG1' HD22 ' A' ' 189' ' ' LEU . 32.4 m -40.65 128.49 1.86 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.511 ' O ' HG13 ' A' ' 198' ' ' ILE . 6.3 Cg_endo -49.2 90.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.164 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.681 ' OE1' HD23 ' A' ' 213' ' ' LEU . 0.9 OUTLIER -42.43 -23.57 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.511 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.64 -37.56 87.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.1 mmmt -77.36 -48.27 17.74 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.118 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.73 -26.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.256 177.286 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.56 ' HA ' HD11 ' A' ' 211' ' ' ILE . 10.4 mtt85 -79.67 -27.25 40.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.937 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 pt-20 -86.42 -50.96 6.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.694 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -51.57 -40.24 59.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.541 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.889 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -98.93 -30.31 12.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.176 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.63 -47.36 87.51 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -61.66 -23.57 63.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.826 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.38 -34.23 77.5 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.044 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.25 -142.53 8.14 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 8.7 mt-10 -90.72 94.67 9.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.256 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -56.59 143.1 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.604 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.5 tp10 -89.27 -47.53 7.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 68.1 m -174.06 147.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.374 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.598 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.16 161.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.437 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.3 OUTLIER -160.47 127.76 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 111.226 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 1.073 HD21 HD12 ' A' ' 198' ' ' ILE . 1.5 mm? -109.55 97.68 28.66 Favored Pre-proline 0 N--CA 1.456 -0.126 0 CA-C-O 121.458 0.647 . . . . 0.0 111.803 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.634 ' HA ' ' P ' ' B' ' 5' ' ' ' DG' . 60.9 Cg_exo -48.41 -167.26 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 123.902 3.068 . . . . 0.0 113.332 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.8 OUTLIER 154.82 125.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.992 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.521 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 14.4 p-10 -51.25 83.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.443 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 215' ' ' MET . 3.1 t-20 -146.08 6.12 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.493 ' C ' ' CG2' ' A' ' 219' ' ' THR . 4.1 mmmt -141.86 -0.88 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -152.46 -26.49 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 219' ' ' THR . 22.2 m-20 78.88 53.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.577 ' HG2' ' N ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -129.35 -158.65 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.862 178.39 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.645 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -87.52 -40.87 13.92 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 118.189 0.449 . . . . 0.0 109.851 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.645 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.5 OUTLIER 19.07 -94.56 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 123.787 0.679 . . . . 0.0 110.615 -178.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 22.43 76.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 O-C-N 123.705 0.628 . . . . 0.0 112.575 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.651 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -147.58 -123.14 0.06 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.357 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.625 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.08 164.57 20.37 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 113.201 178.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.018 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.1 m-85 -148.24 116.05 6.37 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 113.626 -1.625 . . . . 0.0 108.742 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.118 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -115.17 159.58 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.621 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.7 m -136.83 169.02 18.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.197 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 86.2 m-85 -145.94 116.64 7.65 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.604 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.6 -36.93 0.65 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.572 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 3.7 pm0 -89.03 -155.97 0.37 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.473 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.59 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 19.1 pt-20 -141.17 -2.59 1.27 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.885 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.7 -57.33 0.83 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 -177.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.826 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.9 Cg_exo -51.04 -34.18 45.89 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.829 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.1 t -64.72 -51.48 66.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.85 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 16.8 mtpt -44.99 -58.79 2.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.933 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.67 -52.76 64.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.627 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.032 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.92 -62.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.175 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.3 mtp -51.3 -20.85 1.84 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.919 0.39 . . . . 0.0 111.251 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -75.72 -34.28 60.33 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.19 22.39 16.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.617 178.266 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.76 -48.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 0.0 112.29 -179.546 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 242' ' ' LYS . 23.4 m-30 -84.4 71.79 10.66 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.66 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.953 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -72.75 154.49 40.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.18 79.56 1.36 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.04 152.53 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.575 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 0.79 -68.85 0.0 OUTLIER Glycine 0 C--N 1.343 0.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.899 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -117.3 -43.59 2.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.0 110.997 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.561 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 9.1 m -89.77 153.84 20.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.033 0.921 . . . . 0.0 113.283 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.27 139.77 39.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.183 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.872 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.98 169.57 24.52 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 118.613 -1.235 . . . . 0.0 114.157 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.3 tt0 -75.88 92.15 3.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.738 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.965 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -79.93 81.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.837 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.58 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 2.7 mtpt -93.7 116.98 29.5 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.4 p -29.17 119.65 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 122.267 1.032 . . . . 0.0 110.744 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.018 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.25 174.66 10.97 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.47 -175.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.86 148.39 6.07 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.51 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 91.9 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 111.252 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.637 ' H72' ' HA3' ' A' ' 188' ' ' GLY . . . . . . . . 0 C3'--C2' 1.51 -0.751 0 C4'-C3'-C2' 101.728 -1.472 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.889 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.825 0 C3'-C2'-C1' 101.918 -0.559 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.889 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.822 0 C4'-C3'-C2' 101.097 -2.103 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.634 ' P ' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.83 0 C5'-C4'-O4' 108.576 -0.515 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' A' ' 236' ' ' VAL . 40.8 t . . . . . 0 CA--C 1.495 -1.151 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.695 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.6 mttt -148.34 -35.42 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.867 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -94.79 -175.49 3.59 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.978 ' CD1' HD12 ' A' ' 239' ' ' ILE . 5.4 pt -162.38 117.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.837 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.4 109.1 20.67 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.415 -177.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.924 HG13 HG12 ' A' ' 254' ' ' ILE . 2.4 t -97.67 115.32 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.757 0.823 . . . . 0.0 112.984 -178.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -49.3 -177.14 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 114.796 0.678 . . . . 0.0 114.796 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -31.49 161.74 0.0 OUTLIER Glycine 0 C--N 1.342 0.914 0 N-CA-C 114.653 0.621 . . . . 0.0 114.653 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.978 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -175.42 -143.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 189' ' ' LEU . 1.3 m -88.5 135.4 32.64 Favored Pre-proline 0 C--N 1.343 0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 44.2 Cg_exo -28.78 -39.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.159 2.573 . . . . 0.0 113.033 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.5 56.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.978 ' OG1' HD22 ' A' ' 189' ' ' LEU . 86.1 m -39.21 127.95 1.3 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.498 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.9 Cg_endo -50.53 96.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.259 2.64 . . . . 0.0 113.808 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.783 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -39.75 -28.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.207 178.245 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 194' ' ' PRO . 2.9 mm-40 -61.23 -36.78 80.88 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.183 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 200' ' ' GLU . 3.0 mmmt -77.64 -52.29 9.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.166 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -46.91 -26.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.04 176.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.708 ' HG2' HD11 ' A' ' 211' ' ' ILE . 8.1 mtp180 -82.31 -26.84 32.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.101 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.8 OUTLIER -87.48 -41.12 13.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.998 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.3 t80 -67.14 -38.27 85.25 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.369 0.604 . . . . 0.0 110.358 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.99 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -98.26 -37.06 9.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.396 -178.511 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.5 -43.69 96.27 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.14 -23.98 66.69 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.834 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -37.52 86.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.084 0.945 . . . . 0.0 108.902 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.88 -140.51 6.41 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 32.6 mt-10 -92.06 94.6 9.33 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.213 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -60.95 144.91 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.588 ' CD ' HG21 ' A' ' 229' ' ' THR . 15.4 tt0 -89.79 -53.14 4.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.8 m -171.22 148.43 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.625 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.746 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.64 166.84 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.138 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -165.36 123.69 1.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.067 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.834 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.5 mm? -105.72 98.94 19.29 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 111.439 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.62 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 74.4 Cg_exo -51.44 -160.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.209 3.273 . . . . 0.0 114.438 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 153.39 127.52 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.672 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 17.5 p-10 -54.62 82.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.767 0.318 . . . . 0.0 111.786 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 215' ' ' MET . 6.4 t-20 -139.92 0.52 1.78 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.801 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.523 ' HG3' " H3'" ' B' ' 5' ' ' ' DG' . 0.1 OUTLIER -133.68 0.45 3.27 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 111.553 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.614 ' CB ' ' HZ2' ' A' ' 221' ' ' LYS . 0.7 OUTLIER -152.12 -24.8 0.18 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 219' ' ' THR . 6.7 m-80 75.29 41.28 0.29 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.614 ' HZ2' ' CB ' ' A' ' 219' ' ' THR . 0.0 OUTLIER -116.37 -158.96 0.71 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.896 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -87.61 -35.22 18.19 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.313 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.1 OUTLIER 12.76 -79.41 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 124.587 1.18 . . . . 0.0 110.648 -178.296 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.88 81.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.49 0 O-C-N 124.218 0.949 . . . . 0.0 112.212 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.62 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -149.92 -119.85 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.084 -0.558 . . . . 0.0 109.574 -176.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.589 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -172.62 168.91 5.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.0 0.905 . . . . 0.0 112.805 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.026 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.2 m-85 -150.41 125.37 9.88 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.349 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.166 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -119.92 147.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.528 0.68 . . . . 0.0 110.071 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 3.1 m -126.09 153.14 44.91 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.1 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.659 ' CD1' HG22 ' A' ' 236' ' ' VAL . 89.1 m-85 -129.01 120.64 26.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.547 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.26 -38.99 2.81 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mt-10 -90.13 -167.1 1.75 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.665 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.612 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -132.56 15.56 4.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.64 -64.88 0.15 Allowed Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.834 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 52.7 Cg_exo -46.34 -35.2 15.44 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.801 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -65.48 -52.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.241 -1.799 . . . . 0.0 110.349 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.6 pttt -52.26 -45.19 65.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.549 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.654 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.23 -54.78 20.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.618 0.723 . . . . 0.0 109.935 177.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.978 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -29.59 -64.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.159 -179.671 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -49.4 -22.33 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.276 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.4 mm-40 -74.29 -37.1 63.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.613 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -100.33 19.84 15.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.375 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.62 -48.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.52 1.137 . . . . 0.0 112.166 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 242' ' ' LYS . 18.5 m-85 -86.66 71.17 10.41 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.351 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.876 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.7 m-70 -71.68 148.51 46.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.346 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.74 77.23 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.097 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 248' ' ' GLY . 2.2 t -62.97 171.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.67 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.706 ' C ' HD23 ' A' ' 249' ' ' LEU . . . -14.67 -59.27 0.01 OUTLIER Glycine 0 C--N 1.341 0.806 0 O-C-N 123.781 0.676 . . . . 0.0 113.367 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.706 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -132.04 -41.61 1.01 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.398 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -87.94 152.05 22.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.67 0.748 . . . . 0.0 112.755 -177.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.99 135.61 36.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.812 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.921 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.58 157.56 41.2 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.634 -0.826 . . . . 0.0 112.92 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.585 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 64.8 tt0 -60.76 119.16 7.63 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.963 HG21 HD12 ' A' ' 184' ' ' ILE . 1.7 mt -104.36 82.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.813 0.816 . . . . 0.0 111.85 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.586 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.0 118.72 26.57 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.197 -1.365 . . . . 0.0 107.695 178.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.5 p -33.73 120.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 119.546 1.066 . . . . 0.0 109.777 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.026 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.46 -177.26 3.52 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 113.226 -1.807 . . . . 0.0 113.053 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.418 ' CG ' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -164.18 -156.43 0.34 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.319 -1.764 . . . . 0.0 110.595 -179.392 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.81 0.338 . . . . 0.0 110.893 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.608 ' C6 ' ' OP2' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C3'-C2'-C1' 100.413 -1.634 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.617 ' OP2' ' CE1' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.805 0 C3'-C2'-C1' 101.936 -0.546 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.933 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 C4'--C3' 1.519 -0.864 0 C4'-C3'-C2' 100.629 -2.571 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.933 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 O4'-C4'-C3' 106.215 0.615 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.67 HG12 ' HB ' ' A' ' 236' ' ' VAL . 32.0 t . . . . . 0 CA--C 1.497 -1.091 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.6 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.4 mttt -151.44 -35.17 0.14 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.175 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.871 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.73 -173.19 3.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.015 HD13 HD12 ' A' ' 239' ' ' ILE . 7.8 pt -165.86 108.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 122.519 1.152 . . . . 0.0 109.502 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.901 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -81.53 103.59 11.37 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.754 -178.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 254' ' ' ILE . 64.3 t -89.87 131.44 37.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.976 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.512 ' C ' ' HB2' ' A' ' 225' ' ' PHE . . . -64.33 -176.48 4.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -37.82 172.59 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.023 -0.589 . . . . 0.0 114.128 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 225' ' ' PHE . 0.2 OUTLIER 169.63 -139.8 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.361 -0.135 . . . . 0.0 111.123 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.574 ' N ' HD13 ' A' ' 189' ' ' LEU . 6.1 m -88.78 130.69 44.08 Favored Pre-proline 0 C--N 1.339 0.149 0 CA-C-O 120.966 0.412 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -32.63 -30.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.058 2.505 . . . . 0.0 112.931 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -151.29 54.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.861 ' HB ' HD11 ' A' ' 213' ' ' LEU . 47.9 m -39.54 128.51 1.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.268 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.576 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.4 Cg_endo -52.29 96.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.803 2.335 . . . . 0.0 111.889 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.612 ' HA ' HG13 ' A' ' 198' ' ' ILE . 1.1 pm0 -46.31 -17.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 26.9 mt-10 -65.13 -40.47 94.51 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.576 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -78.51 -45.72 21.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.093 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.83 -26.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.892 176.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.576 ' HA ' HD11 ' A' ' 211' ' ' ILE . 2.9 mtt85 -77.36 -28.41 52.97 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.514 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.0 mm-40 -85.29 -60.64 1.97 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.773 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.696 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -42.21 -42.55 3.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.905 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -97.88 -31.5 12.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.15 -49.77 71.68 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 176.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.64 -23.26 60.55 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.29 -36.74 85.09 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.825 0.822 . . . . 0.0 108.805 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.62 -139.01 5.62 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.908 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 66.9 mt-10 -91.71 89.7 7.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.996 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -55.57 141.07 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.566 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.6 tp10 -90.08 -48.3 7.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 21.5 m -174.27 149.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.626 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -113.29 156.92 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.748 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.503 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -154.19 125.74 7.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.991 HD21 ' CD1' ' A' ' 198' ' ' ILE . 3.2 mm? -107.34 96.37 15.77 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 121.219 0.533 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.655 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 87.1 Cg_exo -49.47 -167.19 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.386 2.724 . . . . 0.0 113.057 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.533 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 155.99 130.96 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.74 -179.312 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 0.6 OUTLIER -52.87 83.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.116 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 215' ' ' MET . 0.8 OUTLIER -138.91 -4.15 1.57 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.545 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 3.7 mmtt -138.53 1.32 2.14 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.8 OUTLIER -151.69 -25.26 0.19 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.378 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 219' ' ' THR . 11.6 m-20 73.86 43.52 0.32 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.558 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -122.09 -178.43 3.86 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.623 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -65.6 -43.62 89.08 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.566 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.588 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER 20.87 -83.36 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 O-C-N 124.785 1.303 . . . . 0.0 109.702 -176.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 10.67 82.23 0.01 OUTLIER Glycine 0 C--N 1.336 0.547 0 O-C-N 124.114 0.884 . . . . 0.0 112.008 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.779 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -149.93 -116.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.092 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.576 ' HA ' ' CD ' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -174.07 169.26 4.01 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.496 1.141 . . . . 0.0 112.824 177.157 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.034 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m-85 -151.51 110.6 3.9 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.858 -1.973 . . . . 0.0 108.519 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.093 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.2 mt -108.72 159.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.333 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.8 m -137.38 170.8 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.158 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.655 ' CD1' HG22 ' A' ' 236' ' ' VAL . 75.8 m-85 -148.02 114.08 5.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.566 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -38.67 -35.34 0.19 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 17.2 mt-10 -88.6 -153.63 0.26 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.772 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.7 OUTLIER -148.44 13.27 0.95 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.075 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 1.2 mt-10 -94.27 -57.81 0.21 Allowed Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.842 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 87.7 Cg_exo -51.43 -31.94 40.67 Favored 'Trans proline' 0 CA--C 1.496 -1.417 0 N-CA-C 108.793 -1.272 . . . . 0.0 108.793 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -68.01 -55.02 18.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.821 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -50.99 -42.39 60.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.157 -179.179 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.655 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.06 -54.62 10.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.601 0.715 . . . . 0.0 109.957 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.015 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.2 -63.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.865 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.584 ' HE3' ' O ' ' A' ' 236' ' ' VAL . 19.2 mtm -45.76 -29.63 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.7 mm-40 -64.78 -40.9 96.03 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.36 20.51 13.56 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.586 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.49 -50.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.635 1.209 . . . . 0.0 112.185 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.5 m-85 -85.58 69.29 10.63 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.994 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -69.18 149.7 48.3 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.74 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.62 80.72 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -74.04 100.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.04 -84.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.707 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.54 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -105.54 -42.18 5.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 247' ' ' VAL . 56.1 m -88.81 146.84 24.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.721 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.42 138.32 32.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.475 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.657 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.99 153.59 26.33 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.664 -177.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.574 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 28.2 tt0 -57.96 114.55 2.39 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.969 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.895 ' CG2' HD12 ' A' ' 184' ' ' ILE . 1.8 mt -103.33 83.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.793 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -91.86 117.78 30.11 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.351 178.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.3 p -30.57 122.75 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 119.376 0.989 . . . . 0.0 109.936 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.034 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -82.17 177.31 8.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.677 -1.602 . . . . 0.0 113.004 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.08 135.44 7.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.307 -1.77 . . . . 0.0 110.241 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.436 ' HB3' ' O6 ' ' B' ' 4' ' ' ' DG' . 26.5 p . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.101 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.89 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.73 0 O4'-C1'-C2' 107.035 0.85 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.677 ' C6 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.941 0 C3'-C2'-C1' 101.996 -0.503 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.769 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.52 -0.787 0 C4'-C3'-C2' 100.93 -2.27 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.566 ' OP1' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 O5'--C5' 1.428 -0.766 0 O4'-C4'-C3' 106.115 0.515 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.66 HG12 ' HB ' ' A' ' 236' ' ' VAL . 28.3 t . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 236' ' ' VAL . 26.0 mttt -152.55 -34.97 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.717 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -93.58 -179.32 4.99 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.654 179.094 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.01 HD12 HG21 ' A' ' 254' ' ' ILE . 5.9 pt -161.1 112.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 122.098 0.952 . . . . 0.0 108.897 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.873 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -87.04 104.7 16.57 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.147 -177.334 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.975 HG13 HG12 ' A' ' 254' ' ' ILE . 2.6 t -91.02 112.11 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.431 0.693 . . . . 0.0 111.44 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -52.38 -172.64 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.5 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -28.16 156.95 0.0 OUTLIER Glycine 0 N--CA 1.468 0.794 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.993 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -171.08 -145.41 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.663 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.74 132.4 38.66 Favored Pre-proline 0 C--N 1.341 0.215 0 CA-C-O 120.8 0.333 . . . . 0.0 110.213 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 73.4 Cg_exo -29.7 -33.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.298 2.665 . . . . 0.0 113.126 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 190' ' ' SER . 1.9 m-20 -150.92 54.33 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.408 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.993 ' OG1' HD22 ' A' ' 189' ' ' LEU . 25.5 m -39.95 122.54 1.57 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.608 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 11.2 Cg_endo -53.81 98.56 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.89 2.393 . . . . 0.0 112.22 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.605 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.5 OUTLIER -44.73 -21.39 0.05 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.766 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 2.2 mp0 -62.1 -39.09 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.787 ' HE2' HD21 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.28 -44.97 18.71 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.521 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.121 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.59 -28.63 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.172 -1.377 . . . . 0.0 108.899 177.103 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.565 ' HA ' HD11 ' A' ' 211' ' ' ILE . 0.1 OUTLIER -76.07 -27.99 57.44 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.366 177.715 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mm-40 -84.03 -61.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.898 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.671 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.3 t80 -41.68 -39.38 1.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.284 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.857 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -100.81 -33.93 10.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.372 -177.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.59 -48.28 82.84 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.3 -23.06 63.95 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.774 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -65.93 -38.15 87.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 122.153 0.978 . . . . 0.0 108.849 177.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.24 -143.01 8.04 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.639 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.6 mt-10 -92.05 97.15 10.76 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.293 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -61.39 143.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.689 ' CD ' HG21 ' A' ' 229' ' ' THR . 13.4 tt0 -89.07 -52.45 5.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 60.7 p -169.67 147.47 3.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.628 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.666 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.32 161.68 8.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.449 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -159.55 128.55 5.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.304 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.77 HD21 HD12 ' A' ' 198' ' ' ILE . 1.5 mm? -109.41 95.77 20.05 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 121.442 0.639 . . . . 0.0 110.996 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.653 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 88.5 Cg_exo -44.01 -166.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 124.558 3.505 . . . . 0.0 114.263 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 159.13 132.81 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.105 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.54 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 15.2 p-10 -65.28 81.77 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.642 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -141.16 2.36 1.69 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.724 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.472 ' C ' ' CG2' ' A' ' 219' ' ' THR . 19.2 mmtt -138.11 1.56 2.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.751 0.31 . . . . 0.0 111.818 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.8 OUTLIER -152.0 -26.36 0.18 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.675 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 219' ' ' THR . 31.3 m-20 73.93 52.0 0.11 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.558 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.03 -166.58 1.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -78.69 -39.37 36.83 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.146 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.578 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.5 OUTLIER 17.63 -86.01 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 124.319 1.012 . . . . 0.0 109.645 -177.503 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.93 78.08 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 O-C-N 124.005 0.816 . . . . 0.0 112.994 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.654 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.86 -121.21 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.702 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.81 166.5 11.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.099 0.952 . . . . 0.0 112.888 178.698 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.034 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.0 m-85 -148.24 119.58 7.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.318 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.121 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -115.75 146.18 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.631 0.729 . . . . 0.0 110.3 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.689 HG21 ' CD ' ' A' ' 209' ' ' GLU . 3.3 m -124.15 164.52 19.31 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.101 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 96.4 m-85 -139.44 119.85 13.93 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -42.57 -38.93 2.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.4 mm-40 -91.21 -168.04 1.96 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.488 -1.687 . . . . 0.0 110.732 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.588 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 4.8 pt-20 -129.6 16.8 5.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.656 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -89.62 -64.49 0.19 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.937 ' O ' HD12 ' A' ' 239' ' ' ILE . 82.9 Cg_exo -46.13 -30.83 8.01 Favored 'Trans proline' 0 CA--C 1.5 -1.182 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.858 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -72.23 -54.49 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.757 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -51.18 -32.9 25.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.541 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.664 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -83.75 -56.48 3.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.147 178.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.937 HD12 ' O ' ' A' ' 235' ' ' PRO . 0.8 OUTLIER -30.28 -57.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.322 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.8 mtp -51.24 -19.67 1.32 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.859 0.361 . . . . 0.0 111.733 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 3.8 mm-40 -79.62 -33.57 41.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.58 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -107.67 21.85 16.84 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.309 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.613 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -18.61 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.218 0.949 . . . . 0.0 112.117 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.613 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 22.0 m-85 -85.84 78.97 9.42 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.747 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.816 ' CG ' HD12 ' A' ' 254' ' ' ILE . 13.9 m-70 -76.18 -170.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.9 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 4.7 m120 -151.54 81.32 1.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -81.33 106.59 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.504 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 38.73 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.381 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.787 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -95.6 -43.0 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 111.457 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -88.51 150.26 23.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -147.96 133.1 18.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.331 179.347 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.962 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -154.13 173.72 15.69 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.551 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 61.5 tt0 -76.91 97.78 4.7 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.452 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 1.01 HG21 HD12 ' A' ' 184' ' ' ILE . 1.8 mt -86.59 83.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.709 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.607 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.3 mtpt -94.99 122.46 37.67 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.7 p -32.91 110.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.631 1.205 . . . . 0.0 110.524 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.034 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -67.71 -174.9 0.48 Allowed 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 112.65 -2.068 . . . . 0.0 112.977 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.424 ' CG ' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -179.52 -94.08 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.467 179.508 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.93 0.395 . . . . 0.0 111.423 179.841 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.91 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.833 0 O4'-C1'-C2' 107.129 0.936 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.729 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 O4'-C4'-C3' 106.185 0.585 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.786 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.52 -0.767 0 C4'-C3'-C2' 100.926 -2.274 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.753 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.506 -1.105 0 C4'-C3'-C2' 103.819 0.619 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.74 HG12 ' HB ' ' A' ' 236' ' ' VAL . 38.5 t . . . . . 0 CA--C 1.492 -1.261 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.0 mttt -150.32 -34.02 0.17 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.65 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -103.53 -168.52 1.52 Allowed 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 1.071 HD13 HD12 ' A' ' 239' ' ' ILE . 16.7 pt -163.02 138.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.605 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.749 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -108.87 91.13 3.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.112 0.482 . . . . 0.0 112.24 -178.237 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.927 HG13 HG12 ' A' ' 254' ' ' ILE . 2.0 t -68.21 138.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.602 ' O ' ' C5 ' ' B' ' 2' ' ' ' DT' . . . -130.71 111.49 1.13 Allowed Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.995 -1.098 . . . . 0.0 114.483 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.555 ' H ' ' HB3' ' A' ' 225' ' ' PHE . . . 108.87 102.97 2.8 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.638 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.752 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -170.59 -154.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.61 ' N ' HD13 ' A' ' 189' ' ' LEU . 14.0 m -89.46 136.64 29.59 Favored Pre-proline 0 C--N 1.341 0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.499 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -31.3 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.38 2.72 . . . . 0.0 113.515 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 190' ' ' SER . 8.4 t0 -150.98 56.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.759 HG22 HD11 ' A' ' 198' ' ' ILE . 2.6 m -39.13 128.97 1.26 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 5.2 Cg_endo -47.16 97.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.858 2.372 . . . . 0.0 112.191 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 198' ' ' ILE . 3.5 pt-20 -48.02 -17.95 0.16 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.11 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.79 -36.93 83.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.629 ' HE2' HD21 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -80.0 -46.26 16.95 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.141 HG22 ' CD1' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.08 -31.5 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.519 176.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' A' ' 211' ' ' ILE . 5.3 mtp180 -74.13 -28.89 61.55 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.176 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -87.57 -63.76 1.25 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.992 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.656 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -39.65 -37.16 0.48 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 1.123 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -101.16 -33.25 10.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.222 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.93 -43.6 98.97 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.42 -21.26 72.29 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 176.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.813 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -34.85 79.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 108.7 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.72 -144.9 9.74 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.633 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.6 mm-40 -90.52 91.16 8.32 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 121.881 -0.776 . . . . 0.0 110.539 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.49 141.25 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.515 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.7 tp10 -89.54 -45.72 9.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.45 ' C ' HG12 ' A' ' 211' ' ' ILE . 15.3 m -171.29 173.09 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.298 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.727 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.31 164.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.563 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.558 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.0 OUTLIER -172.43 128.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.823 HD21 HD12 ' A' ' 198' ' ' ILE . 3.0 mm? -113.59 122.32 35.42 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.699 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 51.9 Cg_exo -56.68 -162.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.519 2.813 . . . . 0.0 113.622 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 159.67 106.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.972 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 8.4 p-10 -40.22 84.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.062 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 215' ' ' MET . 1.6 m-20 -148.4 4.19 0.69 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.505 ' HG3' " C5'" ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER -135.96 -4.41 2.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.4 OUTLIER -151.58 -18.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 219' ' ' THR . 7.6 m-80 74.18 49.27 0.12 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.516 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -129.72 178.06 6.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.328 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -70.72 -41.16 72.27 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.826 -179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.6 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 26.04 -97.34 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.617 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 27.19 78.52 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.136 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.699 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 7.5 p90 -140.04 -131.32 0.11 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.668 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -151.41 164.17 37.32 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.11 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.13 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -150.61 113.49 4.77 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.129 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.141 ' CD1' HG22 ' A' ' 198' ' ' ILE . 1.3 mt -115.19 150.69 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 121.724 0.773 . . . . 0.0 110.88 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.644 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.4 m -127.17 151.58 48.49 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.929 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 76.5 m-85 -130.92 119.2 21.78 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -40.69 -37.85 0.81 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.553 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -88.84 -158.68 0.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.373 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.587 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 15.5 pt-20 -137.63 0.64 2.26 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.058 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 238' ' ' LYS . 3.7 mm-40 -79.2 -58.62 0.67 Allowed Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.813 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 72.5 Cg_exo -50.0 -35.35 40.96 Favored 'Trans proline' 0 CA--C 1.488 -1.797 0 CA-C-N 120.485 1.209 . . . . 0.0 109.023 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.759 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.12 -51.99 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 113.251 -1.795 . . . . 0.0 108.726 178.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 24.9 mttt -44.62 -58.65 2.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.13 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.675 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.85 -53.47 57.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.825 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 1.071 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -32.16 -64.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.65 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.6 mtp -48.3 -29.63 4.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 26.3 mm-40 -66.67 -37.39 84.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.67 19.84 17.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.271 177.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.577 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.45 -50.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.646 1.216 . . . . 0.0 112.12 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.4 m-85 -85.35 71.41 10.82 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.258 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.933 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.7 m-70 -70.8 152.88 43.28 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.225 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 4.6 m120 -114.25 74.21 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 250' ' ' SER . 2.1 t -66.72 100.76 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.794 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.3 -85.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.626 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.629 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -104.26 -42.09 5.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.299 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 37.5 m -87.8 144.49 26.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.031 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.72 140.15 36.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.348 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.835 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.75 168.93 24.75 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -177.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 255' ' ' LYS . 43.9 tt0 -73.38 96.64 2.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.648 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.927 HG12 HG13 ' A' ' 186' ' ' VAL . 1.6 mt -85.73 81.97 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -90.91 121.39 32.71 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.55 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 256' ' ' VAL . 2.0 p -36.11 100.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.286 1.517 . . . . 0.0 111.214 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.13 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -45.37 -171.08 0.0 OUTLIER 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.89 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.604 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 173.46 148.67 0.06 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.253 -1.794 . . . . 0.0 110.886 179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 259' ' ' SER . . . . . 0.405 ' OG ' ' C6 ' ' B' ' 4' ' ' ' DG' . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.986 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C3'-C2'-C1' 104.876 1.554 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.548 " H1'" ' OP2' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.774 0 C3'-C2'-C1' 105.275 1.839 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.72 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.93 0 C4'-C3'-C2' 101.091 -2.109 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.566 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.914 0 C4'-C3'-C2' 104.795 1.595 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.675 HG12 ' HB ' ' A' ' 236' ' ' VAL . 21.9 t . . . . . 0 CA--C 1.499 -0.994 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 236' ' ' VAL . 24.1 mttt -150.41 -35.16 0.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.137 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.58 -176.57 3.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.958 ' CD1' HD12 ' A' ' 239' ' ' ILE . 4.8 pt -161.08 114.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.057 0.932 . . . . 0.0 109.297 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.915 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.75 106.43 18.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.485 -177.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.966 HG13 HG12 ' A' ' 254' ' ' ILE . 2.8 t -92.17 111.71 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.642 0.777 . . . . 0.0 112.842 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.58 -176.84 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.46 162.86 0.0 OUTLIER Glycine 0 C--N 1.34 0.787 0 N-CA-C 115.019 0.767 . . . . 0.0 115.019 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 1.019 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -178.82 -143.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.303 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.696 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.8 m -89.21 131.32 41.09 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.425 ' C ' ' O ' ' A' ' 190' ' ' SER . 33.0 Cg_exo -27.36 -35.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.47 2.78 . . . . 0.0 113.494 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -150.96 54.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.06 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . 1.019 ' OG1' HD22 ' A' ' 189' ' ' LEU . 51.9 m -40.23 125.67 1.72 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 110.413 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PRO . . . . . 0.605 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -47.13 101.62 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.399 2.733 . . . . 0.0 113.905 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.38 -20.41 0.22 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.972 178.358 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 10.6 mm-40 -66.34 -39.99 89.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.605 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 2.5 mttp -76.27 -50.53 14.14 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 1.164 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -45.72 -28.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.692 176.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.5 mtp180 -77.13 -29.84 54.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.358 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.7 pt-20 -86.99 -54.12 4.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.696 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -50.7 -37.8 43.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 110.663 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.98 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -100.44 -34.46 9.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.498 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.2 -44.69 96.71 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.0 -23.98 66.45 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.829 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.01 -35.91 81.84 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 122.032 0.92 . . . . 0.0 108.599 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -142.43 7.83 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.971 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -91.0 94.8 9.8 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.688 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -58.64 144.59 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLU . . . . . 0.57 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 3.9 tp10 -89.86 -50.91 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.1 p -172.04 156.61 4.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.443 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.721 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -119.95 167.52 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.002 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -165.02 123.71 1.72 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.684 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.771 HD12 HD21 ' A' ' 189' ' ' LEU . 0.9 OUTLIER -110.48 101.13 47.7 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 121.287 0.565 . . . . 0.0 111.952 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.59 ' HG3' " O4'" ' B' ' 4' ' ' ' DG' . 25.5 Cg_exo -66.66 -167.0 0.12 Allowed 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 124.056 3.171 . . . . 0.0 112.675 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.536 ' HA ' ' CA ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER 167.69 164.7 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.215 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 221' ' ' LYS . 19.9 t0 -81.89 13.01 3.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.172 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -109.48 -2.71 17.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.63 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.482 ' C ' ' CG2' ' A' ' 219' ' ' THR . 4.3 mmtp -124.77 1.48 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.865 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.614 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -151.75 -16.52 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.132 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.2 m-20 77.35 20.83 1.1 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' LYS . . . . . 0.581 ' HB2' ' CD ' ' A' ' 223' ' ' ARG . 4.0 mppt? -129.4 179.08 6.0 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.698 -0.401 . . . . 0.0 112.014 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -70.39 -39.86 74.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.617 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 3.2 mtp85 2.05 -80.02 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 124.34 1.025 . . . . 0.0 111.057 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 10.42 78.93 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 O-C-N 124.588 1.18 . . . . 0.0 111.624 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PHE . . . . . 0.654 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -138.71 -121.38 0.13 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 226' ' ' CYS . . . . . 0.666 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.32 163.11 20.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.973 0.892 . . . . 0.0 112.594 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 1.035 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.4 m-85 -147.83 124.54 11.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.864 -1.517 . . . . 0.0 108.97 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 1.164 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -121.33 150.93 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 CA-C-O 121.555 0.693 . . . . 0.0 109.944 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.751 HG23 ' HG3' ' A' ' 183' ' ' LYS . 2.9 m -129.85 152.41 49.36 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.212 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 87.3 m-85 -130.32 117.26 19.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.57 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.72 -37.31 0.73 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.515 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.59 -155.93 0.35 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.494 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.605 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.2 pt-20 -143.12 4.17 1.42 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.51 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.9 OUTLIER -84.53 -58.51 0.36 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.432 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PRO . . . . . 0.829 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.6 Cg_exo -49.77 -34.68 36.67 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.843 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.28 -51.11 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.801 178.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 6.3 mtpt -45.86 -60.13 2.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.933 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.692 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.99 -52.75 64.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.69 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.958 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -34.72 -66.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.259 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.2 mtp -48.83 -25.56 1.94 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.563 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -69.35 -38.35 78.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.36 21.14 15.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 177.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.594 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.51 -49.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.669 1.231 . . . . 0.0 111.878 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.7 m-85 -85.2 71.85 10.82 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.504 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' HIS . . . . . 0.896 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.6 m-70 -72.62 153.04 41.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.226 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.51 76.38 1.0 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -69.14 101.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.149 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.74 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.45 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.671 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -101.89 -41.84 6.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.126 0.489 . . . . 0.0 110.892 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 247' ' ' VAL . 21.0 m -88.41 146.82 25.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.514 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.38 139.82 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.75 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 252' ' ' CYS . . . . . 0.947 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 166.06 32.83 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 255' ' ' LYS . 48.4 tt0 -71.95 93.58 1.37 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.227 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.966 HG12 HG13 ' A' ' 186' ' ' VAL . 1.5 mt -79.78 80.86 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.133 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -87.89 122.58 31.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.183 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.0 p -33.82 122.32 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 122.244 1.021 . . . . 0.0 109.912 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 1.035 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -82.12 -179.49 7.42 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.204 -1.817 . . . . 0.0 113.494 -175.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' MET . . . . . 0.546 ' N ' ' HE3' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 175.81 153.95 0.17 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.037 -1.892 . . . . 0.0 110.554 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.739 179.756 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' DT' . . . . . 0.837 ' O2 ' " H2'" ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C2'--C1' 1.508 -0.946 0 C4'-C3'-C2' 104.037 0.837 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' DA' . . . . . 0.61 ' C5 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.935 0 O4'-C1'-C2' 106.767 0.607 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' DG' . . . . . 0.75 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.428 -0.763 0 C4'-C3'-C2' 101.454 -1.746 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' DG' . . . . . 0.5 ' OP1' " H1'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.827 0 O4'-C4'-C3' 106.062 0.462 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.738 HG12 ' HB ' ' A' ' 236' ' ' VAL . 30.2 t . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.5 mttt -150.14 -35.11 0.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.591 -1.244 . . . . 0.0 112.462 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -102.55 -167.46 1.4 Allowed 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.064 HD13 HD12 ' A' ' 239' ' ' ILE . 17.3 pt -165.11 139.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.261 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.763 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -109.32 96.75 6.5 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.382 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.902 HG13 HG12 ' A' ' 254' ' ' ILE . 2.0 t -79.39 122.09 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -67.32 -170.34 4.61 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.924 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.555 ' N ' ' HB3' ' A' ' 225' ' ' PHE . . . -26.14 158.03 0.0 OUTLIER Glycine 0 N--CA 1.466 0.675 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.966 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -177.24 -143.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.681 ' N ' HD13 ' A' ' 189' ' ' LEU . 10.7 t -89.69 134.52 32.12 Favored Pre-proline 0 C--N 1.344 0.33 0 CA-C-O 121.13 0.49 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 190' ' ' SER . 80.8 Cg_exo -28.65 -35.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.432 2.755 . . . . 0.0 113.22 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 190' ' ' SER . 34.7 p30 -151.36 56.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.158 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.966 ' OG1' HD22 ' A' ' 189' ' ' LEU . 6.1 m -39.4 123.23 1.39 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.567 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 6.6 Cg_endo -48.79 99.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.661 2.24 . . . . 0.0 112.23 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.45 -19.59 0.18 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.442 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 26.0 mt-10 -64.29 -39.0 93.03 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.567 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -77.56 -46.77 21.24 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.128 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.99 -29.79 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.832 176.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.637 ' HG2' HD11 ' A' ' 211' ' ' ILE . 4.7 mtt180 -75.83 -28.57 58.32 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.86 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -86.12 -63.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.792 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.681 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -39.75 -39.16 0.74 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.556 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.076 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -99.64 -34.16 10.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.452 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.42 -45.59 96.09 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.28 -23.29 68.08 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.82 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.0 -33.69 76.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 122.053 0.93 . . . . 0.0 108.651 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.24 -139.72 6.29 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.01 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.5 mm-40 -91.57 94.24 9.33 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.097 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.54 142.6 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 229' ' ' THR . 11.3 tt0 -89.6 -52.45 5.0 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.1 p -169.82 152.92 4.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.35 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.717 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.72 167.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.491 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -167.2 130.15 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.478 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.063 HD21 HD12 ' A' ' 198' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.529 0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.477 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 120.261 0.077 . . . . 0.0 111.193 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.72 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 32.21 76.1 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.658 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 8.1 p90 -135.4 -128.95 0.15 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.747 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.85 162.44 39.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.64 0.733 . . . . 0.0 111.326 178.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.118 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 2.8 m-85 -149.95 124.62 9.76 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.128 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.4 mt -122.94 153.06 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.972 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.6 m -130.03 152.87 49.01 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.016 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.5 m-85 -130.1 120.62 24.93 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.579 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -40.81 -37.53 0.79 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.8 mt-10 -90.85 -157.64 0.5 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.572 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -137.53 1.23 2.35 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.04 -60.46 0.49 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.82 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 63.9 Cg_exo -48.89 -33.83 26.77 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.764 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.73 -51.16 70.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.747 178.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -46.12 -57.41 4.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.081 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.683 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.19 -52.83 63.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.679 179.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.064 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.2 -64.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.133 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.508 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.0 OUTLIER -48.72 -26.73 2.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.894 0.378 . . . . 0.0 110.588 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.1 mm-40 -68.1 -40.07 82.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.56 13.94 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.345 178.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.543 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.72 -50.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.562 1.164 . . . . 0.0 111.998 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.6 m-85 -84.29 74.15 10.37 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.449 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.918 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.0 m-70 -74.81 152.24 38.99 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.388 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 74.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.371 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -66.05 103.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.23 -83.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.86 -41.23 5.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.175 0.512 . . . . 0.0 110.538 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 67.7 m -87.87 145.46 26.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.398 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.98 141.61 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.848 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.842 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.97 167.58 29.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.499 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 44.5 tt0 -73.11 95.09 2.01 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.511 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.902 HG12 HG13 ' A' ' 186' ' ' VAL . 2.6 mt -83.03 78.96 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.716 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.32 123.67 33.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.709 ' O ' HG13 ' A' ' 256' ' ' VAL . 1.9 p -37.41 99.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 123.331 1.538 . . . . 0.0 111.035 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.118 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.412 -2.35 0 CA-C-N 112.006 -2.361 . . . . 0.0 112.998 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.67 HG12 ' HB ' ' A' ' 236' ' ' VAL . 36.7 t . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 236' ' ' VAL . 22.8 mttt -151.86 -34.83 0.13 Allowed 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.411 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -95.36 -175.11 3.39 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.255 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.037 HD13 HD12 ' A' ' 239' ' ' ILE . 8.2 pt -163.08 120.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.84 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -95.68 104.46 16.38 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.389 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.95 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.9 t -90.73 112.76 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.763 0.825 . . . . 0.0 112.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -48.44 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.632 0.613 . . . . 0.0 114.632 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.92 160.98 0.0 OUTLIER Glycine 0 C--N 1.341 0.846 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 1.039 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -173.33 -144.8 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.658 ' N ' HD13 ' A' ' 189' ' ' LEU . 70.1 m -88.88 135.59 31.76 Favored Pre-proline 0 C--N 1.342 0.261 0 CA-C-O 120.977 0.418 . . . . 0.0 110.623 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 190' ' ' SER . 56.6 Cg_exo -28.77 -37.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.325 2.684 . . . . 0.0 113.051 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 190' ' ' SER . 62.4 t0 -151.4 54.23 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.08 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.039 ' OG1' HD22 ' A' ' 189' ' ' LEU . 86.3 m -39.87 123.87 1.57 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.149 0.499 . . . . 0.0 110.75 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.607 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 10.1 Cg_endo -51.2 101.95 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.351 2.701 . . . . 0.0 113.728 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.815 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.2 OUTLIER -45.74 -20.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.145 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.5 mt-10 -65.2 -41.96 94.02 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.728 ' HE2' HD21 ' A' ' 249' ' ' LEU . 2.2 mttp -75.34 -50.03 17.26 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.109 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -46.48 -26.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.975 176.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.561 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.4 mtp180 -80.12 -28.65 38.93 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.302 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.9 pt-20 -86.89 -47.56 8.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.597 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.685 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.4 t80 -56.46 -40.73 75.32 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 110.342 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.85 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -97.95 -33.9 11.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.43 -44.22 95.6 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.44 -23.2 68.31 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.811 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -66.4 -36.32 82.53 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.155 0.979 . . . . 0.0 108.88 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.9 -142.78 7.99 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.651 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 27.2 mt-10 -91.09 92.59 8.77 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.976 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.15 143.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.557 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.0 tp10 -89.64 -46.9 8.31 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 3.0 p -175.16 152.64 1.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.788 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -116.02 161.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.956 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.486 ' OE1' ' NZ ' ' A' ' 183' ' ' LYS . 0.5 OUTLIER -159.02 125.64 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.922 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 189' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 121.473 0.654 . . . . 0.0 111.054 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.539 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 111.204 0.075 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 20.9 76.46 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 O-C-N 123.906 0.754 . . . . 0.0 112.032 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.651 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -144.27 -121.73 0.08 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -178.068 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.664 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -166.37 164.3 17.46 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.153 0.978 . . . . 0.0 113.251 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.041 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.8 m-85 -147.83 117.0 6.86 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.764 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.109 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -114.35 147.57 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.606 0.717 . . . . 0.0 110.354 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.691 HG23 ' HG2' ' A' ' 183' ' ' LYS . 1.2 m -120.21 172.36 7.84 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.43 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 95.4 m-85 -150.63 111.83 4.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -39.33 -37.13 0.41 Allowed 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 230' ' ' PHE . 21.8 mt-10 -89.09 -155.56 0.35 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.776 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.614 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.4 pt-20 -142.33 -0.93 1.22 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.953 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.13 -58.93 0.56 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.804 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 50.9 Cg_exo -48.09 -36.32 28.07 Favored 'Trans proline' 0 CA--C 1.491 -1.654 0 N-CA-C 108.845 -1.252 . . . . 0.0 108.845 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.823 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.14 -51.79 67.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.177 -1.829 . . . . 0.0 108.921 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -45.04 -59.45 2.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.126 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.675 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.28 -54.23 49.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.539 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.037 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.42 -64.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.142 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.509 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -48.04 -36.18 12.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 238' ' ' LYS . 12.1 mt-10 -60.52 -38.85 85.76 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -103.28 21.65 15.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.558 177.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.53 -50.08 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 O-C-N 124.493 1.12 . . . . 0.0 112.069 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.6 m-85 -83.44 74.91 10.04 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.969 ' CE1' HD13 ' A' ' 239' ' ' ILE . 8.1 m170 -76.65 159.35 30.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 7.4 m-80 -123.01 79.13 1.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.167 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.67 107.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 37.25 -88.18 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.611 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.728 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -95.52 -44.93 7.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 247' ' ' VAL . 5.4 m -88.9 148.09 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.24 140.39 30.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.372 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.95 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.25 166.81 30.5 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.514 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 51.7 tt0 -71.42 97.44 1.63 Allowed 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.411 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.902 HG12 HG13 ' A' ' 186' ' ' VAL . 2.4 mt -86.55 80.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.968 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.2 OUTLIER -89.18 122.63 32.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.4 p -34.52 116.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 122.434 1.112 . . . . 0.0 110.036 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.041 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.418 -2.045 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.518 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.681 HG12 ' HB ' ' A' ' 236' ' ' VAL . 37.6 t . . . . . 0 CA--C 1.497 -1.074 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.564 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.8 mttt -151.2 -34.9 0.14 Allowed 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.073 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.848 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.08 -172.47 3.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.188 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 239' ' ' ILE . 5.9 pt -166.45 111.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 122.12 0.962 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.879 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -87.16 107.74 18.6 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.593 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.982 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.9 t -94.42 109.55 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.461 0.704 . . . . 0.0 112.299 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.33 -176.77 0.01 OUTLIER Glycine 0 N--CA 1.476 1.366 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.68 160.36 0.0 OUTLIER Glycine 0 C--N 1.344 1.025 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.918 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -174.07 -142.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.676 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -89.04 132.1 39.0 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 110.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -31.96 -33.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.152 2.568 . . . . 0.0 113.01 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 190' ' ' SER . 16.5 t0 -150.99 53.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.623 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.918 ' OG1' HD22 ' A' ' 189' ' ' LEU . 52.2 m -40.21 121.68 1.63 Allowed Pre-proline 0 C--N 1.33 -0.246 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -52.01 94.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.634 2.223 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.598 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -41.91 -24.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.296 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 194' ' ' PRO . 36.2 mt-10 -61.22 -34.79 75.68 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.688 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -86.11 -35.05 20.45 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.126 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -62.08 -25.24 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.614 176.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.603 ' HA ' HD11 ' A' ' 211' ' ' ILE . 19.2 mtp180 -77.61 -25.73 50.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 197' ' ' LYS . 3.7 mt-10 -86.07 -60.01 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.928 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.705 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -43.3 -40.63 3.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.761 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.88 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -99.6 -30.66 12.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 -178.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -46.22 92.42 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.84 -22.8 66.8 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.838 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.66 -36.47 84.38 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.961 0.886 . . . . 0.0 108.726 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -138.26 5.21 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.7 mt-10 -91.95 89.99 7.23 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.813 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.497 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -56.33 142.96 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.581 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.2 tp10 -90.25 -49.05 6.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.453 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 5.8 p -172.75 156.75 3.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.543 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.63 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -122.78 153.81 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.237 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -154.41 133.04 12.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.073 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.927 HD21 HD12 ' A' ' 198' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.333 -0.125 0 CA-C-O 121.229 0.537 . . . . 0.0 111.842 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.571 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.511 -0.52 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 11.79 80.52 0.01 OUTLIER Glycine 0 C--N 1.336 0.546 0 O-C-N 123.982 0.801 . . . . 0.0 112.416 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.68 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -145.87 -119.98 0.07 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.707 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.47 169.15 14.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.247 1.022 . . . . 0.0 112.798 178.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.046 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.5 m-85 -152.17 111.92 3.98 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.908 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.126 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -110.79 161.58 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.3 m -138.14 168.98 18.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.165 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.5 m-85 -146.74 115.61 6.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.581 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.2 OUTLIER -39.64 -35.3 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.531 ' O ' ' O ' ' A' ' 230' ' ' PHE . 7.9 mm-40 -88.89 -156.74 0.4 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.998 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.591 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.5 pm0 -144.16 12.77 1.6 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.615 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.664 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -92.29 -63.29 0.17 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.838 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 95.2 Cg_exo -48.47 -32.26 20.13 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.808 HG13 HG23 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.97 -53.43 34.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.372 -1.74 . . . . 0.0 110.209 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.4 OUTLIER -51.6 -46.58 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.609 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.655 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -64.89 -54.29 33.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.69 0.757 . . . . 0.0 109.933 177.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.972 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -30.84 -64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.531 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.479 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -46.19 -31.96 2.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 238' ' ' LYS . 30.4 mm-40 -62.71 -45.04 94.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -94.01 19.77 8.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.14 177.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.97 -50.31 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.625 1.203 . . . . 0.0 111.928 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.1 m-85 -84.84 71.29 10.89 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.621 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.3 m-70 -72.99 153.03 41.09 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.75 82.34 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.688 HG12 ' CE ' ' A' ' 197' ' ' LYS . 1.3 t -75.01 97.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.749 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.06 -80.91 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.752 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.82 -43.45 4.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.44 148.32 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.625 0.726 . . . . 0.0 112.344 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -145.54 140.69 27.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.8 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.982 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.23 169.44 24.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 76.4 tt0 -75.35 91.58 2.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.58 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.982 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -77.99 80.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.534 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.62 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.4 mtpt -91.67 120.09 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -30.55 120.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-O 122.29 1.043 . . . . 0.0 110.367 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.046 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.42 -1.966 0 CA-C-N 113.19 -1.823 . . . . 0.0 112.342 -176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.742 HG12 ' HB ' ' A' ' 236' ' ' VAL . 23.1 t . . . . . 0 CA--C 1.499 -1.004 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.7 mttt -150.21 -36.46 0.15 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.064 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.17 -171.54 2.57 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.967 HD13 HD12 ' A' ' 239' ' ' ILE . 10.2 pt -164.62 121.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.808 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -96.02 109.51 21.9 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.357 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.929 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.5 t -97.71 112.71 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.708 0.803 . . . . 0.0 113.103 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.41 -178.38 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -31.53 161.41 0.0 OUTLIER Glycine 0 C--N 1.342 0.861 0 N-CA-C 114.607 0.603 . . . . 0.0 114.607 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 1.029 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -174.67 -144.67 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.556 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 189' ' ' LEU . 49.2 m -89.44 133.32 34.92 Favored Pre-proline 0 C--N 1.338 0.069 0 CA-C-O 121.018 0.437 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 84.7 Cg_exo -28.18 -36.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.5 2.8 . . . . 0.0 113.116 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.0 t70 -150.85 56.45 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.029 ' OG1' HD22 ' A' ' 189' ' ' LEU . 21.7 m -38.8 132.57 1.09 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.067 0.461 . . . . 0.0 110.308 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.522 ' O ' HG13 ' A' ' 198' ' ' ILE . 14.7 Cg_endo -56.42 92.29 0.05 OUTLIER 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 123.025 2.483 . . . . 0.0 112.381 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.573 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.31 -24.53 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 8.7 mm-40 -62.94 -36.65 84.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.917 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 200' ' ' GLU . 22.7 mmmt -78.12 -49.23 14.3 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.168 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.4 -28.81 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.471 176.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.558 ' HG2' HD11 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -77.1 -28.61 54.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.737 178.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.2 mm-40 -85.61 -63.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.668 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.702 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.1 t80 -40.17 -39.33 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.984 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -100.34 -33.3 10.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.48 -178.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.89 -45.99 95.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.47 -23.12 66.43 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.826 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.6 -34.18 77.64 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.014 0.911 . . . . 0.0 108.818 178.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.35 -141.04 7.02 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.045 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 77.3 mm-40 -91.82 91.54 7.98 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.757 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -55.6 142.24 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.586 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.5 tp10 -88.96 -48.64 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 26.7 m -175.96 150.02 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.344 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.67 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.34 167.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.556 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -166.34 125.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.809 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.966 HD21 HD12 ' A' ' 198' ' ' ILE . 4.4 mm? . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.963 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.524 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 111.401 0.148 . . . . 0.0 111.401 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 23.87 75.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 O-C-N 123.673 0.608 . . . . 0.0 111.807 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.661 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -138.38 -120.2 0.14 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.679 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.72 169.87 13.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.449 1.119 . . . . 0.0 113.02 178.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.027 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.6 m-85 -151.79 125.21 8.84 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.614 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.168 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -122.3 156.57 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.539 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.1 m -134.33 160.31 38.33 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.947 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.2 m-85 -137.86 115.76 11.54 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.586 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -38.51 -36.59 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.301 1.048 . . . . 0.0 108.265 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.1 mt-10 -88.82 -153.88 0.27 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.647 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.1 pt-20 -144.54 4.46 1.18 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.355 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -84.84 -58.19 0.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.826 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 88.6 Cg_exo -50.4 -33.53 37.94 Favored 'Trans proline' 0 CA--C 1.492 -1.605 0 N-CA-C 108.763 -1.283 . . . . 0.0 108.763 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -64.94 -51.91 60.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.618 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.9 mttt -45.71 -57.4 4.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.031 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.685 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.94 -52.49 65.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.605 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.967 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.72 -63.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.237 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.563 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -50.83 -19.16 0.9 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -77.55 -37.22 51.24 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.92 13.36 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.582 178.154 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.605 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -15.43 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.517 1.135 . . . . 0.0 112.433 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.1 m-85 -86.0 72.46 10.45 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.366 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.52 141.64 46.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.262 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -105.26 75.5 1.17 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.354 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -67.05 138.36 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.139 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 15.22 -77.62 0.0 OUTLIER Glycine 0 C--N 1.342 0.895 0 O-C-N 123.932 0.77 . . . . 0.0 113.729 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.07 -40.54 3.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.312 0.577 . . . . 0.0 110.529 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.75 152.92 21.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.886 -178.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.07 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.942 179.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.929 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 156.47 29.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.995 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 41.6 tt0 -60.88 120.27 9.84 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.927 HG12 HG13 ' A' ' 186' ' ' VAL . 2.2 mt -104.52 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.746 0.784 . . . . 0.0 112.428 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.591 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.06 119.47 28.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.465 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.7 p -33.62 122.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.149 0.976 . . . . 0.0 110.055 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.027 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.426 -1.649 0 CA-C-N 113.405 -1.725 . . . . 0.0 113.049 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' A' ' 236' ' ' VAL . 20.5 t . . . . . 0 CA--C 1.499 -0.981 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 21.1 mttt -150.04 -34.58 0.17 Allowed 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.149 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -89.78 -171.4 3.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.056 HD13 HD12 ' A' ' 239' ' ' ILE . 6.1 pt -168.75 110.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.941 0.877 . . . . 0.0 108.92 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.871 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -83.08 101.76 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.733 -177.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.966 HG13 HG12 ' A' ' 254' ' ' ILE . 2.5 t -87.68 111.22 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.32 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.617 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -101.39 120.5 6.89 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 97.04 109.92 2.7 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.97 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -165.56 -157.66 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.638 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.4 m -89.03 133.65 34.94 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.197 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -32.46 -29.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.43 2.754 . . . . 0.0 113.473 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 47.8 t0 -149.38 52.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.97 ' OG1' HD22 ' A' ' 189' ' ' LEU . 17.6 m -43.08 126.79 3.36 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.507 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -53.1 94.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.677 2.251 . . . . 0.0 112.068 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.603 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.9 OUTLIER -45.13 -20.67 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 8.0 mt-10 -64.96 -36.55 84.75 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.12 -47.65 17.75 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.153 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.25 -28.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.847 176.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.609 ' HA ' HD11 ' A' ' 211' ' ' ILE . 11.3 mtp180 -76.41 -28.86 56.84 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 mt-10 -85.27 -61.94 1.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.811 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.698 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -39.56 -42.65 1.18 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.882 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.0 OUTLIER -97.75 -31.49 12.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.728 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.21 -46.85 93.09 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.41 -24.27 65.55 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.828 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.65 -34.21 77.74 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.11 -139.8 6.36 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.833 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.6 mt-10 -91.86 95.3 9.76 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.854 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -57.31 144.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.647 ' CD ' HG21 ' A' ' 229' ' ' THR . 10.5 tt0 -90.6 -50.58 5.85 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 73.1 m -172.42 147.18 1.88 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.914 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.623 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.31 162.08 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.629 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -157.79 123.86 4.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 0.0 111.596 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.021 HD21 HD12 ' A' ' 198' ' ' ILE . 2.0 mm? . . . . . 0 C--N 1.333 -0.125 0 CA-C-O 121.372 0.606 . . . . 0.0 111.028 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.587 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.508 -0.658 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.59 80.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 O-C-N 123.906 0.754 . . . . 0.0 112.505 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.643 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.02 -121.04 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.637 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -167.5 164.58 14.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.347 1.07 . . . . 0.0 113.074 178.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.024 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.9 m-85 -149.18 114.91 5.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.071 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.153 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.6 mt -112.98 161.58 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.344 0.592 . . . . 0.0 110.588 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.647 HG21 ' CD ' ' A' ' 209' ' ' GLU . 1.8 m -138.7 172.36 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.537 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 89.1 m-85 -145.23 119.8 9.75 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.597 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.38 -37.3 0.99 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.8 mt-10 -89.42 -155.59 0.36 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.57 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.6 pt-20 -143.02 5.27 1.5 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.495 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -86.9 -57.28 0.32 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.828 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 99.3 Cg_exo -49.74 -33.22 31.54 Favored 'Trans proline' 0 CA--C 1.493 -1.573 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.87 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.7 -51.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 112.988 -1.915 . . . . 0.0 109.065 178.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 12.4 mttt -46.3 -57.6 4.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.276 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.634 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.13 -54.74 42.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.673 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.056 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.95 -63.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.029 -179.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 9.9 mtp -45.73 -31.32 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 111.139 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.3 mm-40 -63.33 -43.09 98.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -96.56 19.96 11.47 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.268 178.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.18 -50.55 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.696 1.247 . . . . 0.0 111.716 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.9 m-85 -85.51 71.03 10.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.271 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.975 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.9 m-70 -70.49 146.41 50.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.029 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 4.6 m-80 -107.43 79.75 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -69.12 149.48 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.71 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 6.59 -72.08 0.0 OUTLIER Glycine 0 C--N 1.343 0.953 0 O-C-N 124.014 0.821 . . . . 0.0 113.682 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -119.64 -41.88 2.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.076 0.465 . . . . 0.0 110.454 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.57 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 2.0 m -88.89 148.54 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.689 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -131.76 147.62 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.054 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.909 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -160.34 161.85 33.32 Favored 'General case' 0 C--O 1.228 -0.042 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.238 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 185' ' ' PHE . 56.7 tt0 -69.86 93.12 0.73 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.609 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.966 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -83.92 82.73 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.591 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.7 mtpt -98.4 118.91 36.12 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.8 p -28.72 110.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-O 122.612 1.196 . . . . 0.0 110.594 -177.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.024 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.418 -2.026 0 CA-C-N 112.634 -2.076 . . . . 0.0 112.758 -176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.619 HG12 ' HB ' ' A' ' 236' ' ' VAL . 29.9 t . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 22.0 mttt -152.19 -35.66 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.575 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.867 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -94.91 -177.94 4.34 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.37 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.945 HD13 HD12 ' A' ' 239' ' ' ILE . 4.6 pt -161.82 111.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 122.245 1.022 . . . . 0.0 109.57 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.906 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -85.41 101.79 12.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.551 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.99 HG13 HG12 ' A' ' 254' ' ' ILE . 2.6 t -87.27 106.21 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.246 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.62 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -97.43 122.1 7.33 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.45 106.66 2.73 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.676 0.631 . . . . 0.0 114.676 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.973 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.08 -157.16 0.2 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.65 ' N ' HD13 ' A' ' 189' ' ' LEU . 71.0 m -88.6 134.38 34.22 Favored Pre-proline 0 C--N 1.345 0.372 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.187 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -29.29 -32.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.789 2.993 . . . . 0.0 113.919 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.72 54.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.482 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.973 ' OG1' HD22 ' A' ' 189' ' ' LEU . 14.3 m -40.17 123.74 1.68 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.927 0.394 . . . . 0.0 110.537 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 8.2 Cg_endo -50.32 92.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.745 2.297 . . . . 0.0 112.077 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.59 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -42.16 -23.67 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 194' ' ' PRO . 10.0 mt-10 -63.87 -33.5 75.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.573 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -85.76 -34.45 21.17 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.109 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -62.33 -20.87 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.863 176.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.544 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.7 mtt180 -85.39 -25.03 27.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.293 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -88.99 -31.2 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.878 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.697 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -72.99 -38.7 66.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.882 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.0 OUTLIER -100.43 -30.99 11.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.449 -178.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.92 -46.26 92.01 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.63 64.51 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.835 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.22 -34.68 78.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.968 0.89 . . . . 0.0 108.916 178.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.26 -139.99 6.37 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.063 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.6 mt-10 -91.43 90.47 7.69 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.993 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.492 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -55.36 143.59 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.694 ' CD ' HG21 ' A' ' 229' ' ' THR . 9.7 tt0 -89.71 -50.33 6.12 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 50.3 m -172.03 147.25 2.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.293 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.595 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.34 159.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.466 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.3 OUTLIER -155.5 124.67 6.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.34 . . . . 0.0 111.372 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.773 HD21 HD12 ' A' ' 198' ' ' ILE . 1.4 mm? . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.414 0.626 . . . . 0.0 111.066 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.564 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.507 -0.682 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.06 79.64 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 O-C-N 123.994 0.809 . . . . 0.0 112.857 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.664 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.78 -121.16 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.601 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -167.23 162.19 14.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.987 0.899 . . . . 0.0 112.587 177.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.027 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 2.9 m-85 -144.34 113.84 7.09 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.709 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.109 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -111.47 159.13 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-O 121.498 0.666 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.719 HG23 ' HG3' ' A' ' 183' ' ' LYS . 1.5 m -135.04 178.05 7.33 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.338 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 92.0 m-85 -152.56 117.22 5.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.607 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.93 -37.54 1.34 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -89.49 -155.84 0.37 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.606 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -141.43 1.86 1.6 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.716 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -81.62 -58.42 0.48 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.835 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 84.9 Cg_exo -48.91 -35.34 31.27 Favored 'Trans proline' 0 CA--C 1.494 -1.501 0 N-CA-C 109.035 -1.179 . . . . 0.0 109.035 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.879 HG13 HG23 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.66 -51.74 66.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.774 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -44.94 -55.35 5.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.482 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.633 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.0 -54.19 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.107 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.965 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -29.95 -62.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.06 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -49.24 -27.13 3.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.889 0.376 . . . . 0.0 111.255 -179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 238' ' ' LYS . 11.5 mm-40 -68.59 -34.98 76.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.09 20.57 18.75 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.458 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.77 -49.54 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.516 1.135 . . . . 0.0 112.009 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.0 m-85 -85.0 72.83 10.78 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.488 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.965 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -73.04 150.34 42.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.248 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.94 80.94 1.36 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.573 HG12 ' CE ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -75.84 103.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.658 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.456 ' C ' HD23 ' A' ' 249' ' ' LEU . . . 47.64 -85.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.486 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -106.01 -44.94 4.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.976 0.417 . . . . 0.0 110.907 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.21 147.21 24.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.765 0.793 . . . . 0.0 112.372 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.02 145.65 46.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.058 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.93 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.9 163.24 36.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.568 -1.253 . . . . 0.0 114.204 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.493 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.2 tt0 -71.55 91.34 1.06 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.471 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.99 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -80.76 80.19 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.512 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.646 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.3 OUTLIER -93.13 120.46 33.45 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.4 p -30.54 116.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.941 1.246 . . . . 0.0 109.972 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.027 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.426 -1.662 0 CA-C-N 112.971 -1.922 . . . . 0.0 113.369 -175.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.703 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.2 t . . . . . 0 CA--C 1.497 -1.092 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 236' ' ' VAL . 26.3 mttt -151.26 -36.38 0.13 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.727 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.882 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -93.57 -176.8 4.2 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.988 ' CD1' HD12 ' A' ' 239' ' ' ILE . 4.5 pt -161.34 114.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 122.15 0.976 . . . . 0.0 109.118 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.883 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.12 110.54 21.81 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.098 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.929 HG12 ' SG ' ' A' ' 252' ' ' CYS . 3.0 t -100.15 108.72 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.37 -179.87 0.01 OUTLIER Glycine 0 CA--C 1.531 1.065 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.42 161.59 0.0 OUTLIER Glycine 0 C--N 1.344 0.988 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.987 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -173.93 -143.67 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.703 ' N ' HD13 ' A' ' 189' ' ' LEU . 33.1 m -89.18 132.93 36.22 Favored Pre-proline 0 C--N 1.34 0.165 0 CA-C-O 121.037 0.446 . . . . 0.0 110.88 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 72.1 Cg_exo -27.8 -36.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.588 2.859 . . . . 0.0 113.301 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.59 54.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.576 0.226 . . . . 0.0 111.084 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.987 ' OG1' HD22 ' A' ' 189' ' ' LEU . 8.1 m -39.68 120.7 1.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.394 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.59 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -50.35 99.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.717 2.278 . . . . 0.0 112.275 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.6 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -45.88 -21.72 0.15 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.379 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 34.5 mt-10 -60.76 -37.87 83.31 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.59 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.2 mttp -79.73 -46.86 16.27 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.157 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.98 -26.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.897 177.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.558 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 5.3 mtt180 -80.56 -27.1 37.6 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.836 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.4 mt-10 -85.36 -59.85 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.716 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -44.89 -41.56 7.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.58 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.06 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -97.29 -35.08 10.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.997 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.51 -47.04 92.3 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.01 -22.79 65.2 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.83 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.53 -37.86 87.97 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.044 0.926 . . . . 0.0 108.837 178.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.93 -142.0 7.3 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.7 mm-40 -91.66 92.64 8.54 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.874 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.412 HG21 ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.35 143.54 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.555 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.6 tp10 -89.45 -51.02 5.76 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.0 p -170.34 155.48 5.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.1 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.729 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -120.34 159.48 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.121 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.77 132.75 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.089 HD21 HD12 ' A' ' 198' ' ' ILE . 1.6 mm? . . . . . 0 C--N 1.333 -0.15 0 CA-C-O 121.428 0.632 . . . . 0.0 111.001 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.579 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.51 -0.581 0 CA-C-O 119.841 -0.123 . . . . 0.0 111.25 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 17.28 75.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.77 0 O-C-N 124.015 0.822 . . . . 0.0 111.362 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.655 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.54 -119.64 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.611 -0.795 . . . . 0.0 108.923 -176.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -166.4 163.58 17.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.905 0.859 . . . . 0.0 112.487 178.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.03 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -148.54 118.09 6.99 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.963 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.157 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.5 mt -113.23 152.85 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.792 HG23 ' HG3' ' A' ' 183' ' ' LYS . 2.6 m -131.04 152.97 49.77 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.072 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 87.8 m-85 -131.95 116.77 17.57 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.44 -37.75 0.73 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.2 mm-40 -89.21 -158.24 0.49 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.788 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.613 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 16.5 pt-20 -141.09 11.6 2.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.856 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.5 OUTLIER -89.84 -62.75 0.21 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.83 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 66.9 Cg_exo -47.55 -34.08 19.32 Favored 'Trans proline' 0 CA--C 1.494 -1.498 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.821 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.92 -52.69 50.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.611 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 8.0 pttt -52.8 -49.64 65.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.422 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.666 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -61.45 -53.55 55.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.988 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.13 -64.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.333 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.506 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 2.3 mtp -49.23 -22.15 0.96 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.137 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 4.0 mm-40 -73.57 -36.9 65.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.619 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.16 20.88 15.88 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.312 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.61 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.96 -48.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.634 1.209 . . . . 0.0 112.416 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.3 m-85 -86.55 73.91 9.99 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.466 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.931 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.1 m-70 -77.0 147.34 36.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.156 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.436 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -111.48 81.35 1.43 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.987 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.41 96.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.8 -78.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.61 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.81 -43.48 3.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 0.0 110.922 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.32 148.53 24.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.512 0.672 . . . . 0.0 112.209 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.76 145.71 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.929 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -161.6 155.02 21.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.751 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.552 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 47.6 tt0 -59.75 120.47 9.59 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.933 HG21 HD12 ' A' ' 184' ' ' ILE . 2.3 mt -105.06 84.6 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.749 0.785 . . . . 0.0 112.214 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.68 120.45 30.08 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 114.234 -1.348 . . . . 0.0 107.893 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.9 p -35.21 120.39 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 119.457 1.026 . . . . 0.0 109.696 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.03 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.426 -1.649 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.14 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.632 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.1 t . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' HA ' HG21 ' A' ' 236' ' ' VAL . 25.9 mttt -151.63 -35.35 0.13 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.148 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.852 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.13 -171.79 2.78 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 239' ' ' ILE . 6.0 pt -166.46 110.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 122.197 0.998 . . . . 0.0 109.318 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.893 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -84.71 104.14 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.643 -178.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.961 HG13 HG12 ' A' ' 254' ' ' ILE . 3.8 t -89.82 114.46 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.716 0.806 . . . . 0.0 112.735 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -46.21 -177.21 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.936 0.735 . . . . 0.0 114.936 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -33.32 163.5 0.01 OUTLIER Glycine 0 C--N 1.341 0.832 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.95 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -177.7 -146.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.665 ' N ' HD13 ' A' ' 189' ' ' LEU . 39.7 m -89.03 133.13 35.98 Favored Pre-proline 0 C--N 1.34 0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 111.105 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.72 -33.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.498 2.799 . . . . 0.0 113.181 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.2 m-20 -151.45 55.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.53 0.205 . . . . 0.0 111.461 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.95 ' OG1' HD22 ' A' ' 189' ' ' LEU . 24.3 m -39.19 123.21 1.31 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.484 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.519 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.2 Cg_endo -49.51 88.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 0.0 111.682 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -39.74 -25.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 194' ' ' PRO . 49.7 mt-10 -61.32 -33.42 73.56 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.606 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.21 -31.28 19.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.09 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -66.22 -21.95 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.621 176.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.608 ' HG2' HD11 ' A' ' 211' ' ' ILE . 13.9 mtp180 -82.44 -25.24 33.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.365 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 197' ' ' LYS . 4.3 pt-20 -88.91 -37.77 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.842 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.691 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -65.36 -37.69 87.8 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.121 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.895 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -100.69 -30.72 11.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.18 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.97 -44.93 93.81 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.61 -23.53 67.06 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.809 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.36 -35.89 82.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 122.182 0.991 . . . . 0.0 108.849 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 162.77 -138.93 5.61 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.981 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.9 mm-40 -91.46 92.09 8.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.643 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.522 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -58.07 142.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.568 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.61 -47.74 7.49 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.3 m -175.41 150.14 1.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.809 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -113.23 158.62 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.833 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.43 ' HG2' ' C ' ' A' ' 211' ' ' ILE . 0.8 OUTLIER -156.14 129.22 8.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 111.289 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.823 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.4 mm? . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 121.09 0.471 . . . . 0.0 111.428 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.509 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.689 0 CA-C-O 120.934 0.397 . . . . 0.0 109.949 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 20.76 79.96 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.05 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.633 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -142.91 -118.76 0.1 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.671 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -167.69 169.24 11.95 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.209 1.004 . . . . 0.0 112.442 177.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.042 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.3 m-85 -150.66 110.52 4.08 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.886 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.09 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -108.17 160.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.514 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.4 m -138.94 167.63 21.61 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.251 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 82.8 m-85 -144.05 119.82 10.54 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.36 -39.4 3.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.6 mt-10 -92.45 -176.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.894 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.632 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.9 pt-20 -119.05 3.83 11.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -79.86 -61.41 0.46 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.809 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 57.8 Cg_exo -47.59 -35.69 23.16 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 CA-C-N 120.422 1.186 . . . . 0.0 109.203 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.831 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -62.68 -50.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.017 178.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 11.2 mttt -46.78 -59.85 2.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.12 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.653 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -58.46 -51.97 67.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.629 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.972 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.62 -65.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.339 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -47.94 -28.12 2.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.574 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 238' ' ' LYS . 25.6 mm-40 -66.46 -42.15 88.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -98.88 21.64 11.28 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.258 177.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.46 -49.69 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 O-C-N 124.632 1.207 . . . . 0.0 111.846 -179.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.603 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.7 m-85 -85.12 72.57 10.76 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.653 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.93 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.7 m-70 -73.06 152.18 41.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -114.77 80.88 1.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.892 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.606 HG12 ' CE ' ' A' ' 197' ' ' LYS . 1.4 t -74.93 97.5 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.767 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.37 -83.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.568 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.31 -43.57 4.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.964 0.412 . . . . 0.0 110.687 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 1.2 m -88.33 145.34 25.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.695 0.759 . . . . 0.0 112.357 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -140.33 140.57 35.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.855 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.926 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.85 166.42 33.42 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 53.2 tt0 -72.68 93.54 1.65 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.774 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.961 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -81.47 82.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.604 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.573 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -93.8 120.29 33.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -31.01 118.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.373 1.082 . . . . 0.0 110.431 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.042 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.423 -1.823 0 CA-C-N 113.072 -1.876 . . . . 0.0 112.343 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.705 HG12 ' HB ' ' A' ' 236' ' ' VAL . 38.6 t . . . . . 0 CA--C 1.499 -0.995 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.595 ' HA ' HG21 ' A' ' 236' ' ' VAL . 20.7 mttt -152.56 -35.48 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.736 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.24 -174.61 3.42 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.946 ' CD1' HD12 ' A' ' 239' ' ' ILE . 6.5 pt -163.64 114.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.988 0.899 . . . . 0.0 108.878 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.846 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -89.38 110.07 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.864 -177.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.948 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.7 t -100.35 107.66 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.15 -179.56 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.06 160.3 0.0 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 1.041 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -172.15 -145.04 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.684 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -89.23 130.51 43.82 Favored Pre-proline 0 C--N 1.339 0.121 0 CA-C-O 120.898 0.38 . . . . 0.0 110.644 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -30.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.236 2.624 . . . . 0.0 112.979 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 190' ' ' SER . 15.1 t70 -150.43 52.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.266 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.041 ' OG1' HD22 ' A' ' 189' ' ' LEU . 55.1 m -42.9 124.51 3.15 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.271 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.9 Cg_endo -52.17 92.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.761 2.307 . . . . 0.0 112.286 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.65 ' OE1' HD23 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -39.75 -27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 199' ' ' ARG . 2.6 mp0 -61.49 -37.23 82.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 200' ' ' GLU . 20.4 mmmt -73.99 -50.03 21.73 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.168 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -51.72 -27.43 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 113.142 -1.844 . . . . 0.0 107.556 175.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.588 ' HD3' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -75.72 -30.92 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.813 178.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -85.59 -64.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.805 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.72 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -39.35 -39.06 0.61 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.407 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.044 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -99.92 -34.26 10.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.831 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.5 -46.08 94.53 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.63 -22.42 67.96 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.836 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.62 -37.57 86.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.962 0.887 . . . . 0.0 108.834 178.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.07 -142.85 7.86 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.997 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mm-40 -91.48 89.79 7.37 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.809 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.424 ' O ' ' HE2' ' A' ' 231' ' ' LYS . 1.8 t -53.19 141.88 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.568 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.4 -48.04 7.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 17.9 m -175.8 150.91 1.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.169 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -115.62 158.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.701 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.56 124.76 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.76 0.314 . . . . 0.0 111.018 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.971 HD21 HD12 ' A' ' 198' ' ' ILE . 1.7 mm? . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 121.443 0.64 . . . . 0.0 111.438 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.52 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.4 OUTLIER . . . . . 0 CA--C 1.518 -0.251 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.53 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 25.28 74.68 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.636 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.4 OUTLIER -138.49 -123.26 0.13 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -159.51 162.8 35.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.08 0.943 . . . . 0.0 112.692 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.018 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 2.9 m-85 -149.66 109.95 4.18 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 113.602 -1.636 . . . . 0.0 108.28 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.168 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -106.87 157.88 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.723 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 6.6 m -138.38 154.18 48.92 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.527 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.671 ' CD1' HG22 ' A' ' 236' ' ' VAL . 68.9 m-85 -132.37 120.55 22.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -42.13 -38.26 1.65 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 230' ' ' PHE . 31.3 mt-10 -89.32 -164.0 1.08 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.657 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 25.8 pt-20 -134.67 16.93 3.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.6 -63.06 0.17 Allowed Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.015 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.836 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 76.4 Cg_exo -48.03 -34.9 24.28 Favored 'Trans proline' 0 CA--C 1.494 -1.487 0 N-CA-C 108.94 -1.215 . . . . 0.0 108.94 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.832 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -65.82 -54.06 31.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.221 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 37.3 pttt -51.37 -41.83 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.022 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.664 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.22 -55.17 8.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.574 0.702 . . . . 0.0 110.048 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.946 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -29.8 -60.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.846 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -51.89 -18.21 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 111.801 -178.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.4 mm-40 -79.5 -33.47 42.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -104.71 20.87 17.89 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.946 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.617 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.05 -47.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.394 1.059 . . . . 0.0 112.148 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.617 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 20.6 m-85 -85.73 71.2 10.72 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.359 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.935 ' CE1' HD13 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.12 144.71 46.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.147 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -107.6 78.37 1.2 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -68.77 152.74 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.349 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 2.87 -70.87 0.0 OUTLIER Glycine 0 C--N 1.343 0.949 0 O-C-N 123.97 0.794 . . . . 0.0 113.854 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -120.91 -40.01 2.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.9 OUTLIER -88.94 152.41 21.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.81 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.0 134.55 28.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.575 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.948 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -151.8 158.26 43.06 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.885 -178.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.578 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 39.1 tt0 -61.93 121.63 13.44 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.923 HG21 HD12 ' A' ' 184' ' ' ILE . 1.8 mt -106.34 81.39 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.769 0.795 . . . . 0.0 112.039 -176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.1 118.85 26.77 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.784 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.2 p -34.64 115.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.409 1.099 . . . . 0.0 110.083 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.018 ' HB1' ' CE1' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.419 -1.997 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.746 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.72 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.0 t . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.592 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.2 mttt -150.77 -35.92 0.14 Allowed 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.937 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.55 -173.08 3.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.971 HD13 HD12 ' A' ' 239' ' ' ILE . 6.5 pt -165.04 109.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.207 1.003 . . . . 0.0 109.68 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.898 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -83.69 106.56 15.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.563 -178.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.95 HG13 HG12 ' A' ' 254' ' ' ILE . 4.3 t -93.82 111.75 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.643 0.777 . . . . 0.0 112.744 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -44.77 -175.98 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -32.59 162.37 0.0 OUTLIER Glycine 0 C--N 1.342 0.876 0 N-CA-C 114.824 0.69 . . . . 0.0 114.824 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.975 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -175.12 -145.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.656 ' N ' HD13 ' A' ' 189' ' ' LEU . 9.1 t -89.32 133.37 35.0 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 110.225 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 53.8 Cg_exo -29.69 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.209 2.606 . . . . 0.0 113.251 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.79 56.97 0.86 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 0.0 111.279 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.975 ' OG1' HD22 ' A' ' 189' ' ' LEU . 54.0 m -39.48 125.79 1.42 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.558 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -53.61 95.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.802 2.334 . . . . 0.0 112.189 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.6 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.38 -20.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 66.1 mt-10 -62.79 -39.51 94.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.806 ' HE2' HD21 ' A' ' 249' ' ' LEU . 1.0 OUTLIER -79.27 -46.66 17.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.097 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.62 -27.0 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.942 177.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.621 ' HA ' HD11 ' A' ' 211' ' ' ILE . 6.7 mtp85 -77.75 -28.03 50.57 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.697 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.9 mm-40 -85.8 -60.63 1.96 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.695 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -41.51 -41.49 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.613 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.925 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -99.49 -30.98 11.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.821 -178.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.13 -47.01 91.96 Favored Glycine 0 CA--C 1.504 -0.642 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 176.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -22.48 65.93 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.7 -36.89 85.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.89 0.853 . . . . 0.0 108.74 178.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.04 -138.43 5.29 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.904 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.8 mm-40 -91.89 89.88 7.22 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.023 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.47 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -55.57 139.8 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.711 ' CD ' HG21 ' A' ' 229' ' ' THR . 6.0 tt0 -89.66 -47.1 8.17 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 76.3 p -173.48 150.32 1.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.743 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.1 OUTLIER -114.59 161.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.329 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -158.9 137.48 10.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.537 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 198' ' ' ILE . 2.3 mm? . . . . . 0 CA--C 1.533 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.562 ' O ' ' C ' ' A' ' 224' ' ' GLY . 2.7 mtm180 . . . . . 0 CA--C 1.501 -0.907 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.47 81.17 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 O-C-N 124.443 1.089 . . . . 0.0 112.903 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.646 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -143.98 -120.76 0.09 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.648 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -163.4 165.08 24.34 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.325 1.06 . . . . 0.0 113.349 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.051 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.6 m-85 -150.46 111.32 4.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.729 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.097 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.5 mt -112.49 161.79 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-O 121.144 0.497 . . . . 0.0 110.476 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.711 HG21 ' CD ' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -136.7 -179.25 5.58 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.408 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 85.2 m-85 -157.07 115.83 3.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.869 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.38 -36.27 0.53 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.3 mm-40 -89.09 -157.05 0.42 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.759 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.8 pm0 -143.15 12.81 1.81 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.379 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.59 -61.73 0.2 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.842 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 81.1 Cg_exo -49.28 -32.85 26.67 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 N-CA-C 108.946 -1.213 . . . . 0.0 108.946 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.832 HG13 HG23 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.53 -53.04 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.266 -1.788 . . . . 0.0 110.153 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.7 pttt -52.84 -45.39 67.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.659 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.649 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.84 -53.84 34.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.603 0.716 . . . . 0.0 109.852 177.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.971 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -31.18 -62.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.823 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.493 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -48.35 -29.17 3.69 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 238' ' ' LYS . 8.3 mm-40 -65.79 -38.99 90.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.31 20.76 16.25 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.14 177.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.16 -49.71 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.459 0 O-C-N 124.647 1.217 . . . . 0.0 111.966 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.2 m-85 -84.84 74.59 10.46 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.598 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.961 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.4 m-70 -76.1 151.42 37.04 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 1.2 m-80 -115.07 80.67 1.45 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.502 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -74.52 108.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.566 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 39.09 -89.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.441 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.806 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -97.97 -43.37 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 9.0 m -88.25 147.88 24.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.637 0.732 . . . . 0.0 112.92 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.55 141.11 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.524 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.944 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.17 168.37 26.73 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 56.6 tt0 -73.31 96.07 2.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.375 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.95 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -83.95 81.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.737 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.583 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -94.26 118.04 31.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -27.88 120.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 122.217 1.008 . . . . 0.0 110.539 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.051 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.43 -1.474 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.105 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.708 HG12 ' HB ' ' A' ' 236' ' ' VAL . 28.6 t . . . . . 0 CA--C 1.495 -1.15 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.5 mttt -150.33 -34.39 0.17 Allowed 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.911 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -97.07 -173.59 2.73 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.001 HD13 HD12 ' A' ' 239' ' ' ILE . 13.2 pt -162.7 117.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.105 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.855 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.57 99.54 12.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.78 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.012 HG13 HG12 ' A' ' 254' ' ' ILE . 2.7 t -84.84 112.85 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.03 0.932 . . . . 0.0 110.924 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.571 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -99.18 120.91 7.03 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.497 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 97.47 108.72 2.65 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 177.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.941 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.81 -159.22 0.24 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.602 ' N ' HD13 ' A' ' 189' ' ' LEU . 26.3 t -89.04 132.75 36.99 Favored Pre-proline 0 C--N 1.342 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.744 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 190' ' ' SER . 28.2 Cg_exo -31.02 -29.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.872 3.048 . . . . 0.0 113.561 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 190' ' ' SER . 11.4 t70 -148.57 53.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.969 HG22 HD11 ' A' ' 198' ' ' ILE . 7.9 m -39.83 134.15 1.36 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.184 0.516 . . . . 0.0 110.634 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.7 Cg_endo -52.66 83.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.077 2.518 . . . . 0.0 112.084 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.581 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -39.58 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.216 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 194' ' ' PRO . 42.9 mt-10 -63.53 -35.59 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -78.33 -46.45 20.06 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.13 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -49.82 -24.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.624 177.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.569 ' HG2' HD11 ' A' ' 211' ' ' ILE . 7.8 mtp-105 -83.98 -25.96 29.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.69 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.7 OUTLIER -88.06 -35.54 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.044 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.708 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -68.33 -41.12 81.22 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.833 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -97.34 -30.96 12.65 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.894 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.08 -47.28 86.96 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.82 -23.73 61.56 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.834 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.46 -34.1 77.19 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.987 0.898 . . . . 0.0 108.859 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.84 -140.27 6.58 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 113.875 -1.512 . . . . 0.0 109.956 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.4 mm-40 -91.51 90.73 7.76 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.889 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -54.63 144.12 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.688 ' CD ' HG21 ' A' ' 229' ' ' THR . 6.6 tt0 -89.43 -49.34 6.75 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.9 p -173.17 148.99 1.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.236 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.589 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.24 163.81 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.36 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -163.12 126.57 2.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.856 0.36 . . . . 0.0 110.953 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.948 HD21 HD12 ' A' ' 198' ' ' ILE . 1.2 mm? . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.146 0.498 . . . . 0.0 111.264 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.53 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.3 OUTLIER . . . . . 0 CA--C 1.517 -0.315 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 23.28 75.63 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 O-C-N 123.635 0.584 . . . . 0.0 111.683 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.681 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.14 -120.4 0.12 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.63 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -169.77 162.95 9.77 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.194 0.997 . . . . 0.0 113.263 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.031 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.8 m-85 -144.42 123.94 13.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.634 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.13 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -119.85 157.21 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.523 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.688 HG21 ' CD ' ' A' ' 209' ' ' GLU . 1.3 m -132.77 173.52 11.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.88 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 93.1 m-85 -148.2 117.4 6.86 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.609 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.48 -37.37 1.06 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.507 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -90.19 -154.87 0.35 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.62 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -142.07 1.98 1.48 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.696 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -83.75 -57.46 0.41 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.834 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 75.2 Cg_exo -49.18 -33.29 27.22 Favored 'Trans proline' 0 CA--C 1.492 -1.584 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.795 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -64.94 -52.07 58.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.419 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.4 mtpt -46.54 -56.45 6.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.03 -53.58 56.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.6 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.006 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -32.94 -61.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.699 -179.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.582 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 30.8 mtm -49.94 -20.12 0.85 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -75.57 -33.31 60.6 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.34 22.83 15.39 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.075 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -16.05 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 112.332 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.91 72.7 10.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.314 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 1.006 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.3 m-70 -73.55 146.61 44.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.2 m-80 -107.63 79.6 1.31 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.365 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.69 147.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.256 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 7.4 -73.9 0.0 OUTLIER Glycine 0 C--N 1.343 0.941 0 O-C-N 124.032 0.833 . . . . 0.0 113.679 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -116.71 -41.18 3.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.731 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -89.16 152.07 21.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.866 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.87 144.76 39.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.94 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.879 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.26 168.88 25.36 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 118.739 -1.185 . . . . 0.0 114.093 -177.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 49.9 tt0 -75.39 93.01 2.87 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 1.012 HG12 HG13 ' A' ' 186' ' ' VAL . 1.1 mt -80.18 83.44 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.751 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.588 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.9 OUTLIER -96.04 117.36 30.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.5 p -29.74 117.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 119.703 1.138 . . . . 0.0 110.161 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.031 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.422 -1.828 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.451 -175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.764 HG12 ' HB ' ' A' ' 236' ' ' VAL . 42.2 t . . . . . 0 CA--C 1.494 -1.182 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.9 mttt -150.57 -35.36 0.15 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 118.889 -1.124 . . . . 0.0 112.042 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.941 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -96.46 -173.9 2.9 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.058 HD13 HD12 ' A' ' 239' ' ' ILE . 4.9 pt -162.45 115.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.831 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -93.08 92.57 7.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.019 -177.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.054 HG13 HG12 ' A' ' 254' ' ' ILE . 2.2 t -73.37 148.09 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.546 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -93.84 -167.64 37.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.389 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -23.55 150.11 0.0 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 1.051 HD21 HD12 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -176.46 -147.11 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.669 ' N ' HD13 ' A' ' 189' ' ' LEU . 1.3 m -89.41 129.93 45.58 Favored Pre-proline 0 C--N 1.341 0.199 0 CA-C-O 120.96 0.409 . . . . 0.0 110.508 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -32.03 -28.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.391 2.728 . . . . 0.0 113.409 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.8 t0 -149.68 53.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.624 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.974 ' OG1' HD22 ' A' ' 189' ' ' LEU . 16.9 m -39.91 124.75 1.59 Allowed Pre-proline 0 CA--C 1.519 -0.245 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.087 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 6.2 Cg_endo -48.58 94.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.56 2.174 . . . . 0.0 111.988 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.601 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -45.24 -21.32 0.07 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.707 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -37.65 88.06 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.763 ' HE2' HD21 ' A' ' 249' ' ' LEU . 1.3 mttp -77.68 -49.09 15.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.129 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -47.18 -28.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.931 176.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.674 ' HG2' HD11 ' A' ' 211' ' ' ILE . 12.0 mtt180 -79.64 -27.99 40.92 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.33 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 5.2 pt-20 -87.47 -53.01 5.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.677 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -51.48 -39.5 57.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.342 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.131 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -98.75 -35.83 10.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.673 -178.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.94 -42.93 99.57 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -66.04 -22.48 70.62 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.823 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.21 -37.85 84.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.3 1.048 . . . . 0.0 108.399 178.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.52 -156.67 28.3 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.157 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.5 mt-10 -81.6 90.91 6.32 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.645 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.6 t -53.01 142.75 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.559 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.1 tp10 -89.41 -46.97 8.33 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.4 ' C ' HG12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -167.79 169.79 11.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.184 178.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.674 HD11 ' HG2' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -133.49 166.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.763 ' C ' HD22 ' A' ' 213' ' ' LEU . 2.1 tp10 -162.67 148.37 12.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.709 0.29 . . . . 0.0 111.352 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.051 HD12 HD21 ' A' ' 189' ' ' LEU . 2.8 mm? . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.305 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.522 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.871 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 23.58 77.87 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.136 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.554 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 7.2 p90 -131.26 -130.6 0.2 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.744 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -154.27 162.53 41.12 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.198 0.523 . . . . 0.0 110.355 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.161 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 1.8 m-85 -150.5 118.02 6.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.525 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.131 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.3 mt -119.13 142.35 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 122.051 0.929 . . . . 0.0 110.492 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.0 m -120.09 149.55 42.01 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.284 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.66 ' CD1' HG22 ' A' ' 236' ' ' VAL . 63.8 m-85 -130.71 116.67 18.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -39.39 -36.63 0.37 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.227 1.013 . . . . 0.0 108.299 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.2 mm-40 -88.44 -155.87 0.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.992 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.6 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.3 OUTLIER -144.97 11.4 1.37 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.4 -59.07 0.22 Allowed Pre-proline 0 C--O 1.224 -0.254 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.823 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.0 Cg_exo -51.33 -32.48 41.89 Favored 'Trans proline' 0 CA--C 1.496 -1.388 0 N-CA-C 108.678 -1.316 . . . . 0.0 108.678 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.764 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -66.95 -54.5 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.056 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.6 OUTLIER -51.54 -45.25 62.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.84 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.688 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -53.97 31.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.456 0.646 . . . . 0.0 109.74 178.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.058 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -32.69 -65.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.336 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -48.71 -25.35 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 238' ' ' LYS . 5.6 mm-40 -67.88 -37.14 81.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -105.52 22.96 14.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.241 178.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.609 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.78 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.655 1.222 . . . . 0.0 111.985 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -84.52 72.22 10.67 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.983 0.42 . . . . 0.0 110.742 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.924 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.0 m-70 -74.23 159.15 32.88 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.393 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 251' ' ' LYS . 5.2 m-80 -119.75 74.26 1.01 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.45 101.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.675 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.65 -87.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.54 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.763 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -99.87 -42.34 6.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.158 0.504 . . . . 0.0 110.559 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 247' ' ' VAL . 41.9 m -88.44 143.81 26.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.372 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.02 133.19 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.266 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.039 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -153.62 169.35 23.47 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.483 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 47.8 tt0 -72.9 104.9 4.2 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.004 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 1.054 HG12 HG13 ' A' ' 186' ' ' VAL . 1.8 mt -91.12 79.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.643 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.6 mtpt -87.45 119.04 27.33 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.1 p -33.73 115.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.518 1.152 . . . . 0.0 110.644 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.161 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.421 -1.881 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.955 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.689 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.6 t . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 25.6 mttt -151.27 -35.41 0.14 Allowed 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 118.873 -1.131 . . . . 0.0 112.259 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -92.47 -172.64 3.14 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.041 HD13 HD12 ' A' ' 239' ' ' ILE . 6.8 pt -166.03 111.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 122.025 0.916 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.935 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -83.57 103.27 12.77 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.046 -178.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.95 HG13 HG12 ' A' ' 254' ' ' ILE . 2.7 t -89.62 106.37 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.638 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -98.08 122.71 7.6 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 115.964 1.145 . . . . 0.0 115.964 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.58 107.72 2.85 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.973 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.64 -158.89 0.23 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.6 ' N ' HD13 ' A' ' 189' ' ' LEU . 46.3 t -88.85 135.61 31.79 Favored Pre-proline 0 C--N 1.343 0.318 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.878 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 192' ' ' ASP . 87.8 Cg_exo -29.63 -32.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.669 2.913 . . . . 0.0 113.576 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.8 OUTLIER -150.65 54.75 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.617 0.246 . . . . 0.0 111.195 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.973 ' OG1' HD22 ' A' ' 189' ' ' LEU . 17.9 m -39.77 134.1 1.34 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 110.819 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.52 ' O ' HG13 ' A' ' 198' ' ' ILE . 11.8 Cg_endo -55.1 89.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.774 2.316 . . . . 0.0 111.75 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.594 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -44.43 -22.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.034 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.51 -35.69 81.78 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.17 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.84 -47.11 17.24 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.128 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -50.02 -24.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.196 177.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.559 ' HG2' HD11 ' A' ' 211' ' ' ILE . 1.7 mtt180 -82.03 -26.8 33.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.792 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -87.37 -43.86 11.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.874 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.721 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -58.63 -43.25 89.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.441 0.639 . . . . 0.0 110.066 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.849 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.2 m-85 -94.97 -32.05 13.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.369 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.3 -44.68 95.13 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.674 -2.171 . . . . 0.0 107.674 175.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -23.36 66.82 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.869 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.29 -34.31 77.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.072 0.939 . . . . 0.0 108.709 177.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.92 -142.4 7.97 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.895 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 18.1 mt-10 -91.18 92.54 8.71 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.7 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -55.66 144.84 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.558 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.4 tp10 -89.76 -50.33 6.12 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 72.2 m -171.77 148.1 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.296 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.02 158.85 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 211' ' ' ILE . 0.3 OUTLIER -155.23 129.69 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.969 HD21 HD12 ' A' ' 198' ' ' ILE . 4.5 mm? . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.55 0.69 . . . . 0.0 111.322 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.554 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.4 OUTLIER . . . . . 0 CA--C 1.516 -0.354 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 8.64 82.26 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.923 0.764 . . . . 0.0 113.062 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.71 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.22 -120.57 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.03 167.47 12.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.143 0.973 . . . . 0.0 112.288 177.018 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.058 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.2 m-85 -148.95 113.48 5.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.099 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.128 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -109.3 158.58 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.0 m -140.28 155.64 46.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.927 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 70.5 m-85 -131.41 123.0 27.24 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -43.93 -38.22 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mm-40 -90.31 -168.06 2.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.372 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.608 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -131.12 15.57 5.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -92.4 -62.07 0.19 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.869 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.8 Cg_exo -49.03 -31.96 22.21 Favored 'Trans proline' 0 CA--C 1.497 -1.332 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -66.82 -54.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.637 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 30.9 pttt -50.93 -46.77 61.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.549 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.641 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -56.4 11.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.414 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.041 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.19 -60.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.028 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.49 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.4 mtp -46.23 -31.25 2.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.0 OUTLIER -65.83 -39.54 90.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.17 19.69 14.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.585 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.44 -50.42 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 O-C-N 124.722 1.264 . . . . 0.0 112.114 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.68 72.45 10.57 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.42 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 1.027 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.1 m-70 -73.54 142.19 46.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.965 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -103.54 79.32 1.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.929 0.395 . . . . 0.0 111.394 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -66.88 151.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.171 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 1.82 -69.76 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 O-C-N 124.002 0.814 . . . . 0.0 113.817 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -118.91 -44.3 2.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.093 0.473 . . . . 0.0 110.787 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.568 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -89.82 152.29 21.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.615 -178.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.52 144.35 46.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.169 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.941 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -155.41 164.48 38.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -178.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 44.9 tt0 -72.74 92.01 1.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.453 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.95 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -81.38 81.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.935 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.7 OUTLIER -96.64 119.06 34.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -27.87 119.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 122.264 1.031 . . . . 0.0 110.197 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.058 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.424 -1.731 0 CA-C-N 113.186 -1.824 . . . . 0.0 113.323 -175.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.734 HG12 ' HB ' ' A' ' 236' ' ' VAL . 41.3 t . . . . . 0 CA--C 1.491 -1.304 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 236' ' ' VAL . 20.2 mttt -150.81 -33.55 0.16 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.81 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.893 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -104.9 -166.96 1.29 Allowed 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.043 HD13 HD12 ' A' ' 239' ' ' ILE . 12.4 pt -164.05 139.1 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.421 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.706 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -110.48 98.4 7.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.096 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 1.082 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.1 t -80.83 148.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.556 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -95.45 -171.74 36.41 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.766 -0.73 . . . . 0.0 114.085 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -21.51 148.44 0.0 OUTLIER Glycine 0 C--N 1.343 0.97 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.996 HD21 HD12 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -169.9 -144.85 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.734 ' N ' HD13 ' A' ' 189' ' ' LEU . 36.0 m -89.39 129.63 46.71 Favored Pre-proline 0 C--N 1.343 0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -29.66 -31.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.546 2.831 . . . . 0.0 113.532 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 190' ' ' SER . 41.7 m-20 -151.14 54.2 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.987 ' OG1' HD22 ' A' ' 189' ' ' LEU . 24.1 m -41.16 117.46 1.57 Allowed Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.371 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.578 ' HG2' ' CE ' ' A' ' 197' ' ' LYS . 9.0 Cg_endo -49.9 101.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.882 2.388 . . . . 0.0 112.209 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.599 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -48.38 -18.28 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.973 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 60.1 mt-10 -63.92 -37.43 87.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.578 ' CE ' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -81.52 -45.88 15.3 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.14 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -51.13 -27.59 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.346 176.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.621 ' HG2' HD11 ' A' ' 211' ' ' ILE . 1.2 mtt180 -77.04 -27.88 54.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.812 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.2 mm-40 -85.76 -62.74 1.46 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.586 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.666 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -41.3 -40.93 1.79 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.067 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -98.11 -34.15 10.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.614 -178.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.36 -45.68 95.45 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 176.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.67 -22.41 68.03 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.803 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.82 -36.94 84.89 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 122.521 1.153 . . . . 0.0 108.227 177.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.74 -162.15 35.61 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.863 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.7 mt-10 -76.58 93.09 3.54 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.557 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 202' ' ' PHE . 1.6 t -53.73 142.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.56 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -89.53 -44.05 10.38 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 211' ' ' ILE . 67.2 m -170.92 172.42 5.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.112 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -137.13 161.08 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.981 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.838 ' C ' HD22 ' A' ' 213' ' ' LEU . 0.3 OUTLIER -161.33 143.94 12.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.996 HD12 HD21 ' A' ' 189' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 111.319 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.527 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.801 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.714 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 21.41 78.62 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.472 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 8.4 p90 -130.1 -130.15 0.21 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.716 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.386 0.612 . . . . 0.0 111.375 178.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.121 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -151.02 111.58 4.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.912 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.14 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.5 mt -112.8 148.49 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 8.4 m -124.56 152.28 43.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.126 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 68.6 m-85 -132.11 119.02 20.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.56 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.21 -38.19 0.74 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.2 mt-10 -89.06 -155.48 0.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.711 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 2.0 pm0 -141.83 4.89 1.72 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.552 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 14.2 mt-10 -86.63 -56.15 0.36 Allowed Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.803 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 94.0 Cg_exo -51.45 -31.99 41.06 Favored 'Trans proline' 0 CA--C 1.494 -1.482 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.734 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -65.41 -50.62 71.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.342 177.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 22.3 mttm -47.93 -58.64 4.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.043 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.685 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.23 -51.99 66.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.155 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.043 HD12 HD13 ' A' ' 184' ' ' ILE . 0.7 OUTLIER -36.65 -63.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.114 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -52.56 -18.17 1.6 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.298 -179.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' LYS . 14.0 mm-40 -76.67 -33.52 58.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.81 24.15 13.51 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.766 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.599 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.34 -47.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.354 1.034 . . . . 0.0 112.122 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.599 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 23.0 m-85 -84.69 69.87 10.71 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.529 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.861 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.4 m-70 -70.46 156.22 39.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.832 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -122.04 72.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.639 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -61.55 141.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.446 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 12.14 -76.82 0.0 OUTLIER Glycine 0 C--N 1.338 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 113.899 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.99 -42.5 3.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 14.5 m -88.01 145.37 26.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.702 0.763 . . . . 0.0 112.645 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.6 133.28 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 107.888 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 1.082 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.54 163.53 39.41 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 118.636 -1.226 . . . . 0.0 114.27 -176.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.462 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 42.5 tt0 -67.57 108.66 2.95 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.215 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.972 HG12 HG13 ' A' ' 186' ' ' VAL . 2.1 mt -98.49 79.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.196 -1.365 . . . . 0.0 112.453 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.629 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.39 119.92 28.15 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.709 ' O ' HG13 ' A' ' 256' ' ' VAL . 2.9 p -36.25 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 123.051 1.405 . . . . 0.0 110.876 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.121 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.412 -2.368 0 CA-C-N 112.097 -2.32 . . . . 0.0 112.059 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.702 HG12 ' HB ' ' A' ' 236' ' ' VAL . 29.2 t . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HA ' HG21 ' A' ' 236' ' ' VAL . 21.9 mttt -150.31 -35.03 0.16 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.133 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.18 -170.84 2.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.032 HD13 HD12 ' A' ' 239' ' ' ILE . 11.6 pt -165.33 117.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.825 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.06 100.22 12.68 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.879 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.965 HG13 HG12 ' A' ' 254' ' ' ILE . 2.8 t -85.04 111.26 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.067 0.947 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . -97.77 119.43 6.42 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.117 1.207 . . . . 0.0 116.117 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.494 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . 98.72 105.95 2.59 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 114.903 0.721 . . . . 0.0 114.903 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.943 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -166.07 -157.63 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.631 ' N ' HD13 ' A' ' 189' ' ' LEU . 58.8 m -89.25 133.17 35.54 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -29.76 -31.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.695 2.93 . . . . 0.0 113.663 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.8 m-20 -150.41 54.2 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.431 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.943 ' OG1' HD22 ' A' ' 189' ' ' LEU . 32.4 m -40.65 128.49 1.86 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.511 ' O ' HG13 ' A' ' 198' ' ' ILE . 6.3 Cg_endo -49.2 90.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.164 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.681 ' OE1' HD23 ' A' ' 213' ' ' LEU . 0.9 OUTLIER -42.43 -23.57 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.511 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.64 -37.56 87.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.1 mmmt -77.36 -48.27 17.74 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.118 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.73 -26.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.256 177.286 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.56 ' HA ' HD11 ' A' ' 211' ' ' ILE . 10.4 mtt85 -79.67 -27.25 40.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.937 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 pt-20 -86.42 -50.96 6.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.694 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -51.57 -40.24 59.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.541 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.889 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -98.93 -30.31 12.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.176 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.63 -47.36 87.51 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -61.66 -23.57 63.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.826 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.38 -34.23 77.5 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.25 -142.53 8.14 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 8.7 mt-10 -90.72 94.67 9.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.256 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -56.59 143.1 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.604 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.5 tp10 -89.27 -47.53 7.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 68.1 m -174.06 147.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.374 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.598 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.16 161.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.437 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.3 OUTLIER -160.47 127.76 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 111.226 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 1.073 HD21 HD12 ' A' ' 198' ' ' ILE . 1.5 mm? . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.458 0.647 . . . . 0.0 111.803 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.513 -0.459 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 22.43 76.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 O-C-N 123.705 0.628 . . . . 0.0 112.575 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.651 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -147.58 -123.14 0.06 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.625 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.08 164.57 20.37 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 113.201 178.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.018 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.1 m-85 -148.24 116.05 6.37 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 113.626 -1.625 . . . . 0.0 108.742 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.118 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -115.17 159.58 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.621 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.7 m -136.83 169.02 18.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.197 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 86.2 m-85 -145.94 116.64 7.65 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.604 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.6 -36.93 0.65 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.572 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 3.7 pm0 -89.03 -155.97 0.37 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.473 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.59 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 19.1 pt-20 -141.17 -2.59 1.27 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.885 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.7 -57.33 0.83 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 -177.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.826 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.9 Cg_exo -51.04 -34.18 45.89 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.829 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.1 t -64.72 -51.48 66.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.85 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 16.8 mtpt -44.99 -58.79 2.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.933 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.67 -52.76 64.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.627 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.032 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.92 -62.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.175 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.3 mtp -51.3 -20.85 1.84 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.919 0.39 . . . . 0.0 111.251 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -75.72 -34.28 60.33 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.19 22.39 16.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.617 178.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.76 -48.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 0.0 112.29 -179.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 242' ' ' LYS . 23.4 m-30 -84.4 71.79 10.66 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.66 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.953 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -72.75 154.49 40.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.18 79.56 1.36 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.04 152.53 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.575 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 0.79 -68.85 0.0 OUTLIER Glycine 0 C--N 1.343 0.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.899 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -117.3 -43.59 2.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.0 110.997 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.561 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 9.1 m -89.77 153.84 20.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.033 0.921 . . . . 0.0 113.283 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.27 139.77 39.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.183 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.872 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.98 169.57 24.52 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 118.613 -1.235 . . . . 0.0 114.157 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.3 tt0 -75.88 92.15 3.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.738 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.965 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -79.93 81.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.837 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.58 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 2.7 mtpt -93.7 116.98 29.5 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.4 p -29.17 119.65 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 122.267 1.032 . . . . 0.0 110.744 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.018 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.428 -1.557 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.47 -175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' A' ' 236' ' ' VAL . 40.8 t . . . . . 0 CA--C 1.495 -1.151 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.695 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.6 mttt -148.34 -35.42 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.867 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -94.79 -175.49 3.59 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.978 ' CD1' HD12 ' A' ' 239' ' ' ILE . 5.4 pt -162.38 117.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.837 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.4 109.1 20.67 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.415 -177.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.924 HG13 HG12 ' A' ' 254' ' ' ILE . 2.4 t -97.67 115.32 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.757 0.823 . . . . 0.0 112.984 -178.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -49.3 -177.14 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 114.796 0.678 . . . . 0.0 114.796 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -31.49 161.74 0.0 OUTLIER Glycine 0 C--N 1.342 0.914 0 N-CA-C 114.653 0.621 . . . . 0.0 114.653 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.978 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -175.42 -143.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 189' ' ' LEU . 1.3 m -88.5 135.4 32.64 Favored Pre-proline 0 C--N 1.343 0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 44.2 Cg_exo -28.78 -39.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.159 2.573 . . . . 0.0 113.033 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.5 56.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.978 ' OG1' HD22 ' A' ' 189' ' ' LEU . 86.1 m -39.21 127.95 1.3 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.498 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.9 Cg_endo -50.53 96.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.259 2.64 . . . . 0.0 113.808 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.783 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -39.75 -28.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.207 178.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 194' ' ' PRO . 2.9 mm-40 -61.23 -36.78 80.88 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.183 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 200' ' ' GLU . 3.0 mmmt -77.64 -52.29 9.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.166 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -46.91 -26.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.04 176.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.708 ' HG2' HD11 ' A' ' 211' ' ' ILE . 8.1 mtp180 -82.31 -26.84 32.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.101 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.8 OUTLIER -87.48 -41.12 13.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.998 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.3 t80 -67.14 -38.27 85.25 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.369 0.604 . . . . 0.0 110.358 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.99 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -98.26 -37.06 9.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.396 -178.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.5 -43.69 96.27 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.14 -23.98 66.69 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.834 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -37.52 86.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.084 0.945 . . . . 0.0 108.902 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.88 -140.51 6.41 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 32.6 mt-10 -92.06 94.6 9.33 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.213 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -60.95 144.91 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.588 ' CD ' HG21 ' A' ' 229' ' ' THR . 15.4 tt0 -89.79 -53.14 4.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.8 m -171.22 148.43 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.625 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.746 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.64 166.84 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.138 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -165.36 123.69 1.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.067 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.834 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.5 mm? . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 111.439 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.1 OUTLIER . . . . . 0 CA--C 1.505 -0.782 0 CA-C-O 119.79 -0.147 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.584 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.88 81.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.49 0 O-C-N 124.218 0.949 . . . . 0.0 112.212 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.617 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -149.92 -119.85 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.084 -0.558 . . . . 0.0 109.574 -176.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.589 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -172.62 168.91 5.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.0 0.905 . . . . 0.0 112.805 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.026 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.2 m-85 -150.41 125.37 9.88 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.349 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.166 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -119.92 147.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.528 0.68 . . . . 0.0 110.071 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 3.1 m -126.09 153.14 44.91 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.1 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.659 ' CD1' HG22 ' A' ' 236' ' ' VAL . 89.1 m-85 -129.01 120.64 26.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.547 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.26 -38.99 2.81 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mt-10 -90.13 -167.1 1.75 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.665 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.612 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -132.56 15.56 4.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.64 -64.88 0.15 Allowed Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.834 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 52.7 Cg_exo -46.34 -35.2 15.44 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.801 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -65.48 -52.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.241 -1.799 . . . . 0.0 110.349 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.6 pttt -52.26 -45.19 65.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.549 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.654 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.23 -54.78 20.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.618 0.723 . . . . 0.0 109.935 177.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.978 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -29.59 -64.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.159 -179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -49.4 -22.33 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.276 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.4 mm-40 -74.29 -37.1 63.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.613 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -100.33 19.84 15.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.375 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.62 -48.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.52 1.137 . . . . 0.0 112.166 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 242' ' ' LYS . 18.5 m-85 -86.66 71.17 10.41 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.351 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.876 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.7 m-70 -71.68 148.51 46.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.346 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.74 77.23 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.097 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 248' ' ' GLY . 2.2 t -62.97 171.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.67 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.706 ' C ' HD23 ' A' ' 249' ' ' LEU . . . -14.67 -59.27 0.01 OUTLIER Glycine 0 C--N 1.341 0.806 0 O-C-N 123.781 0.676 . . . . 0.0 113.367 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.706 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -132.04 -41.61 1.01 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.398 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -87.94 152.05 22.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.67 0.748 . . . . 0.0 112.755 -177.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.99 135.61 36.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.812 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.921 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.58 157.56 41.2 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.634 -0.826 . . . . 0.0 112.92 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.585 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 64.8 tt0 -60.76 119.16 7.63 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.963 HG21 HD12 ' A' ' 184' ' ' ILE . 1.7 mt -104.36 82.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.813 0.816 . . . . 0.0 111.85 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.586 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.0 118.72 26.57 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.197 -1.365 . . . . 0.0 107.695 178.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.5 p -33.73 120.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 119.546 1.066 . . . . 0.0 109.777 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.026 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.423 -1.799 0 CA-C-N 113.226 -1.807 . . . . 0.0 113.053 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.67 HG12 ' HB ' ' A' ' 236' ' ' VAL . 32.0 t . . . . . 0 CA--C 1.497 -1.091 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.6 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.4 mttt -151.44 -35.17 0.14 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.175 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.871 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.73 -173.19 3.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.015 HD13 HD12 ' A' ' 239' ' ' ILE . 7.8 pt -165.86 108.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 122.519 1.152 . . . . 0.0 109.502 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.901 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -81.53 103.59 11.37 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.754 -178.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 254' ' ' ILE . 64.3 t -89.87 131.44 37.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.976 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.512 ' C ' ' HB2' ' A' ' 225' ' ' PHE . . . -64.33 -176.48 4.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -37.82 172.59 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.023 -0.589 . . . . 0.0 114.128 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 225' ' ' PHE . 0.2 OUTLIER 169.63 -139.8 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.361 -0.135 . . . . 0.0 111.123 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.574 ' N ' HD13 ' A' ' 189' ' ' LEU . 6.1 m -88.78 130.69 44.08 Favored Pre-proline 0 C--N 1.339 0.149 0 CA-C-O 120.966 0.412 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -32.63 -30.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.058 2.505 . . . . 0.0 112.931 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -151.29 54.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.861 ' HB ' HD11 ' A' ' 213' ' ' LEU . 47.9 m -39.54 128.51 1.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.268 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.576 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.4 Cg_endo -52.29 96.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.803 2.335 . . . . 0.0 111.889 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.612 ' HA ' HG13 ' A' ' 198' ' ' ILE . 1.1 pm0 -46.31 -17.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 26.9 mt-10 -65.13 -40.47 94.51 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.576 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -78.51 -45.72 21.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.093 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.83 -26.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.892 176.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.576 ' HA ' HD11 ' A' ' 211' ' ' ILE . 2.9 mtt85 -77.36 -28.41 52.97 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.514 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.0 mm-40 -85.29 -60.64 1.97 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.773 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.696 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -42.21 -42.55 3.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.905 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -97.88 -31.5 12.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.15 -49.77 71.68 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 176.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.64 -23.26 60.55 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.29 -36.74 85.09 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.825 0.822 . . . . 0.0 108.805 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.62 -139.01 5.62 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.908 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 66.9 mt-10 -91.71 89.7 7.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.996 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -55.57 141.07 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.566 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.6 tp10 -90.08 -48.3 7.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 21.5 m -174.27 149.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.626 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -113.29 156.92 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.748 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.1 OUTLIER -154.19 125.74 7.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.991 HD21 ' CD1' ' A' ' 198' ' ' ILE . 3.2 mm? . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 121.219 0.533 . . . . 0.0 111.103 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.588 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 CA--C 1.508 -0.636 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.588 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.67 82.23 0.01 OUTLIER Glycine 0 C--N 1.336 0.547 0 O-C-N 124.114 0.884 . . . . 0.0 112.008 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.779 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -149.93 -116.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.563 ' SG ' HD22 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -174.07 169.26 4.01 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.496 1.141 . . . . 0.0 112.824 177.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.034 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m-85 -151.51 110.6 3.9 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.858 -1.973 . . . . 0.0 108.519 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.093 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.2 mt -108.72 159.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.333 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.8 m -137.38 170.8 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.158 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.655 ' CD1' HG22 ' A' ' 236' ' ' VAL . 75.8 m-85 -148.02 114.08 5.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.566 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -38.67 -35.34 0.19 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 17.2 mt-10 -88.6 -153.63 0.26 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.772 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.7 OUTLIER -148.44 13.27 0.95 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.075 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 1.2 mt-10 -94.27 -57.81 0.21 Allowed Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.842 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 87.7 Cg_exo -51.43 -31.94 40.67 Favored 'Trans proline' 0 CA--C 1.496 -1.417 0 N-CA-C 108.793 -1.272 . . . . 0.0 108.793 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -68.01 -55.02 18.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.821 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -50.99 -42.39 60.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.157 -179.179 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.655 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.06 -54.62 10.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.601 0.715 . . . . 0.0 109.957 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.015 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.2 -63.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.865 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.584 ' HE3' ' O ' ' A' ' 236' ' ' VAL . 19.2 mtm -45.76 -29.63 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.7 mm-40 -64.78 -40.9 96.03 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.36 20.51 13.56 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.586 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.49 -50.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.635 1.209 . . . . 0.0 112.185 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.5 m-85 -85.58 69.29 10.63 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.994 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -69.18 149.7 48.3 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.74 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -112.62 80.72 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -74.04 100.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.04 -84.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.707 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.54 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -105.54 -42.18 5.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 247' ' ' VAL . 56.1 m -88.81 146.84 24.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.721 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.42 138.32 32.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.475 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.657 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.99 153.59 26.33 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.664 -177.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.574 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 28.2 tt0 -57.96 114.55 2.39 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.969 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.895 ' CG2' HD12 ' A' ' 184' ' ' ILE . 1.8 mt -103.33 83.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.793 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -91.86 117.78 30.11 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.351 178.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.3 p -30.57 122.75 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 119.376 0.989 . . . . 0.0 109.936 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.034 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.431 -1.421 0 CA-C-N 113.677 -1.602 . . . . 0.0 113.004 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.66 HG12 ' HB ' ' A' ' 236' ' ' VAL . 28.3 t . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 236' ' ' VAL . 26.0 mttt -152.55 -34.97 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.717 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -93.58 -179.32 4.99 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.654 179.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.01 HD12 HG21 ' A' ' 254' ' ' ILE . 5.9 pt -161.1 112.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 122.098 0.952 . . . . 0.0 108.897 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.873 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -87.04 104.7 16.57 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.147 -177.334 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.975 HG13 HG12 ' A' ' 254' ' ' ILE . 2.6 t -91.02 112.11 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.431 0.693 . . . . 0.0 111.44 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -52.38 -172.64 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.5 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -28.16 156.95 0.0 OUTLIER Glycine 0 N--CA 1.468 0.794 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.993 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -171.08 -145.41 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.663 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.74 132.4 38.66 Favored Pre-proline 0 C--N 1.341 0.215 0 CA-C-O 120.8 0.333 . . . . 0.0 110.213 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 73.4 Cg_exo -29.7 -33.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.298 2.665 . . . . 0.0 113.126 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 190' ' ' SER . 1.9 m-20 -150.92 54.33 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.408 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.993 ' OG1' HD22 ' A' ' 189' ' ' LEU . 25.5 m -39.95 122.54 1.57 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.608 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 11.2 Cg_endo -53.81 98.56 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.89 2.393 . . . . 0.0 112.22 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.605 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.5 OUTLIER -44.73 -21.39 0.05 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.766 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 2.2 mp0 -62.1 -39.09 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.787 ' HE2' HD21 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.28 -44.97 18.71 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.121 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.59 -28.63 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.172 -1.377 . . . . 0.0 108.899 177.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.565 ' HA ' HD11 ' A' ' 211' ' ' ILE . 0.1 OUTLIER -76.07 -27.99 57.44 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.366 177.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mm-40 -84.03 -61.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.898 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.671 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.3 t80 -41.68 -39.38 1.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.284 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.857 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -100.81 -33.93 10.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.372 -177.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.59 -48.28 82.84 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.3 -23.06 63.95 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.774 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -65.93 -38.15 87.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 122.153 0.978 . . . . 0.0 108.849 177.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.24 -143.01 8.04 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.639 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.6 mt-10 -92.05 97.15 10.76 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.293 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -61.39 143.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.689 ' CD ' HG21 ' A' ' 229' ' ' THR . 13.4 tt0 -89.07 -52.45 5.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 60.7 p -169.67 147.47 3.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.628 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.666 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.32 161.68 8.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.449 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -159.55 128.55 5.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.304 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.77 HD21 HD12 ' A' ' 198' ' ' ILE . 1.5 mm? . . . . . 0 CA--C 1.53 0.201 0 CA-C-O 121.442 0.639 . . . . 0.0 110.996 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.553 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.507 -0.683 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.93 78.08 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 O-C-N 124.005 0.816 . . . . 0.0 112.994 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.654 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.86 -121.21 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.702 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.81 166.5 11.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.099 0.952 . . . . 0.0 112.888 178.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.034 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.0 m-85 -148.24 119.58 7.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.318 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.121 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -115.75 146.18 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.631 0.729 . . . . 0.0 110.3 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.689 HG21 ' CD ' ' A' ' 209' ' ' GLU . 3.3 m -124.15 164.52 19.31 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.101 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 96.4 m-85 -139.44 119.85 13.93 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -42.57 -38.93 2.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.4 mm-40 -91.21 -168.04 1.96 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.488 -1.687 . . . . 0.0 110.732 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.588 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 4.8 pt-20 -129.6 16.8 5.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.656 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -89.62 -64.49 0.19 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.937 ' O ' HD12 ' A' ' 239' ' ' ILE . 82.9 Cg_exo -46.13 -30.83 8.01 Favored 'Trans proline' 0 CA--C 1.5 -1.182 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.858 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -72.23 -54.49 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.757 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -51.18 -32.9 25.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.541 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.664 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -83.75 -56.48 3.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.147 178.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.937 HD12 ' O ' ' A' ' 235' ' ' PRO . 0.8 OUTLIER -30.28 -57.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.322 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.8 mtp -51.24 -19.67 1.32 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.859 0.361 . . . . 0.0 111.733 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 3.8 mm-40 -79.62 -33.57 41.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.58 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -107.67 21.85 16.84 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.309 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.613 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -18.61 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.218 0.949 . . . . 0.0 112.117 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.613 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 22.0 m-85 -85.84 78.97 9.42 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.747 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.816 ' CG ' HD12 ' A' ' 254' ' ' ILE . 13.9 m-70 -76.18 -170.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.9 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.5 m-80 -151.54 81.32 1.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -81.33 106.59 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.504 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 38.73 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.381 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.787 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -95.6 -43.0 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 111.457 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -88.51 150.26 23.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -147.96 133.1 18.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.331 179.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.962 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -154.13 173.72 15.69 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.551 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 61.5 tt0 -76.91 97.78 4.7 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.452 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 1.01 HG21 HD12 ' A' ' 184' ' ' ILE . 1.8 mt -86.59 83.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.709 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.607 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.3 mtpt -94.99 122.46 37.67 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.7 p -32.91 110.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.631 1.205 . . . . 0.0 110.524 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.034 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.419 -2.021 0 CA-C-N 112.65 -2.068 . . . . 0.0 112.977 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.74 HG12 ' HB ' ' A' ' 236' ' ' VAL . 38.5 t . . . . . 0 CA--C 1.492 -1.261 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.0 mttt -150.32 -34.02 0.17 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.65 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -103.53 -168.52 1.52 Allowed 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 1.071 HD13 HD12 ' A' ' 239' ' ' ILE . 16.7 pt -163.02 138.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.605 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.749 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -108.87 91.13 3.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.112 0.482 . . . . 0.0 112.24 -178.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.927 HG13 HG12 ' A' ' 254' ' ' ILE . 2.0 t -68.21 138.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.585 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -130.71 111.49 1.13 Allowed Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.995 -1.098 . . . . 0.0 114.483 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.555 ' H ' ' HB3' ' A' ' 225' ' ' PHE . . . 108.87 102.97 2.8 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.638 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.752 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -170.59 -154.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.61 ' N ' HD13 ' A' ' 189' ' ' LEU . 14.0 m -89.46 136.64 29.59 Favored Pre-proline 0 C--N 1.341 0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.499 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -31.3 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.38 2.72 . . . . 0.0 113.515 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 190' ' ' SER . 8.4 t0 -150.98 56.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.759 HG22 HD11 ' A' ' 198' ' ' ILE . 2.6 m -39.13 128.97 1.26 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 5.2 Cg_endo -47.16 97.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.858 2.372 . . . . 0.0 112.191 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 198' ' ' ILE . 3.5 pt-20 -48.02 -17.95 0.16 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.11 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.79 -36.93 83.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.629 ' HE2' HD21 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -80.0 -46.26 16.95 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.141 HG22 ' CD1' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.08 -31.5 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.519 176.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' A' ' 211' ' ' ILE . 5.3 mtp180 -74.13 -28.89 61.55 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.176 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -87.57 -63.76 1.25 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.992 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.656 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -39.65 -37.16 0.48 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 1.123 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -101.16 -33.25 10.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.222 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.93 -43.6 98.97 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.42 -21.26 72.29 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 176.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.813 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -34.85 79.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 108.7 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.72 -144.9 9.74 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.633 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.6 mm-40 -90.52 91.16 8.32 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 121.881 -0.776 . . . . 0.0 110.539 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.49 141.25 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.515 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.7 tp10 -89.54 -45.72 9.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.45 ' C ' HG12 ' A' ' 211' ' ' ILE . 15.3 m -171.29 173.09 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.298 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.727 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.31 164.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.563 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.505 ' CG ' ' C ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -172.43 128.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.823 HD21 HD12 ' A' ' 198' ' ' ILE . 3.0 mm? . . . . . 0 CA--C 1.532 0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.519 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.445 -0.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.617 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 27.19 78.52 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.136 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.62 ' HB2' ' O ' ' A' ' 186' ' ' VAL . 7.5 p90 -140.04 -131.32 0.11 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.668 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -151.41 164.17 37.32 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.11 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.13 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -150.61 113.49 4.77 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.129 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.141 ' CD1' HG22 ' A' ' 198' ' ' ILE . 1.3 mt -115.19 150.69 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 121.724 0.773 . . . . 0.0 110.88 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.644 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.4 m -127.17 151.58 48.49 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.929 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 76.5 m-85 -130.92 119.2 21.78 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -40.69 -37.85 0.81 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.553 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -88.84 -158.68 0.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.373 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.587 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 15.5 pt-20 -137.63 0.64 2.26 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.058 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 238' ' ' LYS . 3.7 mm-40 -79.2 -58.62 0.67 Allowed Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.813 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 72.5 Cg_exo -50.0 -35.35 40.96 Favored 'Trans proline' 0 CA--C 1.488 -1.797 0 CA-C-N 120.485 1.209 . . . . 0.0 109.023 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.759 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.12 -51.99 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 113.251 -1.795 . . . . 0.0 108.726 178.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 24.9 mttt -44.62 -58.65 2.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.13 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.675 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.85 -53.47 57.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.825 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 1.071 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -32.16 -64.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.65 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.6 mtp -48.3 -29.63 4.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 26.3 mm-40 -66.67 -37.39 84.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.67 19.84 17.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.271 177.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.577 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.45 -50.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.646 1.216 . . . . 0.0 112.12 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.4 m-85 -85.35 71.41 10.82 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.258 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.933 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.7 m-70 -70.8 152.88 43.28 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.225 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -114.25 74.21 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.72 100.76 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.794 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.3 -85.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.626 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.629 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -104.26 -42.09 5.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.299 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 37.5 m -87.8 144.49 26.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.031 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.72 140.15 36.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.348 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.835 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.75 168.93 24.75 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -177.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 255' ' ' LYS . 43.9 tt0 -73.38 96.64 2.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.648 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.927 HG12 HG13 ' A' ' 186' ' ' VAL . 1.6 mt -85.73 81.97 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -90.91 121.39 32.71 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 256' ' ' VAL . 2.0 p -36.11 100.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.286 1.517 . . . . 0.0 111.214 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.13 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.414 -2.233 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.89 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.675 HG12 ' HB ' ' A' ' 236' ' ' VAL . 21.9 t . . . . . 0 CA--C 1.499 -0.994 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 236' ' ' VAL . 24.1 mttt -150.41 -35.16 0.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.137 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.58 -176.57 3.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.958 ' CD1' HD12 ' A' ' 239' ' ' ILE . 4.8 pt -161.08 114.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.057 0.932 . . . . 0.0 109.297 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.915 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.75 106.43 18.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.485 -177.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.966 HG13 HG12 ' A' ' 254' ' ' ILE . 2.8 t -92.17 111.71 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.642 0.777 . . . . 0.0 112.842 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.58 -176.84 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.46 162.86 0.0 OUTLIER Glycine 0 C--N 1.34 0.787 0 N-CA-C 115.019 0.767 . . . . 0.0 115.019 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 1.019 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -178.82 -143.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.696 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.8 m -89.21 131.32 41.09 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.425 ' C ' ' O ' ' A' ' 190' ' ' SER . 33.0 Cg_exo -27.36 -35.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.47 2.78 . . . . 0.0 113.494 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -150.96 54.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.06 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 1.019 ' OG1' HD22 ' A' ' 189' ' ' LEU . 51.9 m -40.23 125.67 1.72 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 110.413 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PRO . . . . . 0.605 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -47.13 101.62 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.399 2.733 . . . . 0.0 113.905 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.38 -20.41 0.22 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.972 178.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 10.6 mm-40 -66.34 -39.99 89.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.605 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 2.5 mttp -76.27 -50.53 14.14 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 1.164 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -45.72 -28.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.692 176.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.5 mtp180 -77.13 -29.84 54.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.358 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.7 pt-20 -86.99 -54.12 4.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.696 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -50.7 -37.8 43.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 110.663 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.98 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -100.44 -34.46 9.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.498 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.2 -44.69 96.71 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.0 -23.98 66.45 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.829 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.01 -35.91 81.84 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 122.032 0.92 . . . . 0.0 108.599 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -142.43 7.83 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.971 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -91.0 94.8 9.8 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.688 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -58.64 144.59 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLU . . . . . 0.57 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 3.9 tp10 -89.86 -50.91 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.1 p -172.04 156.61 4.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.443 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.721 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -119.95 167.52 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.002 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -165.02 123.71 1.72 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.684 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.771 HD12 HD21 ' A' ' 189' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 121.287 0.565 . . . . 0.0 111.952 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.586 ' O ' ' C ' ' A' ' 224' ' ' GLY . 3.2 mtp85 . . . . . 0 CA--C 1.502 -0.896 0 CA-C-O 120.212 0.053 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 10.42 78.93 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 O-C-N 124.588 1.18 . . . . 0.0 111.624 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PHE . . . . . 0.654 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -138.71 -121.38 0.13 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . 0.666 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.32 163.11 20.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.973 0.892 . . . . 0.0 112.594 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 1.035 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.4 m-85 -147.83 124.54 11.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.864 -1.517 . . . . 0.0 108.97 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 1.164 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -121.33 150.93 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 CA-C-O 121.555 0.693 . . . . 0.0 109.944 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.751 HG23 ' HG3' ' A' ' 183' ' ' LYS . 2.9 m -129.85 152.41 49.36 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.212 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 87.3 m-85 -130.32 117.26 19.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.57 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.72 -37.31 0.73 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . 0.515 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.59 -155.93 0.35 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.494 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.605 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.2 pt-20 -143.12 4.17 1.42 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.51 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.9 OUTLIER -84.53 -58.51 0.36 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PRO . . . . . 0.829 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.6 Cg_exo -49.77 -34.68 36.67 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.843 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.28 -51.11 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.801 178.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 6.3 mtpt -45.86 -60.13 2.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.933 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.692 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.99 -52.75 64.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.69 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.958 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -34.72 -66.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.259 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.2 mtp -48.83 -25.56 1.94 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.563 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -69.35 -38.35 78.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.36 21.14 15.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 177.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.594 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.51 -49.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.669 1.231 . . . . 0.0 111.878 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.7 m-85 -85.2 71.85 10.82 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.504 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' HIS . . . . . 0.896 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.6 m-70 -72.62 153.04 41.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.226 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -115.51 76.38 1.0 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -69.14 101.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.149 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.74 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.45 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.671 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -101.89 -41.84 6.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.126 0.489 . . . . 0.0 110.892 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 247' ' ' VAL . 21.0 m -88.41 146.82 25.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.514 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.38 139.82 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.75 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' CYS . . . . . 0.947 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 166.06 32.83 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 255' ' ' LYS . 48.4 tt0 -71.95 93.58 1.37 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.227 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ILE . . . . . 0.966 HG12 HG13 ' A' ' 186' ' ' VAL . 1.5 mt -79.78 80.86 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.133 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -87.89 122.58 31.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.0 p -33.82 122.32 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 122.244 1.021 . . . . 0.0 109.912 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 1.035 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . . . . . . 0 N--CA 1.429 -1.517 0 CA-C-N 113.204 -1.817 . . . . 0.0 113.494 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.738 HG12 ' HB ' ' A' ' 236' ' ' VAL . 30.2 t . . . . . 0 CA--C 1.495 -1.159 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.5 mttt -150.14 -35.11 0.16 Allowed 'General case' 0 N--CA 1.435 -1.19 0 C-N-CA 118.591 -1.244 . . . . 0.0 112.462 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -102.55 -167.46 1.4 Allowed 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.064 HD13 HD12 ' A' ' 239' ' ' ILE . 17.3 pt -165.11 139.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 120.088 -0.645 . . . . 0.0 109.261 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.763 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -109.32 96.75 6.5 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.382 -178.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.902 HG13 HG12 ' A' ' 254' ' ' ILE . 2.0 t -79.39 122.09 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.598 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -67.32 -170.34 4.61 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.924 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.564 ' H ' " H1'" ' B' ' 2' ' ' ' DT' . . . -26.14 158.03 0.0 OUTLIER Glycine 0 N--CA 1.466 0.675 0 N-CA-C 115.074 0.79 . . . . 0.0 115.074 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.966 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -177.24 -143.04 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.681 ' N ' HD13 ' A' ' 189' ' ' LEU . 10.7 t -89.69 134.52 32.12 Favored Pre-proline 0 C--N 1.344 0.33 0 CA-C-O 121.13 0.49 . . . . 0.0 111.173 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.416 ' C ' ' O ' ' A' ' 190' ' ' SER . 80.8 Cg_exo -28.65 -35.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.432 2.755 . . . . 0.0 113.22 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 190' ' ' SER . 34.7 p30 -151.36 56.23 0.87 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.158 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.966 ' OG1' HD22 ' A' ' 189' ' ' LEU . 6.1 m -39.4 123.23 1.39 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.86 0.362 . . . . 0.0 110.475 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.567 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 6.6 Cg_endo -48.79 99.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.661 2.24 . . . . 0.0 112.23 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.45 -19.59 0.18 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.442 179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 26.0 mt-10 -64.29 -39.0 93.03 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.567 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.4 mttp -77.56 -46.77 21.24 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.128 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.99 -29.79 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.832 176.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.637 ' HG2' HD11 ' A' ' 211' ' ' ILE . 4.7 mtt180 -75.83 -28.57 58.32 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.86 178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.0 OUTLIER -86.12 -63.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.792 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.681 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -39.75 -39.16 0.74 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.556 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.076 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -99.64 -34.16 10.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.452 -178.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.42 -45.59 96.09 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.28 -23.29 68.08 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 176.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.82 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.0 -33.69 76.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 122.053 0.93 . . . . 0.0 108.651 178.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.523 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.24 -139.72 6.29 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.01 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 21.5 mm-40 -91.57 94.24 9.33 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.097 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.54 142.6 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 229' ' ' THR . 11.3 tt0 -89.6 -52.45 5.0 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 86.1 p -169.82 152.92 4.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.35 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.717 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.72 167.97 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.491 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -167.2 130.15 1.75 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.793 0.33 . . . . 0.0 111.478 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.063 HD21 HD12 ' A' ' 198' ' ' ILE . 2.3 mm? -118.43 104.5 47.67 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.658 ' HG2' ' CD2' ' A' ' 225' ' ' PHE . 72.6 Cg_exo -48.95 -158.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.508 2.805 . . . . 0.0 113.778 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.49 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.1 OUTLIER 158.61 125.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.285 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 8.3 p-10 -62.73 71.78 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.54 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 215' ' ' MET . 18.3 t-20 -130.6 -13.42 3.77 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.805 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.16 -22.06 12.96 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 120.932 0.396 . . . . 0.0 111.355 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -136.0 -16.13 1.71 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.05 -178.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.4 m120 68.39 48.48 0.86 Allowed 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.585 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -119.35 -156.43 0.66 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.985 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.698 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -85.51 -38.71 18.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 122.421 -0.174 . . . . 0.0 110.578 -179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.698 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.7 OUTLIER 4.37 -106.36 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 124.305 1.003 . . . . 0.0 111.193 -178.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.72 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 32.21 76.1 0.04 OUTLIER Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.471 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.679 ' CZ ' " H4'" ' B' ' 3' ' ' ' DA' . 8.1 p90 -135.4 -128.95 0.15 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.747 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.85 162.44 39.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.64 0.733 . . . . 0.0 111.326 178.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.118 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 2.8 m-85 -149.95 124.62 9.76 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.505 -1.225 . . . . 0.0 108.738 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.128 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.4 mt -122.94 153.06 27.84 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.364 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.972 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.6 m -130.03 152.87 49.01 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.016 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.5 m-85 -130.1 120.62 24.93 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.579 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -40.81 -37.53 0.79 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.8 mt-10 -90.85 -157.64 0.5 Allowed 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.572 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.599 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -137.53 1.23 2.35 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.361 -179.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -80.04 -60.46 0.49 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.166 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.82 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 63.9 Cg_exo -48.89 -33.83 26.77 Favored 'Trans proline' 0 CA--C 1.494 -1.484 0 N-CA-C 109.017 -1.186 . . . . 0.0 109.017 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.764 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.73 -51.16 70.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.747 178.141 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -46.12 -57.41 4.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.081 179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.683 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.19 -52.83 63.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.679 179.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.064 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.2 -64.97 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.781 -1.099 . . . . 0.0 111.133 -179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.508 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.0 OUTLIER -48.72 -26.73 2.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.894 0.378 . . . . 0.0 110.588 -179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.1 mm-40 -68.1 -40.07 82.68 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.56 13.94 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.345 178.004 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.543 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.72 -50.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 O-C-N 124.562 1.164 . . . . 0.0 111.998 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.6 m-85 -84.29 74.15 10.37 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.449 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.918 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.0 m-70 -74.81 152.24 38.99 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.388 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 74.28 0.86 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.371 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -66.05 103.01 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 45.23 -83.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.574 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.86 -41.23 5.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.175 0.512 . . . . 0.0 110.538 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.51 ' O ' ' N ' ' A' ' 247' ' ' VAL . 67.7 m -87.87 145.46 26.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.398 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -140.98 141.61 34.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.848 179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.842 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.97 167.58 29.53 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -178.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.505 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 44.5 tt0 -73.11 95.09 2.01 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.511 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.902 HG12 HG13 ' A' ' 186' ' ' VAL . 2.6 mt -83.03 78.96 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.716 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.32 123.67 33.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.709 ' O ' HG13 ' A' ' 256' ' ' VAL . 1.9 p -37.41 99.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-O 123.331 1.538 . . . . 0.0 111.035 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.118 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -44.98 -171.57 0.0 OUTLIER 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.006 -2.361 . . . . 0.0 112.998 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.666 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 171.76 144.06 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.088 -1.869 . . . . 0.0 110.584 178.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.787 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.911 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.837 0 O4'-C1'-C2' 107.203 1.003 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.679 " H4'" ' CZ ' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.423 -1.037 0 N19-C1'-C2' 112.961 -0.774 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.801 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.429 -0.71 0 C4'-C3'-C2' 101.353 -1.847 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.801 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.506 -1.066 0 C4'-C3'-C2' 104.275 1.075 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.67 HG12 ' HB ' ' A' ' 236' ' ' VAL . 36.7 t . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 236' ' ' VAL . 22.8 mttt -151.86 -34.83 0.13 Allowed 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.411 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -95.36 -175.11 3.39 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.255 178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.037 HD13 HD12 ' A' ' 239' ' ' ILE . 8.2 pt -163.08 120.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.84 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -95.68 104.46 16.38 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.389 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.95 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.9 t -90.73 112.76 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 123.763 0.825 . . . . 0.0 112.355 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -48.44 -173.86 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.632 0.613 . . . . 0.0 114.632 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.505 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.92 160.98 0.0 OUTLIER Glycine 0 C--N 1.341 0.846 0 N-CA-C 114.533 0.573 . . . . 0.0 114.533 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.039 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -173.33 -144.8 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.658 ' N ' HD13 ' A' ' 189' ' ' LEU . 70.1 m -88.88 135.59 31.76 Favored Pre-proline 0 C--N 1.342 0.261 0 CA-C-O 120.977 0.418 . . . . 0.0 110.623 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 190' ' ' SER . 56.6 Cg_exo -28.77 -37.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.325 2.684 . . . . 0.0 113.051 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 190' ' ' SER . 62.4 t0 -151.4 54.23 0.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.08 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.039 ' OG1' HD22 ' A' ' 189' ' ' LEU . 86.3 m -39.87 123.87 1.57 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.149 0.499 . . . . 0.0 110.75 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.607 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 10.1 Cg_endo -51.2 101.95 0.05 OUTLIER 'Trans proline' 0 CA--C 1.531 0.347 0 C-N-CA 123.351 2.701 . . . . 0.0 113.728 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.815 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.2 OUTLIER -45.74 -20.47 0.08 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.145 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 2.5 mt-10 -65.2 -41.96 94.02 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.728 ' HE2' HD21 ' A' ' 249' ' ' LEU . 2.2 mttp -75.34 -50.03 17.26 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.109 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -46.48 -26.04 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.975 176.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.561 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 2.4 mtp180 -80.12 -28.65 38.93 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.302 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.9 pt-20 -86.89 -47.56 8.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.597 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.685 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.4 t80 -56.46 -40.73 75.32 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.221 0.534 . . . . 0.0 110.342 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.85 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -97.95 -33.9 11.03 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.643 -178.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.43 -44.22 95.6 Favored Glycine 0 CA--C 1.505 -0.593 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.44 -23.2 68.31 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.811 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -66.4 -36.32 82.53 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.155 0.979 . . . . 0.0 108.88 178.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.532 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.9 -142.78 7.99 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 113.68 -1.6 . . . . 0.0 109.651 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 27.2 mt-10 -91.09 92.59 8.77 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.976 178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.485 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.15 143.0 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.557 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.0 tp10 -89.64 -46.9 8.31 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.425 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 3.0 p -175.16 152.64 1.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.788 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -116.02 161.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.956 179.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.571 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.5 OUTLIER -159.02 125.64 4.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.922 179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 189' ' ' LEU . 1.0 OUTLIER -108.86 94.02 13.63 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 121.473 0.654 . . . . 0.0 111.054 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.577 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 71.4 Cg_exo -47.81 -167.22 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.737 2.958 . . . . 0.0 113.333 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.578 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 154.67 120.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.087 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER -35.43 85.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.777 -179.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 215' ' ' MET . 20.6 t-20 -139.92 -13.3 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 23.0 mmmt -119.99 -12.74 9.1 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.74 0.305 . . . . 0.0 111.704 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -143.24 -13.19 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 219' ' ' THR . 25.7 m-20 66.33 44.45 2.45 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.587 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -117.9 -155.3 0.59 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.101 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.643 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -86.47 -40.04 15.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.75 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.643 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.7 OUTLIER 10.87 -93.4 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 123.907 0.754 . . . . 0.0 111.204 -177.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 20.9 76.46 0.01 OUTLIER Glycine 0 C--N 1.331 0.287 0 O-C-N 123.906 0.754 . . . . 0.0 112.032 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.651 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -144.27 -121.73 0.08 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -178.068 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.664 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -166.37 164.3 17.46 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.153 0.978 . . . . 0.0 113.251 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.041 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.8 m-85 -147.83 117.0 6.86 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.764 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.109 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -114.35 147.57 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.606 0.717 . . . . 0.0 110.354 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.691 HG23 ' HG2' ' A' ' 183' ' ' LYS . 1.2 m -120.21 172.36 7.84 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.43 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.644 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 95.4 m-85 -150.63 111.83 4.38 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.557 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.4 OUTLIER -39.33 -37.13 0.41 Allowed 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.525 ' O ' ' O ' ' A' ' 230' ' ' PHE . 21.8 mt-10 -89.09 -155.56 0.35 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.776 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.614 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.4 pt-20 -142.33 -0.93 1.22 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.953 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.2 OUTLIER -80.13 -58.93 0.56 Allowed Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.804 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 50.9 Cg_exo -48.09 -36.32 28.07 Favored 'Trans proline' 0 CA--C 1.491 -1.654 0 N-CA-C 108.845 -1.252 . . . . 0.0 108.845 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.823 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.14 -51.79 67.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 113.177 -1.829 . . . . 0.0 108.921 178.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 2.1 mtpp -45.04 -59.45 2.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.126 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.675 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.28 -54.23 49.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.539 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.037 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.42 -64.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.142 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.509 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -48.04 -36.18 12.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.189 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 238' ' ' LYS . 12.1 mt-10 -60.52 -38.85 85.76 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.585 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -103.28 21.65 15.52 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.558 177.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.584 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.53 -50.08 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.382 0 O-C-N 124.493 1.12 . . . . 0.0 112.069 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.585 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.6 m-85 -83.44 74.91 10.04 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.614 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.969 ' CE1' HD13 ' A' ' 239' ' ' ILE . 8.1 m170 -76.65 159.35 30.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 7.4 m-80 -123.01 79.13 1.63 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.167 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.67 107.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.145 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 37.25 -88.18 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.611 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.728 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -95.52 -44.93 7.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 247' ' ' VAL . 5.4 m -88.9 148.09 24.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -143.24 140.39 30.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.372 179.075 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.95 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.25 166.81 30.5 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -178.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.514 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 51.7 tt0 -71.42 97.44 1.63 Allowed 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.411 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.902 HG12 HG13 ' A' ' 186' ' ' VAL . 2.4 mt -86.55 80.18 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.128 -1.396 . . . . 0.0 112.968 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.2 OUTLIER -89.18 122.63 32.66 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.4 p -34.52 116.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 CA-C-O 122.434 1.112 . . . . 0.0 110.036 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.041 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -72.93 -177.63 2.47 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.518 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.558 ' HG3' ' N1 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -152.34 -151.25 0.37 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 113.703 -1.59 . . . . 0.0 111.16 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.85 -179.911 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.778 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.798 0 C3'-C2'-C1' 104.247 1.105 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.98 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.804 0 C3'-C2'-C1' 101.78 -0.657 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.98 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.518 -1.021 0 C4'-C3'-C2' 100.993 -2.207 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.553 ' C6 ' ' N7 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.955 0 O4'-C4'-C3' 106.136 0.536 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.681 HG12 ' HB ' ' A' ' 236' ' ' VAL . 37.6 t . . . . . 0 CA--C 1.497 -1.074 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.564 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.8 mttt -151.2 -34.9 0.14 Allowed 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 118.819 -1.153 . . . . 0.0 112.073 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.848 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.08 -172.47 3.16 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.188 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 239' ' ' ILE . 5.9 pt -166.45 111.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 122.12 0.962 . . . . 0.0 109.115 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.879 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -87.16 107.74 18.6 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.593 -178.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.982 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.9 t -94.42 109.55 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.461 0.704 . . . . 0.0 112.299 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.581 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.33 -176.77 0.01 OUTLIER Glycine 0 N--CA 1.476 1.366 0 N-CA-C 114.422 0.529 . . . . 0.0 114.422 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.506 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.68 160.36 0.0 OUTLIER Glycine 0 C--N 1.344 1.025 0 N-CA-C 114.932 0.733 . . . . 0.0 114.932 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.918 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -174.07 -142.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.676 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -89.04 132.1 39.0 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-O 121.066 0.46 . . . . 0.0 110.914 -179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -31.96 -33.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.152 2.568 . . . . 0.0 113.01 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 190' ' ' SER . 16.5 t0 -150.99 53.34 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.623 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.918 ' OG1' HD22 ' A' ' 189' ' ' LEU . 52.2 m -40.21 121.68 1.63 Allowed Pre-proline 0 C--N 1.33 -0.246 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.638 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -52.01 94.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.634 2.223 . . . . 0.0 111.987 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.598 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -41.91 -24.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.296 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 194' ' ' PRO . 36.2 mt-10 -61.22 -34.79 75.68 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.688 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -86.11 -35.05 20.45 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.126 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -62.08 -25.24 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.713 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.614 176.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.603 ' HA ' HD11 ' A' ' 211' ' ' ILE . 19.2 mtp180 -77.61 -25.73 50.09 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.276 177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 197' ' ' LYS . 3.7 mt-10 -86.07 -60.01 2.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.928 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.705 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -43.3 -40.63 3.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.761 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.88 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -99.6 -30.66 12.0 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.663 -178.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.77 -46.22 92.42 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -63.84 -22.8 66.8 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.838 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.66 -36.47 84.38 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.961 0.886 . . . . 0.0 108.726 178.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.507 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -138.26 5.21 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.742 -1.572 . . . . 0.0 109.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.7 mt-10 -91.95 89.99 7.23 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.813 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.497 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -56.33 142.96 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.581 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.2 tp10 -90.25 -49.05 6.77 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.453 ' HB3' ' OE2' ' A' ' 209' ' ' GLU . 5.8 p -172.75 156.75 3.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.543 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.63 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -122.78 153.81 27.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.237 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -154.41 133.04 12.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.707 0.289 . . . . 0.0 111.073 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.927 HD21 HD12 ' A' ' 198' ' ' ILE . 4.4 mm? -112.11 99.37 45.88 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 121.229 0.537 . . . . 0.0 111.842 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.618 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 70.0 Cg_exo -50.51 -167.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.47 0.147 0 C-N-CA 123.628 2.885 . . . . 0.0 113.392 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.529 ' CG ' ' C ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 160.09 138.27 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.552 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 5.4 p-10 -63.53 82.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.601 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.47 2.96 1.47 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.498 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 4.7 mmtt -138.85 0.32 1.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.1 p -152.3 -26.91 0.17 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 219' ' ' THR . 4.5 m120 76.86 50.82 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.558 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.41 177.49 7.31 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.582 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -65.42 -36.85 85.17 Favored 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.001 -178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.582 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.1 OUTLIER 13.93 -85.23 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 124.255 0.972 . . . . 0.0 110.47 -177.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.571 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 11.79 80.52 0.01 OUTLIER Glycine 0 C--N 1.336 0.546 0 O-C-N 123.982 0.801 . . . . 0.0 112.416 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.68 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -145.87 -119.98 0.07 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.707 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.47 169.15 14.15 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.247 1.022 . . . . 0.0 112.798 178.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.046 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.5 m-85 -152.17 111.92 3.98 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.908 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.126 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -110.79 161.58 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.237 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.77 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.3 m -138.14 168.98 18.6 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.165 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 75.5 m-85 -146.74 115.61 6.87 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.581 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.2 OUTLIER -39.64 -35.3 0.3 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.531 ' O ' ' O ' ' A' ' 230' ' ' PHE . 7.9 mm-40 -88.89 -156.74 0.4 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.998 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.591 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.5 pm0 -144.16 12.77 1.6 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.615 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.664 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.4 OUTLIER -92.29 -63.29 0.17 Allowed Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.838 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 95.2 Cg_exo -48.47 -32.26 20.13 Favored 'Trans proline' 0 CA--C 1.496 -1.39 0 N-CA-C 108.856 -1.248 . . . . 0.0 108.856 178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.808 HG13 HG23 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.97 -53.43 34.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.372 -1.74 . . . . 0.0 110.209 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.4 OUTLIER -51.6 -46.58 63.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.609 -179.031 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.655 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -64.89 -54.29 33.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.69 0.757 . . . . 0.0 109.933 177.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.972 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -30.84 -64.91 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.531 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.479 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -46.19 -31.96 2.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.017 0.437 . . . . 0.0 110.612 -179.549 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 238' ' ' LYS . 30.4 mm-40 -62.71 -45.04 94.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -94.01 19.77 8.7 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.14 177.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.97 -50.31 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.625 1.203 . . . . 0.0 111.928 -179.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.1 m-85 -84.84 71.29 10.89 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.621 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.3 m-70 -72.99 153.03 41.09 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.75 82.34 1.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.972 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.688 HG12 ' CE ' ' A' ' 197' ' ' LYS . 1.3 t -75.01 97.39 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.749 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 50.06 -80.91 0.01 OUTLIER Glycine 0 C--N 1.332 0.309 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.752 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -106.82 -43.45 4.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.44 148.32 24.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.625 0.726 . . . . 0.0 112.344 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.542 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -145.54 140.69 27.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.589 -1.187 . . . . 0.0 108.8 179.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.982 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.23 169.44 24.51 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 76.4 tt0 -75.35 91.58 2.72 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.58 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.982 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -77.99 80.29 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.034 -1.439 . . . . 0.0 112.534 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.62 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.4 mtpt -91.67 120.09 32.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.592 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.5 p -30.55 120.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 CA-C-O 122.29 1.043 . . . . 0.0 110.367 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.046 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.92 172.3 13.68 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 113.19 -1.823 . . . . 0.0 112.342 -176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.483 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -139.0 -166.22 1.98 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.804 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 179.843 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.583 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C3'--C2' 1.51 -0.838 0 C4'-C3'-C2' 101.814 -1.386 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.612 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 C3'-C2'-C1' 101.832 -0.62 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.771 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.881 0 C4'-C3'-C2' 101.198 -2.002 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.601 ' C8 ' " H2'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.51 -0.789 0 C1'-O4'-C4' 110.415 0.511 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.742 HG12 ' HB ' ' A' ' 236' ' ' VAL . 23.1 t . . . . . 0 CA--C 1.499 -1.004 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.636 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.7 mttt -150.21 -36.46 0.15 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.064 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.17 -171.54 2.57 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.967 HD13 HD12 ' A' ' 239' ' ' ILE . 10.2 pt -164.62 121.13 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.808 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -96.02 109.51 21.9 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.357 -178.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.929 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.5 t -97.71 112.71 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.708 0.803 . . . . 0.0 113.103 -178.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.41 -178.38 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.823 0.689 . . . . 0.0 114.823 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -31.53 161.41 0.0 OUTLIER Glycine 0 C--N 1.342 0.861 0 N-CA-C 114.607 0.603 . . . . 0.0 114.607 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.029 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -174.67 -144.67 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.748 -0.226 . . . . 0.0 111.556 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 189' ' ' LEU . 49.2 m -89.44 133.32 34.92 Favored Pre-proline 0 C--N 1.338 0.069 0 CA-C-O 121.018 0.437 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 84.7 Cg_exo -28.18 -36.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.5 2.8 . . . . 0.0 113.116 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.0 t70 -150.85 56.45 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.997 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.029 ' OG1' HD22 ' A' ' 189' ' ' LEU . 21.7 m -38.8 132.57 1.09 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.067 0.461 . . . . 0.0 110.308 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.522 ' O ' HG13 ' A' ' 198' ' ' ILE . 14.7 Cg_endo -56.42 92.29 0.05 OUTLIER 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 123.025 2.483 . . . . 0.0 112.381 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.573 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -41.31 -24.53 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.959 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 194' ' ' PRO . 8.7 mm-40 -62.94 -36.65 84.14 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.917 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 200' ' ' GLU . 22.7 mmmt -78.12 -49.23 14.3 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.168 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.4 -28.81 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.471 176.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.558 ' HG2' HD11 ' A' ' 211' ' ' ILE . 0.0 OUTLIER -77.1 -28.61 54.51 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.737 178.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LYS . 1.2 mm-40 -85.61 -63.51 1.31 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.668 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.702 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.1 t80 -40.17 -39.33 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.716 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.984 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -100.34 -33.3 10.45 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.48 -178.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -61.89 -45.99 95.04 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 176.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.47 -23.12 66.43 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.826 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.6 -34.18 77.64 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 122.014 0.911 . . . . 0.0 108.818 178.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.35 -141.04 7.02 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 113.756 -1.565 . . . . 0.0 110.045 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 77.3 mm-40 -91.82 91.54 7.98 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.757 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -55.6 142.24 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.586 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.5 tp10 -88.96 -48.64 7.3 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 26.7 m -175.96 150.02 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.344 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.67 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.34 167.73 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.556 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -166.34 125.63 1.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.755 0.312 . . . . 0.0 110.809 179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.966 HD21 HD12 ' A' ' 198' ' ' ILE . 4.4 mm? -107.67 101.57 40.66 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.645 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 49.2 Cg_exo -46.0 -164.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.863 3.042 . . . . 0.0 113.2 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.3 OUTLIER 158.78 129.68 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.007 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 31.3 p-10 -61.82 72.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.249 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 215' ' ' MET . 1.5 t-20 -131.83 -10.57 3.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.746 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.478 ' HD2' " H4'" ' B' ' 5' ' ' ' DG' . 2.6 mmpt? -121.45 -0.12 9.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.774 0.321 . . . . 0.0 111.424 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.614 HG23 ' NH2' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -151.49 -25.31 0.2 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 219' ' ' THR . 18.0 m-20 72.41 44.52 0.41 Allowed 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.621 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -117.96 -155.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.475 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.653 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -86.87 -39.22 16.02 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.653 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 8.01 -96.47 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 124.352 1.032 . . . . 0.0 111.401 -178.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.57 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 23.87 75.03 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 O-C-N 123.673 0.608 . . . . 0.0 111.807 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.664 ' CE1' " C5'" ' B' ' 3' ' ' ' DA' . 0.2 OUTLIER -138.38 -120.2 0.14 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.679 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.5 OUTLIER -166.72 169.87 13.03 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 122.449 1.119 . . . . 0.0 113.02 178.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.027 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 5.6 m-85 -151.79 125.21 8.84 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 112.932 -1.94 . . . . 0.0 108.614 177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.168 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -122.3 156.57 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.539 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.1 m -134.33 160.31 38.33 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.947 -178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 80.2 m-85 -137.86 115.76 11.54 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.586 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -38.51 -36.59 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 122.301 1.048 . . . . 0.0 108.265 -179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.1 mt-10 -88.82 -153.88 0.27 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.281 -1.781 . . . . 0.0 110.647 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.592 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 10.1 pt-20 -144.54 4.46 1.18 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.355 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -84.84 -58.19 0.36 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -178.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.826 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 88.6 Cg_exo -50.4 -33.53 37.94 Favored 'Trans proline' 0 CA--C 1.492 -1.605 0 N-CA-C 108.763 -1.283 . . . . 0.0 108.763 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -64.94 -51.91 60.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.618 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 13.9 mttt -45.71 -57.4 4.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.031 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.685 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.94 -52.49 65.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.605 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.967 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.72 -63.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.237 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.563 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -50.83 -19.16 0.9 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -77.55 -37.22 51.24 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.36 21.92 13.36 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.582 178.154 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.605 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -15.43 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.517 1.135 . . . . 0.0 112.433 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.1 m-85 -86.0 72.46 10.45 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.366 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.952 ' CE1' HD13 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.52 141.64 46.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.262 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.4 OUTLIER -105.26 75.5 1.17 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.354 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -67.05 138.36 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.139 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.494 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 15.22 -77.62 0.0 OUTLIER Glycine 0 C--N 1.342 0.895 0 O-C-N 123.932 0.77 . . . . 0.0 113.729 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -114.07 -40.54 3.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.312 0.577 . . . . 0.0 110.529 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.75 152.92 21.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.886 -178.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.07 141.46 30.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.942 179.174 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.929 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 156.47 29.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.995 -178.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.564 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 41.6 tt0 -60.88 120.27 9.84 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.927 HG12 HG13 ' A' ' 186' ' ' VAL . 2.2 mt -104.52 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.746 0.784 . . . . 0.0 112.428 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.591 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.06 119.47 28.47 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.465 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.7 p -33.62 122.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 CA-C-O 122.149 0.976 . . . . 0.0 110.055 -177.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.027 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.55 176.09 9.25 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.405 -1.725 . . . . 0.0 113.049 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -151.15 -148.63 0.27 Allowed 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.857 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.46 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.63 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 C3'-C2'-C1' 100.528 -1.552 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.945 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.929 0 C4'-C3'-C2' 104.891 1.691 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.945 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.837 0 C4'-C3'-C2' 100.725 -2.475 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.717 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.858 0 O4'-C4'-C3' 106.276 0.676 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.64 HG12 ' HB ' ' A' ' 236' ' ' VAL . 20.5 t . . . . . 0 CA--C 1.499 -0.981 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 21.1 mttt -150.04 -34.58 0.17 Allowed 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.149 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -89.78 -171.4 3.16 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.056 HD13 HD12 ' A' ' 239' ' ' ILE . 6.1 pt -168.75 110.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.941 0.877 . . . . 0.0 108.92 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.871 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -83.08 101.76 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.733 -177.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.966 HG13 HG12 ' A' ' 254' ' ' ILE . 2.5 t -87.68 111.22 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.32 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.617 ' C ' ' HB3' ' A' ' 252' ' ' CYS . . . -101.39 120.5 6.89 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 116.073 1.189 . . . . 0.0 116.073 -177.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.675 ' HA3' ' H72' ' B' ' 2' ' ' ' DT' . . . 97.04 109.92 2.7 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.97 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -165.56 -157.66 0.33 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.638 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.4 m -89.03 133.65 34.94 Favored Pre-proline 0 C--N 1.342 0.243 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.197 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -32.46 -29.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.43 2.754 . . . . 0.0 113.473 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 190' ' ' SER . 47.8 t0 -149.38 52.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.25 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.97 ' OG1' HD22 ' A' ' 189' ' ' LEU . 17.6 m -43.08 126.79 3.36 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 110.667 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.507 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.2 Cg_endo -53.1 94.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.677 2.251 . . . . 0.0 112.068 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.603 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.9 OUTLIER -45.13 -20.67 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.379 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 8.0 mt-10 -64.96 -36.55 84.75 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.12 -47.65 17.75 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.153 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -49.25 -28.9 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 113.582 -1.645 . . . . 0.0 108.847 176.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.609 ' HA ' HD11 ' A' ' 211' ' ' ILE . 11.3 mtp180 -76.41 -28.86 56.84 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.763 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 mt-10 -85.27 -61.94 1.65 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.811 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.698 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -39.56 -42.65 1.18 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.882 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.0 OUTLIER -97.75 -31.49 12.22 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.728 -178.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.21 -46.85 93.09 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.41 -24.27 65.55 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.828 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.65 -34.21 77.74 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.996 0.903 . . . . 0.0 108.64 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.11 -139.8 6.36 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.833 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.6 mt-10 -91.86 95.3 9.76 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.854 178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.466 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -57.31 144.61 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 177.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.647 ' CD ' HG21 ' A' ' 229' ' ' THR . 10.5 tt0 -90.6 -50.58 5.85 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 73.1 m -172.42 147.18 1.88 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.914 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.623 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.31 162.08 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.629 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -157.79 123.86 4.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 0.0 111.596 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.021 HD21 HD12 ' A' ' 198' ' ' ILE . 2.0 mm? -108.8 92.93 11.26 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-O 121.372 0.606 . . . . 0.0 111.028 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.639 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 72.0 Cg_exo -43.81 -165.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 124.577 3.518 . . . . 0.0 114.182 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.542 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 155.94 119.94 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.052 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 18.1 p-10 -44.8 83.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.887 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 215' ' ' MET . 1.9 m-20 -144.16 4.06 1.23 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.953 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.401 ' CG ' HH12 ' A' ' 223' ' ' ARG . 17.4 mmmt -132.79 -19.04 2.35 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -141.97 -9.31 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.0 m120 68.31 48.16 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.594 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -126.78 -177.52 4.05 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.572 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -69.5 -37.39 77.19 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.639 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.594 ' HG2' ' HG2' ' A' ' 221' ' ' LYS . 0.2 OUTLIER 15.81 -83.16 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 124.445 1.09 . . . . 0.0 109.994 -176.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.587 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.59 80.75 0.01 OUTLIER Glycine 0 C--N 1.335 0.484 0 O-C-N 123.906 0.754 . . . . 0.0 112.505 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.643 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.02 -121.04 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.637 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -167.5 164.58 14.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.347 1.07 . . . . 0.0 113.074 178.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.024 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.9 m-85 -149.18 114.91 5.64 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 113.125 -1.852 . . . . 0.0 108.071 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.153 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.6 mt -112.98 161.58 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-O 121.344 0.592 . . . . 0.0 110.588 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.647 HG21 ' CD ' ' A' ' 209' ' ' GLU . 1.8 m -138.7 172.36 12.99 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.537 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 89.1 m-85 -145.23 119.8 9.75 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.597 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.38 -37.3 0.99 Allowed 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.514 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.8 mt-10 -89.42 -155.59 0.36 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 113.338 -1.755 . . . . 0.0 110.57 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.576 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.6 pt-20 -143.02 5.27 1.5 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.495 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 1.0 OUTLIER -86.9 -57.28 0.32 Allowed Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -178.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.828 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 99.3 Cg_exo -49.74 -33.22 31.54 Favored 'Trans proline' 0 CA--C 1.493 -1.573 0 N-CA-C 108.791 -1.273 . . . . 0.0 108.791 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.87 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.7 -51.85 64.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 112.988 -1.915 . . . . 0.0 109.065 178.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.56 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 12.4 mttt -46.3 -57.6 4.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.276 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.634 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.13 -54.74 42.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.673 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.056 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.95 -63.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.029 -179.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 9.9 mtp -45.73 -31.32 1.94 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 111.139 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 238' ' ' LYS . 2.3 mm-40 -63.33 -43.09 98.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -96.56 19.96 11.47 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.268 178.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.18 -50.55 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.483 0 O-C-N 124.696 1.247 . . . . 0.0 111.716 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.9 m-85 -85.51 71.03 10.82 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.271 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.975 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.9 m-70 -70.49 146.41 50.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.029 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 4.6 m-80 -107.43 79.75 1.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.176 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.5 t -69.12 149.48 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.71 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 6.59 -72.08 0.0 OUTLIER Glycine 0 C--N 1.343 0.953 0 O-C-N 124.014 0.821 . . . . 0.0 113.682 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -119.64 -41.88 2.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.076 0.465 . . . . 0.0 110.454 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.57 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 2.0 m -88.89 148.54 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.689 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -131.76 147.62 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.711 -1.131 . . . . 0.0 108.054 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.909 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -160.34 161.85 33.32 Favored 'General case' 0 C--O 1.228 -0.042 0 C-N-CA 118.594 -1.242 . . . . 0.0 114.238 -178.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 185' ' ' PHE . 56.7 tt0 -69.86 93.12 0.73 Allowed 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.609 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.966 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -83.92 82.73 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.078 -1.419 . . . . 0.0 112.591 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.7 mtpt -98.4 118.91 36.12 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.8 p -28.72 110.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-O 122.612 1.196 . . . . 0.0 110.594 -177.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.024 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -67.65 179.16 1.43 Allowed 'General case' 0 N--CA 1.418 -2.026 0 CA-C-N 112.634 -2.076 . . . . 0.0 112.758 -176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.559 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 4.1 mtm -150.02 -151.75 0.41 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.7 -1.591 . . . . 0.0 110.693 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.891 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.963 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.896 0 O4'-C1'-C2' 106.957 0.779 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.775 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C1'-O4'-C4' 110.378 0.484 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.775 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.893 0 C4'-C3'-C2' 101.002 -2.198 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.583 " H5'" " H1'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.921 0 C3'-C2'-C1' 102.164 -0.383 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.619 HG12 ' HB ' ' A' ' 236' ' ' VAL . 29.9 t . . . . . 0 CA--C 1.496 -1.108 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 22.0 mttt -152.19 -35.66 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 118.496 -1.282 . . . . 0.0 112.575 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.867 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -94.91 -177.94 4.34 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.37 178.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.945 HD13 HD12 ' A' ' 239' ' ' ILE . 4.6 pt -161.82 111.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 122.245 1.022 . . . . 0.0 109.57 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.906 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -85.41 101.79 12.89 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.702 -1.135 . . . . 0.0 111.551 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.99 HG13 HG12 ' A' ' 254' ' ' ILE . 2.6 t -87.27 106.21 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 123.992 0.917 . . . . 0.0 111.246 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.641 ' HA3' ' C2 ' ' B' ' 2' ' ' ' DT' . . . -97.43 122.1 7.33 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.45 106.66 2.73 Favored Glycine 0 C--N 1.349 1.281 0 N-CA-C 114.676 0.631 . . . . 0.0 114.676 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.973 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.08 -157.16 0.2 Allowed 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.65 ' N ' HD13 ' A' ' 189' ' ' LEU . 71.0 m -88.6 134.38 34.22 Favored Pre-proline 0 C--N 1.345 0.372 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.187 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -29.29 -32.42 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.789 2.993 . . . . 0.0 113.919 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.533 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.72 54.53 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.482 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.973 ' OG1' HD22 ' A' ' 189' ' ' LEU . 14.3 m -40.17 123.74 1.68 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.927 0.394 . . . . 0.0 110.537 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 8.2 Cg_endo -50.32 92.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.745 2.297 . . . . 0.0 112.077 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.59 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -42.16 -23.67 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.446 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 194' ' ' PRO . 10.0 mt-10 -63.87 -33.5 75.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.573 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -85.76 -34.45 21.17 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.109 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -62.33 -20.87 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 114.196 -1.365 . . . . 0.0 108.863 176.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.544 ' O ' ' HA3' ' A' ' 203' ' ' GLY . 6.7 mtt180 -85.39 -25.03 27.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.293 178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -88.99 -31.2 18.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.878 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.697 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -72.99 -38.7 66.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.285 0.564 . . . . 0.0 110.045 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.882 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.0 OUTLIER -100.43 -30.99 11.52 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.449 -178.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.92 -46.26 92.01 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.26 -23.63 64.51 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.835 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.22 -34.68 78.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.968 0.89 . . . . 0.0 108.916 178.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.26 -139.99 6.37 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 113.933 -1.485 . . . . 0.0 110.063 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.6 mt-10 -91.43 90.47 7.69 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.993 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.492 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -55.36 143.59 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.694 ' CD ' HG21 ' A' ' 229' ' ' THR . 9.7 tt0 -89.71 -50.33 6.12 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 50.3 m -172.03 147.25 2.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.293 178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.595 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -111.34 159.34 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.466 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.3 OUTLIER -155.5 124.67 6.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.815 0.34 . . . . 0.0 111.372 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.773 HD21 HD12 ' A' ' 198' ' ' ILE . 1.4 mm? -105.4 93.96 7.65 Favored Pre-proline 0 N--CA 1.454 -0.238 0 CA-C-O 121.414 0.626 . . . . 0.0 111.066 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.644 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 50.4 Cg_exo -43.05 -169.18 0.0 OUTLIER 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 124.348 3.365 . . . . 0.0 113.864 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.509 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 158.02 121.72 0.0 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.039 -179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 17.3 p-10 -51.99 85.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 215' ' ' MET . 0.1 OUTLIER -145.19 9.33 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.654 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.561 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 22.3 mmtt -136.78 -27.42 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -132.99 -14.68 2.68 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.542 ' HB2' ' O ' ' A' ' 219' ' ' THR . 4.1 m120 71.85 53.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.559 0.578 . . . . 0.0 112.559 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.577 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -128.2 -171.0 2.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.574 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -76.59 -37.42 56.49 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.792 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.577 ' HG2' ' HG2' ' A' ' 221' ' ' LYS . 0.2 OUTLIER 17.65 -85.46 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.682 0 O-C-N 124.369 1.043 . . . . 0.0 109.992 -177.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.564 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.06 79.64 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 O-C-N 123.994 0.809 . . . . 0.0 112.857 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.664 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.78 -121.16 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -178.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.601 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -167.23 162.19 14.88 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.987 0.899 . . . . 0.0 112.587 177.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.027 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 2.9 m-85 -144.34 113.84 7.09 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 113.705 -1.589 . . . . 0.0 108.709 177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.109 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -111.47 159.13 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.408 0 CA-C-O 121.498 0.666 . . . . 0.0 110.719 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.719 HG23 ' HG3' ' A' ' 183' ' ' LYS . 1.5 m -135.04 178.05 7.33 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.338 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.67 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 92.0 m-85 -152.56 117.22 5.05 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.607 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.93 -37.54 1.34 Allowed 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -89.49 -155.84 0.37 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.4 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.606 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -141.43 1.86 1.6 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.716 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -81.62 -58.42 0.48 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.835 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 84.9 Cg_exo -48.91 -35.34 31.27 Favored 'Trans proline' 0 CA--C 1.494 -1.501 0 N-CA-C 109.035 -1.179 . . . . 0.0 109.035 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.879 HG13 HG23 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -63.66 -51.74 66.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 113.145 -1.843 . . . . 0.0 108.774 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 1.0 OUTLIER -44.94 -55.35 5.56 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.482 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.633 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.0 -54.19 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.107 179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.965 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -29.95 -62.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.06 -179.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -49.24 -27.13 3.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.889 0.376 . . . . 0.0 111.255 -179.115 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 238' ' ' LYS . 11.5 mm-40 -68.59 -34.98 76.73 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -106.09 20.57 18.75 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.458 178.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.615 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.77 -49.54 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.516 1.135 . . . . 0.0 112.009 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.0 m-85 -85.0 72.83 10.78 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.488 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.965 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -73.04 150.34 42.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.248 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -109.94 80.94 1.36 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.864 0.364 . . . . 0.0 110.963 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.573 HG12 ' CE ' ' A' ' 197' ' ' LYS . 0.9 OUTLIER -75.84 103.15 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.658 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.456 ' C ' HD23 ' A' ' 249' ' ' LEU . . . 47.64 -85.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.486 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.752 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -106.01 -44.94 4.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.976 0.417 . . . . 0.0 110.907 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.542 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.21 147.21 24.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.765 0.793 . . . . 0.0 112.372 -178.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -136.02 145.65 46.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.058 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.93 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.9 163.24 36.75 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 118.568 -1.253 . . . . 0.0 114.204 -177.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.493 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.2 tt0 -71.55 91.34 1.06 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 114.603 -1.18 . . . . 0.0 111.471 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.99 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -80.76 80.19 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.512 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.646 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.3 OUTLIER -93.13 120.46 33.45 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.4 p -30.54 116.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.941 1.246 . . . . 0.0 109.972 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.027 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.16 -173.06 3.04 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 112.971 -1.922 . . . . 0.0 113.369 -175.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.53 ' N ' ' HE3' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 170.03 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 112.665 -2.061 . . . . 0.0 110.198 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.823 179.708 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.719 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.767 0 O4'-C4'-C3' 104.082 -1.518 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.99 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 C3'-C2'-C1' 101.936 -0.546 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.99 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C4'--C3' 1.52 -0.801 0 C4'-C3'-C2' 101.164 -2.036 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.57 ' P ' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 C2'--C1' 1.509 -0.827 0 O4'-C4'-C3' 106.19 0.59 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.703 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.2 t . . . . . 0 CA--C 1.497 -1.092 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HA ' HG21 ' A' ' 236' ' ' VAL . 26.3 mttt -151.26 -36.38 0.13 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 119.072 -1.051 . . . . 0.0 111.727 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.882 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -93.57 -176.8 4.2 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.988 ' CD1' HD12 ' A' ' 239' ' ' ILE . 4.5 pt -161.34 114.93 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 122.15 0.976 . . . . 0.0 109.118 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.883 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.12 110.54 21.81 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.098 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.929 HG12 ' SG ' ' A' ' 252' ' ' CYS . 3.0 t -100.15 108.72 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.37 -179.87 0.01 OUTLIER Glycine 0 CA--C 1.531 1.065 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.42 161.59 0.0 OUTLIER Glycine 0 C--N 1.344 0.988 0 N-CA-C 114.815 0.686 . . . . 0.0 114.815 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.987 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -173.93 -143.67 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.703 ' N ' HD13 ' A' ' 189' ' ' LEU . 33.1 m -89.18 132.93 36.22 Favored Pre-proline 0 C--N 1.34 0.165 0 CA-C-O 121.037 0.446 . . . . 0.0 110.88 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.422 ' C ' ' O ' ' A' ' 190' ' ' SER . 72.1 Cg_exo -27.8 -36.19 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.588 2.859 . . . . 0.0 113.301 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.7 OUTLIER -150.59 54.84 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.576 0.226 . . . . 0.0 111.084 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.987 ' OG1' HD22 ' A' ' 189' ' ' LEU . 8.1 m -39.68 120.7 1.41 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.848 0.356 . . . . 0.0 110.394 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.59 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -50.35 99.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.717 2.278 . . . . 0.0 112.275 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.6 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.4 OUTLIER -45.88 -21.72 0.15 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.379 179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 200' ' ' GLU . 34.5 mt-10 -60.76 -37.87 83.31 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.59 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 1.2 mttp -79.73 -46.86 16.27 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.157 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.98 -26.8 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.897 177.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.558 ' HG2' ' CD1' ' A' ' 211' ' ' ILE . 5.3 mtt180 -80.56 -27.1 37.6 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.836 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.4 mt-10 -85.36 -59.85 2.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.634 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.716 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -44.89 -41.56 7.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.58 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.06 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -97.29 -35.08 10.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.997 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.51 -47.04 92.3 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.01 -22.79 65.2 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.83 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.53 -37.86 87.97 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 122.044 0.926 . . . . 0.0 108.837 178.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.93 -142.0 7.3 Favored Glycine 0 N--CA 1.441 -1.018 0 CA-C-N 113.688 -1.596 . . . . 0.0 109.833 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.7 mm-40 -91.66 92.64 8.54 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 119.989 -0.685 . . . . 0.0 110.874 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.412 HG21 ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -58.35 143.54 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.555 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.6 tp10 -89.45 -51.02 5.76 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 5.0 p -170.34 155.48 5.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.1 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.729 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -120.34 159.48 21.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.121 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.77 132.75 8.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.778 0.323 . . . . 0.0 111.205 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.089 HD21 HD12 ' A' ' 198' ' ' ILE . 1.6 mm? -115.7 98.24 50.51 Favored Pre-proline 0 C--N 1.333 -0.15 0 CA-C-O 121.428 0.632 . . . . 0.0 111.001 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.647 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 71.4 Cg_exo -49.14 -161.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.472 0.213 0 C-N-CA 123.86 3.04 . . . . 0.0 113.399 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.546 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 153.95 131.29 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.466 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.509 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 1.0 OUTLIER -58.43 75.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.453 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 215' ' ' MET . 26.9 t30 -145.4 4.64 1.05 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.507 ' C ' ' CG2' ' A' ' 219' ' ' THR . 6.9 mmmt -142.5 3.96 1.53 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.666 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 8.3 p -151.73 -37.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.099 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.666 ' HB2' ' O ' ' A' ' 219' ' ' THR . 77.6 m-20 91.32 57.77 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.524 ' CD ' ' OG1' ' A' ' 219' ' ' THR . 0.0 OUTLIER -143.91 -164.42 1.88 Allowed 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 119.779 -0.769 . . . . 0.0 111.579 178.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.613 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -83.16 -38.19 22.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.613 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 7.41 -87.39 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 O-C-N 124.235 0.959 . . . . 0.0 111.25 -179.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.579 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 17.28 75.69 0.01 OUTLIER Glycine 0 C--N 1.34 0.77 0 O-C-N 124.015 0.822 . . . . 0.0 111.362 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.655 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.54 -119.64 0.12 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 114.611 -0.795 . . . . 0.0 108.923 -176.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.632 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -166.4 163.58 17.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 121.905 0.859 . . . . 0.0 112.487 178.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.03 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -148.54 118.09 6.99 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.963 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.157 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.5 mt -113.23 152.85 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.294 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.792 HG23 ' HG3' ' A' ' 183' ' ' LYS . 2.6 m -131.04 152.97 49.77 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.072 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 87.8 m-85 -131.95 116.77 17.57 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.555 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.44 -37.75 0.73 Allowed 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.517 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.2 mm-40 -89.21 -158.24 0.49 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.788 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.613 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 16.5 pt-20 -141.09 11.6 2.19 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.856 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.5 OUTLIER -89.84 -62.75 0.21 Allowed Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.83 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 66.9 Cg_exo -47.55 -34.08 19.32 Favored 'Trans proline' 0 CA--C 1.494 -1.498 0 N-CA-C 109.231 -1.103 . . . . 0.0 109.231 178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.821 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.92 -52.69 50.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 113.156 -1.838 . . . . 0.0 110.611 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 8.0 pttt -52.8 -49.64 65.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.422 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.666 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -61.45 -53.55 55.04 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.049 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.988 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -34.13 -64.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.333 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.506 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 2.3 mtp -49.23 -22.15 0.96 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.921 0.391 . . . . 0.0 111.137 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 4.0 mm-40 -73.57 -36.9 65.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.619 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.16 20.88 15.88 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.312 177.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.61 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.96 -48.25 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.634 1.209 . . . . 0.0 112.416 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.619 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.3 m-85 -86.55 73.91 9.99 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.466 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.931 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.1 m-70 -77.0 147.34 36.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.156 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.436 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -111.48 81.35 1.43 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.987 179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -70.41 96.62 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.757 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 53.8 -78.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.61 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.554 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -113.81 -43.48 3.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.945 0.402 . . . . 0.0 110.922 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -88.32 148.53 24.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.512 0.672 . . . . 0.0 112.209 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.76 145.71 35.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.431 179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.929 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -161.6 155.02 21.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.751 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.552 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 47.6 tt0 -59.75 120.47 9.59 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.933 HG21 HD12 ' A' ' 184' ' ' ILE . 2.3 mt -105.06 84.6 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.749 0.785 . . . . 0.0 112.214 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.571 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -88.68 120.45 30.08 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 114.234 -1.348 . . . . 0.0 107.893 178.407 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.9 p -35.21 120.39 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 CA-C-N 119.457 1.026 . . . . 0.0 109.696 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.03 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -77.94 -178.44 5.5 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 113.247 -1.797 . . . . 0.0 113.14 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.542 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.1 OUTLIER 173.84 -90.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.245 -1.798 . . . . 0.0 110.449 179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 73.3 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.981 179.775 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.619 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 C4'-C3'-C2' 102.247 -0.953 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.991 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 O4'-C4'-C3' 106.188 0.588 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.991 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.783 0 C4'-C3'-C2' 101.195 -2.005 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.513 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.822 0 C3'-C2'-C1' 102.121 -0.413 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.632 ' O ' ' CB ' ' A' ' 233' ' ' GLU . 25.1 t . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' HA ' HG21 ' A' ' 236' ' ' VAL . 25.9 mttt -151.63 -35.35 0.13 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.148 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.852 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.13 -171.79 2.78 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.972 HD13 HD12 ' A' ' 239' ' ' ILE . 6.0 pt -166.46 110.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 122.197 0.998 . . . . 0.0 109.318 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.893 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -84.71 104.14 14.42 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.643 -178.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.961 HG13 HG12 ' A' ' 254' ' ' ILE . 3.8 t -89.82 114.46 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.716 0.806 . . . . 0.0 112.735 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.55 ' N ' ' HB2' ' A' ' 252' ' ' CYS . . . -46.21 -177.21 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.936 0.735 . . . . 0.0 114.936 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -33.32 163.5 0.01 OUTLIER Glycine 0 C--N 1.341 0.832 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.95 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.1 OUTLIER -177.7 -146.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.665 ' N ' HD13 ' A' ' 189' ' ' LEU . 39.7 m -89.03 133.13 35.98 Favored Pre-proline 0 C--N 1.34 0.193 0 CA-C-O 121.152 0.501 . . . . 0.0 111.105 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.72 -33.51 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.498 2.799 . . . . 0.0 113.181 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.2 m-20 -151.45 55.8 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.53 0.205 . . . . 0.0 111.461 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.95 ' OG1' HD22 ' A' ' 189' ' ' LEU . 24.3 m -39.19 123.21 1.31 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.333 . . . . 0.0 110.484 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.519 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.2 Cg_endo -49.51 88.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 0.0 111.682 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.584 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.7 OUTLIER -39.74 -25.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.0 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 194' ' ' PRO . 49.7 mt-10 -61.32 -33.42 73.56 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.43 0.529 . . . . 0.0 112.43 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.606 ' CE ' HG12 ' A' ' 247' ' ' VAL . 0.0 OUTLIER -88.21 -31.28 19.16 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.09 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -66.22 -21.95 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.621 176.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.608 ' HG2' HD11 ' A' ' 211' ' ' ILE . 13.9 mtp180 -82.44 -25.24 33.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.025 -0.988 . . . . 0.0 109.365 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 197' ' ' LYS . 4.3 pt-20 -88.91 -37.77 15.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.842 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.691 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -65.36 -37.69 87.8 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.238 0.542 . . . . 0.0 110.121 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.895 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -100.69 -30.72 11.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.18 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.97 -44.93 93.81 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 107.672 -2.171 . . . . 0.0 107.672 175.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.61 -23.53 67.06 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.809 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.36 -35.89 82.34 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 122.182 0.991 . . . . 0.0 108.849 178.099 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 162.77 -138.93 5.61 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 113.664 -1.607 . . . . 0.0 109.981 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.9 mm-40 -91.46 92.09 8.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.643 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.522 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -58.07 142.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.568 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.61 -47.74 7.49 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 12.3 m -175.41 150.14 1.09 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.809 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -113.23 158.62 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.833 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.43 ' HG2' ' C ' ' A' ' 211' ' ' ILE . 0.8 OUTLIER -156.14 129.22 8.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.649 0.262 . . . . 0.0 111.289 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.823 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.4 mm? -111.7 99.07 43.63 Favored Pre-proline 0 CA--C 1.529 0.162 0 CA-C-O 121.09 0.471 . . . . 0.0 111.428 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.68 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 83.6 Cg_exo -43.07 -165.39 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 124.461 3.441 . . . . 0.0 114.25 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.521 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 156.93 117.09 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.409 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.521 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 36.8 p-10 -51.73 81.04 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 112.052 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 215' ' ' MET . 9.8 t-20 -139.4 3.75 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.207 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.576 ' HG3' " C4'" ' B' ' 5' ' ' ' DG' . 7.1 mmmt -136.36 1.59 2.66 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.2 OUTLIER -151.95 -20.13 0.18 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 219' ' ' THR . 34.7 m-20 74.74 42.77 0.27 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.624 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -119.65 -152.66 0.51 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.056 178.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.555 ' O ' ' C ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -105.8 -27.04 11.5 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.624 ' HG2' ' CD ' ' A' ' 221' ' ' LYS . 0.0 OUTLIER 12.48 -82.17 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 124.639 1.212 . . . . 0.0 109.949 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 20.76 79.96 0.01 OUTLIER Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.05 178.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.68 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -142.91 -118.76 0.1 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.671 ' SG ' HD13 ' A' ' 213' ' ' LEU . 0.4 OUTLIER -167.69 169.24 11.95 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.209 1.004 . . . . 0.0 112.442 177.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.042 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.3 m-85 -150.66 110.52 4.08 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.457 -1.701 . . . . 0.0 108.886 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.09 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -108.17 160.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.514 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.4 m -138.94 167.63 21.61 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.251 -178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 82.8 m-85 -144.05 119.82 10.54 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.36 -39.4 3.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.6 mt-10 -92.45 -176.56 4.34 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.894 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.632 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.9 pt-20 -119.05 3.83 11.43 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -79.86 -61.41 0.46 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -177.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.809 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 57.8 Cg_exo -47.59 -35.69 23.16 Favored 'Trans proline' 0 CA--C 1.492 -1.599 0 CA-C-N 120.422 1.186 . . . . 0.0 109.203 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.831 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -62.68 -50.07 81.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.114 -1.857 . . . . 0.0 109.017 178.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 11.2 mttt -46.78 -59.85 2.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.12 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.653 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -58.46 -51.97 67.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.629 179.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.972 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.62 -65.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.339 -179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.1 OUTLIER -47.94 -28.12 2.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.016 0.436 . . . . 0.0 110.574 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.563 ' N ' ' O ' ' A' ' 238' ' ' LYS . 25.6 mm-40 -66.46 -42.15 88.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.603 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -98.88 21.64 11.28 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.258 177.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.46 -49.69 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.43 0 O-C-N 124.632 1.207 . . . . 0.0 111.846 -179.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.603 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.7 m-85 -85.12 72.57 10.76 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.653 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.93 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.7 m-70 -73.06 152.18 41.38 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.247 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.42 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -114.77 80.88 1.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.892 179.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.606 HG12 ' CE ' ' A' ' 197' ' ' LYS . 1.4 t -74.93 97.5 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.767 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 51.37 -83.23 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.568 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -107.31 -43.57 4.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.964 0.412 . . . . 0.0 110.687 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 1.2 m -88.33 145.34 25.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.695 0.759 . . . . 0.0 112.357 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.1 OUTLIER -140.33 140.57 35.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.493 -1.23 . . . . 0.0 108.855 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.926 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.85 166.42 33.42 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.438 ' HG2' ' HD2' ' A' ' 255' ' ' LYS . 53.2 tt0 -72.68 93.54 1.65 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 114.348 -1.297 . . . . 0.0 110.774 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.961 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -81.47 82.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.604 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.573 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -93.8 120.29 33.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -31.01 118.02 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.622 0 CA-C-O 122.373 1.082 . . . . 0.0 110.431 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.042 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -76.4 175.31 9.27 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.072 -1.876 . . . . 0.0 112.343 -176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -147.41 -151.41 0.38 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.736 -1.575 . . . . 0.0 111.144 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.797 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.973 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O4'--C4' 1.437 -0.788 0 C3'-C2'-C1' 104.872 1.551 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.989 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.424 -0.996 0 C4'-C3'-C2' 104.77 1.57 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.989 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 C2'--C1' 1.533 0.89 0 C4'-C3'-C2' 100.62 -2.58 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.863 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -0.986 0 C4'-C3'-C2' 104.12 0.92 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.705 HG12 ' HB ' ' A' ' 236' ' ' VAL . 38.6 t . . . . . 0 CA--C 1.499 -0.995 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.595 ' HA ' HG21 ' A' ' 236' ' ' VAL . 20.7 mttt -152.56 -35.48 0.12 Allowed 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.551 -1.26 . . . . 0.0 112.736 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.842 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.24 -174.61 3.42 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.946 ' CD1' HD12 ' A' ' 239' ' ' ILE . 6.5 pt -163.64 114.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.988 0.899 . . . . 0.0 108.878 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.846 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -89.38 110.07 20.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.864 -177.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.948 HG12 ' SG ' ' A' ' 252' ' ' CYS . 2.7 t -100.35 107.66 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -41.15 -179.56 0.01 OUTLIER Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.892 0.717 . . . . 0.0 114.892 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -30.06 160.3 0.0 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 114.579 0.592 . . . . 0.0 114.579 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.041 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -172.15 -145.04 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.684 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -89.23 130.51 43.82 Favored Pre-proline 0 C--N 1.339 0.121 0 CA-C-O 120.898 0.38 . . . . 0.0 110.644 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -30.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.236 2.624 . . . . 0.0 112.979 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 190' ' ' SER . 15.1 t70 -150.43 52.76 0.89 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.266 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.041 ' OG1' HD22 ' A' ' 189' ' ' LEU . 55.1 m -42.9 124.51 3.15 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.931 0.396 . . . . 0.0 110.271 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.9 Cg_endo -52.17 92.14 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.761 2.307 . . . . 0.0 112.286 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.65 ' OE1' HD23 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -39.75 -27.73 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.104 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 199' ' ' ARG . 2.6 mp0 -61.49 -37.23 82.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 200' ' ' GLU . 20.4 mmmt -73.99 -50.03 21.73 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.168 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -51.72 -27.43 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.568 0 CA-C-N 113.142 -1.844 . . . . 0.0 107.556 175.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.588 ' HD3' ' CD1' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -75.72 -30.92 59.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.813 178.146 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 197' ' ' LYS . 8.5 mm-40 -85.59 -64.35 1.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.805 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.72 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -39.35 -39.06 0.61 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.407 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.044 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -99.92 -34.26 10.19 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.831 -178.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.5 -46.08 94.53 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 176.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -64.63 -22.42 67.96 Favored Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.836 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.62 -37.57 86.96 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.962 0.887 . . . . 0.0 108.834 178.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 167.07 -142.85 7.86 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.997 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.505 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 2.2 mm-40 -91.48 89.79 7.37 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.809 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.424 ' O ' ' HE2' ' A' ' 231' ' ' LYS . 1.8 t -53.19 141.88 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.568 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.9 tp10 -90.4 -48.04 7.36 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 17.9 m -175.8 150.91 1.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.169 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.747 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -115.62 158.38 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.701 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.489 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -155.56 124.76 6.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.76 0.314 . . . . 0.0 111.018 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.971 HD21 HD12 ' A' ' 198' ' ' ILE . 1.7 mm? -108.16 94.79 13.8 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.443 0.64 . . . . 0.0 111.438 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.619 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 74.1 Cg_exo -46.71 -165.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.527 0.174 0 C-N-CA 123.813 3.008 . . . . 0.0 113.795 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.539 ' HG2' ' OP1' ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER 156.46 130.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.721 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.47 ' HB2' ' HA ' ' A' ' 220' ' ' ASN . 3.9 p30 -50.13 82.77 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 111.645 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.534 ' N ' ' O ' ' A' ' 215' ' ' MET . 32.5 t30 -135.57 -5.91 2.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.735 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.439 ' C ' ' CG2' ' A' ' 219' ' ' THR . 17.7 mmmt -128.75 -3.89 5.26 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.4 OUTLIER -151.21 -20.43 0.21 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' A' ' 219' ' ' THR . 4.0 m-80 71.35 45.94 0.45 Allowed 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.606 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -116.65 -154.42 0.55 Allowed 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.562 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.656 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -89.17 -37.87 14.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 122.199 -0.313 . . . . 0.0 110.431 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.656 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.4 OUTLIER 6.87 -98.78 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 124.143 0.902 . . . . 0.0 111.536 -178.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.53 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 25.28 74.68 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.636 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.4 OUTLIER -138.49 -123.26 0.13 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -177.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -159.51 162.8 35.55 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.08 0.943 . . . . 0.0 112.692 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.018 ' CE1' ' HB1' ' A' ' 257' ' ' ALA . 2.9 m-85 -149.66 109.95 4.18 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 113.602 -1.636 . . . . 0.0 108.28 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.168 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -106.87 157.88 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.723 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 6.6 m -138.38 154.18 48.92 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.527 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.671 ' CD1' HG22 ' A' ' 236' ' ' VAL . 68.9 m-85 -132.37 120.55 22.2 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.568 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -42.13 -38.26 1.65 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.512 ' O ' ' O ' ' A' ' 230' ' ' PHE . 31.3 mt-10 -89.32 -164.0 1.08 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.657 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 25.8 pt-20 -134.67 16.93 3.6 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.664 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.6 -63.06 0.17 Allowed Pre-proline 0 C--N 1.327 -0.373 0 C-N-CA 120.692 -0.403 . . . . 0.0 112.015 -178.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.836 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 76.4 Cg_exo -48.03 -34.9 24.28 Favored 'Trans proline' 0 CA--C 1.494 -1.487 0 N-CA-C 108.94 -1.215 . . . . 0.0 108.94 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.832 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -65.82 -54.06 31.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.07 -1.877 . . . . 0.0 110.221 179.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 37.3 pttt -51.37 -41.83 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.022 -178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.664 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.22 -55.17 8.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.574 0.702 . . . . 0.0 110.048 178.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.946 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.5 OUTLIER -29.8 -60.25 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.846 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.552 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.7 OUTLIER -51.89 -18.21 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.761 0.315 . . . . 0.0 111.801 -178.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.4 mm-40 -79.5 -33.47 42.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -104.71 20.87 17.89 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.946 178.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.617 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.05 -47.37 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.394 1.059 . . . . 0.0 112.148 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.617 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 20.6 m-85 -85.73 71.2 10.72 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.359 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.935 ' CE1' HD13 ' A' ' 239' ' ' ILE . 11.3 m-70 -73.12 144.71 46.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.147 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -107.6 78.37 1.2 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.344 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -68.77 152.74 9.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.349 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.532 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 2.87 -70.87 0.0 OUTLIER Glycine 0 C--N 1.343 0.949 0 O-C-N 123.97 0.794 . . . . 0.0 113.854 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -120.91 -40.01 2.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.269 0.557 . . . . 0.0 110.736 179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.54 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.9 OUTLIER -88.94 152.41 21.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.81 -178.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -142.0 134.55 28.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.582 -1.19 . . . . 0.0 108.575 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.948 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -151.8 158.26 43.06 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.885 -178.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.578 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 39.1 tt0 -61.93 121.63 13.44 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.923 HG21 HD12 ' A' ' 184' ' ' ILE . 1.8 mt -106.34 81.39 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.769 0.795 . . . . 0.0 112.039 -176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.1 118.85 26.77 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 114.207 -1.36 . . . . 0.0 107.784 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.2 p -34.64 115.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 122.409 1.099 . . . . 0.0 110.083 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.018 ' HB1' ' CE1' ' A' ' 227' ' ' PHE . . . -69.09 178.73 2.15 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 112.853 -1.976 . . . . 0.0 112.746 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.589 ' HG3' ' C2 ' ' B' ' 3' ' ' ' DA' . 0.0 OUTLIER -170.19 139.66 1.81 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.41 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.054 0.454 . . . . 0.0 111.133 -179.675 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.626 " C2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.425 -0.92 0 C3'-C2'-C1' 100.782 -1.37 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.68 ' N7 ' ' CE2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 O4'-C1'-C2' 107.044 0.858 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.751 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.52 -0.847 0 C4'-C3'-C2' 100.835 -2.365 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.598 ' C6 ' ' N7 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 O4'-C1'-N19 108.1 0.375 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.72 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.0 t . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.592 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.2 mttt -150.77 -35.92 0.14 Allowed 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.937 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -92.55 -173.08 3.26 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.971 HD13 HD12 ' A' ' 239' ' ' ILE . 6.5 pt -165.04 109.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 122.207 1.003 . . . . 0.0 109.68 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.898 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -83.69 106.56 15.49 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.563 -178.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.95 HG13 HG12 ' A' ' 254' ' ' ILE . 4.3 t -93.82 111.75 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.643 0.777 . . . . 0.0 112.744 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -44.77 -175.98 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 114.751 0.66 . . . . 0.0 114.751 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -32.59 162.37 0.0 OUTLIER Glycine 0 C--N 1.342 0.876 0 N-CA-C 114.824 0.69 . . . . 0.0 114.824 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.975 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -175.12 -145.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.656 ' N ' HD13 ' A' ' 189' ' ' LEU . 9.1 t -89.32 133.37 35.0 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-O 120.953 0.406 . . . . 0.0 110.225 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 53.8 Cg_exo -29.69 -34.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.209 2.606 . . . . 0.0 113.251 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.79 56.97 0.86 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 0.0 111.279 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.975 ' OG1' HD22 ' A' ' 189' ' ' LEU . 54.0 m -39.48 125.79 1.42 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.558 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.2 Cg_endo -53.61 95.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.802 2.334 . . . . 0.0 112.189 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.6 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.6 OUTLIER -43.38 -20.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.146 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 66.1 mt-10 -62.79 -39.51 94.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.806 ' HE2' HD21 ' A' ' 249' ' ' LEU . 1.0 OUTLIER -79.27 -46.66 17.33 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.097 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.62 -27.0 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.932 -1.486 . . . . 0.0 108.942 177.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.621 ' HA ' HD11 ' A' ' 211' ' ' ILE . 6.7 mtp85 -77.75 -28.03 50.57 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.697 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 197' ' ' LYS . 6.9 mm-40 -85.8 -60.63 1.96 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.683 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.695 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.7 t80 -41.51 -41.49 2.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.613 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.925 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -99.49 -30.98 11.86 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.821 -178.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -63.13 -47.01 91.96 Favored Glycine 0 CA--C 1.504 -0.642 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 176.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -22.48 65.93 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.7 -36.89 85.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 121.89 0.853 . . . . 0.0 108.74 178.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.04 -138.43 5.29 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 113.87 -1.514 . . . . 0.0 109.904 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.522 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.8 mm-40 -91.89 89.88 7.22 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 120.342 -0.543 . . . . 0.0 111.023 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.47 HG23 ' C ' ' A' ' 202' ' ' PHE . 2.0 t -55.57 139.8 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.711 ' CD ' HG21 ' A' ' 229' ' ' THR . 6.0 tt0 -89.66 -47.1 8.17 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 76.3 p -173.48 150.32 1.8 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.743 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.621 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.1 OUTLIER -114.59 161.44 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.329 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.0 OUTLIER -158.9 137.48 10.93 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.844 0.354 . . . . 0.0 111.537 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 198' ' ' ILE . 2.3 mm? -125.44 111.62 25.84 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.605 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 1.8 Cg_endo -85.75 -162.44 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.783 2.989 . . . . 0.0 113.474 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.538 ' HA ' ' CA ' ' A' ' 224' ' ' GLY . 2.9 ptp 164.43 172.17 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.939 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 0.5 OUTLIER -83.43 75.41 10.0 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.27 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 218' ' ' LYS . 11.0 m120 -144.89 8.47 1.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.736 0.303 . . . . 0.0 111.453 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.517 ' HG3' ' OP2' ' B' ' 5' ' ' ' DG' . 20.0 mmtp -123.98 -36.91 2.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.371 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -138.92 -2.9 1.66 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.1 -177.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.8 m120 71.22 55.09 0.22 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.591 ' CE ' ' CZ ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.41 163.52 26.73 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.141 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.637 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -59.48 -36.43 76.0 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.979 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.637 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 2.7 mtm180 6.39 -84.99 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 124.501 1.126 . . . . 0.0 109.659 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.562 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 10.47 81.17 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 O-C-N 124.443 1.089 . . . . 0.0 112.903 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.646 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -143.98 -120.76 0.09 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.648 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -163.4 165.08 24.34 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 122.325 1.06 . . . . 0.0 113.349 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.051 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.6 m-85 -150.46 111.32 4.3 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.729 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.097 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.5 mt -112.49 161.79 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.366 0 CA-C-O 121.144 0.497 . . . . 0.0 110.476 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.711 HG21 ' CD ' ' A' ' 209' ' ' GLU . 0.3 OUTLIER -136.7 -179.25 5.58 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.408 -178.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.645 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 85.2 m-85 -157.07 115.83 3.3 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.869 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.38 -36.27 0.53 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.3 mm-40 -89.09 -157.05 0.42 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 113.403 -1.726 . . . . 0.0 110.759 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.584 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.8 pm0 -143.15 12.81 1.81 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.379 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.59 -61.73 0.2 Allowed Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.842 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 81.1 Cg_exo -49.28 -32.85 26.67 Favored 'Trans proline' 0 CA--C 1.496 -1.393 0 N-CA-C 108.946 -1.213 . . . . 0.0 108.946 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.832 HG13 HG23 ' A' ' 184' ' ' ILE . 0.8 OUTLIER -66.53 -53.04 39.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 113.266 -1.788 . . . . 0.0 110.153 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.7 pttt -52.84 -45.39 67.32 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.659 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.649 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -65.84 -53.84 34.63 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.603 0.716 . . . . 0.0 109.852 177.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.971 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -31.18 -62.91 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.823 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.493 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -48.35 -29.17 3.69 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 238' ' ' LYS . 8.3 mm-40 -65.79 -38.99 90.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.31 20.76 16.25 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.14 177.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.586 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.16 -49.71 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.459 0 O-C-N 124.647 1.217 . . . . 0.0 111.966 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.6 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.2 m-85 -84.84 74.59 10.46 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.598 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.961 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.4 m-70 -76.1 151.42 37.04 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.903 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.446 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 1.2 m-80 -115.07 80.67 1.45 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.502 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -74.52 108.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.566 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 39.09 -89.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.441 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.806 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -97.97 -43.37 7.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.989 0.423 . . . . 0.0 111.204 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 9.0 m -88.25 147.88 24.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.637 0.732 . . . . 0.0 112.92 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.55 141.11 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.524 179.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.944 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.17 168.37 26.73 Favored 'General case' 0 CA--C 1.522 -0.115 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -178.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 56.6 tt0 -73.31 96.07 2.25 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.375 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.95 HG12 HG13 ' A' ' 186' ' ' VAL . 1.4 mt -83.95 81.92 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 114.024 -1.444 . . . . 0.0 112.737 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.583 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -94.26 118.04 31.0 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.9 p -27.88 120.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 122.217 1.008 . . . . 0.0 110.539 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.051 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -80.44 174.04 12.0 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.105 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.29 150.36 14.48 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.138 -1.846 . . . . 0.0 110.924 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.578 " C4'" ' HD3' ' A' ' 222' ' ' ARG . . . . . . . . 0 O5'--C5' 1.428 -0.731 0 O4'-C4'-C3' 104.367 -1.233 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.87 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 C3'-C2'-C1' 104.951 1.608 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 1.087 " H5'" ' N3 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.535 1.011 0 C4'-C3'-C2' 100.82 -2.38 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.838 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.836 0 O4'-C1'-C2' 106.701 0.547 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.708 HG12 ' HB ' ' A' ' 236' ' ' VAL . 28.6 t . . . . . 0 CA--C 1.495 -1.15 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.5 mttt -150.33 -34.39 0.17 Allowed 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.037 -1.065 . . . . 0.0 111.911 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -97.07 -173.59 2.73 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.001 HD13 HD12 ' A' ' 239' ' ' ILE . 13.2 pt -162.7 117.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-O 121.818 0.818 . . . . 0.0 109.105 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.855 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.57 99.54 12.45 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.78 -177.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.012 HG13 HG12 ' A' ' 254' ' ' ILE . 2.7 t -84.84 112.85 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.03 0.932 . . . . 0.0 110.924 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.603 ' O ' ' C5 ' ' B' ' 2' ' ' ' DT' . . . -99.18 120.91 7.03 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.563 ' HA3' ' C7 ' ' B' ' 2' ' ' ' DT' . . . 97.47 108.72 2.65 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 177.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.941 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.81 -159.22 0.24 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 178.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.602 ' N ' HD13 ' A' ' 189' ' ' LEU . 26.3 t -89.04 132.75 36.99 Favored Pre-proline 0 C--N 1.342 0.254 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.744 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 190' ' ' SER . 28.2 Cg_exo -31.02 -29.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.872 3.048 . . . . 0.0 113.561 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 190' ' ' SER . 11.4 t70 -148.57 53.52 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.686 0.279 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.969 HG22 HD11 ' A' ' 198' ' ' ILE . 7.9 m -39.83 134.15 1.36 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.184 0.516 . . . . 0.0 110.634 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.51 ' O ' HG13 ' A' ' 198' ' ' ILE . 9.7 Cg_endo -52.66 83.31 0.02 OUTLIER 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.077 2.518 . . . . 0.0 112.084 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.581 ' HA ' ' CD1' ' A' ' 198' ' ' ILE . 0.4 OUTLIER -39.58 -27.02 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.216 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 194' ' ' PRO . 42.9 mt-10 -63.53 -35.59 80.97 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.0 OUTLIER -78.33 -46.45 20.06 Favored 'General case' 0 CA--C 1.492 -1.265 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 178.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.13 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -49.82 -24.08 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.624 177.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.569 ' HG2' HD11 ' A' ' 211' ' ' ILE . 7.8 mtp-105 -83.98 -25.96 29.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.69 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.7 OUTLIER -88.06 -35.54 17.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.044 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.708 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.5 t80 -68.33 -41.12 81.22 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.833 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.9 OUTLIER -97.34 -30.96 12.65 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.894 -178.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.08 -47.28 86.96 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.82 -23.73 61.56 Favored Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.834 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.46 -34.1 77.19 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.987 0.898 . . . . 0.0 108.859 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 160.84 -140.27 6.58 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 113.875 -1.512 . . . . 0.0 109.956 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.4 mm-40 -91.51 90.73 7.76 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.889 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -54.63 144.12 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 177.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.688 ' CD ' HG21 ' A' ' 229' ' ' THR . 6.6 tt0 -89.43 -49.34 6.75 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.9 p -173.17 148.99 1.75 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.236 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.589 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -112.24 163.81 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.36 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' A' ' 211' ' ' ILE . 0.0 OUTLIER -163.12 126.57 2.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.856 0.36 . . . . 0.0 110.953 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.948 HD21 HD12 ' A' ' 198' ' ' ILE . 1.2 mm? -109.94 98.37 33.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.146 0.498 . . . . 0.0 111.264 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 53.4 Cg_exo -48.18 -161.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.528 0.183 0 C-N-CA 123.691 2.927 . . . . 0.0 113.269 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 155.86 122.53 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.714 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.495 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 8.8 p-10 -59.81 74.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.26 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 215' ' ' MET . 3.6 t-20 -131.05 -2.48 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.365 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.507 ' HG3' H5'' ' B' ' 5' ' ' ' DG' . 4.0 mmmt -132.1 5.73 4.18 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 120.965 0.412 . . . . 0.0 111.76 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.578 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -151.86 -24.98 0.19 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.305 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.578 ' HB2' ' O ' ' A' ' 219' ' ' THR . 3.8 m120 75.06 40.99 0.32 Allowed 'General case' 0 CA--C 1.522 -0.11 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.63 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -116.12 -155.82 0.59 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.306 178.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.639 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -91.08 -37.02 13.68 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 122.256 -0.278 . . . . 0.0 110.267 -179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.639 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.3 OUTLIER 7.47 -96.29 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 124.084 0.865 . . . . 0.0 111.573 -178.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 23.28 75.63 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 O-C-N 123.635 0.584 . . . . 0.0 111.683 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.681 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -140.14 -120.4 0.12 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.101 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.63 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -169.77 162.95 9.77 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.194 0.997 . . . . 0.0 113.263 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.031 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.8 m-85 -144.42 123.94 13.2 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.634 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.13 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -119.85 157.21 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.373 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.523 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.688 HG21 ' CD ' ' A' ' 209' ' ' GLU . 1.3 m -132.77 173.52 11.28 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.88 -178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 93.1 m-85 -148.2 117.4 6.86 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.609 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -41.48 -37.37 1.06 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.507 ' O ' ' O ' ' A' ' 230' ' ' PHE . 2.4 mm-40 -90.19 -154.87 0.35 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 113.316 -1.766 . . . . 0.0 110.62 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.607 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.0 OUTLIER -142.07 1.98 1.48 Allowed 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.696 -178.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -83.75 -57.46 0.41 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.834 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 75.2 Cg_exo -49.18 -33.29 27.22 Favored 'Trans proline' 0 CA--C 1.492 -1.584 0 N-CA-C 109.068 -1.166 . . . . 0.0 109.068 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.795 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.0 OUTLIER -64.94 -52.07 58.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.419 177.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 20.4 mtpt -46.54 -56.45 6.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -60.03 -53.58 56.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.352 -1.295 . . . . 0.0 110.6 179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.006 HD13 ' CE1' ' A' ' 245' ' ' HIS . 0.5 OUTLIER -32.94 -61.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.699 -179.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.582 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 30.8 mtm -49.94 -20.12 0.85 Allowed 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.543 ' CG ' ' O ' ' A' ' 238' ' ' LYS . 2.6 mm-40 -75.57 -33.31 60.6 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.34 22.83 15.39 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.075 179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.614 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -16.05 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.492 1.12 . . . . 0.0 112.332 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.91 72.7 10.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.314 179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 1.006 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.3 m-70 -73.55 146.61 44.65 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.142 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.2 m-80 -107.63 79.6 1.31 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.365 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.69 147.79 11.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.256 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 7.4 -73.9 0.0 OUTLIER Glycine 0 C--N 1.343 0.941 0 O-C-N 124.032 0.833 . . . . 0.0 113.679 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -116.71 -41.18 3.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.193 0.52 . . . . 0.0 110.731 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 0.8 OUTLIER -89.16 152.07 21.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.866 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.87 144.76 39.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.526 -1.215 . . . . 0.0 107.94 178.588 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.879 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.26 168.88 25.36 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 118.739 -1.185 . . . . 0.0 114.093 -177.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 49.9 tt0 -75.39 93.01 2.87 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 1.012 HG12 HG13 ' A' ' 186' ' ' VAL . 1.1 mt -80.18 83.44 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.751 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.588 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 0.9 OUTLIER -96.04 117.36 30.52 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.5 p -29.74 117.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 119.703 1.138 . . . . 0.0 110.161 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.031 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.46 -173.16 2.02 Favored 'General case' 0 N--CA 1.422 -1.828 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.451 -175.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.452 ' HG2' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -175.93 142.21 0.51 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 112.763 -2.017 . . . . 0.0 110.63 -179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.789 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.699 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 C3'-C2'-C1' 101.71 -0.707 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.992 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.868 0 O4'-C4'-C3' 106.215 0.615 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.992 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.426 -0.854 0 C4'-C3'-C2' 100.849 -2.351 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.859 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.505 -1.123 0 C4'-C3'-C2' 104.218 1.018 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.764 HG12 ' HB ' ' A' ' 236' ' ' VAL . 42.2 t . . . . . 0 CA--C 1.494 -1.182 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.9 mttt -150.57 -35.36 0.15 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 118.889 -1.124 . . . . 0.0 112.042 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.941 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -96.46 -173.9 2.9 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.058 HD13 HD12 ' A' ' 239' ' ' ILE . 4.9 pt -162.45 115.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.831 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -93.08 92.57 7.87 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.019 -177.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.054 HG13 HG12 ' A' ' 254' ' ' ILE . 2.2 t -73.37 148.09 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.546 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -93.84 -167.64 37.74 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.578 -0.82 . . . . 0.0 114.389 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -23.55 150.11 0.0 OUTLIER Glycine 0 C--N 1.34 0.769 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.051 HD21 HD12 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -176.46 -147.11 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.669 ' N ' HD13 ' A' ' 189' ' ' LEU . 1.3 m -89.41 129.93 45.58 Favored Pre-proline 0 C--N 1.341 0.199 0 CA-C-O 120.96 0.409 . . . . 0.0 110.508 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -32.03 -28.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.391 2.728 . . . . 0.0 113.409 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' A' ' 190' ' ' SER . 2.8 t0 -149.68 53.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.624 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.974 ' OG1' HD22 ' A' ' 189' ' ' LEU . 16.9 m -39.91 124.75 1.59 Allowed Pre-proline 0 CA--C 1.519 -0.245 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.087 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.548 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 6.2 Cg_endo -48.58 94.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.56 2.174 . . . . 0.0 111.988 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.601 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.3 OUTLIER -45.24 -21.32 0.07 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.707 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -37.65 88.06 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.763 ' HE2' HD21 ' A' ' 249' ' ' LEU . 1.3 mttp -77.68 -49.09 15.2 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.129 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -47.18 -28.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.931 176.805 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.674 ' HG2' HD11 ' A' ' 211' ' ' ILE . 12.0 mtt180 -79.64 -27.99 40.92 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.33 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' A' ' 197' ' ' LYS . 5.2 pt-20 -87.47 -53.01 5.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.677 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -51.48 -39.5 57.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.342 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.131 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -98.75 -35.83 10.02 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.673 -178.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.94 -42.93 99.57 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 108.284 -1.927 . . . . 0.0 108.284 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 200' ' ' GLU . . . -66.04 -22.48 70.62 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.823 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.21 -37.85 84.29 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 122.3 1.048 . . . . 0.0 108.399 178.011 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 168.52 -156.67 28.3 Favored Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.157 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 3.5 mt-10 -81.6 90.91 6.32 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.776 -0.769 . . . . 0.0 110.645 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.6 t -53.01 142.75 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.559 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 5.1 tp10 -89.41 -46.97 8.33 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.4 ' C ' HG12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -167.79 169.79 11.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.184 178.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.674 HD11 ' HG2' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -133.49 166.45 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.763 ' C ' HD22 ' A' ' 213' ' ' LEU . 2.1 tp10 -162.67 148.37 12.38 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.709 0.29 . . . . 0.0 111.352 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.051 HD12 HD21 ' A' ' 189' ' ' LEU . 2.8 mm? -140.25 106.1 6.65 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.305 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.636 ' HG2' ' CE2' ' A' ' 225' ' ' PHE . 21.0 Cg_exo -69.64 -172.32 0.55 Allowed 'Trans proline' 0 N--CA 1.477 0.535 0 C-N-CA 124.005 3.137 . . . . 0.0 113.68 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.538 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 156.08 107.14 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.054 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.482 ' C ' ' O ' ' A' ' 215' ' ' MET . 33.9 p-10 -14.91 78.95 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.828 0.705 . . . . 0.0 112.749 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 215' ' ' MET . 3.3 t-20 -137.25 -4.14 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.478 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.437 ' C ' ' CG2' ' A' ' 219' ' ' THR . 5.2 mmmt -147.03 3.49 0.81 Allowed 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.629 HG23 ' NH2' ' A' ' 223' ' ' ARG . 0.2 OUTLIER -151.01 -5.37 0.29 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 219' ' ' THR . 19.6 m-20 70.69 2.83 4.3 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 216' ' ' ASP . 0.4 OUTLIER -94.78 158.26 15.58 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.459 -178.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -56.77 -42.43 79.39 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.629 ' NH2' HG23 ' A' ' 219' ' ' THR . 0.0 OUTLIER 26.36 -91.41 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.871 0 O-C-N 124.641 1.213 . . . . 0.0 108.918 -177.261 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 23.58 77.87 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.136 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.636 ' CE2' ' HG2' ' A' ' 214' ' ' PRO . 7.2 p90 -131.26 -130.6 0.2 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.744 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -154.27 162.53 41.12 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.198 0.523 . . . . 0.0 110.355 178.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.161 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 1.8 m-85 -150.5 118.02 6.11 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.525 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.131 HD12 ' CG ' ' A' ' 202' ' ' PHE . 1.3 mt -119.13 142.35 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 122.051 0.929 . . . . 0.0 110.492 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 4.0 m -120.09 149.55 42.01 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 114.001 -1.454 . . . . 0.0 109.284 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.66 ' CD1' HG22 ' A' ' 236' ' ' VAL . 63.8 m-85 -130.71 116.67 18.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.559 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -39.39 -36.63 0.37 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 122.227 1.013 . . . . 0.0 108.299 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 230' ' ' PHE . 3.2 mm-40 -88.44 -155.87 0.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 113.468 -1.696 . . . . 0.0 110.992 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.6 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.3 OUTLIER -144.97 11.4 1.37 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.175 -179.064 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.663 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -92.4 -59.07 0.22 Allowed Pre-proline 0 C--O 1.224 -0.254 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.823 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.0 Cg_exo -51.33 -32.48 41.89 Favored 'Trans proline' 0 CA--C 1.496 -1.388 0 N-CA-C 108.678 -1.316 . . . . 0.0 108.678 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.764 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.9 OUTLIER -66.95 -54.5 24.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.056 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.663 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.6 OUTLIER -51.54 -45.25 62.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.84 -179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.688 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -53.97 31.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.456 0.646 . . . . 0.0 109.74 178.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.058 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -32.69 -65.66 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.336 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.9 OUTLIER -48.71 -25.35 1.76 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.894 0.378 . . . . 0.0 111.055 -178.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 238' ' ' LYS . 5.6 mm-40 -67.88 -37.14 81.41 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -105.52 22.96 14.58 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.241 178.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.609 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.78 -48.34 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.655 1.222 . . . . 0.0 111.985 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -84.52 72.22 10.67 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 120.983 0.42 . . . . 0.0 110.742 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.924 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.0 m-70 -74.23 159.15 32.88 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.393 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.44 ' OD1' ' HG2' ' A' ' 251' ' ' LYS . 5.2 m-80 -119.75 74.26 1.01 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.45 101.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.675 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.65 -87.55 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.54 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.763 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -99.87 -42.34 6.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.158 0.504 . . . . 0.0 110.559 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 247' ' ' VAL . 41.9 m -88.44 143.81 26.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.372 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.02 133.19 27.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.266 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.039 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -153.62 169.35 23.47 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -177.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.483 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 47.8 tt0 -72.9 104.9 4.2 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.004 179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 1.054 HG12 HG13 ' A' ' 186' ' ' VAL . 1.8 mt -91.12 79.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.643 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.61 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 1.6 mtpt -87.45 119.04 27.33 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.1 p -33.73 115.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 CA-C-O 122.518 1.152 . . . . 0.0 110.644 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.161 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -67.9 -179.96 1.31 Allowed 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 112.717 -2.038 . . . . 0.0 112.955 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.485 ' CG ' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER 176.9 149.52 0.14 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.289 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.475 ' HB2' ' O6 ' ' B' ' 4' ' ' ' DG' . 1.8 t . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.0 111.207 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.914 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.881 0 C4'-C3'-C2' 103.938 0.738 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.706 ' C6 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.849 0 O4'-C1'-N19 108.388 0.735 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.755 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.835 0 C4'-C3'-C2' 101.094 -2.106 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.552 ' C6 ' ' N7 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.507 -1.021 0 C4'-C3'-C2' 104.515 1.315 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.689 HG12 ' HB ' ' A' ' 236' ' ' VAL . 25.6 t . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 181' ' ' VAL . 25.6 mttt -151.27 -35.41 0.14 Allowed 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 118.873 -1.131 . . . . 0.0 112.259 178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -92.47 -172.64 3.14 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.041 HD13 HD12 ' A' ' 239' ' ' ILE . 6.8 pt -166.03 111.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-O 122.025 0.916 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.935 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -83.57 103.27 12.77 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.046 -178.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.95 HG13 HG12 ' A' ' 254' ' ' ILE . 2.7 t -89.62 106.37 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.645 ' HA3' ' C2 ' ' B' ' 2' ' ' ' DT' . . . -98.08 122.71 7.6 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 115.964 1.145 . . . . 0.0 115.964 -177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 252' ' ' CYS . . . 99.58 107.72 2.85 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.973 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -168.64 -158.89 0.23 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.6 ' N ' HD13 ' A' ' 189' ' ' LEU . 46.3 t -88.85 135.61 31.79 Favored Pre-proline 0 C--N 1.343 0.318 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.878 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 192' ' ' ASP . 87.8 Cg_exo -29.63 -32.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.669 2.913 . . . . 0.0 113.576 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.8 OUTLIER -150.65 54.75 0.9 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.617 0.246 . . . . 0.0 111.195 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.973 ' OG1' HD22 ' A' ' 189' ' ' LEU . 17.9 m -39.77 134.1 1.34 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 110.819 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.52 ' O ' HG13 ' A' ' 198' ' ' ILE . 11.8 Cg_endo -55.1 89.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.774 2.316 . . . . 0.0 111.75 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.594 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.1 OUTLIER -44.43 -22.26 0.07 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.034 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.51 -35.69 81.78 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.17 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 200' ' ' GLU . 0.2 OUTLIER -78.84 -47.11 17.24 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.128 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.5 OUTLIER -50.02 -24.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.196 177.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.559 ' HG2' HD11 ' A' ' 211' ' ' ILE . 1.7 mtt180 -82.03 -26.8 33.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.792 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.6 OUTLIER -87.37 -43.86 11.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.874 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.721 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.0 OUTLIER -58.63 -43.25 89.62 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.441 0.639 . . . . 0.0 110.066 179.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.849 ' CE2' HD12 ' A' ' 228' ' ' ILE . 1.2 m-85 -94.97 -32.05 13.35 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.369 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.3 -44.68 95.13 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 107.674 -2.171 . . . . 0.0 107.674 175.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.56 -23.36 66.82 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.869 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -67.29 -34.31 77.12 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-O 122.072 0.939 . . . . 0.0 108.709 177.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.92 -142.4 7.97 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.895 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 18.1 mt-10 -91.18 92.54 8.71 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.7 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -55.66 144.84 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.558 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 2.4 tp10 -89.76 -50.33 6.12 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 72.2 m -171.77 148.1 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.296 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.592 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -113.02 158.85 13.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.803 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.3 OUTLIER -155.23 129.69 9.06 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.969 HD21 HD12 ' A' ' 198' ' ' ILE . 4.5 mm? -110.29 92.03 12.73 Favored Pre-proline 0 N--CA 1.455 -0.183 0 CA-C-O 121.55 0.69 . . . . 0.0 111.322 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.604 ' HA ' ' P ' ' B' ' 5' ' ' ' DG' . 84.4 Cg_exo -48.06 -170.02 0.0 OUTLIER 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 124.109 3.206 . . . . 0.0 113.909 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.542 ' HG2' ' OP1' ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER 157.7 141.2 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.656 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 223' ' ' ARG . 3.8 p-10 -51.03 87.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.214 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 215' ' ' MET . 2.8 t30 -147.39 6.3 0.85 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.487 ' HD2' ' OP2' ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER -135.59 -25.97 1.26 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.789 HG23 ' NH1' ' A' ' 223' ' ' ARG . 0.1 OUTLIER -143.54 -6.89 0.78 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -177.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 219' ' ' THR . 6.9 m-20 71.42 52.29 0.24 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.556 ' CD ' ' HD2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -126.83 172.54 10.3 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.506 179.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -60.74 -35.69 77.01 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.497 -179.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.789 ' NH1' HG23 ' A' ' 219' ' ' THR . 0.4 OUTLIER 17.41 -81.83 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.354 0 O-C-N 124.548 1.155 . . . . 0.0 110.35 -177.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 8.64 82.26 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 123.923 0.764 . . . . 0.0 113.062 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.71 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -151.22 -120.57 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -178.329 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.583 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.03 167.47 12.59 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 122.143 0.973 . . . . 0.0 112.288 177.018 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.058 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.2 m-85 -148.95 113.48 5.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 113.521 -1.672 . . . . 0.0 108.099 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.128 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -109.3 158.58 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.271 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.511 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.0 m -140.28 155.64 46.77 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.927 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.673 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 70.5 m-85 -131.41 123.0 27.24 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.558 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -43.93 -38.22 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mm-40 -90.31 -168.06 2.01 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.593 -1.639 . . . . 0.0 110.372 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.608 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.4 OUTLIER -131.12 15.57 5.13 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.1 OUTLIER -92.4 -62.07 0.19 Allowed Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.869 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.8 Cg_exo -49.03 -31.96 22.21 Favored 'Trans proline' 0 CA--C 1.497 -1.332 0 N-CA-C 108.986 -1.198 . . . . 0.0 108.986 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -66.82 -54.11 28.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.262 -1.79 . . . . 0.0 110.637 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 30.9 pttt -50.93 -46.77 61.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.549 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.641 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.01 -56.4 11.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.414 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.041 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.19 -60.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.028 -179.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.49 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.4 mtp -46.23 -31.25 2.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.252 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.0 OUTLIER -65.83 -39.54 90.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.602 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.17 19.69 14.84 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.585 178.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.44 -50.42 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.455 0 O-C-N 124.722 1.264 . . . . 0.0 112.114 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.5 m-85 -85.68 72.45 10.57 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.147 -0.621 . . . . 0.0 110.42 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 1.027 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.1 m-70 -73.54 142.19 46.68 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.965 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 0.1 OUTLIER -103.54 79.32 1.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.929 0.395 . . . . 0.0 111.394 179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.4 t -66.88 151.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.171 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.525 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 1.82 -69.76 0.0 OUTLIER Glycine 0 C--N 1.344 1.001 0 O-C-N 124.002 0.814 . . . . 0.0 113.817 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -118.91 -44.3 2.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.093 0.473 . . . . 0.0 110.787 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.568 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -89.82 152.29 21.35 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.615 -178.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.52 144.35 46.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.169 178.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.941 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -155.41 164.48 38.66 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -178.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 44.9 tt0 -72.74 92.01 1.53 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 114.704 -1.134 . . . . 0.0 111.453 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.95 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -81.38 81.5 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 114.083 -1.417 . . . . 0.0 112.935 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.582 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.7 OUTLIER -96.64 119.06 34.44 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 2.4 p -27.87 119.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 CA-C-O 122.264 1.031 . . . . 0.0 110.197 -177.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.058 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -80.06 174.47 11.56 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 113.186 -1.824 . . . . 0.0 113.323 -175.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.41 ' O ' ' CB ' ' A' ' 259' ' ' SER . 0.0 OUTLIER 176.68 -87.01 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 113.234 -1.803 . . . . 0.0 110.746 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 258' ' ' MET . 9.0 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.648 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.797 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C4'--C3' 1.52 -0.835 0 O4'-C4'-C3' 104.23 -1.37 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.579 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.846 0 C3'-C2'-C1' 102.108 -0.423 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.741 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.521 -0.732 0 C4'-C3'-C2' 100.959 -2.241 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.718 ' C6 ' ' C5 ' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.901 0 C3'-C2'-C1' 101.989 -0.508 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.734 HG12 ' HB ' ' A' ' 236' ' ' VAL . 41.3 t . . . . . 0 CA--C 1.491 -1.304 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 236' ' ' VAL . 20.2 mttt -150.81 -33.55 0.16 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.81 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.893 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 1.0 OUTLIER -104.9 -166.96 1.29 Allowed 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.043 HD13 HD12 ' A' ' 239' ' ' ILE . 12.4 pt -164.05 139.1 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.421 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.706 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -110.48 98.4 7.61 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.096 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 1.082 HG12 ' HB2' ' A' ' 252' ' ' CYS . 2.1 t -80.83 148.8 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.556 ' C ' ' CB ' ' A' ' 225' ' ' PHE . . . -95.45 -171.74 36.41 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.766 -0.73 . . . . 0.0 114.085 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -21.51 148.44 0.0 OUTLIER Glycine 0 C--N 1.343 0.97 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.996 HD21 HD12 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -169.9 -144.85 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.734 ' N ' HD13 ' A' ' 189' ' ' LEU . 36.0 m -89.39 129.63 46.71 Favored Pre-proline 0 C--N 1.343 0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -29.66 -31.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.546 2.831 . . . . 0.0 113.532 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 190' ' ' SER . 41.7 m-20 -151.14 54.2 0.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.987 ' OG1' HD22 ' A' ' 189' ' ' LEU . 24.1 m -41.16 117.46 1.57 Allowed Pre-proline 0 C--N 1.331 -0.212 0 C-N-CA 120.599 -0.441 . . . . 0.0 110.371 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.578 ' HG2' ' CE ' ' A' ' 197' ' ' LYS . 9.0 Cg_endo -49.9 101.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.882 2.388 . . . . 0.0 112.209 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.599 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 1.0 OUTLIER -48.38 -18.28 0.21 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.973 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 60.1 mt-10 -63.92 -37.43 87.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.578 ' CE ' ' HG2' ' A' ' 194' ' ' PRO . 0.1 OUTLIER -81.52 -45.88 15.3 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.14 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -51.13 -27.59 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.346 176.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.621 ' HG2' HD11 ' A' ' 211' ' ' ILE . 1.2 mtt180 -77.04 -27.88 54.65 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.97 -1.013 . . . . 0.0 109.812 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.2 mm-40 -85.76 -62.74 1.46 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.586 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.666 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.2 t80 -41.3 -40.93 1.79 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.661 178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.067 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -98.11 -34.15 10.88 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.614 -178.398 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.36 -45.68 95.45 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 176.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -64.67 -22.41 68.03 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.803 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -65.82 -36.94 84.89 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 122.521 1.153 . . . . 0.0 108.227 177.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.74 -162.15 35.61 Favored Glycine 0 N--CA 1.431 -1.668 0 CA-C-N 112.734 -2.03 . . . . 0.0 108.863 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 4.7 mt-10 -76.58 93.09 3.54 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.557 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 202' ' ' PHE . 1.6 t -53.73 142.74 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.56 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 0.6 OUTLIER -89.53 -44.05 10.38 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 178.243 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.436 ' C ' HG12 ' A' ' 211' ' ' ILE . 67.2 m -170.92 172.42 5.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.112 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -137.13 161.08 35.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.981 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.838 ' C ' HD22 ' A' ' 213' ' ' LEU . 0.3 OUTLIER -161.33 143.94 12.28 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.996 HD12 HD21 ' A' ' 189' ' ' LEU . 3.3 mm? -134.1 107.82 11.46 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.996 0.427 . . . . 0.0 111.319 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.636 ' HA ' ' P ' ' B' ' 5' ' ' ' DG' . 73.4 Cg_exo -50.49 -164.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.323 0 C-N-CA 123.436 2.757 . . . . 0.0 113.619 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.51 ' H ' ' HD3' ' A' ' 223' ' ' ARG . 6.9 ptt? 161.75 128.33 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.646 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.499 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 51.9 p-10 -58.19 80.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.602 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 215' ' ' MET . 44.1 m-20 -147.23 11.46 1.03 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.211 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.562 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 4.9 mmtt -134.15 -30.22 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.1 OUTLIER -135.76 -7.04 2.16 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 219' ' ' THR . 20.4 m-80 70.39 46.44 0.58 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.596 ' HG2' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -128.59 161.13 30.34 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.07 178.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -55.52 -42.0 73.91 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.218 -179.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 221' ' ' LYS . 0.0 OUTLIER 23.51 -89.55 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.541 1.151 . . . . 0.0 109.574 -177.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.714 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 21.41 78.62 0.01 OUTLIER Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.472 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.657 ' CE1' " H4'" ' B' ' 3' ' ' ' DA' . 8.4 p90 -130.1 -130.15 0.21 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.716 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.386 0.612 . . . . 0.0 111.375 178.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.121 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -151.02 111.58 4.21 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.912 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.14 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.5 mt -112.8 148.49 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.614 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 8.4 m -124.56 152.28 43.7 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.126 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 235' ' ' PRO . 68.6 m-85 -132.11 119.02 20.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.56 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.21 -38.19 0.74 Allowed 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 230' ' ' PHE . 1.2 mt-10 -89.06 -155.48 0.35 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 113.564 -1.653 . . . . 0.0 110.711 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.619 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 2.0 pm0 -141.83 4.89 1.72 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.552 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 235' ' ' PRO . 14.2 mt-10 -86.63 -56.15 0.36 Allowed Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.803 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 94.0 Cg_exo -51.45 -31.99 41.06 Favored 'Trans proline' 0 CA--C 1.494 -1.482 0 N-CA-C 108.78 -1.277 . . . . 0.0 108.78 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.734 ' HB ' HG12 ' A' ' 181' ' ' VAL . 0.8 OUTLIER -65.41 -50.62 71.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.342 177.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 22.3 mttm -47.93 -58.64 4.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.043 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.685 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.23 -51.99 66.1 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.155 179.346 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.043 HD12 HD13 ' A' ' 184' ' ' ILE . 0.7 OUTLIER -36.65 -63.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.114 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -52.56 -18.17 1.6 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.298 -179.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 238' ' ' LYS . 14.0 mm-40 -76.67 -33.52 58.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -108.81 24.15 13.51 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.766 178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.599 ' HE2' ' CD2' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -17.34 -47.77 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.354 1.034 . . . . 0.0 112.122 -179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.599 ' CD2' ' HE2' ' A' ' 243' ' ' LYS . 23.0 m-85 -84.69 69.87 10.71 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.529 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.861 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.4 m-70 -70.46 156.22 39.65 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.832 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 0.9 OUTLIER -122.04 72.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.639 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.6 t -61.55 141.7 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.446 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 12.14 -76.82 0.0 OUTLIER Glycine 0 C--N 1.338 0.66 0 O-C-N 123.97 0.794 . . . . 0.0 113.899 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -110.99 -42.5 3.96 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.888 0.375 . . . . 0.0 110.929 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 14.5 m -88.01 145.37 26.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.702 0.763 . . . . 0.0 112.645 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -135.6 133.28 38.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.395 -1.275 . . . . 0.0 107.888 179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 1.082 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.54 163.53 39.41 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 118.636 -1.226 . . . . 0.0 114.27 -176.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.519 ' HB2' ' O4 ' ' B' ' 2' ' ' ' DT' . 42.5 tt0 -67.57 108.66 2.95 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.215 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.972 HG12 HG13 ' A' ' 186' ' ' VAL . 2.1 mt -98.49 79.48 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 114.196 -1.365 . . . . 0.0 112.453 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.629 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.39 119.92 28.15 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.709 ' O ' HG13 ' A' ' 256' ' ' VAL . 2.9 p -36.25 101.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.503 -0.838 0 CA-C-O 123.051 1.405 . . . . 0.0 110.876 -177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.121 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -45.38 -171.91 0.0 OUTLIER 'General case' 0 N--CA 1.412 -2.368 0 CA-C-N 112.097 -2.32 . . . . 0.0 112.059 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.618 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.8 OUTLIER -162.7 -156.0 0.38 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.572 -1.649 . . . . 0.0 110.981 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.89 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.793 0 C4'-C3'-C2' 104.092 0.892 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.657 " H4'" ' CE1' ' A' ' 225' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 N19-C1'-C2' 112.908 -0.808 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.736 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 C4'-C3'-C2' 101.235 -1.965 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.636 ' P ' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 C2'--C1' 1.506 -1.063 0 C4'-C3'-C2' 104.769 1.569 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.702 HG12 ' HB ' ' A' ' 236' ' ' VAL . 29.2 t . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HA ' HG21 ' A' ' 236' ' ' VAL . 21.9 mttt -150.31 -35.03 0.16 Allowed 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.133 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.841 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.18 -170.84 2.38 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.032 HD13 HD12 ' A' ' 239' ' ' ILE . 11.6 pt -165.33 117.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.825 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.06 100.22 12.68 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.879 -177.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.965 HG13 HG12 ' A' ' 254' ' ' ILE . 2.8 t -85.04 111.26 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.067 0.947 . . . . 0.0 111.152 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.594 ' HA3' ' C2 ' ' B' ' 2' ' ' ' DT' . . . -97.77 119.43 6.42 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.117 1.207 . . . . 0.0 116.117 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.637 ' HA3' ' H72' ' B' ' 2' ' ' ' DT' . . . 98.72 105.95 2.59 Favored Glycine 0 C--N 1.346 1.135 0 N-CA-C 114.903 0.721 . . . . 0.0 114.903 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.943 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -166.07 -157.63 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 179.107 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.631 ' N ' HD13 ' A' ' 189' ' ' LEU . 58.8 m -89.25 133.17 35.54 Favored Pre-proline 0 C--N 1.342 0.241 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.806 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -29.76 -31.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.695 2.93 . . . . 0.0 113.663 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 190' ' ' SER . 5.8 m-20 -150.41 54.2 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.431 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.943 ' OG1' HD22 ' A' ' 189' ' ' LEU . 32.4 m -40.65 128.49 1.86 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 121.003 0.43 . . . . 0.0 110.726 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.511 ' O ' HG13 ' A' ' 198' ' ' ILE . 6.3 Cg_endo -49.2 90.4 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.844 2.363 . . . . 0.0 112.164 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.681 ' OE1' HD23 ' A' ' 213' ' ' LEU . 0.9 OUTLIER -42.43 -23.57 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.511 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -63.64 -37.56 87.8 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 200' ' ' GLU . 1.1 mmmt -77.36 -48.27 17.74 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.118 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.73 -26.85 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 113.599 -1.637 . . . . 0.0 109.256 177.286 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.56 ' HA ' HD11 ' A' ' 211' ' ' ILE . 10.4 mtt85 -79.67 -27.25 40.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.937 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.4 pt-20 -86.42 -50.96 6.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.508 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.694 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -51.57 -40.24 59.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.541 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.889 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -98.93 -30.31 12.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.176 -178.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.63 -47.36 87.51 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -61.66 -23.57 63.17 Favored Glycine 0 N--CA 1.442 -0.948 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.826 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.38 -34.23 77.5 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.044 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 161.25 -142.53 8.14 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 8.7 mt-10 -90.72 94.67 9.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.256 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -56.59 143.1 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.604 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.5 tp10 -89.27 -47.53 7.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 68.1 m -174.06 147.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.374 178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.598 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -114.16 161.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.437 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.3 OUTLIER -160.47 127.76 4.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 0.0 111.226 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 1.073 HD21 HD12 ' A' ' 198' ' ' ILE . 1.5 mm? -109.55 97.68 28.66 Favored Pre-proline 0 N--CA 1.456 -0.126 0 CA-C-O 121.458 0.647 . . . . 0.0 111.803 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.634 ' HA ' ' P ' ' B' ' 5' ' ' ' DG' . 60.9 Cg_exo -48.41 -167.26 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 123.902 3.068 . . . . 0.0 113.332 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.8 OUTLIER 154.82 125.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.992 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.521 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 14.4 p-10 -51.25 83.03 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.443 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 215' ' ' MET . 3.1 t-20 -146.08 6.12 1.0 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.493 ' C ' ' CG2' ' A' ' 219' ' ' THR . 4.1 mmmt -141.86 -0.88 1.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 1.0 OUTLIER -152.46 -26.49 0.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.624 ' HB2' ' O ' ' A' ' 219' ' ' THR . 22.2 m-20 78.88 53.43 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.577 ' HG2' ' N ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -129.35 -158.65 0.9 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.862 178.39 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.645 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -87.52 -40.87 13.92 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 118.189 0.449 . . . . 0.0 109.851 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.645 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.5 OUTLIER 19.07 -94.56 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 123.787 0.679 . . . . 0.0 110.615 -178.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.516 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 22.43 76.83 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 O-C-N 123.705 0.628 . . . . 0.0 112.575 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.651 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.2 OUTLIER -147.58 -123.14 0.06 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -178.357 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.625 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.08 164.57 20.37 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.048 0.928 . . . . 0.0 113.201 178.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.018 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.1 m-85 -148.24 116.05 6.37 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 113.626 -1.625 . . . . 0.0 108.742 177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.118 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.3 mt -115.17 159.58 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.424 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.621 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.7 m -136.83 169.02 18.45 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.197 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.675 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 86.2 m-85 -145.94 116.64 7.65 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.604 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.6 -36.93 0.65 Allowed 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.572 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 3.7 pm0 -89.03 -155.97 0.37 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.473 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.59 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 19.1 pt-20 -141.17 -2.59 1.27 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.885 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.6 OUTLIER -78.7 -57.33 0.83 Allowed Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 113.448 0.906 . . . . 0.0 113.448 -177.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.826 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 86.9 Cg_exo -51.04 -34.18 45.89 Favored 'Trans proline' 0 CA--C 1.495 -1.451 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.829 HG13 ' CG2' ' A' ' 184' ' ' ILE . 1.1 t -64.72 -51.48 66.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 113.309 -1.769 . . . . 0.0 108.85 177.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 16.8 mtpt -44.99 -58.79 2.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.933 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.67 -52.76 64.12 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.027 -1.442 . . . . 0.0 110.627 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.032 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -33.92 -62.88 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.175 -179.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.3 mtp -51.3 -20.85 1.84 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.919 0.39 . . . . 0.0 111.251 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -75.72 -34.28 60.33 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -107.19 22.39 16.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.617 178.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.76 -48.18 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.13 . . . . 0.0 112.29 -179.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 242' ' ' LYS . 23.4 m-30 -84.4 71.79 10.66 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.66 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.953 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -72.75 154.49 40.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -117.18 79.56 1.36 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.9 t -70.04 152.53 9.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.575 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' A' ' 247' ' ' VAL . . . 0.79 -68.85 0.0 OUTLIER Glycine 0 C--N 1.343 0.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.899 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 247' ' ' VAL . 0.0 OUTLIER -117.3 -43.59 2.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.0 110.997 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.561 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 9.1 m -89.77 153.84 20.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.033 0.921 . . . . 0.0 113.283 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -138.27 139.77 39.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.183 178.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.872 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -156.98 169.57 24.52 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 118.613 -1.235 . . . . 0.0 114.157 -177.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 255' ' ' LYS . 64.3 tt0 -75.88 92.15 3.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.738 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.965 HG12 HG13 ' A' ' 186' ' ' VAL . 1.3 mt -79.93 81.17 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.837 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.58 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 2.7 mtpt -93.7 116.98 29.5 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 184' ' ' ILE . 1.4 p -29.17 119.65 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 122.267 1.032 . . . . 0.0 110.744 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.018 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -78.25 174.66 10.97 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 113.13 -1.85 . . . . 0.0 113.47 -175.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.86 148.39 6.07 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.51 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 91.9 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.864 0.364 . . . . 0.0 111.252 -179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.637 ' H72' ' HA3' ' A' ' 188' ' ' GLY . . . . . . . . 0 C3'--C2' 1.51 -0.751 0 C4'-C3'-C2' 101.728 -1.472 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.889 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.825 0 C3'-C2'-C1' 101.918 -0.559 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.889 " O5'" " H4'" ' B' ' 3' ' ' ' DA' . . . . . . . . 0 O5'--C5' 1.427 -0.822 0 C4'-C3'-C2' 101.097 -2.103 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.634 ' P ' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.83 0 C5'-C4'-O4' 108.576 -0.515 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.722 HG12 ' HB ' ' A' ' 236' ' ' VAL . 40.8 t . . . . . 0 CA--C 1.495 -1.151 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.695 ' HA ' HG21 ' A' ' 236' ' ' VAL . 19.6 mttt -148.34 -35.42 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 118.999 -1.081 . . . . 0.0 111.867 178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.858 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -94.79 -175.49 3.59 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.978 ' CD1' HD12 ' A' ' 239' ' ' ILE . 5.4 pt -162.38 117.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.837 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -93.4 109.1 20.67 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.415 -177.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.924 HG13 HG12 ' A' ' 254' ' ' ILE . 2.4 t -97.67 115.32 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.757 0.823 . . . . 0.0 112.984 -178.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -49.3 -177.14 0.01 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 114.796 0.678 . . . . 0.0 114.796 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 187' ' ' GLY . . . -31.49 161.74 0.0 OUTLIER Glycine 0 C--N 1.342 0.914 0 N-CA-C 114.653 0.621 . . . . 0.0 114.653 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.978 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -175.42 -143.17 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 189' ' ' LEU . 1.3 m -88.5 135.4 32.64 Favored Pre-proline 0 C--N 1.343 0.319 0 CA-C-O 120.853 0.359 . . . . 0.0 110.369 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 44.2 Cg_exo -28.78 -39.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.159 2.573 . . . . 0.0 113.033 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -151.5 56.49 0.87 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.978 ' OG1' HD22 ' A' ' 189' ' ' LEU . 86.1 m -39.21 127.95 1.3 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 110.425 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.498 ' HG2' ' CG ' ' A' ' 197' ' ' LYS . 7.9 Cg_endo -50.53 96.94 0.03 OUTLIER 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.259 2.64 . . . . 0.0 113.808 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.783 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -39.75 -28.08 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.207 178.245 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 194' ' ' PRO . 2.9 mm-40 -61.23 -36.78 80.88 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.183 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 200' ' ' GLU . 3.0 mmmt -77.64 -52.29 9.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.166 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -46.91 -26.02 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 114.204 -1.362 . . . . 0.0 109.04 176.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.708 ' HG2' HD11 ' A' ' 211' ' ' ILE . 8.1 mtp180 -82.31 -26.84 32.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.101 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 197' ' ' LYS . 0.8 OUTLIER -87.48 -41.12 13.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.998 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.678 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.3 t80 -67.14 -38.27 85.25 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.369 0.604 . . . . 0.0 110.358 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.99 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.6 OUTLIER -98.26 -37.06 9.82 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.396 -178.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -64.5 -43.69 96.27 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 107.7 -2.16 . . . . 0.0 107.7 175.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.14 -23.98 66.69 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.834 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -37.52 86.1 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 122.084 0.945 . . . . 0.0 108.902 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 165.88 -140.51 6.41 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.769 -1.559 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 32.6 mt-10 -92.06 94.6 9.33 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.213 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.429 HG21 ' HB2' ' A' ' 202' ' ' PHE . 1.7 t -60.95 144.91 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.588 ' CD ' HG21 ' A' ' 229' ' ' THR . 15.4 tt0 -89.79 -53.14 4.64 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 66.8 m -171.22 148.43 2.66 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.625 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.746 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.64 166.84 5.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.138 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.497 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -165.36 123.69 1.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.652 0.263 . . . . 0.0 111.067 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.834 ' CD1' HD21 ' A' ' 189' ' ' LEU . 4.5 mm? -105.72 98.94 19.29 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 111.439 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.62 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 74.4 Cg_exo -51.44 -160.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.209 3.273 . . . . 0.0 114.438 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 153.39 127.52 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.672 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 17.5 p-10 -54.62 82.37 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.767 0.318 . . . . 0.0 111.786 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 215' ' ' MET . 6.4 t-20 -139.92 0.52 1.78 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.801 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.523 ' HG3' " H3'" ' B' ' 5' ' ' ' DG' . 0.1 OUTLIER -133.68 0.45 3.27 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 111.553 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.614 ' CB ' ' HZ2' ' A' ' 221' ' ' LYS . 0.7 OUTLIER -152.12 -24.8 0.18 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 219' ' ' THR . 6.7 m-80 75.29 41.28 0.29 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.614 ' HZ2' ' CB ' ' A' ' 219' ' ' THR . 0.0 OUTLIER -116.37 -158.96 0.71 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.896 179.087 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.584 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -87.61 -35.22 18.19 Favored 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.313 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.1 OUTLIER 12.76 -79.41 0.0 OUTLIER 'General case' 0 CA--C 1.505 -0.782 0 O-C-N 124.587 1.18 . . . . 0.0 110.648 -178.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 10.88 81.78 0.01 OUTLIER Glycine 0 C--N 1.335 0.49 0 O-C-N 124.218 0.949 . . . . 0.0 112.212 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.62 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -149.92 -119.85 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.084 -0.558 . . . . 0.0 109.574 -176.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.589 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -172.62 168.91 5.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 122.0 0.905 . . . . 0.0 112.805 179.138 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.026 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.2 m-85 -150.41 125.37 9.88 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 113.822 -1.535 . . . . 0.0 109.349 177.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.166 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -119.92 147.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 121.528 0.68 . . . . 0.0 110.071 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 3.1 m -126.09 153.14 44.91 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.1 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.659 ' CD1' HG22 ' A' ' 236' ' ' VAL . 89.1 m-85 -129.01 120.64 26.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.547 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -43.26 -38.99 2.81 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.333 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 230' ' ' PHE . 4.6 mt-10 -90.13 -167.1 1.75 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.518 -1.674 . . . . 0.0 110.665 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.612 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -132.56 15.56 4.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.527 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -91.64 -64.88 0.15 Allowed Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.834 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 52.7 Cg_exo -46.34 -35.2 15.44 Favored 'Trans proline' 0 CA--C 1.495 -1.471 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.801 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -65.48 -52.84 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.241 -1.799 . . . . 0.0 110.349 179.143 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 40.6 pttt -52.26 -45.19 65.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.549 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.654 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -66.23 -54.78 20.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.618 0.723 . . . . 0.0 109.935 177.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.978 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -29.59 -64.28 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.159 -179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.496 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.7 mtp -49.4 -22.33 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.913 0.387 . . . . 0.0 111.276 -178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.4 mm-40 -74.29 -37.1 63.76 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.613 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -100.33 19.84 15.89 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.375 177.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.623 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.62 -48.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.52 1.137 . . . . 0.0 112.166 -179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' A' ' 242' ' ' LYS . 18.5 m-85 -86.66 71.17 10.41 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.351 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.876 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.7 m-70 -71.68 148.51 46.4 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.346 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -112.74 77.23 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.097 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.604 HG12 ' H ' ' A' ' 248' ' ' GLY . 2.2 t -62.97 171.25 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.67 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.706 ' C ' HD23 ' A' ' 249' ' ' LEU . . . -14.67 -59.27 0.01 OUTLIER Glycine 0 C--N 1.341 0.806 0 O-C-N 123.781 0.676 . . . . 0.0 113.367 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.706 HD23 ' C ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -132.04 -41.61 1.01 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.172 -0.514 . . . . 0.0 111.398 -179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 189' ' ' LEU . 0.7 OUTLIER -87.94 152.05 22.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.67 0.748 . . . . 0.0 112.755 -177.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -137.99 135.61 36.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.812 179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.921 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -152.58 157.56 41.2 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 119.634 -0.826 . . . . 0.0 112.92 -178.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.585 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 64.8 tt0 -60.76 119.16 7.63 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.963 HG21 HD12 ' A' ' 184' ' ' ILE . 1.7 mt -104.36 82.03 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.813 0.816 . . . . 0.0 111.85 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.586 ' HE3' ' CD2' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -87.0 118.72 26.57 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 114.197 -1.365 . . . . 0.0 107.695 178.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.5 p -33.73 120.45 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-N 119.546 1.066 . . . . 0.0 109.777 -178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.026 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -75.46 -177.26 3.52 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 113.226 -1.807 . . . . 0.0 113.053 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.418 ' CG ' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -164.18 -156.43 0.34 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.319 -1.764 . . . . 0.0 110.595 -179.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.81 0.338 . . . . 0.0 110.893 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.608 ' OP2' ' C6 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C3'-C2'-C1' 100.413 -1.634 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.617 ' OP2' ' CE1' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.427 -0.805 0 C3'-C2'-C1' 101.936 -0.546 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.933 H2'' " O5'" ' B' ' 5' ' ' ' DG' . . . . . . . . 0 C4'--C3' 1.519 -0.864 0 C4'-C3'-C2' 100.629 -2.571 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.933 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.427 -0.826 0 O4'-C4'-C3' 106.215 0.615 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.67 HG12 ' HB ' ' A' ' 236' ' ' VAL . 32.0 t . . . . . 0 CA--C 1.497 -1.091 0 N-CA-C 110.41 -0.218 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.6 ' HA ' HG21 ' A' ' 236' ' ' VAL . 23.4 mttt -151.44 -35.17 0.14 Allowed 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.175 178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.871 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.73 -173.19 3.45 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.015 HD13 HD12 ' A' ' 239' ' ' ILE . 7.8 pt -165.86 108.53 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 122.519 1.152 . . . . 0.0 109.502 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.901 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.2 OUTLIER -81.53 103.59 11.37 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.754 -178.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.74 HG22 HD13 ' A' ' 254' ' ' ILE . 64.3 t -89.87 131.44 37.11 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.473 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.976 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.512 ' C ' ' HB2' ' A' ' 225' ' ' PHE . . . -64.33 -176.48 4.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 114.981 0.752 . . . . 0.0 114.981 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.497 ' HA2' ' HB3' ' A' ' 225' ' ' PHE . . . -37.82 172.59 0.01 OUTLIER Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.023 -0.589 . . . . 0.0 114.128 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.779 HD21 ' O ' ' A' ' 225' ' ' PHE . 0.2 OUTLIER 169.63 -139.8 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 121.361 -0.135 . . . . 0.0 111.123 -179.181 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.574 ' N ' HD13 ' A' ' 189' ' ' LEU . 6.1 m -88.78 130.69 44.08 Favored Pre-proline 0 C--N 1.339 0.149 0 CA-C-O 120.966 0.412 . . . . 0.0 110.17 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -32.63 -30.17 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.058 2.505 . . . . 0.0 112.931 -179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.1 OUTLIER -151.29 54.79 0.86 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.861 ' HB ' HD11 ' A' ' 213' ' ' LEU . 47.9 m -39.54 128.51 1.43 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.268 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.576 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 9.4 Cg_endo -52.29 96.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.803 2.335 . . . . 0.0 111.889 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.612 ' HA ' HG13 ' A' ' 198' ' ' ILE . 1.1 pm0 -46.31 -17.54 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 26.9 mt-10 -65.13 -40.47 94.51 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.576 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 0.6 OUTLIER -78.51 -45.72 21.3 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.093 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.2 OUTLIER -49.83 -26.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.892 176.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.576 ' HA ' HD11 ' A' ' 211' ' ' ILE . 2.9 mtt85 -77.36 -28.41 52.97 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.514 177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 197' ' ' LYS . 2.0 mm-40 -85.29 -60.64 1.97 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.773 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.696 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.8 t80 -42.21 -42.55 3.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.82 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.905 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -97.88 -31.5 12.17 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.506 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 199' ' ' ARG . . . -62.15 -49.77 71.68 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 176.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -60.64 -23.26 60.55 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.842 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -64.29 -36.74 85.09 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 121.825 0.822 . . . . 0.0 108.805 178.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.62 -139.01 5.62 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.908 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 66.9 mt-10 -91.71 89.7 7.22 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.996 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 2.0 t -55.57 141.07 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.566 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.6 tp10 -90.08 -48.3 7.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 209' ' ' GLU . 21.5 m -174.27 149.19 1.36 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.626 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 199' ' ' ARG . 0.0 OUTLIER -113.29 156.92 14.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.748 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.503 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.1 OUTLIER -154.19 125.74 7.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.991 HD21 ' CD1' ' A' ' 198' ' ' ILE . 3.2 mm? -107.34 96.37 15.77 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 121.219 0.533 . . . . 0.0 111.103 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.655 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 87.1 Cg_exo -49.47 -167.19 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 123.386 2.724 . . . . 0.0 113.057 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.533 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 155.99 130.96 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.74 -179.312 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 0.6 OUTLIER -52.87 83.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.116 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 215' ' ' MET . 0.8 OUTLIER -138.91 -4.15 1.57 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.545 ' HG3' " C3'" ' B' ' 5' ' ' ' DG' . 3.7 mmtt -138.53 1.32 2.14 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.8 OUTLIER -151.69 -25.26 0.19 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 219' ' ' THR . 11.6 m-20 73.86 43.52 0.32 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.558 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -122.09 -178.43 3.86 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.623 ' O ' ' N ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -65.6 -43.62 89.08 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.566 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.588 ' O ' ' C ' ' A' ' 224' ' ' GLY . 0.2 OUTLIER 20.87 -83.36 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 O-C-N 124.785 1.303 . . . . 0.0 109.702 -176.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 222' ' ' ARG . . . 10.67 82.23 0.01 OUTLIER Glycine 0 C--N 1.336 0.547 0 O-C-N 124.114 0.884 . . . . 0.0 112.008 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.779 ' O ' HD21 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -149.93 -116.73 0.05 Allowed 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.092 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.576 ' HA ' ' CD ' ' A' ' 214' ' ' PRO . 0.5 OUTLIER -174.07 169.26 4.01 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 122.496 1.141 . . . . 0.0 112.824 177.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.034 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.7 m-85 -151.51 110.6 3.9 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 112.858 -1.973 . . . . 0.0 108.519 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.093 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.2 mt -108.72 159.49 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.432 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.333 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.653 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 2.8 m -137.38 170.8 15.47 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.158 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.655 ' CD1' HG22 ' A' ' 236' ' ' VAL . 75.8 m-85 -148.02 114.08 5.82 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.566 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.1 OUTLIER -38.67 -35.34 0.19 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 230' ' ' PHE . 17.2 mt-10 -88.6 -153.63 0.26 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.772 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 0.7 OUTLIER -148.44 13.27 0.95 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.075 -179.126 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.665 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 1.2 mt-10 -94.27 -57.81 0.21 Allowed Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.842 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 87.7 Cg_exo -51.43 -31.94 40.67 Favored 'Trans proline' 0 CA--C 1.496 -1.417 0 N-CA-C 108.793 -1.272 . . . . 0.0 108.793 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.844 HG13 HG23 ' A' ' 184' ' ' ILE . 0.9 OUTLIER -68.01 -55.02 18.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 113.225 -1.807 . . . . 0.0 109.821 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -50.99 -42.39 60.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.157 -179.179 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.655 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -71.06 -54.62 10.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.601 0.715 . . . . 0.0 109.957 178.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.015 HD12 HD13 ' A' ' 184' ' ' ILE . 0.4 OUTLIER -28.2 -63.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.865 -179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.584 ' HE3' ' O ' ' A' ' 236' ' ' VAL . 19.2 mtm -45.76 -29.63 1.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.869 0.366 . . . . 0.0 111.217 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 238' ' ' LYS . 1.7 mm-40 -64.78 -40.9 96.03 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -99.36 20.51 13.56 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.586 178.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.581 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.49 -50.56 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 O-C-N 124.635 1.209 . . . . 0.0 112.185 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 22.5 m-85 -85.58 69.29 10.63 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.844 -0.743 . . . . 0.0 110.329 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.994 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.2 m-70 -69.18 149.7 48.3 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.74 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.493 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.1 OUTLIER -112.62 80.72 1.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.278 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 249' ' ' LEU . 1.7 t -74.04 100.96 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 48.04 -84.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.707 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.54 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -105.54 -42.18 5.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.283 0.563 . . . . 0.0 110.611 179.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 247' ' ' VAL . 56.1 m -88.81 146.84 24.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.721 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -141.42 138.32 32.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.475 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.657 ' HB2' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -157.99 153.59 26.33 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 119.184 -1.007 . . . . 0.0 113.664 -177.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.574 ' O ' ' HE2' ' A' ' 255' ' ' LYS . 28.2 tt0 -57.96 114.55 2.39 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.969 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.895 ' CG2' HD12 ' A' ' 184' ' ' ILE . 1.8 mt -103.33 83.29 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.793 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.0 OUTLIER -91.86 117.78 30.11 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.351 178.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 183' ' ' LYS . 4.3 p -30.57 122.75 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-N 119.376 0.989 . . . . 0.0 109.936 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.034 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -82.17 177.31 8.87 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.677 -1.602 . . . . 0.0 113.004 -175.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.08 135.44 7.14 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.307 -1.77 . . . . 0.0 110.241 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.436 ' HB3' ' O6 ' ' B' ' 4' ' ' ' DG' . 26.5 p . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.101 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.89 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.428 -0.73 0 O4'-C1'-C2' 107.035 0.85 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.677 ' C6 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.941 0 C3'-C2'-C1' 101.996 -0.503 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.769 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.52 -0.787 0 C4'-C3'-C2' 100.93 -2.27 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.566 ' OP1' ' HA ' ' A' ' 214' ' ' PRO . . . . . . . . 0 O5'--C5' 1.428 -0.766 0 O4'-C4'-C3' 106.115 0.515 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.66 HG12 ' HB ' ' A' ' 236' ' ' VAL . 28.3 t . . . . . 0 CA--C 1.497 -1.08 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 236' ' ' VAL . 26.0 mttt -152.55 -34.97 0.12 Allowed 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 118.853 -1.139 . . . . 0.0 112.717 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -93.58 -179.32 4.99 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.654 179.094 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.01 HD12 HG21 ' A' ' 254' ' ' ILE . 5.9 pt -161.1 112.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 122.098 0.952 . . . . 0.0 108.897 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.873 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -87.04 104.7 16.57 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.147 -177.334 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.975 HG13 HG12 ' A' ' 254' ' ' ILE . 2.6 t -91.02 112.11 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 123.431 0.693 . . . . 0.0 111.44 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -52.38 -172.64 0.03 OUTLIER Glycine 0 CA--C 1.53 0.985 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.5 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -28.16 156.95 0.0 OUTLIER Glycine 0 N--CA 1.468 0.794 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.993 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -171.08 -145.41 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.663 ' N ' HD13 ' A' ' 189' ' ' LEU . 0.3 OUTLIER -88.74 132.4 38.66 Favored Pre-proline 0 C--N 1.341 0.215 0 CA-C-O 120.8 0.333 . . . . 0.0 110.213 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.414 ' C ' ' O ' ' A' ' 190' ' ' SER . 73.4 Cg_exo -29.7 -33.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.298 2.665 . . . . 0.0 113.126 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 190' ' ' SER . 1.9 m-20 -150.92 54.33 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.408 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.993 ' OG1' HD22 ' A' ' 189' ' ' LEU . 25.5 m -39.95 122.54 1.57 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.996 0.427 . . . . 0.0 110.376 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.608 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 11.2 Cg_endo -53.81 98.56 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.89 2.393 . . . . 0.0 112.22 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.605 ' HA ' HG13 ' A' ' 198' ' ' ILE . 0.5 OUTLIER -44.73 -21.39 0.05 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.766 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 200' ' ' GLU . 2.2 mp0 -62.1 -39.09 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.787 ' HE2' HD21 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -80.28 -44.97 18.71 Favored 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.121 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.3 OUTLIER -50.59 -28.63 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 CA-C-N 114.172 -1.377 . . . . 0.0 108.899 177.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.565 ' HA ' HD11 ' A' ' 211' ' ' ILE . 0.1 OUTLIER -76.07 -27.99 57.44 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.366 177.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.2 mm-40 -84.03 -61.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.898 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.671 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.3 t80 -41.68 -39.38 1.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.284 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.857 ' CE2' HD12 ' A' ' 228' ' ' ILE . 0.8 OUTLIER -100.81 -33.93 10.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.372 -177.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -62.59 -48.28 82.84 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.696 -1.761 . . . . 0.0 108.696 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -62.3 -23.06 63.95 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.774 ' HB2' ' HA ' ' A' ' 202' ' ' PHE . 0.1 OUTLIER -65.93 -38.15 87.92 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 122.153 0.978 . . . . 0.0 108.849 177.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 166.24 -143.01 8.04 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 113.455 -1.702 . . . . 0.0 109.639 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 7.6 mt-10 -92.05 97.15 10.76 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.293 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.472 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.8 t -61.39 143.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.689 ' CD ' HG21 ' A' ' 229' ' ' THR . 13.4 tt0 -89.07 -52.45 5.07 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 60.7 p -169.67 147.47 3.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.878 -1.056 . . . . 0.0 111.628 177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.666 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -110.32 161.68 8.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.449 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.428 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -159.55 128.55 5.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 0.0 111.304 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.77 HD21 HD12 ' A' ' 198' ' ' ILE . 1.5 mm? -109.41 95.77 20.05 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 121.442 0.639 . . . . 0.0 110.996 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.653 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 88.5 Cg_exo -44.01 -166.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 124.558 3.505 . . . . 0.0 114.263 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER 159.13 132.81 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.105 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.54 ' HA ' ' HD2' ' A' ' 223' ' ' ARG . 15.2 p-10 -65.28 81.77 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.642 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 217' ' ' ASN . 8.5 t30 -141.16 2.36 1.69 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.724 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.472 ' C ' ' CG2' ' A' ' 219' ' ' THR . 19.2 mmtt -138.11 1.56 2.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.751 0.31 . . . . 0.0 111.818 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.8 OUTLIER -152.0 -26.36 0.18 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 219' ' ' THR . 31.3 m-20 73.93 52.0 0.11 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.558 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -130.03 -166.58 1.69 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 178.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.578 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -78.69 -39.37 36.83 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.146 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.578 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.5 OUTLIER 17.63 -86.01 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.683 0 O-C-N 124.319 1.012 . . . . 0.0 109.645 -177.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.553 ' C ' ' O ' ' A' ' 223' ' ' ARG . . . 15.93 78.08 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.571 0 O-C-N 124.005 0.816 . . . . 0.0 112.994 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.654 ' HA ' ' HG ' ' A' ' 189' ' ' LEU . 0.1 OUTLIER -150.86 -121.21 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.702 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.1 OUTLIER -168.81 166.5 11.46 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 122.099 0.952 . . . . 0.0 112.888 178.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.034 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 4.0 m-85 -148.24 119.58 7.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.318 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.121 HD11 ' CG2' ' A' ' 198' ' ' ILE . 2.4 mt -115.75 146.18 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 CA-C-O 121.631 0.729 . . . . 0.0 110.3 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.689 HG21 ' CD ' ' A' ' 209' ' ' GLU . 3.3 m -124.15 164.52 19.31 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.101 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 96.4 m-85 -139.44 119.85 13.93 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -42.57 -38.93 2.14 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 230' ' ' PHE . 5.4 mm-40 -91.21 -168.04 1.96 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.488 -1.687 . . . . 0.0 110.732 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.588 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 4.8 pt-20 -129.6 16.8 5.89 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.656 ' O ' ' HG2' ' A' ' 237' ' ' LYS . 0.0 OUTLIER -89.62 -64.49 0.19 Allowed Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.937 ' O ' HD12 ' A' ' 239' ' ' ILE . 82.9 Cg_exo -46.13 -30.83 8.01 Favored 'Trans proline' 0 CA--C 1.5 -1.182 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.858 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -72.23 -54.49 16.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 112.998 -1.91 . . . . 0.0 109.757 179.418 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -51.18 -32.9 25.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.541 -179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.664 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -83.75 -56.48 3.69 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.147 178.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.937 HD12 ' O ' ' A' ' 235' ' ' PRO . 0.8 OUTLIER -30.28 -57.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.322 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.8 mtp -51.24 -19.67 1.32 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.859 0.361 . . . . 0.0 111.733 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 238' ' ' LYS . 3.8 mm-40 -79.62 -33.57 41.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.58 ' O ' ' CD2' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -107.67 21.85 16.84 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.309 179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.613 ' HE2' ' CG ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -18.61 -47.79 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.218 0.949 . . . . 0.0 112.117 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.613 ' CG ' ' HE2' ' A' ' 243' ' ' LYS . 22.0 m-85 -85.84 78.97 9.42 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.747 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.816 ' CG ' HD12 ' A' ' 254' ' ' ILE . 13.9 m-70 -76.18 -170.33 1.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.9 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.465 ' HA ' ' HB3' ' A' ' 251' ' ' LYS . 2.5 m-80 -151.54 81.32 1.29 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.164 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.0 t -81.33 106.59 12.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.504 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 38.73 -88.6 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.381 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.787 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -95.6 -43.0 8.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.045 0.45 . . . . 0.0 111.457 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.542 ' O ' ' N ' ' A' ' 247' ' ' VAL . 0.1 OUTLIER -88.51 150.26 23.2 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -147.96 133.1 18.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.331 179.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.962 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -154.13 173.72 15.69 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.551 ' HG3' ' CE1' ' A' ' 244' ' ' TYR . 61.5 tt0 -76.91 97.78 4.7 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.452 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 1.01 HG21 HD12 ' A' ' 184' ' ' ILE . 1.8 mt -86.59 83.13 2.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.709 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.607 ' HD3' ' CE2' ' A' ' 185' ' ' PHE . 3.3 mtpt -94.99 122.46 37.67 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 183' ' ' LYS . 1.7 p -32.91 110.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-O 122.631 1.205 . . . . 0.0 110.524 -178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.034 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -67.71 -174.9 0.48 Allowed 'General case' 0 N--CA 1.419 -2.021 0 CA-C-N 112.65 -2.068 . . . . 0.0 112.977 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.424 ' CG ' ' C ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -179.52 -94.08 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.026 -1.897 . . . . 0.0 110.467 179.508 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.93 0.395 . . . . 0.0 111.423 179.841 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.91 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.427 -0.833 0 O4'-C1'-C2' 107.129 0.936 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.729 " H4'" " O5'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.426 -0.903 0 O4'-C4'-C3' 106.185 0.585 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.786 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 C4'--C3' 1.52 -0.767 0 C4'-C3'-C2' 100.926 -2.274 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.753 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.506 -1.105 0 C4'-C3'-C2' 103.819 0.619 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.74 HG12 ' HB ' ' A' ' 236' ' ' VAL . 38.5 t . . . . . 0 CA--C 1.492 -1.261 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 236' ' ' VAL . 18.0 mttt -150.32 -34.02 0.17 Allowed 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.65 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.927 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 0.9 OUTLIER -103.53 -168.52 1.52 Allowed 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 1.071 HD13 HD12 ' A' ' 239' ' ' ILE . 16.7 pt -163.02 138.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.605 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.749 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.7 OUTLIER -108.87 91.13 3.52 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.112 0.482 . . . . 0.0 112.24 -178.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.927 HG13 HG12 ' A' ' 254' ' ' ILE . 2.0 t -68.21 138.49 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.602 ' O ' ' C5 ' ' B' ' 2' ' ' ' DT' . . . -130.71 111.49 1.13 Allowed Glycine 0 CA--C 1.525 0.712 0 C-N-CA 119.995 -1.098 . . . . 0.0 114.483 -177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.555 ' H ' ' HB3' ' A' ' 225' ' ' PHE . . . 108.87 102.97 2.8 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.638 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.752 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -170.59 -154.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.61 ' N ' HD13 ' A' ' 189' ' ' LEU . 14.0 m -89.46 136.64 29.59 Favored Pre-proline 0 C--N 1.341 0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.499 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -31.3 -33.32 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.38 2.72 . . . . 0.0 113.515 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 190' ' ' SER . 8.4 t0 -150.98 56.67 0.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.724 0.297 . . . . 0.0 111.317 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.759 HG22 HD11 ' A' ' 198' ' ' ILE . 2.6 m -39.13 128.97 1.26 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.967 0.413 . . . . 0.0 110.394 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.526 ' HB2' ' HD2' ' A' ' 197' ' ' LYS . 5.2 Cg_endo -47.16 97.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.858 2.372 . . . . 0.0 112.191 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 198' ' ' ILE . 3.5 pt-20 -48.02 -17.95 0.16 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.11 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.79 -36.93 83.55 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.629 ' HE2' HD21 ' A' ' 249' ' ' LEU . 0.7 OUTLIER -80.0 -46.26 16.95 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.141 HG22 ' CD1' ' A' ' 228' ' ' ILE . 0.3 OUTLIER -48.08 -31.5 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.526 0 CA-C-N 114.022 -1.445 . . . . 0.0 108.519 176.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' A' ' 211' ' ' ILE . 5.3 mtp180 -74.13 -28.89 61.55 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.176 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 197' ' ' LYS . 3.0 mt-10 -87.57 -63.76 1.25 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.992 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.656 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 1.9 t80 -39.65 -37.16 0.48 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.0 110.359 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 1.123 ' CG ' HD12 ' A' ' 228' ' ' ILE . 0.4 OUTLIER -101.16 -33.25 10.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.222 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -61.93 -43.6 98.97 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 176.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -67.42 -21.26 72.29 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 176.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.813 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.02 -34.85 79.03 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 108.7 178.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.559 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 164.72 -144.9 9.74 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 113.536 -1.666 . . . . 0.0 109.633 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.6 mm-40 -90.52 91.16 8.32 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 121.881 -0.776 . . . . 0.0 110.539 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 1.8 t -54.49 141.25 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.515 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 1.7 tp10 -89.54 -45.72 9.19 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.45 ' C ' HG12 ' A' ' 211' ' ' ILE . 15.3 m -171.29 173.09 5.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.298 178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.727 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -136.31 164.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.563 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.558 ' OE1' ' N7 ' ' B' ' 4' ' ' ' DG' . 0.0 OUTLIER -172.43 128.19 0.54 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.823 HD21 HD12 ' A' ' 198' ' ' ILE . 3.0 mm? -113.59 122.32 35.42 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.732 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.699 ' HG2' ' CD1' ' A' ' 225' ' ' PHE . 51.9 Cg_exo -56.68 -162.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.519 2.813 . . . . 0.0 113.622 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 217' ' ' ASN . 0.0 OUTLIER 159.67 106.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.972 -179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 221' ' ' LYS . 8.4 p-10 -40.22 84.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.062 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 215' ' ' MET . 1.6 m-20 -148.4 4.19 0.69 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.505 ' HG3' " C5'" ' B' ' 5' ' ' ' DG' . 0.0 OUTLIER -135.96 -4.41 2.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.4 OUTLIER -151.58 -18.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 219' ' ' THR . 7.6 m-80 74.18 49.27 0.12 Allowed 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.516 ' CD ' ' HG2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -129.72 178.06 6.78 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.328 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.6 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -70.72 -41.16 72.27 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.826 -179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.6 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 26.04 -97.34 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.617 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 27.19 78.52 0.01 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.136 177.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.699 ' CD1' ' HG2' ' A' ' 214' ' ' PRO . 7.5 p90 -140.04 -131.32 0.11 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.668 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -151.41 164.17 37.32 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.465 0.65 . . . . 0.0 111.11 177.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.13 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.0 m-85 -150.61 113.49 4.77 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.129 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.141 ' CD1' HG22 ' A' ' 198' ' ' ILE . 1.3 mt -115.19 150.69 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 CA-C-O 121.724 0.773 . . . . 0.0 110.88 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.644 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 5.4 m -127.17 151.58 48.49 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.929 -178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 76.5 m-85 -130.92 119.2 21.78 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 207' ' ' GLU . 0.0 OUTLIER -40.69 -37.85 0.81 Allowed 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.553 ' CG ' ' HD2' ' A' ' 235' ' ' PRO . 0.5 OUTLIER -88.84 -158.68 0.51 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.373 178.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.587 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 15.5 pt-20 -137.63 0.64 2.26 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.058 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 238' ' ' LYS . 3.7 mm-40 -79.2 -58.62 0.67 Allowed Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.813 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 72.5 Cg_exo -50.0 -35.35 40.96 Favored 'Trans proline' 0 CA--C 1.488 -1.797 0 CA-C-N 120.485 1.209 . . . . 0.0 109.023 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.759 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.8 OUTLIER -64.12 -51.99 61.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 113.251 -1.795 . . . . 0.0 108.726 178.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 24.9 mttt -44.62 -58.65 2.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.13 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.675 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -59.85 -53.47 57.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.015 -1.448 . . . . 0.0 110.825 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 1.071 HD12 HD13 ' A' ' 184' ' ' ILE . 0.5 OUTLIER -32.16 -64.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.65 -179.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.439 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 3.6 mtp -48.3 -29.63 4.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.094 0.473 . . . . 0.0 110.667 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.571 ' N ' ' O ' ' A' ' 238' ' ' LYS . 26.3 mm-40 -66.67 -37.39 84.66 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -101.67 19.84 17.33 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.271 177.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.577 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -14.45 -50.7 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.646 1.216 . . . . 0.0 112.12 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.598 ' N ' ' O ' ' A' ' 242' ' ' LYS . 21.4 m-85 -85.35 71.41 10.82 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.258 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.933 ' CE1' HD13 ' A' ' 239' ' ' ILE . 10.7 m-70 -70.8 152.88 43.28 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.225 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 251' ' ' LYS . 0.8 OUTLIER -114.25 74.21 0.86 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.1 t -66.72 100.76 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.794 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 46.3 -85.38 0.01 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.626 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.629 HD21 ' HE2' ' A' ' 197' ' ' LYS . 0.0 OUTLIER -104.26 -42.09 5.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.185 0.517 . . . . 0.0 110.299 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.577 ' HB3' ' HB2' ' A' ' 189' ' ' LEU . 37.5 m -87.8 144.49 26.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.031 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -139.72 140.15 36.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.348 179.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.835 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -159.75 168.93 24.75 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -177.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.465 ' OE1' ' HE3' ' A' ' 255' ' ' LYS . 43.9 tt0 -73.38 96.64 2.38 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.648 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.927 HG12 HG13 ' A' ' 186' ' ' VAL . 1.6 mt -85.73 81.97 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.847 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -90.91 121.39 32.71 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.696 ' O ' HG13 ' A' ' 256' ' ' VAL . 2.0 p -36.11 100.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 CA-C-O 123.286 1.517 . . . . 0.0 111.214 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.13 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -45.37 -171.08 0.0 OUTLIER 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.89 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.604 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 173.46 148.67 0.06 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.253 -1.794 . . . . 0.0 110.886 179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . 0.405 ' OG ' ' C6 ' ' B' ' 4' ' ' ' DG' . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.693 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.986 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C3'-C2'-C1' 104.876 1.554 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.548 " H1'" ' OP2' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 O5'--C5' 1.428 -0.774 0 C3'-C2'-C1' 105.275 1.839 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.72 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.93 0 C4'-C3'-C2' 101.091 -2.109 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.566 " O5'" H2'' ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.508 -0.914 0 C4'-C3'-C2' 104.795 1.595 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.675 HG12 ' HB ' ' A' ' 236' ' ' VAL . 21.9 t . . . . . 0 CA--C 1.499 -0.994 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 236' ' ' VAL . 24.1 mttt -150.41 -35.16 0.16 Allowed 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.088 -1.045 . . . . 0.0 112.137 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -94.58 -176.57 3.95 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.958 ' CD1' HD12 ' A' ' 239' ' ' ILE . 4.8 pt -161.08 114.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 CA-C-O 122.057 0.932 . . . . 0.0 109.297 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.915 ' N ' ' HB2' ' A' ' 257' ' ' ALA . 0.1 OUTLIER -91.75 106.43 18.47 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.485 -177.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.966 HG13 HG12 ' A' ' 254' ' ' ILE . 2.8 t -92.17 111.71 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.642 0.777 . . . . 0.0 112.842 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 225' ' ' PHE . . . -45.58 -176.84 0.01 OUTLIER Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.626 0.61 . . . . 0.0 114.626 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.496 ' O ' ' SG ' ' A' ' 252' ' ' CYS . . . -31.46 162.86 0.0 OUTLIER Glycine 0 C--N 1.34 0.787 0 N-CA-C 115.019 0.767 . . . . 0.0 115.019 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 1.019 HD22 ' OG1' ' A' ' 193' ' ' THR . 0.0 OUTLIER -178.82 -143.79 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.696 ' N ' HD13 ' A' ' 189' ' ' LEU . 3.8 m -89.21 131.32 41.09 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.425 ' C ' ' O ' ' A' ' 190' ' ' SER . 33.0 Cg_exo -27.36 -35.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.47 2.78 . . . . 0.0 113.494 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 190' ' ' SER . 0.5 OUTLIER -150.96 54.9 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.06 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 1.019 ' OG1' HD22 ' A' ' 189' ' ' LEU . 51.9 m -40.23 125.67 1.72 Allowed Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.161 0.505 . . . . 0.0 110.413 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . 0.605 ' HG2' ' CD ' ' A' ' 197' ' ' LYS . 4.7 Cg_endo -47.13 101.62 0.04 OUTLIER 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.399 2.733 . . . . 0.0 113.905 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.814 ' HA ' ' CG1' ' A' ' 198' ' ' ILE . 0.0 OUTLIER -47.38 -20.41 0.22 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.972 178.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 199' ' ' ARG . 10.6 mm-40 -66.34 -39.99 89.55 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.605 ' CD ' ' HG2' ' A' ' 194' ' ' PRO . 2.5 mttp -76.27 -50.53 14.14 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 1.164 ' CG2' HD11 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -45.72 -28.2 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.692 176.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 195' ' ' GLU . 2.5 mtp180 -77.13 -29.84 54.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.358 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.589 ' N ' ' O ' ' A' ' 197' ' ' LYS . 4.7 pt-20 -86.99 -54.12 4.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.403 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.696 ' HB3' ' CD1' ' A' ' 202' ' ' PHE . 2.0 t80 -50.7 -37.8 43.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.141 0.496 . . . . 0.0 110.663 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.98 ' CD2' HD12 ' A' ' 228' ' ' ILE . 0.7 OUTLIER -100.44 -34.46 9.94 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.498 -178.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 206' ' ' GLY . . . -63.2 -44.69 96.71 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -63.0 -23.98 66.45 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.829 ' HB3' ' HB3' ' A' ' 235' ' ' PRO . 0.1 OUTLIER -66.01 -35.91 81.84 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 122.032 0.92 . . . . 0.0 108.599 177.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 203' ' ' GLY . . . 163.6 -142.43 7.83 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 113.641 -1.618 . . . . 0.0 109.971 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 231' ' ' LYS . 1.0 OUTLIER -91.0 94.8 9.8 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.688 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.429 ' CG2' ' HB2' ' A' ' 202' ' ' PHE . 1.9 t -58.64 144.59 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLU . . . . . 0.57 ' HB2' ' N ' ' A' ' 231' ' ' LYS . 3.9 tp10 -89.86 -50.91 5.77 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.1 p -172.04 156.61 4.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.443 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.721 HG23 HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -119.95 167.52 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.002 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 227' ' ' PHE . 0.2 OUTLIER -165.02 123.71 1.72 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.683 0.278 . . . . 0.0 110.684 179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.771 HD12 HD21 ' A' ' 189' ' ' LEU . 0.9 OUTLIER -110.48 101.13 47.7 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 121.287 0.565 . . . . 0.0 111.952 -179.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.59 ' HG3' " O4'" ' B' ' 4' ' ' ' DG' . 25.5 Cg_exo -66.66 -167.0 0.12 Allowed 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 124.056 3.171 . . . . 0.0 112.675 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.536 ' HA ' ' CA ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER 167.69 164.7 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.215 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 221' ' ' LYS . 19.9 t0 -81.89 13.01 3.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.172 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -109.48 -2.71 17.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.63 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.482 ' C ' ' CG2' ' A' ' 219' ' ' THR . 4.3 mmtp -124.77 1.48 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.865 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.614 ' O ' ' HB2' ' A' ' 220' ' ' ASN . 0.5 OUTLIER -151.75 -16.52 0.19 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.614 ' HB2' ' O ' ' A' ' 219' ' ' THR . 0.8 OUTLIER 77.35 20.83 1.1 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' LYS . . . . . 0.581 ' HB2' ' CD ' ' A' ' 223' ' ' ARG . 4.0 mppt? -129.4 179.08 6.0 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.698 -0.401 . . . . 0.0 112.014 -178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -70.39 -39.86 74.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.617 ' N ' ' HG3' ' A' ' 222' ' ' ARG . 3.2 mtp85 2.05 -80.02 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 124.34 1.025 . . . . 0.0 111.057 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.606 ' O ' HD12 ' A' ' 189' ' ' LEU . . . 10.42 78.93 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 O-C-N 124.588 1.18 . . . . 0.0 111.624 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PHE . . . . . 0.654 ' HA ' ' CD1' ' A' ' 189' ' ' LEU . 0.2 OUTLIER -138.71 -121.38 0.13 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . 0.666 ' SG ' HD23 ' A' ' 189' ' ' LEU . 0.0 OUTLIER -165.32 163.11 20.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.973 0.892 . . . . 0.0 112.594 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 1.035 ' CE2' ' HB1' ' A' ' 257' ' ' ALA . 3.4 m-85 -147.83 124.54 11.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.864 -1.517 . . . . 0.0 108.97 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 1.164 HD11 ' CG2' ' A' ' 198' ' ' ILE . 1.6 mt -121.33 150.93 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 CA-C-O 121.555 0.693 . . . . 0.0 109.944 178.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.751 HG23 ' HG3' ' A' ' 183' ' ' LYS . 2.9 m -129.85 152.41 49.36 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.212 -178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 202' ' ' PHE . 87.3 m-85 -130.32 117.26 19.51 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.57 ' N ' ' HB2' ' A' ' 209' ' ' GLU . 0.0 OUTLIER -40.72 -37.31 0.73 Allowed 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.515 ' O ' ' O ' ' A' ' 230' ' ' PHE . 0.0 OUTLIER -88.59 -155.93 0.35 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.375 -1.738 . . . . 0.0 110.494 179.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.605 ' CB ' ' O ' ' A' ' 181' ' ' VAL . 1.2 pt-20 -143.12 4.17 1.42 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.51 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 237' ' ' LYS . 0.9 OUTLIER -84.53 -58.51 0.36 Allowed Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . 0.829 ' HB3' ' HB3' ' A' ' 205' ' ' PHE . 82.6 Cg_exo -49.77 -34.68 36.67 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 N-CA-C 108.819 -1.262 . . . . 0.0 108.819 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.843 HG13 ' CG2' ' A' ' 184' ' ' ILE . 0.9 OUTLIER -63.28 -51.11 75.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.306 -1.77 . . . . 0.0 108.801 178.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 233' ' ' GLU . 6.3 mtpt -45.86 -60.13 2.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.933 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.692 ' HG3' ' CE1' ' A' ' 205' ' ' PHE . 0.0 OUTLIER -56.99 -52.75 64.0 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 113.701 -1.59 . . . . 0.0 110.69 179.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.958 HD12 ' CD1' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -34.72 -66.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.629 -1.168 . . . . 0.0 111.259 -179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' A' ' 243' ' ' LYS . 1.2 mtp -48.83 -25.56 1.94 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.563 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 238' ' ' LYS . 3.0 mm-40 -69.35 -38.35 78.08 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -102.36 21.14 15.6 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.151 177.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.594 ' O ' HG13 ' A' ' 254' ' ' ILE . 0.0 OUTLIER -15.51 -49.31 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.669 1.231 . . . . 0.0 111.878 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 242' ' ' LYS . 20.7 m-85 -85.2 71.85 10.82 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.504 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' HIS . . . . . 0.896 ' CE1' HD13 ' A' ' 239' ' ' ILE . 9.6 m-70 -72.62 153.04 41.44 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.226 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 246' ' ' ASN . 0.0 OUTLIER -115.51 76.38 1.0 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.898 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 249' ' ' LEU . 2.2 t -69.14 101.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.149 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 43.74 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.45 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.671 HD23 ' N ' ' A' ' 249' ' ' LEU . 0.0 OUTLIER -101.89 -41.84 6.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.126 0.489 . . . . 0.0 110.892 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 247' ' ' VAL . 21.0 m -88.41 146.82 25.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.514 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 245' ' ' HIS . 0.0 OUTLIER -144.38 139.82 28.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.75 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' CYS . . . . . 0.947 ' SG ' HG12 ' A' ' 186' ' ' VAL . 0.0 OUTLIER -158.77 166.06 32.83 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -178.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLU . . . . . 0.411 ' CG ' ' HD2' ' A' ' 255' ' ' LYS . 48.4 tt0 -71.95 93.58 1.37 Allowed 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.227 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.966 HG12 HG13 ' A' ' 186' ' ' VAL . 1.5 mt -79.78 80.86 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.197 -1.365 . . . . 0.0 113.133 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.54 ' O ' ' C ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -87.89 122.58 31.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 183' ' ' LYS . 2.0 p -33.82 122.32 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 122.244 1.021 . . . . 0.0 109.912 -178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 1.035 ' HB1' ' CE2' ' A' ' 227' ' ' PHE . . . -82.12 -179.49 7.42 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.204 -1.817 . . . . 0.0 113.494 -175.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' MET . . . . . 0.546 ' N ' ' HE3' ' A' ' 183' ' ' LYS . 0.0 OUTLIER 175.81 153.95 0.17 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.037 -1.892 . . . . 0.0 110.554 179.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.739 179.756 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' DT' . . . . . 0.837 " H2'" ' O2 ' ' B' ' 2' ' ' ' DT' . . . . . . . . 0 C2'--C1' 1.508 -0.946 0 C4'-C3'-C2' 104.037 0.837 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' DA' . . . . . 0.61 ' C5 ' ' CD2' ' A' ' 185' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.935 0 O4'-C1'-C2' 106.767 0.607 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' DG' . . . . . 0.75 ' N2 ' ' CZ ' ' A' ' 227' ' ' PHE . . . . . . . . 0 O5'--C5' 1.428 -0.763 0 C4'-C3'-C2' 101.454 -1.746 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' DG' . . . . . 0.5 ' OP1' " H1'" ' B' ' 4' ' ' ' DG' . . . . . . . . 0 C2'--C1' 1.509 -0.827 0 O4'-C4'-C3' 106.062 0.462 . . . . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_